Virus interference. I. The interferon

Cole K, Al-Kadhimi Z and Talmadge J (2023) Highlights into historical and current immune interventions for cancer, International Immunopharmacology, 10.1016/j.intimp.2023.109882, 117, (109882), Online publication date: 1-Apr-2023.

Mogensen T, Skouboe M and Mølle I (2023) Successful use of interferon alfa-2a for persistent parvovirus B19 infection, The Lancet Infectious Diseases, 10.1016/S1473-3099(22)00685-5, 23:4, (e160-e165), Online publication date: 1-Apr-2023.

Cruz-Reyes N and Radisky D (2023) Inflammation, Infiltration, and Evasion—Tumor Promotion in the Aging Breast, Cancers, 10.3390/cancers15061836, 15:6, (1836)

Mesas‐Fernández A, Bodner E, Hilke F, Meier K, Ghoreschi K and Solimani F (2023) Interleukin‐21 in autoimmune and inflammatory skin diseases, European Journal of Immunology, 10.1002/eji.202250075, (2250075)

Bühler M, Li D, Li L, Runft S, Waltl I, Pavlou A, Kalinke U, Ciurkiewicz M, Huehn J, Floess S, Beineke A, Baumgärtner W and Gerhauser I (2023) IFNAR signaling of neuroectodermal cells is essential for the survival of C57BL/6 mice infected with Theiler’s murine encephalomyelitis virus, Journal of Neuroinflammation, 10.1186/s12974-023-02737-6, 20:1

Le‐Trilling V, Banchenko S, Paydar D, Leipe P, Binting L, Lauer S, Graziadei A, Klingen R, Gotthold C, Bürger J, Bracht T, Sitek B, Jan Lebbink R, Malyshkina A, Mielke T, Rappsilber J, Spahn C, Voigt S, Trilling M and Schwefel D (2023) Structural mechanism of CRL4‐instructed STAT2 degradation via a novel cytomegaloviral DCAF receptor, The EMBO Journal, 10.15252/embj.2022112351, 42:5, Online publication date: 1-Mar-2023.

Qu X, Wang X, Liu B, Chen M, Ning J, Liu H, Liu G, Xu X, Zhang X, Yu K, Xu H, Lu X and Wang C (2023) Potential roles of IFI44 genes in high resistance to Vibrio in hybrids of Argopecten scallops, Fish & Shellfish Immunology, 10.1016/j.fsi.2023.108702, (108702), Online publication date: 1-Mar-2023.

Adeyemi O, Tian Y, Khwatenge C, Grayfer L and Sang Y (2023) Molecular diversity and functional implication of amphibian interferon complex: Remarking immune adaptation in vertebrate evolution, Developmental & Comparative Immunology, 10.1016/j.dci.2022.104624, 140, (104624), Online publication date: 1-Mar-2023.

Tessema M, Tuipulotu D, Oates C, Brooks A, Man S, Londrigan S and Reading P (2023) Mouse guanylate‐binding protein 1 does not mediate antiviral activity against influenza virus in vitro or in vivo , Immunology & Cell Biology, 10.1111/imcb.12627

Novick D (2023) A natural goldmine of binding proteins and soluble receptors simplified their translation to blockbuster drugs, all in one decade, Frontiers in Immunology, 10.3389/fimmu.2023.1151620, 14

Tan S (2023) Cancer Immunotherapy: A Brief History, The Latest Development of Typical Subtypes and Therapy Combination, Highlights in Science, Engineering and Technology, 10.54097/hset.v30i.4943, 30, (34-43)

Deng S, Graham M and Chen X (2023) The Complexity of Interferon Signaling in Host Defense against Protozoan Parasite Infection, Pathogens, 10.3390/pathogens12020319, 12:2, (319)

Al-Ibraheem A, Abdlkadir A, Juweid M, Al-Rabi K, Ma’koseh M, Abdel-Razeq H and Mansour A (2023) FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects, Cancers, 10.3390/cancers15041063, 15:4, (1063)

Blaney H, Khalid M, Heller T and Koh C (2022) Epidemiology, presentation, and therapeutic approaches for hepatitis D infections, Expert Review of Anti-infective Therapy, 10.1080/14787210.2023.2159379, 21:2, (127-142), Online publication date: 1-Feb-2023.

Wallis R, O’Garra A, Sher A and Wack A (2022) Host-directed immunotherapy of viral and bacterial infections: past, present and future, Nature Reviews Immunology, 10.1038/s41577-022-00734-z, 23:2, (121-133), Online publication date: 1-Feb-2023.

Mann J, Riley B and Baker S (2023) All differential on the splicing front: Host alternative splicing alters the landscape of virus-host conflict, Seminars in Cell & Developmental Biology, 10.1016/j.semcdb.2023.01.013, Online publication date: 1-Feb-2023.

Shippy D and Ulland T (2023) Genome-wide identification of murine interferon genes in microglial-mediated neuroinflammation in Alzheimer's disease, Journal of Neuroimmunology, 10.1016/j.jneuroim.2023.578031, 375, (578031), Online publication date: 1-Feb-2023.

Leiba J, Özbilgiç R, Hernández L, Demou M, Lutfalla G, Yatime L and Nguyen-Chi M (2023) Molecular Actors of Inflammation and Their Signaling Pathways: Mechanistic Insights from Zebrafish, Biology, 10.3390/biology12020153, 12:2, (153)

Bruera S, Chavula T, Madan R and Agarwal S (2023) Targeting type I interferons in systemic lupus erythematous, Frontiers in Pharmacology, 10.3389/fphar.2022.1046687, 13

Franzoni G, Pedrera M and Sánchez-Cordón P (2023) African Swine Fever Virus Infection and Cytokine Response In Vivo: An Update, Viruses, 10.3390/v15010233, 15:1, (233)

Koukourakis I and Koukourakis M (2021) Combining the past and present to advance immuno-radiotherapy of cancer, International Reviews of Immunology, 10.1080/08830185.2021.1974020, 42:1, (26-42), Online publication date: 2-Jan-2023.

P.B. B, Roy V, Rajagopal R and Alfarhan A (2023) Role of nutraceuticals as immunomodulators to combat viruses Viral Infections and Antiviral Therapies, 10.1016/B978-0-323-91814-5.00019-2, (653-689), .

Louten J (2023) The immune response to viruses Essential Human Virology, 10.1016/B978-0-323-90565-7.00006-X, (101-117), .

Shing K, Kan W, Nero T, Hercus T, Tvorogov D, Metcalfe R, Griffin M, De Weerd N, Guthridge M, Hertzog P, Lopez A and Parker M (2023) Cytokine Receptors and Their Ligands Encyclopedia of Cell Biology, 10.1016/B978-0-12-821618-7.00079-1, (21-45), .

Gaspar B (2023) Current Concepts and Future Prospects in Immune-Mediated Myopathies Immune-Mediated Myopathies and Neuropathies, 10.1007/978-981-19-8421-1_13, (161-189), .

Jeon D and McNeel D (2022) Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression, OncoImmunology, 10.1080/2162402X.2022.2054758, 11:1, Online publication date: 31-Dec-2022.

Song X, Zhao M, Cao Q, Wang S, Li R, Zhang X, Zhang L and Shi K (2022) Transcriptome provides insights into bovine mammary regulatory mechanisms during the lactation cycle, Journal of Applied Animal Research, 10.1080/09712119.2022.2064865, 50:1, (275-288), Online publication date: 31-Dec-2022.

Huang L, Chiu C, Hsing C and Hsu Y (2022) Interferon Family Cytokines in Obesity and Insulin Sensitivity, Cells, 10.3390/cells11244041, 11:24, (4041)

McConnel C, Slanzon G, Parrish L, Trombetta S, Shaw L, Moore D, Sischo W and Abuelo A (2022) Transcriptional changes detected in fecal RNA from neonatal dairy calves of different breeds following gastrointestinal disease of varying severity, PLOS ONE, 10.1371/journal.pone.0278664, 17:12, (e0278664)

Guo Y, Bamunuarachchi G, Vaddadi K, Zhu Z, Gandikota C, Ahmed K, Pushparaj S, More S, Xiao X, Yang X, Liang Y, Mukherjee S, Baviskar P, Huang C, Li S, Oomens A, Metcalf J and Liu L (2022) Axin1: A novel scaffold protein joins the antiviral network of interferon, Molecular Microbiology, 10.1111/mmi.14995, 118:6, (731-743), Online publication date: 1-Dec-2022.

Samuel C (2022) Interferonopathy Resulting from Dysregulation of Interferon Production, Journal of Interferon & Cytokine Research, 10.1089/jir.2022.0097, 42:12, (655-657), Online publication date: 1-Dec-2022.

Raftopoulou S, Rapti A, Karathanasis D, Evangelopoulos M and Mavragani C (2022) The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement, Frontiers in Neurology, 10.3389/fneur.2022.1026449, 13

Zhang Y, Chen Y, Zhou J, Wang X, Ma L, Li J, Yang L, Yuan H, Pang D and Ouyang H (2022) Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus–Host Interactions, Viruses, 10.3390/v14112434, 14:11, (2434)

Zhang L, Ma J, Jin X, Zhang L, Zhang M, Li P, Li J and Zhang L (2022) Human IFNAR2 Mutant Generated by CRISPR/Cas9-Induced Exon Skipping Upregulates a Subset of Tonic-Like Interferon-Stimulated Genes Upon IFNβ Stimulation, Journal of Interferon & Cytokine Research, 10.1089/jir.2022.0158, 42:11, (580-589), Online publication date: 1-Nov-2022.

Jin R, Chan A, Wu J and Lee T (2022) Relationships between Inflammation and Age-Related Neurocognitive Changes, International Journal of Molecular Sciences, 10.3390/ijms232012573, 23:20, (12573)

Aiman A, Farhat Basir S and Islam A (2022) Interferons Horizon Therapeutics Basic and Clinical Aspects of Interferon Gamma, 10.5772/intechopen.104718

Prochwicz A and Krochmalczyk D (2022) Perspective Chapter: Impact of Interferon Alpha/Beta in the Management of Chronic Myeloproliferative Disorders Basic and Clinical Aspects of Interferon Gamma, 10.5772/intechopen.104501

Ribas A, Haining W and Schumacher T (2022) When Cancer Cells Become the Enablers of an Antitumor Immune Response, Cancer Discovery, 10.1158/2159-8290.CD-22-0706, 12:10, (2244-2248), Online publication date: 5-Oct-2022.

Mountford J, Gheyas A, Vervelde L and Smith J (2022) Genetic variation in chicken interferon signalling pathway genes in research lines showing differential viral resistance, Animal Genetics, 10.1111/age.13233, 53:5, (640-656), Online publication date: 1-Oct-2022.

Zhang H, Huang J, Song Y, Liu X, Qian M, Huang P, Li Y, Zhao L and Wang H (2022) Regulation of innate immune responses by rabies virus, Animal Models and Experimental Medicine, 10.1002/ame2.12273, 5:5, (418-429), Online publication date: 1-Oct-2022.

Thoner T, Meloy M, Long J, Diller J, Slaughter J, Ogden K and Heise M (2022) Reovirus Efficiently Reassorts Genome Segments during Coinfection and Superinfection, Journal of Virology, 10.1128/jvi.00910-22, 96:18, Online publication date: 28-Sep-2022.

Hornick E, Wallis A and Bishop G (2022) TRAF3 enhances type I interferon receptor signaling in T cells by modulating the phosphatase PTPN22, Science Signaling, 10.1126/scisignal.abn5507, 15:753, Online publication date: 27-Sep-2022.

Bisom T, White L, Lanchy J and Lodmell J (2022) RIOK3 and Its Alternatively Spliced Isoform Have Disparate Roles in the Innate Immune Response to Rift Valley Fever Virus (MP12) Infection, Viruses, 10.3390/v14092064, 14:9, (2064)

Pujantell M and Altfeld M (2022) Consequences of sex differences in Type I IFN responses for the regulation of antiviral immunity, Frontiers in Immunology, 10.3389/fimmu.2022.986840, 13

Zheng Q, Wang D, Lin R, Lv Q and Wang W (2022) IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA, Frontiers in Immunology, 10.3389/fimmu.2022.1013322, 13

Xiong F, Wang Q, Wu G, Liu W, Wang B and Chen Y (2022) Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow, Biomarker Research, 10.1186/s40364-022-00415-y, 10:1

Li Y, Chen C, Yang J and Chiu Y (2022) Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection, Frontiers in Immunology, 10.3389/fimmu.2022.982264, 13

MAZIN P, KHAFISIANOVA R, MAZIN V, GALKIN A and OSKANOV A (2022) Cycloferon as a Means for Prevention, Treatment, and Control of COVID-19: Multidisciplinary and Comparative Historical Aspects, Antibiotics and Chemotherapy, 10.37489/0235-2990-2022-67-5-6-61-69, 67:5-6, (61-69)

Zoellner N, Coesfeld N, De Vos F, Denter J, Xu H, Zimmer E, Knebel B, Al-Hasani H, Mossner S, Lang P, Floss D and Scheller J (2022) Synthetic mimetics assigned a major role to IFNAR2 in type I interferon signaling, Frontiers in Microbiology, 10.3389/fmicb.2022.947169, 13

Miao J, Li F, Zhang M, Zhou C, Ren W, Hu X, Li N and Lei L (2022) Carnosine Synthase 1 Contributes to Interferon Gamma-Induced Arginine Depletion via Mitogen-activated Protein Kinase 11 Signaling in Bovine Mammary Epithelial Cells, Journal of Interferon & Cytokine Research, 10.1089/jir.2022.0025, 42:9, (501-512), Online publication date: 1-Sep-2022.

Weidler S and Lee-Kirsch M (2022) Typ-1-Interferonopathien, Arthritis und Rheuma, 10.1055/a-1849-5251, 42:04, (236-240), Online publication date: 1-Sep-2022.

Sadighi Akha A and Kumánovics A (2022) Anti-cytokine autoantibodies and inborn errors of immunity, Journal of Immunological Methods, 10.1016/j.jim.2022.113313, 508, (113313), Online publication date: 1-Sep-2022.

Perusina Lanfranca M, van Loben Sels J, Ly C, Grams T, Dhummakupt A, Bloom D, Davido D and Miranda J (2022) A 77 Amino Acid Region in the N-Terminal Half of the HSV-1 E3 Ubiquitin Ligase ICP0 Contributes to Counteracting an Established Type 1 Interferon Response, Microbiology Spectrum, 10.1128/spectrum.00593-22, 10:4, Online publication date: 31-Aug-2022.

Chen J, Xu W, Li P, Song L, Jiang Y, Hao P, Gao Z, Zou W, Jin N and Li C (2022) Antiviral Effect of pIFNLs against PEDV and VSV Infection in Different Cells, International Journal of Molecular Sciences, 10.3390/ijms23179661, 23:17, (9661)

Song C, Kim Y, Naskar M, Hayes B, Abraham M, Noh J, Suk G, Kim M, Cho K, Shin M, Lee E, Abraham S and Choi H (2022) Lactobacillus crispatus Limits Bladder Uropathogenic E. coli Infection by Triggering a Host Type I Interferon Response , Proceedings of the National Academy of Sciences, 10.1073/pnas.2117904119, 119:33, Online publication date: 16-Aug-2022.

Chen J, Guan Y, Guan H, Mu Y, Ding Y, Zou J, Ouyang S and Chen X (2022) Molecular and Structural Basis of Receptor Binding and Signaling of a Fish Type I IFN with Three Disulfide Bonds, The Journal of Immunology, 10.4049/jimmunol.2200202, 209:4, (806-819), Online publication date: 15-Aug-2022.

Nengroo M, Verma A and Datta D (2022) Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications, Cytokine, 10.1016/j.cyto.2022.155916, 156, (155916), Online publication date: 1-Aug-2022.

Shaw E, Rosen L, Ding L, Holland S and Su H (2022) Detection of Neutralizing Anti‐Type 1 Interferon Autoantibodies, Current Protocols, 10.1002/cpz1.511, 2:8, Online publication date: 1-Aug-2022.

Badia R, Garcia-Vidal E and Ballana E (2022) Viral-Host Dependency Factors as Therapeutic Targets to Overcome Antiviral Drug-Resistance: A Focus on Innate Immune Modulation, Frontiers in Virology, 10.3389/fviro.2022.935933, 2

Duncan C, Skouboe M, Howarth S, Hollensen A, Chen R, Børresen M, Thompson B, Stremenova Spegarova J, Hatton C, Stæger F, Andersen M, Whittaker J, Paludan S, Jørgensen S, Thomsen M, Mikkelsen J, Heilmann C, Buhas D, Øbro N, Bay J, Marquart H, de la Morena M, Klejka J, Hirschfeld M, Borgwardt L, Forss I, Masmas T, Poulsen A, Noya F, Rouleau G, Hansen T, Zhou S, Albrechtsen A, Alizadehfar R, Allenspach E, Hambleton S and Mogensen T (2022) Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic , Journal of Experimental Medicine, 10.1084/jem.20212427, 219:6, Online publication date: 6-Jun-2022.

Lodi L, Mastrolia M, Bello F, Rossi G, Angelotti M, Crow Y, Romagnani P and Vaglio A (2022) Type I interferon–related kidney disorders, Kidney International, 10.1016/j.kint.2022.02.031, 101:6, (1142-1159), Online publication date: 1-Jun-2022.

Lüscher B, Verheirstraeten M, Krieg S and Korn P (2022) Intracellular mono-ADP-ribosyltransferases at the host–virus interphase, Cellular and Molecular Life Sciences, 10.1007/s00018-022-04290-6, 79:6, Online publication date: 1-Jun-2022.

Wang J and Sun L (2022) PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph(-) Myeloproliferative Neoplasm: A Review, International Journal of Molecular Sciences, 10.3390/ijms23105837, 23:10, (5837)

Kountz T, Biyasheva A, Schleimer R and Prakriya M (2022) Extracellular Nucleotides and Histamine Suppress TLR3- and RIG-I–Mediated Release of Antiviral IFNs from Human Airway Epithelial Cells, The Journal of Immunology, 10.4049/jimmunol.2101085, 208:10, (2390-2402), Online publication date: 15-May-2022.

Huang Y, Qin A, Fang J, Wang T, Tsai C, Lin K, Teng C and Larouche R (2021) Novel long‐acting ropeginterferon alfa‐2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial, British Journal of Clinical Pharmacology, 10.1111/bcp.15176, 88:5, (2396-2407), Online publication date: 1-May-2022.

Grochowska J, Czerwinska J, Borowski L and Szczesny R (2021) Mitochondrial RNA , a new trigger of the innate immune system , WIREs RNA, 10.1002/wrna.1690, 13:3, Online publication date: 1-May-2022.

Halgrain M, Georgeault S, Bernardet N, Hincke M and Réhault-Godbert S (2022) Concomitant Morphological Modifications of the Avian Eggshell, Eggshell Membranes and the Chorioallantoic Membrane During Embryonic Development, Frontiers in Physiology, 10.3389/fphys.2022.838013, 13

Pararajasingam A, Bradley R, Evans J, Lowe A, Goodwin R and Jolles S (2022) Case Report: Generalised Panniculitis as a Post-COVID-19 Presentation in Aicardi-Goutières Syndrome Treated With Ruxolitinib, Frontiers in Pediatrics, 10.3389/fped.2022.837568, 10

Kaaijk P, Swaans N, Nicolaie A, Bruin J, van Boxtel R, de Lange M, Meijer A, Sanders E, van Houten M, Rots N, Luytjes W and van Beek J (2022) Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults, Viruses, 10.3390/v14040797, 14:4, (797)

Zuo Y, He J, Liu S, Xu Y, Liu J, Qiao C, Zang L, Sun W, Yuan Y, Zhang H, Chen X, Jin L, Miao Y, Huang F, Ren T, Wang J, Qian F, Zhu C, Zhang W, Liu Y, Xu G, Ma F and Zheng H (2022) LATS1 is a central signal transmitter for achieving full type-I interferon activity, Science Advances, 10.1126/sciadv.abj3887, 8:14, Online publication date: 8-Apr-2022.

Martínez-Sabadell A, Arenas E and Arribas J (2021) IFNγ Signaling in Natural and Therapy-Induced Antitumor Responses, Clinical Cancer Research, 10.1158/1078-0432.CCR-21-3226, 28:7, (1243-1249), Online publication date: 1-Apr-2022.

Qin X, Duan M, Pei D, Lin J, Wang L, Zhou P, Yao W, Guo Y, Li X, Tao L, Ding Y, Liu L, Zhou Y, Jia C, Rao C and Wang J (2022) Development of novel-nanobody-based lateral-flow immunochromatographic strip test for rapid detection of recombinant human interferon α2b, Journal of Pharmaceutical Analysis, 10.1016/j.jpha.2021.07.003, 12:2, (308-316), Online publication date: 1-Apr-2022.

Gu H, Zhang Y, Zeng W and Xia Y (2022) Participation of interferons in psoriatic inflammation, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2021.12.002, 64, (12-20), Online publication date: 1-Apr-2022.

Barchi J (2022) Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates, Frontiers in Immunology, 10.3389/fimmu.2022.852147, 13

McFarlane A, Pohler E and Moraga I (2022) Molecular and cellular factors determining the functional pleiotropy of cytokines, The FEBS Journal, 10.1111/febs.16420

Fleischmann R (2022) Recent issues in JAK inhibitor safety: perspective for the clinician, Expert Review of Clinical Immunology, 10.1080/1744666X.2022.2039122, 18:3, (295-307), Online publication date: 4-Mar-2022.

Mary Loordhuswamy A and Elango S (2022) Interferon Therapy for Hypertrophic Scars and Keloids Recent Advances in Wound Healing, 10.5772/intechopen.96789

Goldstein M and Scull M (2022) Modeling Innate Antiviral Immunity in Physiological Context, Journal of Molecular Biology, 10.1016/j.jmb.2021.167374, 434:6, (167374), Online publication date: 1-Mar-2022.

Hauptstein N, Meinel L and Lühmann T (2022) Bioconjugation strategies and clinical implications of Interferon-bioconjugates, European Journal of Pharmaceutics and Biopharmaceutics, 10.1016/j.ejpb.2022.02.006, 172, (157-167), Online publication date: 1-Mar-2022.

Yu R, Zhu B and Chen D (2022) Type I interferon-mediated tumor immunity and its role in immunotherapy, Cellular and Molecular Life Sciences, 10.1007/s00018-022-04219-z, 79:3, Online publication date: 1-Mar-2022.

Ito G, Rodrigues V, Hümmelgen J, Meschino G, Abou‐Rejaile G, Brenny I, Castro Júnior C, Artigas R, Munhoz J, Cardoso G and Picheth G (2022) COVID ‐19 pathophysiology and ultrasound imaging: A multiorgan review , Journal of Clinical Ultrasound, 10.1002/jcu.23160, 50:3, (326-338), Online publication date: 1-Mar-2022.

Schirrmacher V (2022) Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus, Biomedicines, 10.3390/biomedicines10030562, 10:3, (562)

Arnaiz E and Harris A (2022) Role of Hypoxia in the Interferon Response, Frontiers in Immunology, 10.3389/fimmu.2022.821816, 13

Tzipilevich E, Pollak‐Fiyaksel O, Shraiteh B and Ben‐Yehuda S (2021) Bacteria elicit a phage tolerance response subsequent to infection of their neighbors, The EMBO Journal, 10.15252/embj.2021109247, 41:3, Online publication date: 1-Feb-2022.

Cacoub P and Asselah T (2021) Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease, American Journal of Gastroenterology, 10.14309/ajg.0000000000001575, 117:2, (253-263), Online publication date: 1-Feb-2022.

Pandey P and Karupiah G (2021) Targeting tumour necrosis factor to ameliorate viral pneumonia, The FEBS Journal, 10.1111/febs.15782, 289:4, (883-900), Online publication date: 1-Feb-2022.

Cao L, Zhang L, Zhang X, Liu J, Jia M, Zhang J, Liu J and Wang F (2022) Types of Interferons and Their Expression in Plant Systems, Journal of Interferon & Cytokine Research, 10.1089/jir.2021.0148, 42:2, (62-71), Online publication date: 1-Feb-2022.

Bastard P, Zhang Q, Zhang S, Jouanguy E and Casanova J (2022) Type I interferons and SARS-CoV-2: from cells to organisms, Current Opinion in Immunology, 10.1016/j.coi.2022.01.003, 74, (172-182), Online publication date: 1-Feb-2022.

Liu H (2021) Intracellular innate immunity and mechanism of action of cytosolic nucleic acid receptor‐mediated type I IFN against viruses , IUBMB Life, 10.1002/iub.2551, 74:2, (180-189), Online publication date: 1-Feb-2022.

Razzuoli E, Armando F, De Paolis L, Ciurkiewicz M and Amadori M (2022) The Swine IFN System in Viral Infections: Major Advances and Translational Prospects, Pathogens, 10.3390/pathogens11020175, 11:2, (175)

Hu H, Yang H, Liu Y and Yan B (2022) Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System, Frontiers in Medicine, 10.3389/fmed.2021.833114, 8

Thomsen E, Andersen S, Marqvorsen M, Skipper K, Paludan S and Mikkelsen J (2022) Single-Cell Monitoring of Activated Innate Immune Signaling by a d2eGFP-Based Reporter Mimicking Time-Restricted Activation of IFNB1 Expression, Frontiers in Cellular and Infection Microbiology, 10.3389/fcimb.2021.784762, 11

Dowling J and Forero A (2022) Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions, The Journal of Immunology, 10.4049/jimmunol.2100707, 208:2, (247-256), Online publication date: 15-Jan-2022.

Parisien J, Lenoir J, Alvarado G, Horvath C and Heise M (2022) The Human STAT2 Coiled-Coil Domain Contains a Degron for Zika Virus Interferon Evasion, Journal of Virology, 10.1128/JVI.01301-21, 96:1, Online publication date: 12-Jan-2022.

Layton D, Mara K, Dai M, Malaver-Ortega L, Gough T, Bruce K, Jenkins K and Bean A (2022) Interferon Signaling in Chickens Plays a Crucial Role in Inhibiting Influenza Replication in DF1 Cells, Microorganisms, 10.3390/microorganisms10010133, 10:1, (133)

Knight V (2022) Immunodeficiency and Autoantibodies to Cytokines, The Journal of Applied Laboratory Medicine, 10.1093/jalm/jfab139, 7:1, (151-164), Online publication date: 5-Jan-2022.

Liu Z, Jiang C, Lei Z, Dong S, Kuang L, Huang C, Gao Y, Liu M, Xiao H, Legembre P, Jung J, Liang H and Liang X (2021) Phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein PINLYP regulates type I interferon innate immunity, Proceedings of the National Academy of Sciences, 10.1073/pnas.2111115119, 119:1, Online publication date: 5-Jan-2022.

Gulko H and Furie R (2022) Anifrolumab: An Inhibitor of Type I Interferon for the Treatment of Patients with Systemic Lupus Erythematosus, Rheumatology, 10.17925/RMD.2022.1.1.29, 1:1, (29), .

Fu X, De Angelis C and Schiff R (2021) Interferon Signaling in Estrogen Receptor–positive Breast Cancer: A Revitalized Topic, Endocrinology, 10.1210/endocr/bqab235, 163:1, Online publication date: 1-Jan-2022.

Mora-Ramírez M and Amezcua-Guerra L (2022) The role of type III interferons in systemic autoimmune diseases Translational Autoimmunity, 10.1016/B978-0-12-822564-6.00006-9, (199-212), .

Schultz U and Magor K (2022) Comparative immunology of agricultural birds Avian Immunology, 10.1016/B978-0-12-818708-1.00001-4, (489-518), .

Ganguly D (2022) Discovery of a New Dendritic Cell Subset Plasmacytoid Dendritic Cells, 10.1007/978-981-19-5595-2_1, (1-10), .

Gupta A (2022) Bench-to-Bedside Research in Ophthalmology Biomedical Translational Research, 10.1007/978-981-16-8845-4_5, (67-124), .

Chandra V, Tiwari A, Pant K and Bhatt R (2022) Animal Cell Culture: Basics and Applications Industrial Microbiology and Biotechnology, 10.1007/978-981-16-5214-1_24, (691-719), .

Heinrich P, Haan S, Hermanns H, Müller-Newen G and Schaper F (2022) Rezeptoren und ihre Signaltransduktion Löffler/Petrides Biochemie und Pathobiochemie, 10.1007/978-3-662-60266-9_35, (533-571), .

Rashed W (2022) Immunotherapy for Pediatric Cancer Handbook of Cancer and Immunology, 10.1007/978-3-030-80962-1_246-1, (1-38), .

Foster C, Panse K and Klisovic D (2022) Adamantiades–Behçet’s Disease Albert and Jakobiec's Principles and Practice of Ophthalmology, 10.1007/978-3-030-42634-7_301, (7169-7192), .

Chen L, Yang C and Cheng X (2021) Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection, Frontiers in Immunology, 10.3389/fimmu.2021.788368, 12

Dumitrescu L, Papathanasiou A, Coclitu C, Constantinescu C, Popescu B and Tanasescu R (2021) Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic, QJM: An International Journal of Medicine, 10.1093/qjmed/hcaa348, 114:10, (691-697), Online publication date: 20-Dec-2021.

Capozza P, Pratelli A, Camero M, Lanave G, Greco G, Pellegrini F and Tempesta M (2021) Feline Coronavirus and Alpha-Herpesvirus Infections: Innate Immune Response and Immune Escape Mechanisms, Animals, 10.3390/ani11123548, 11:12, (3548)

Smrke A, Tam Y, Anderson P, Jones R and Huang P (2021) The perplexing role of immuno-oncology drugs in osteosarcoma, Journal of Bone Oncology, 10.1016/j.jbo.2021.100400, 31, (100400), Online publication date: 1-Dec-2021.

Wang J, Du L and Tang H (2021) Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection, Frontiers in Medicine, 10.3389/fmed.2021.784172, 8

Guo C, Reuss D, Coey J, Sukumar S, Lang B, McLauchlan J, Boulant S, Stanifer M and Bamford C (2021) Conserved Induction of Distinct Antiviral Signalling Kinetics by Primate Interferon Lambda 4 Proteins, Frontiers in Immunology, 10.3389/fimmu.2021.772588, 12

Mercer D, Francis M and Fraser-Pitt D (2021) Antimicrobial immunotherapeutics: past, present and future, Emerging Topics in Life Sciences, 10.1042/ETLS20200348, 5:5, (609-628), Online publication date: 12-Nov-2021.

Walker F, Sridhar P and Baldridge M (2021) Differential roles of interferons in innate responses to mucosal viral infections, Trends in Immunology, 10.1016/j.it.2021.09.003, 42:11, (1009-1023), Online publication date: 1-Nov-2021.

Madany E, Lee J, Halprin C, Seo J, Baca N, Majlessipour F, Hendrickson J, Pepkowitz S, Hayes C, Klapper E and Gibb D (2021) Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease, eJHaem, 10.1002/jha2.270, 2:4, (700-710), Online publication date: 1-Nov-2021.

Jasyk I and Siednienko J (2021) Type I interferon therapies of multiple sclerosis and hepatitis C virus infection, Postępy Higieny i Medycyny Doświadczalnej, 10.2478/ahem-2021-0001, 75:1, (537-547), Online publication date: 21-Oct-2021., Online publication date: 1-Jan-2021.

Wu M and Assassi S (2021) Dysregulation of Type I Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?, Current Treatment Options in Rheumatology, 10.1007/s40674-021-00188-9, 7:4, (349-360)

Kleinehr J, Wilden J, Boergeling Y, Ludwig S and Hrincius E (2021) Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets, Viruses, 10.3390/v13102068, 13:10, (2068)

Pilna H, Hajkova V, Knitlova J, Liskova J, Elsterova J and Melkova Z (2021) Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism, Viruses, 10.3390/v13101986, 13:10, (1986)

Zrzavy T, Wimmer I, Rommer P and Berger T (2020) Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown, European Journal of Neurology, 10.1111/ene.14578, 28:10, (3503-3516), Online publication date: 1-Oct-2021.

Gallucci S, Meka S and Gamero A (2021) Abnormalities of the type I interferon signaling pathway in lupus autoimmunity, Cytokine, 10.1016/j.cyto.2021.155633, 146, (155633), Online publication date: 1-Oct-2021.

Zhang S, Harschnitz O, Studer L and Casanova J (2021) Neuron-intrinsic immunity to viruses in mice and humans, Current Opinion in Immunology, 10.1016/j.coi.2021.07.004, 72, (309-317), Online publication date: 1-Oct-2021.

Akbar S, Al Mahtab M, Cesar Aguilar J, Uddin M, Khan M, Yoshida O, Penton E, Gerardo G and Hiasa Y (2021) Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical, Exploration of Medicine, 10.37349/emed.2021.00058

Yuan S, Balaji S, Lomakin I and Xiong Y (2021) Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition, Frontiers in Microbiology, 10.3389/fmicb.2021.752214, 12

Rojas M, Luz-Crawford P, Soto-Rifo R, Reyes-Cerpa S and Toro-Ascuy D (2021) The Landscape of IFN/ISG Signaling in HIV-1-Infected Macrophages and Its Possible Role in the HIV-1 Latency, Cells, 10.3390/cells10092378, 10:9, (2378)

Audsley K, Wagner T, Ta C, Newnes H, Buzzai A, Barnes S, Wylie B, Armitage J, Kaisho T, Bosco A, McDonnell A, Cruickshank M, Fear V, Foley B and Waithman J (2021) IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies, Frontiers in Immunology, 10.3389/fimmu.2021.735133, 12

Musella M, Galassi C, Manduca N and Sistigu A (2021) The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation, Biology, 10.3390/biology10090856, 10:9, (856)

Ku C, Chen I and Lai M (2021) Infection‐induced inflammation from specific inborn errors of immunity to COVID‐19, The FEBS Journal, 10.1111/febs.15961, 288:17, (5021-5041), Online publication date: 1-Sep-2021.

Van Eyndhoven L, Singh A and Tel J (2021) Decoding the dynamics of multilayered stochastic antiviral IFN-I responses, Trends in Immunology, 10.1016/j.it.2021.07.004, 42:9, (824-839), Online publication date: 1-Sep-2021.

Chauhan P, Nair A, Patidar A, Dandapat J, Sarkar A and Saha B (2021) A primer on cytokines, Cytokine, 10.1016/j.cyto.2021.155458, 145, (155458), Online publication date: 1-Sep-2021.

Zhou Z, Zhang S, Yang G and Gao Y (2021) Enhanced delivery efficiency and sustained release of biopharmaceuticals by complexation-based gel encapsulated coated microneedles: rhIFNα-1b example, Asian Journal of Pharmaceutical Sciences, 10.1016/j.ajps.2021.05.002, 16:5, (612-622), Online publication date: 1-Sep-2021.

Huang Y, Tsai C, Tsai C, Wang W, Zhang J, Qin A, Teng C, Song B and Wang M (2021) Pharmacokinetics and Pharmacodynamics of Novel Long-Acting Ropeginterferon Alfa-2b in Healthy Chinese Subjects, Advances in Therapy, 10.1007/s12325-021-01863-y, 38:9, (4756-4770), Online publication date: 1-Sep-2021.

Sehgal P (2021) Metastable biomolecular condensates of interferon-inducible antiviral Mx-family GTPases: A paradigm shift in the last three years, Journal of Biosciences, 10.1007/s12038-021-00187-x, 46:3, Online publication date: 1-Sep-2021.

Shemesh M, Aktepe T, Deerain J, McAuley J, Audsley M, David C, Purcell D, Urin V, Hartmann R, Moseley G, Mackenzie J, Schreiber G, Harari D and Pekosz A (2021) SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon, PLOS Pathogens, 10.1371/journal.ppat.1009800, 17:8, (e1009800)

Cheemarla N, Watkins T, Mihaylova V, Wang B, Zhao D, Wang G, Landry M and Foxman E (2021) Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics, Journal of Experimental Medicine, 10.1084/jem.20210583, 218:8, Online publication date: 2-Aug-2021.

Zhai H, Shi J, Sun R, Tan Z, Swaiba U, Li W, Zhang L, Zhang L, Guo Y and Huang J (2021) The superposition anti-viral activity of porcine tri-subtype interferon expressed by Saccharomyces cerevisiae, Veterinary Microbiology, 10.1016/j.vetmic.2021.109150, 259, (109150), Online publication date: 1-Aug-2021.

Obolenskaya M, Dotsenko V, Martsenyuk O, Ralchenko S, Krupko O, Pastukhov A, Filimonova N, Starosila D, Chernykh S and Borisova T (2021) A new insight into mechanisms of interferon alpha neurotoxicity: Expression of GRIN3A subunit of NMDA receptors and NMDA-evoked exocytosis, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2021.110317, 110, (110317), Online publication date: 1-Aug-2021.

Wang M, Zhai X, Li J, Guan J, Xu S, Li Y and Zhu H (2021) The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors, Frontiers in Immunology, 10.3389/fimmu.2021.670391, 12

Almeida S, Martins M, Barros J, Lowen M, Alves M and Burnier M (2021)(2021)(2021)(2021) Ocular surface findings in impression cytology after interferon a2b or mitomycin C in rabbits, Revista Brasileira de Oftalmologia, 10.37039/1982.8551.20210018, 80:4, Online publication date: 21-Jul-2021., Online publication date: 21-Jul-2021., ., .

Li B, Tan W, Zou J, He Y, Yoshida S, Jiang B and Zhou Y (2021) Role of interferons in diabetic retinopathy, World Journal of Diabetes, 10.4239/wjd.v12.i7.939, 12:7, (939-953), Online publication date: 15-Jul-2021.

Gu Y, Zuo X, Zhang S, Ouyang Z, Jiang S, Wang F and Wang G (2021) The Mechanism behind Influenza Virus Cytokine Storm, Viruses, 10.3390/v13071362, 13:7, (1362)

Bastard P, Orlova E, Sozaeva L, Lévy R, James A, Schmitt M, Ochoa S, Kareva M, Rodina Y, Gervais A, Le Voyer T, Rosain J, Philippot Q, Neehus A, Shaw E, Migaud M, Bizien L, Ekwall O, Berg S, Beccuti G, Ghizzoni L, Thiriez G, Pavot A, Goujard C, Frémond M, Carter E, Rothenbuhler A, Linglart A, Mignot B, Comte A, Cheikh N, Hermine O, Breivik L, Husebye E, Humbert S, Rohrlich P, Coaquette A, Vuoto F, Faure K, Mahlaoui N, Kotnik P, Battelino T, Trebušak Podkrajšek K, Kisand K, Ferré E, DiMaggio T, Rosen L, Burbelo P, McIntyre M, Kann N, Shcherbina A, Pavlova M, Kolodkina A, Holland S, Zhang S, Crow Y, Notarangelo L, Su H, Abel L, Anderson M, Jouanguy E, Neven B, Puel A, Casanova J and Lionakis M (2021) Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1, Journal of Experimental Medicine, 10.1084/jem.20210554, 218:7, Online publication date: 5-Jul-2021.

Padayachee Y, Flicker S, Linton S, Cafferkey J, Kon O, Johnston S, Ellis A, Desrosiers M, Turner P, Valenta R and Scadding G (2021) Review: The Nose as a Route for Therapy. Part 2 Immunotherapy, Frontiers in Allergy, 10.3389/falgy.2021.668781, 2

Santos N, Vaz da Silva Z, Gomes C, Reis C, Amorim M and Yount J (2021) Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology, PLOS Pathogens, 10.1371/journal.ppat.1009381, 17:7, (e1009381)

Stutte S, Ruf J, Kugler I, Ishikawa-Ankerhold H, Parzefall A, Marconi P, Maeda T, Kaisho T, Krug A, Popper B, Lauterbach H, Colonna M, von Andrian U and Brocker T (2021) Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in mice, Brain, Behavior, and Immunity, 10.1016/j.bbi.2021.04.018, 95, (429-443), Online publication date: 1-Jul-2021.

Li Y, Ran C, Wei K, Xie Y, Xie M, Zhou W, Yang Y, Zhang Z, Lv H, Ma X and Zhou Z (2021) The effect of Astragalus polysaccharide on growth, gut and liver health, and anti-viral immunity of zebrafish, Aquaculture, 10.1016/j.aquaculture.2021.736677, 540, (736677), Online publication date: 1-Jul-2021.

Cohan S, Hendin B, Reder A, Smoot K, Avila R, Mendoza J and Weinstock-Guttman B (2021) Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex), CNS Drugs, 10.1007/s40263-021-00822-z, 35:7, (743-767), Online publication date: 1-Jul-2021.

Chung S (2021) Vasculitis: From Target Molecules to Novel Therapeutic Approaches, Biomedicines, 10.3390/biomedicines9070757, 9:7, (757)

Rafeld H, Kolanus W, van Driel I and Hartland E (2021) Interferon-induced GTPases orchestrate host cell-autonomous defence against bacterial pathogens, Biochemical Society Transactions, 10.1042/BST20200900, 49:3, (1287-1297), Online publication date: 30-Jun-2021.

Santibañez A, Paine D, Parra M, Muñoz C, Valdes N, Zapata C, Vargas R, Gonzalez A and Tello M (2021) Oral Administration of Lactococcus lactis Producing Interferon Type II, Enhances the Immune Response Against Bacterial Pathogens in Rainbow Trout, Frontiers in Immunology, 10.3389/fimmu.2021.696803, 12

Bodewes I, Björk A, Versnel M and Wahren-Herlenius M (2019) Innate immunity and interferons in the pathogenesis of Sjögren’s syndrome, Rheumatology, 10.1093/rheumatology/key360, 60:6, (2561-2573), Online publication date: 18-Jun-2021.

Li C, Han H, Li X, Wu J, Li X, Niu H, Li W and Ma Z (2021) Analysis of lncRNA, miRNA, and mRNA Expression Profiling in Type I IFN and Type II IFN Overexpressed in Porcine Alveolar Macrophages, International Journal of Genomics, 10.1155/2021/6666160, 2021, (1-28), Online publication date: 16-Jun-2021.

Frazzini S, Riva F and Amadori M (2021) Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future, Veterinary Sciences, 10.3390/vetsci8060109, 8:6, (109)

Escobedo-Bonilla C (2021) Mini Review: Virus Interference: History, Types and Occurrence in Crustaceans, Frontiers in Immunology, 10.3389/fimmu.2021.674216, 12

Anjum F, Rahman S, Aslam M and Qureshi A (2021) Antiviral potential and stability analysis of chicken interferon-α produced by Newcastle disease virus in chicken embryo fibroblast cells, Veterinární medicína, 10.17221/106/2020-VETMED, 66:5, (197-207), Online publication date: 31-May-2021.

Blalock W (2021) Opposing forces fight over the same ground to regulate interferon signaling, Biochemical Journal, 10.1042/BCJ20210110, 478:10, (1853-1859), Online publication date: 28-May-2021.

Tesser A, Pin A, Mencaroni E, Gulino V and Tommasini A (2021) Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain, International Journal of Environmental Research and Public Health, 10.3390/ijerph18115585, 18:11, (5585)

Carlin J and Borden E (2021) Interferons and Their Induction Interferon and Nonviral Pathogens, 10.1201/9781003210054-2, (3-26)

Morvan M, Teque F, Locher C and Levy J (2021) The CD8 + T Cell Noncytotoxic Antiviral Responses , Microbiology and Molecular Biology Reviews, 10.1128/MMBR.00155-20, 85:2, Online publication date: 19-May-2021.

Yu H, Gao D, Zhou W, Xia B, He Z, Wu B, Jiang M, Wang M and Zhao J (2021) Acute and sub-chronic toxicity study of recombinant bovine interferon alpha in rodents, Journal of Veterinary Research, 10.2478/jvetres-2021-0023, 65:2, (183-192), Online publication date: 16-May-2021., Online publication date: 1-Jun-2021.

Georgel P (2021) Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases, Cells, 10.3390/cells10051134, 10:5, (1134)

Temizoz B and Ishii K (2021) Type I and II interferons toward ideal vaccine and immunotherapy, Expert Review of Vaccines, 10.1080/14760584.2021.1927724, 20:5, (527-544), Online publication date: 4-May-2021.

Johnson B, Uchimura T, Gallovic M, Thamilarasan M, Chou W, Gibson S, Deng M, Tam J, Batty C, Williams J, Matsushima G, Bachelder E, Ainslie K, Markovic-Plese S and Ting J (2021) STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways, The Journal of Immunology, 10.4049/jimmunol.2001317, 206:9, (2015-2028), Online publication date: 1-May-2021.

Qiu Y, Su M, Liu L, Tang Y, Pan Y and Sun J (2021) Clinical Application of Cytokines in Cancer Immunotherapy, Drug Design, Development and Therapy, 10.2147/DDDT.S308578, Volume 15, (2269-2287)

Bolko L, Jiang W, Tawara N, Landon‐Cardinal O, Anquetil C, Benveniste O and Allenbach Y (2021) The role of interferons type I, II and III in myositis: A review, Brain Pathology, 10.1111/bpa.12955, 31:3, Online publication date: 1-May-2021.

Wang W, Wang C, Chen W and Ding S (2021) Advances in immunological research of amphioxus, Developmental & Comparative Immunology, 10.1016/j.dci.2020.103992, 118, (103992), Online publication date: 1-May-2021.

Yang L, Wang J, Hui P, Yarovinsky T, Badeti S, Pham K and Liu C (2021) Potential role of IFN-α in COVID-19 patients and its underlying treatment options, Applied Microbiology and Biotechnology, 10.1007/s00253-021-11319-6, 105:10, (4005-4015), Online publication date: 1-May-2021.

Meyts I and Casanova J (2021) Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway, European Journal of Immunology, 10.1002/eji.202048793, 51:5, (1039-1061), Online publication date: 1-May-2021.

Yoon S and Won J (2021) The clinical role of interferon alpha in Philadelphia-negative myeloproliferative neoplasms, BLOOD RESEARCH, 10.5045/br.2021.2020334, 56:S1, (S44-S50), Online publication date: 30-Apr-2021.

Hay-McCullough E and Morrison J (2021) Contributions of Ubiquitin and Ubiquitination to Flaviviral Antagonism of Type I IFN, Viruses, 10.3390/v13050763, 13:5, (763)

Padariya M, Sznarkowska A, Kote S, Gómez-Herranz M, Mikac S, Pilch M, Alfaro J, Fahraeus R, Hupp T and Kalathiya U (2021) Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes, Biomolecules, 10.3390/biom11050622, 11:5, (622)

Chelbi-Alix M and Thibault P (2021) Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense, Frontiers in Cell and Developmental Biology, 10.3389/fcell.2021.671067, 9

Chasset F, Dayer J and Chizzolini C (2021) Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment, Frontiers in Pharmacology, 10.3389/fphar.2021.633821, 12

Castro L, Lobo G, Pereira P, Freire M, Neves M and Pedro A (2021) Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation, Vaccines, 10.3390/vaccines9040328, 9:4, (328)

Friedman R and Vilcek J (2021) Joseph A. Sonnabend (1933–2021): Pioneering Interferon Researcher Turned AIDS Activist, Journal of Interferon & Cytokine Research, 10.1089/jir.2021.29020.rmf, 41:4, (137-138), Online publication date: 1-Apr-2021.

Stolzer I, Ruder B, Neurath M and Günther C (2021) Interferons at the crossroad of cell death pathways during gastrointestinal inflammation and infection, International Journal of Medical Microbiology, 10.1016/j.ijmm.2021.151491, 311:3, (151491), Online publication date: 1-Apr-2021.

Opdenakker G and Van Damme J (2021) Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2021.01.004, 58, (134-140), Online publication date: 1-Apr-2021.

d'Angelo D, Di Filippo P, Breda L and Chiarelli F (2021) Type I Interferonopathies in Children: An Overview, Frontiers in Pediatrics, 10.3389/fped.2021.631329, 9

Pekmezovic M, Hovhannisyan H, Gresnigt M, Iracane E, Oliveira-Pacheco J, Siscar-Lewin S, Seemann E, Qualmann B, Kalkreuter T, Müller S, Kamradt T, Mogavero S, Brunke S, Butler G, Gabaldón T and Hube B (2021) Candida pathogens induce protective mitochondria-associated type I interferon signalling and a damage-driven response in vaginal epithelial cells, Nature Microbiology, 10.1038/s41564-021-00875-2, 6:5, (643-657)

Di Cola I, Ruscitti P, Giacomelli R and Cipriani P (2021) The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still’s Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets, Journal of Clinical Medicine, 10.3390/jcm10061164, 10:6, (1164)

Alphonse N, Dickenson R and Odendall C (2021) Interferons: Tug of War Between Bacteria and Their Host, Frontiers in Cellular and Infection Microbiology, 10.3389/fcimb.2021.624094, 11

Ray S, Meshram Y and Mukherjee S Cancer Immunology and CAR-T Cells: A Turning Point Therapeutic Approach in Colorectal Carcinoma with Clinical Insight, Current Molecular Medicine, 10.2174/1566524020666200824103749, 21:3, (221-236)

Reimer E, Stempel M, Chan B, Bley H and Brinkmann M (2020) Protein tyrosine phosphatase 1B is involved in efficient type I interferon secretion upon viral infection, Journal of Cell Science, 10.1242/jcs.246421, 134:5, Online publication date: 1-Mar-2021.

Vierbuchen T and Fitzgerald K (2021) Long non-coding RNAs in antiviral immunity, Seminars in Cell & Developmental Biology, 10.1016/j.semcdb.2020.06.009, 111, (126-134), Online publication date: 1-Mar-2021.

Blaauboer A, Sideras K, van Eijck C and Hofland L (2021) Type I interferons in pancreatic cancer and development of new therapeutic approaches, Critical Reviews in Oncology/Hematology, 10.1016/j.critrevonc.2020.103204, 159, (103204), Online publication date: 1-Mar-2021.

Villa T, Abril A, Sánchez S, de Miguel T and Sánchez-Pérez A (2020) Animal and human RNA viruses: genetic variability and ability to overcome vaccines, Archives of Microbiology, 10.1007/s00203-020-02040-5, 203:2, (443-464), Online publication date: 1-Mar-2021.

Rabin R and Walter M (2021) Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons, Frontiers in Immunology, 10.3389/fimmu.2021.638479, 12

Soday L, Potts M, Hunter L, Ravenhill B, Houghton J, Williamson J, Antrobus R, Wills M, Matheson N and Weekes M (2021) Comparative Cell Surface Proteomic Analysis of the Primary Human T Cell and Monocyte Responses to Type I Interferon, Frontiers in Immunology, 10.3389/fimmu.2021.600056, 12

Saeng-chuto K, Madapong A, Kaeoket K, Piñeyro P, Tantituvanont A and Nilubol D (2021) Coinfection of porcine deltacoronavirus and porcine epidemic diarrhea virus increases disease severity, cell trophism and earlier upregulation of IFN-α and IL12, Scientific Reports, 10.1038/s41598-021-82738-8, 11:1

Chao C, Huang H, Su M, Lin H and Wu W (2021) The Lanostane Triterpenoids in Poria cocos Play Beneficial Roles in Immunoregulatory Activity, Life, 10.3390/life11020111, 11:2, (111)

Schwerk J, Negash A, Savan R and Gale M (2020) Innate Immunity in Hepatitis C Virus Infection, Cold Spring Harbor Perspectives in Medicine, 10.1101/cshperspect.a036988, 11:2, (a036988), Online publication date: 1-Feb-2021.

Tang Z, Zhang X, Shu Y, Guo M, Zhang H and Tao W (2021) Insights from nanotechnology in COVID-19 treatment, Nano Today, 10.1016/j.nantod.2020.101019, 36, (101019), Online publication date: 1-Feb-2021.

Rojas J, Alejo A, Martín V and Sevilla N (2020) Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway, Cellular and Molecular Life Sciences, 10.1007/s00018-020-03671-z, 78:4, (1423-1444), Online publication date: 1-Feb-2021.

Yu H, Gao D, Zhou W, Xia B, He Z, Wu B, Jiang M, Wang M and Zhao J (2021) Expression, purification, and bioactivity of a soluble recombinant ovine interferon-tau in Escherichia coli , Journal of Veterinary Research, 10.2478/jvetres-2021-0011, 65:1, (101-108), Online publication date: 29-Jan-2021., Online publication date: 1-Mar-2021.

Kienes I, Weidl T, Mirza N, Chamaillard M and Kufer T (2021) Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation, International Journal of Molecular Sciences, 10.3390/ijms22031301, 22:3, (1301)

Singh H, Koury J and Kaul M (2021) Innate Immune Sensing of Viruses and Its Consequences for the Central Nervous System, Viruses, 10.3390/v13020170, 13:2, (170)

Feng H, Zhang Y, Gui J, Lemon S, Yamane D and Blumenthal A (2021) Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses, PLOS Pathogens, 10.1371/journal.ppat.1009220, 17:1, (e1009220)

Wittling M, Cahalan S, Levenson E and Rabin R (2021) Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes, Frontiers in Immunology, 10.3389/fimmu.2020.605673, 11

Keller E, Patel N, Patt M, Nguyen J and Jørgensen T (2021) Partial Protection From Lupus-Like Disease by B-Cell Specific Type I Interferon Receptor Deficiency, Frontiers in Immunology, 10.3389/fimmu.2020.616064, 11

Bastard P, Manry J, Chen J, Rosain J, Seeleuthner Y, AbuZaitun O, Lorenzo L, Khan T, Hasek M, Hernandez N, Bigio B, Zhang P, Lévy R, Shrot S, Reino E, Lee Y, Boucherit S, Aubart M, Gijsbers R, Béziat V, Li Z, Pellegrini S, Rozenberg F, Marr N, Meyts I, Boisson B, Cobat A, Bustamante J, Zhang Q, Jouangy E, Abel L, Somech R, Casanova J and Zhang S (2021) Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency, Journal of Clinical Investigation, 10.1172/JCI139980, 131:1, Online publication date: 4-Jan-2021., Online publication date: 4-Jan-2021.

Beloborodova N, Zuev E, Zamyatin M and Gusarov V (2021) Causal Therapy of COVID-19: Critical Review and Prospects, General Reanimatology, 10.15360/1813-9779-2020-4-0-1, 16:6, (65-90)

Ouyang Y, Zhong X, Liao H, Zhu P, Luo K and Zhu H (2021) A New Method for Screening Natural Products to Stimulate IFN-γ Production in Jurkat Human T Lymphocytes, SLAS Discovery, 10.1177/2472555220922475, 26:1, (130-139), Online publication date: 1-Jan-2021.

Liu C, Lu I, Wang L, Chen J, Li Y, Yang C, Liu P, Cheng W and Tan P (2021) Interferon-β suppresses inflammatory pain through activating µ-opioid receptor, Molecular Pain, 10.1177/17448069211045211, 17, (174480692110452), Online publication date: 1-Jan-2021.

Zhang X, Wang S, Zhu Y, Zhang M, Zhao Y, Yan Z, Wang Q and Li X (2021) Double-edged effects of interferons on the regulation of cancer-immunity cycle, OncoImmunology, 10.1080/2162402X.2021.1929005, 10:1, Online publication date: 1-Jan-2021.

De Clercq E (2021) Perspectives for antivirals to limit SARS-CoV-2 infection (COVID-19), Microbiology Australia, 10.1071/MA21013, 42:1, (47), .

Jamali A, Kenyon B, Ortiz G, Abou-Slaybi A, Sendra V, Harris D and Hamrah P (2021) Plasmacytoid dendritic cells in the eye, Progress in Retinal and Eye Research, 10.1016/j.preteyeres.2020.100877, 80, (100877), Online publication date: 1-Jan-2021.

Vonderhaar E, Barnekow N, McAllister D, McOlash L, Eid M, Riese M, Tarakanova V, Johnson B and Dwinell M (2021) STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer, Cellular and Molecular Gastroenterology and Hepatology, 10.1016/j.jcmgh.2021.01.018, 12:1, (41-58), .

Varga Z, Rácz E, Mázló A, Korodi M, Szabó A, Molnár T, Szöőr Á, Veréb Z, Bácsi A and Koncz G (2021) Cytotoxic activity of human dendritic cells induces RIPK1-dependent cell death, Immunobiology, 10.1016/j.imbio.2020.152032, 226:1, (152032), Online publication date: 1-Jan-2021.

Marroqui L, Perez-Serna A, Babiloni-Chust I and Dos Santos R (2021) Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes Pancreatic ß-Cell Biology in Health and Disease, 10.1016/bs.ircmb.2021.02.011, (1-80), .

Maeng H and Berzofsky J (2021) Cancer vaccines: translational strategies Principles of Translational Science in Medicine, 10.1016/B978-0-12-820493-1.00033-7, (307-328), .

Hunt D (2021) Pathogenesis of tissue injury in the brain in patients with systemic lupus erythematosus Systemic Lupus Erythematosus, 10.1016/B978-0-12-814551-7.00038-6, (341-348), .

Foster C, Panse K and Klisovic D (2021) Adamantiades–Behçet’s Disease Albert and Jakobiec's Principles and Practice of Ophthalmology, 10.1007/978-3-319-90495-5_301-1, (1-24), .

Connelly K and Hoi A (2021) Type I Interferons and the Perpetuation of a Loss of Tolerance Pathogenesis of Systemic Lupus Erythematosus, 10.1007/978-3-030-85161-3_4, (53-65), .

Pribnow A, Straathof K and Majzner R (2021) Immunotherapy for Pediatric Sarcomas Sarcomas of Bone and Soft Tissues in Children and Adolescents, 10.1007/978-3-030-51160-9_12, (165-180), .

Gorgulho C, Romagnoli G and Kaneno R (2021) Type I Interferons: History and Perspectives as Immunotherapeutic Agents Against Cancer Cancer Immunology, 10.1007/978-3-030-50287-4_11, (183-197), .

Cazzato S, Omenetti A, Ravaglia C and Poletti V (2020) Lung involvement in monogenic interferonopathies, European Respiratory Review, 10.1183/16000617.0001-2020, 29:158, (200001), Online publication date: 31-Dec-2021.

Fox L, Locke M and Lenschow D (2020) Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease, Frontiers in Immunology, 10.3389/fimmu.2020.606874, 11

Valentinuzzi D and Jeraj R (2020) Computational modelling of modern cancer immunotherapy, Physics in Medicine & Biology, 10.1088/1361-6560/abc3fc, 65:24, (24TR01), Online publication date: 21-Dec-2020.

Wang P, Deng Y, Guo Y, Xu Z, Li Y, Ou X, Xie L, Lu M, Zhong J, Li B, Hu L, Deng S, Peng T, Cai M and Li M (2020) Epstein-Barr Virus Early Protein BFRF1 Suppresses IFN-β Activity by Inhibiting the Activation of IRF3, Frontiers in Immunology, 10.3389/fimmu.2020.513383, 11

Stanifer M, Guo C, Doldan P and Boulant S (2020) Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces, Frontiers in Immunology, 10.3389/fimmu.2020.608645, 11

He X, Xia L, Tumas K, Wu J and Su X (2020) Type I Interferons and Malaria: A Double-Edge Sword Against a Complex Parasitic Disease, Frontiers in Cellular and Infection Microbiology, 10.3389/fcimb.2020.594621, 10

Dai M, Xie T, Liao M, Zhang X and Feng M (2020) Systematic identification of chicken type I, II and III interferon-stimulated genes, Veterinary Research, 10.1186/s13567-020-00793-x, 51:1, Online publication date: 1-Dec-2020.

Cetintas V and Batada N (2020) Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?, Journal of Translational Medicine, 10.1186/s12967-020-02219-w, 18:1, Online publication date: 1-Dec-2020.

Zhang Q, Wang C, Ma F, Yao L, Gao H, Zhu L and Zheng L (2020) Development and biological activity of long-acting recombinant human interferon-α2b, BMC Biotechnology, 10.1186/s12896-020-00605-2, 20:1, Online publication date: 1-Dec-2020.

Mazewski C, Perez R, Fish E and Platanias L (2020) Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways, Frontiers in Immunology, 10.3389/fimmu.2020.606456, 11

Walter M (2020) The Role of Structure in the Biology of Interferon Signaling, Frontiers in Immunology, 10.3389/fimmu.2020.606489, 11

Robertsen B (2020) Medfødt immunitet mot virus- interferonsystemet, Naturen, 10.18261/issn.1504-3118-2020-05-06, 144:5, (182-188), Online publication date: 5-Nov-2020.

Xi Y and Upham J (2020) Plasmacytoid dendritic cells and asthma: a review of current knowledge, Expert Review of Respiratory Medicine, 10.1080/17476348.2020.1803741, 14:11, (1095-1106), Online publication date: 1-Nov-2020.

Loughlin K (2020) William B. Coley, Urologic Clinics of North America, 10.1016/j.ucl.2020.07.001, 47:4, (413-417), Online publication date: 1-Nov-2020.

Zhou L, Zhang Y, Wang Y, Zhang M, Sun W, Dai T, Wang A, Wu X, Zhang S, Wang S and Zhou F (2020) A Dual Role of Type I Interferons in Antitumor Immunity, Advanced Biosystems, 10.1002/adbi.201900237, 4:11, (1900237), Online publication date: 1-Nov-2020.

McLendon B, Seo H, Kramer A, Burghardt R, Bazer F and Johnson G (2020) Pig conceptuses secrete interferon gamma to recruit T cells to the endometrium during the peri-implantation period, Biology of Reproduction, 10.1093/biolre/ioaa132, 103:5, (1018-1029), Online publication date: 29-Oct-2020.

Chia B, Li B, Cui A, Eisenhaure T, Raychowdhury R, Lieb D, Hacohen N and Williams B (2020) Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication, Journal of Virology, 10.1128/JVI.00319-20, 94:22, Online publication date: 27-Oct-2020.

Ma Y, Su X and Lu F (2020) The Roles of Type I Interferon in Co-infections With Parasites and Viruses, Bacteria, or Other Parasites, Frontiers in Immunology, 10.3389/fimmu.2020.01805, 11

Bastard P, Rosen L, Zhang Q, Michailidis E, Hoffmann H, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus A, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan A, Delmonte O, Abers M, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton R, Vasse M, Smadja D, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh D, Tangye S, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig M, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen T, Oler A, Gu J, Burbelo P, Cohen J, Biondi A, Bettini L, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye E, Fusco F, Ursini M, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia G, Duval X, Ghosn J, Tsang J, Goldbach-Mansky R, Kisand K, Lionakis M, Puel A, Zhang S, Holland S, Gorochov G, Jouanguy E, Rice C, Cobat A, Notarangelo L, Abel L, Su H, Casanova J, Arias A, Boisson B, Boucherit S, Bustamante J, Chbihi M, Chen J, Chrabieh M, Kochetkov T, Le Voyer T, Liu D, Nemirovskaya Y, Ogishi M, Papandrea D, Patissier C, Rapaport F, Roynard M, Vladikine N, Woollett M, Zhang P, Kashyap A, Ding L, Bosticardo M, Wang Q, Ochoa S, Liu H, Chauvin S, Stack M, Koroleva G, Bansal N, Dalgard C, Snow A, Abad J, Aguilera-Albesa S, Akcan O, Darazam I, Aldave J, Ramos M, Nadji S, Alkan G, Allardet-Servent J, Allende L, Alsina L, Alyanakian M, Amador-Borrero B, Amoura Z, Antolí A, Arslan S, Assant S, Auguet T, Azot A, Bajolle F, Baldolli A, Ballester M, Feldman H, Barrou B, Beurton A, Bilbao A, Blanchard-Rohner G, Blanco I, Blandinières A, Blazquez-Gamero D, Bloomfield M, Bolivar-Prados M, Borie R, Bousfiha A, Bouvattier C, Boyarchuk O, Bueno M, Bustamante J, Cáceres Agra J, Calimli S, Capra R, Carrabba M, Casasnovas C, Caseris M, Castelle M, Castelli F, de Vera M, Castro M, Catherinot E, Chalumeau M, Charbit B, Cheng M, Clavé P, Clotet B, Codina A, Colkesen F, Colkesen F, Colobran R, Comarmond C, Corsico A, Dalmau D, Darley D, Dauby N, Dauger S, de Pontual L, Dehban A, Delplancq G, Demoule A, Di Sabatino A, Diehl J, Dobbelaere S, Durand S, Eldars W, Elgamal M, Elnagdy M, Emiroglu M, Erdeniz E, Aytekin S, Euvrard R, Evcen R, Fabio G, Faivre L, Falck A, Fartoukh M, Faure M, Arquero M, Flores C, Francois B, Fumadó V, Fusco F, Solis B, Gaussem P, Gil-Herrera J, Gilardin L, Alarcon M, Girona-Alarcón M, Goffard J, Gok F, González-Montelongo R, Guerder A, Gul Y, Guner S, Gut M, Hadjadj J, Haerynck F, Halwani R, Hammarström L, Hatipoglu N, Hernandez-Brito E, Holanda-Peña M, Horcajada J, Hraiech S, Humbert L, Iglesias A, Íñigo-Campos A, Jamme M, Arranz M, Jordan I, Kanat F, Kapakli H, Kara I, Karbuz A, Yasar K, Keles S, Demirkol Y, Klocperk A, Król Z, Kuentz P, Kwan Y, Lagier J, Lau Y, Le Bourgeois F, Leo Y, Lopez R, Leung D, Levin M, Levy M, Lévy R, Li Z, Linglart A, Lorenzo-Salazar J, Louapre C, Lubetzki C, Luyt C, Lye D, Mansouri D, Marjani M, Pereira J, Martin A, Pueyo D, Martinez-Picado J, Marzana I, Mathian A, Matos L, Matthews G, Mayaux J, Mège J, Melki I, Meritet J, Metin O, Meyts I, Mezidi M, Migeotte I, Millereux M, Mirault T, Mircher C, Mirsaeidi M, Melián A, Martinez A, Morange P, Mordacq C, Morelle G, Mouly S, Muñoz-Barrera A, Nafati C, Neves J, Ng L, Medina Y, Cuadros E, Ocejo-Vinyals J, Orbak Z, Oualha M, Özçelik T, Hammarström Q, Parizot C, Pascreau T, Paz-Artal E, de Diego R, Philippe A, Philippot Q, Planas-Serra L, Ploin D, Poissy J, Poncelet G, Pouletty M, Quentric P, Raoult D, Rebillat A, Reisli I, Ricart P, Richard J, Rivet N, Rivière J, Blanch G, Rodrigo C, Rodriguez-Gallego C, Rodríguez-Palmero A, Romero C, Rothenbuhler A, Rozenberg F, Ruiz del Prado M, Riera J, Sanchez O, Sánchez-Ramón S, Schluter A, Schmidt M, Schweitzer C, Scolari F, Sediva A, Seijo L, Sene D, Senoglu S, Seppänen M, Ilovich A, Shahrooei M, Smadja D, Sobh A, Moreno X, Solé-Violán J, Soler C, Soler-Palacín P, Stepanovskiy Y, Stoclin A, Taccone F, Tandjaoui-Lambiotte Y, Taupin J, Tavernier S, Terrier B, Thumerelle C, Tomasoni G, Toubiana J, Alvarez J, Trouillet-Assant S, Troya J, Tucci A, Ursini M, Uzunhan Y, Vabres P, Valencia-Ramos J, Van Den Rym A, Vandernoot I, Vatansev H, Vélez-Santamaria V, Viel S, Vilain C, Vilaire M, Vincent A, Voiriot G, Vuotto F, Yosunkaya A, Young B, Yucel F, Zannad F, Zatz M, Belot A, Foti G, Bellani G, Citerio G, Contro E, Pesci A, Valsecchi M, Cazzaniga M, Bole-Feysot C, Lyonnet S, Masson C, Nitschke P, Pouliet A, Schmitt Y, Tores F, Zarhrate M, Abel L, Andrejak C, Angoulvant F, Bachelet D, Basmaci R, Behillil S, Beluze M, Benkerrou D, Bhavsar K, Bompart F, Bouadma L, Bouscambert M, Caralp M, Cervantes-Gonzalez M, Chair A, Coelho A, Couffignal C, Couffin-Cadiergues S, D’ortenzio E, Da Silveira C, Debray M, Deplanque D, Descamps D, Desvallées M, Diallo A, Diouf A, Dorival C, Dubos F, Duval X, Eloy P, Enouf V, Esperou H, Esposito-Farese M, Etienne M, Ettalhaoui N, Gault N, Gaymard A, Ghosn J, Gigante T, Gorenne I, Guedj J, Hoctin A, Hoffmann I, Jaafoura S, Kafif O, Kaguelidou F, Kali S, Khalil A, Khan C, Laouénan C, Laribi S, Le M, Le Hingrat Q, Le Mestre S, Le Nagard H, Lescure F, Lévy Y, Levy-Marchal C, Lina B, Lingas G, Lucet J, Malvy D, Mambert M, Mentré F, Mercier N, Meziane A, Mouquet H, Mullaert J, Neant N, Noret M, Pages J, Papadopoulos A, Paul C, Peiffer-Smadja N, Petrov-Sanchez V, Peytavin G, Picone O, Puéchal O, Rosa-Calatrava M, Rossignol B, Rossignol P, Roy C, Schneider M, Semaille C, Mohammed N, Tagherset L, Tardivon C, Tellier M, Téoulé F, Terrier O, Timsit J, Treoux T, Tual C, Tubiana S, van der Werf S, Vanel N, Veislinger A, Visseaux B, Wiedemann A, Yazdanpanah Y, Abel L, Alcover A, Aschard H, Astrom K, Bousso P, Bruhns P, Cumano A, Demangel C, Deriano L, Di Santo J, Dromer F, Eberl G, Enninga J, Fellay J, Gomperts-Boneca I, Hasan M, Hercberg S, Lantz O, Mouquet H, Patin E, Pellegrini S, Pol S, Rausell A, Rogge L, Sakuntabhai A, Schwartz O, Schwikowski B, Shorte S, Tangy F, Toubert A, Touvier M, Ungeheuer M, Albert M, Duffy D, Quintana-Murci L, Alavoine L, Amat K, Behillil S, Bielicki J, Bruijning P, Burdet C, Caumes E, Charpentier C, Coignard B, Costa Y, Couffin-Cadiergues S, Damond F, Dechanet A, Delmas C, Descamps D, Duval X, Ecobichon J, Enouf V, Espérou H, Frezouls W, Houhou N, Ilic-Habensus E, Kafif O, Kikoine J, Le Hingrat Q, Lebeaux D, Leclercq A, Lehacaut J, Letrou S, Lina B, Lucet J, Malvy D, Manchon P, Mandic M, Meghadecha M, Motiejunaite J, Nouroudine M, Piquard V, Postolache A, Quintin C, Rexach J, Roufai L, Terzian Z, Thy M, Tubiana S, van der Werf S, Vignali V, Visseaux B, Yazdanpanah Y, van Agtmael M, Algera A, van Baarle F, Bax D, Beudel M, Bogaard H, Bomers M, Bos L, Botta M, de Brabander J, Bree G, Brouwer M, de Bruin S, Bugiani M, Bulle E, Chouchane O, Cloherty A, Elbers P, Fleuren L, Geerlings S, Geerts B, Geijtenbeek T, Girbes A, Goorhuis B, Grobusch M, Hafkamp F, Hagens L, Hamann J, Harris V, Hemke R, Hermans S, Heunks L, Hollmann M, Horn J, Hovius J, de Jong M, Koning R, van Mourik N, Nellen J, Paulus F, Peters E, van der Poll T, Preckel B, Prins J, Raasveld J, Reijnders T, Schinkel M, Schultz M, Schuurman A, Sigaloff K, Smit M, Stijnis C, Stilma W, Teunissen C, Thoral P, Tsonas A, van der Valk M, Veelo D, Vlaar A, de Vries H, van Vugt M, Wiersinga W, Wouters D, Zwinderman A, van de Beek D, Abel L, Aiuti A, Al Muhsen S, Al-Mulla F, Anderson M, Arias A, Feldman H, Bogunovic D, Bolze A, Bondarenko A, Bousfiha A, Brodin P, Bryceson Y, Bustamante C, Butte M, Casari G, Chakravorty S, Christodoulou J, Cirulli E, Condino-Neto A, Cooper M, Dalgard C, DeRisi J, Desai M, Drolet B, Espinosa S, Fellay J, Flores C, Franco J, Gregersen P, Haerynck F, Hagin D, Halwani R, Heath J, Henrickson S, Hsieh E, Imai K, Itan Y, Karamitros T, Kisand K, Ku C, Lau Y, Ling Y, Lucas C, Maniatis T, Mansouri D, Marodi L, Meyts I, Milner J, Mironska K, Mogensen T, Morio T, Ng L, Notarangelo L, Novelli G, Novelli A, O'Farrelly C, Okada S, Ozcelik T, de Diego R, Planas A, Prando C, Pujol A, Quintana-Murci L, Renia L, Renieri A, Rodríguez-Gallego C, Sancho-Shimizu V, Sankaran V, Barrett K, Shahrooei M, Snow A, Soler-Palacín P, Spaan A, Tangye S, Turvey S, Uddin F, Uddin M, van de Beek D, Vazquez S, Vinh D, von Bernuth H, Washington N, Zawadzki P, Su H and Casanova J (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19, Science, 10.1126/science.abd4585, 370:6515, Online publication date: 23-Oct-2020.

Kovesdi I and Bakacs T Therapeutic Exploitation of Viral Interference, Infectious Disorders - Drug Targets, 10.2174/1871526519666190405140858, 20:4, (423-432)

Fischer K, Tschismarov R, Pilz A, Straubinger S, Carotta S, McDowell A and Decker T (2020) Cutibacterium acnes Infection Induces Type I Interferon Synthesis Through the cGAS-STING Pathway, Frontiers in Immunology, 10.3389/fimmu.2020.571334, 11

Lopez Sanchez M, Ziemann M, Bachem A, Makam R, Crowston J, Pinkert C, McKenzie M, Bedoui S, Trounce I and Shukla D (2020) Nuclear response to divergent mitochondrial DNA genotypes modulates the interferon immune response, PLOS ONE, 10.1371/journal.pone.0239804, 15:10, (e0239804)

El-Asmi F, McManus F, Thibault P and Chelbi-Alix M (2020) Interferon, restriction factors and SUMO pathways, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2020.03.001, 55, (37-47), Online publication date: 1-Oct-2020.

Wu A, Mihaylova V, Landry M and Foxman E (2020) Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study, The Lancet Microbe, 10.1016/S2666-5247(20)30114-2, 1:6, (e254-e262), Online publication date: 1-Oct-2020.

Kim M, Lee E, Song Y and Park J (2020) Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseases, Clinical Rheumatology, 10.1007/s10067-020-05049-9, 39:10, (2899-2906), Online publication date: 1-Oct-2020.

Lotfi M and Rezaei N (2020) SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences, Journal of Medical Virology, 10.1002/jmv.26123, 92:10, (1864-1874), Online publication date: 1-Oct-2020.

Lee J, Madany E, El Kadi N, Pandya S, Ng K, Yamashita M, Jefferies C and Gibb D (2020) Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model, Frontiers in Immunology, 10.3389/fimmu.2020.584254, 11

Johdi N and Sukor N (2020) Colorectal Cancer Immunotherapy: Options and Strategies, Frontiers in Immunology, 10.3389/fimmu.2020.01624, 11

Shibabaw T, Molla M, Teferi B and Ayelign B (2020) <p>Role of IFN and Complements System: Innate Immunity in SARS-CoV-2</p>, Journal of Inflammation Research, 10.2147/JIR.S267280, Volume 13, (507-518)

Hasanov E, Gao J and Tannir N (2020) The Immunotherapy Revolution in Kidney Cancer Treatment, The Cancer Journal, 10.1097/PPO.0000000000000471, 26:5, (419-431), Online publication date: 1-Sep-2020.

Rehwinkel J and Gack M (2020) RIG-I-like receptors: their regulation and roles in RNA sensing, Nature Reviews Immunology, 10.1038/s41577-020-0288-3, 20:9, (537-551), Online publication date: 1-Sep-2020.

de Weerd N, Vivian J, Lim S, Huang S and Hertzog P (2020) Structural integrity with functional plasticity: what type I IFN receptor polymorphisms reveal, Journal of Leukocyte Biology, 10.1002/JLB.2MR0420-152R, 108:3, (909-924), Online publication date: 1-Sep-2020.

Tizard I (2020) Interferons Cytokines in Animal Health and Disease, 10.1201/9781003067382-1, (1-58)

Heras M, Ramirez Y, Fernández Martín C, L. Espinosa R, Lavín A and Holgado M (2020) A Point-of-Care Based on Label-Free Interferometric Optical Detection Method to Evaluate Interferon Gamma (IFN-γ): A Correlation with the ELISA Technique, Sensors, 10.3390/s20174776, 20:17, (4776)

How J and Hobbs G (2020) Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature, Cancers, 10.3390/cancers12071954, 12:7, (1954)

Soto J, Gálvez N, Andrade C, Pacheco G, Bohmwald K, Berrios R, Bueno S and Kalergis A (2020) The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses, Frontiers in Immunology, 10.3389/fimmu.2020.01513, 11

Metcalfe R, Putoczki T and Griffin M (2020) Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11, Frontiers in Immunology, 10.3389/fimmu.2020.01424, 11

Schwanke H, Stempel M and Brinkmann M (2020) Of Keeping and Tipping the Balance: Host Regulation and Viral Modulation of IRF3-Dependent IFNB1 Expression, Viruses, 10.3390/v12070733, 12:7, (733)

Cooper L and Good‐Jacobson K (2020) Dysregulation of humoral immunity in chronic infection, Immunology & Cell Biology, 10.1111/imcb.12338, 98:6, (456-466), Online publication date: 1-Jul-2020.

Li B, Chen S, Ren L, Wang S, Liu L, Liu Y, Liu S and Nie P (2020) Identification of type I IFNs and their receptors in a cyprinid fish, the topmouth culter Culter alburnus, Fish & Shellfish Immunology, 10.1016/j.fsi.2020.04.069, 102, (326-335), Online publication date: 1-Jul-2020.

Andrade C, Pacheco G, Gálvez N, Soto J, Bueno S and Kalergis A (2020) Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections, Viruses, 10.3390/v12060637, 12:6, (637)

Gu H and Jan Fada B (2020) Specificity in Ubiquitination Triggered by Virus Infection, International Journal of Molecular Sciences, 10.3390/ijms21114088, 21:11, (4088)

Agasing A, Wu Q, Khatri B, Borisow N, Ruprecht K, Brandt A, Gawde S, Kumar G, Quinn J, Ko R, Mao-Draayer Y, Lessard C, Paul F and Axtell R (2020) Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica, Nature Communications, 10.1038/s41467-020-16625-7, 11:1

Vesely M and Chen L (2020) Normalization Cancer Immunotherapy for Melanoma, Journal of Investigative Dermatology, 10.1016/j.jid.2020.02.005, 140:6, (1134-1142), Online publication date: 1-Jun-2020.

Tang Z, Wang T, Chen Y and Chen T (2020) Cloning and characterisation of type I interferon receptor 1 in orange-spotted grouper (Epinephelus coioides) for response to nodavirus infection, Fish & Shellfish Immunology, 10.1016/j.fsi.2020.04.044, 101, (302-311), Online publication date: 1-Jun-2020.

Zhang Q (2020) Human genetics of life-threatening influenza pneumonitis, Human Genetics, 10.1007/s00439-019-02108-3, 139:6-7, (941-948), Online publication date: 1-Jun-2020.

Barrass S and Butcher S (2019) Advances in high-throughput methods for the identification of virus receptors, Medical Microbiology and Immunology, 10.1007/s00430-019-00653-2, 209:3, (309-323), Online publication date: 1-Jun-2020.

Razzuoli E, Franzoni G, Carta T, Zinellu S, Amadori M, Modesto P and Oggiano A (2020) Modulation of Type I Interferon System by African Swine Fever Virus, Pathogens, 10.3390/pathogens9050361, 9:5, (361)

Santer D, Minty G, Golec D, Lu J, May J, Namdar A, Shah J, Elahi S, Proud D, Joyce M, Tyrrell D, Houghton M and Yount J (2020) Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells, PLOS Pathogens, 10.1371/journal.ppat.1008515, 16:4, (e1008515)

Bamford C (2020) mSphere of Influence: Interferon Ultra Is a Means To Fight Viral Disease, mSphere, 10.1128/mSphere.00134-20, 5:2, Online publication date: 29-Apr-2020.

Mitchell J, Takata H, Muir R, Colby D, Kroon E, Crowell T, Sacdalan C, Pinyakorn S, Puttamaswin S, Benjapornpong K, Trichavaroj R, Tressler R, Fox L, Polonis V, Bolton D, Maldarelli F, Lewin S, Haddad E, Phanuphak P, Robb M, Michael N, de Souza M, Phanuphak N, Ananworanich J and Trautmann L (2020) Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption, Journal of Clinical Investigation, 10.1172/JCI130597, 130:6, (2845-2858), Online publication date: 27-Apr-2020., Online publication date: 1-Jun-2020.

Gadina M, Chisolm D, Philips R, McInness I, Changelian P and O’Shea J (2020) Translating JAKs to Jakinibs, The Journal of Immunology, 10.4049/jimmunol.1901477, 204:8, (2011-2020), Online publication date: 15-Apr-2020.

Karimi Y, Giles E, Vahedi F, Chew M, Nham T, Loukov D, Lee A, Bowdish D and Ashkar A (2019) IFN- β signalling regulates RAW 264.7 macrophage activation, cytokine production, and killing activity , Innate Immunity, 10.1177/1753425919878839, 26:3, (172-182), Online publication date: 1-Apr-2020.

Martin-Hijano L and Sainz B (2020) The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway, Frontiers in Immunology, 10.3389/fimmu.2020.00526, 11

Sun C, Dong M, Song Y, Zhang J, Wang Y, Chang Y, Yu H, Xu N, Xie Z and Liu W (2020) Enhancing the antivirus activity of chimeric canine interferon with ricin subunit B by using nanoparticle formulations, RSC Advances, 10.1039/C9RA10557C, 10:21, (12671-12679)

Ahmad I, Valverde A, Siddiqui H, Schaller S and Naqvi A Viral MicroRNAs: Interfering the Interferon Signaling, Current Pharmaceutical Design, 10.2174/1381612826666200109181238, 26:4, (446-454)

Seoane P, Taylor-Smith L, Stirling D, Bell L, Noursadeghi M, Bailey D, May R and Rappleye C (2020) Viral infection triggers interferon-induced expulsion of live Cryptococcus neoformans by macrophages, PLOS Pathogens, 10.1371/journal.ppat.1008240, 16:2, (e1008240)

Nekoufar S, Fazeli A and Fazeli M (2020) Solubilization of Human Interferon β-1b Inclusion Body Proteins by Organic Solvents, Advanced Pharmaceutical Bulletin, 10.34172/apb.2020.027, 10:2, (233-238)

Couret C, Servant M, Lebranchu P, Hamidou M and Weber M (2019) Efficacy and Safety of Interferon Alpha 2A and Pegylated Interferon Alpha 2A in Inflammatory Macular Edema, Ocular Immunology and Inflammation, 10.1080/09273948.2019.1604001, 28:2, (329-336), Online publication date: 17-Feb-2020.

Duerr C and Fritz J (2020) Editorial: Immunoregulatory Mechanisms of Interferon, Frontiers in Immunology, 10.3389/fimmu.2020.00187, 11

Aiello A, Giannessi F, Percario Z and Affabris E (2020) An emerging interplay between extracellular vesicles and cytokines, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2019.12.003, 51, (49-60), Online publication date: 1-Feb-2020.

Anjum F, Rahman S, Aslam M and Qureshi A (2020) Comprehensive network map of transcriptional activation of chicken type I IFNs and IFN-stimulated genes, Comparative Immunology, Microbiology and Infectious Diseases, 10.1016/j.cimid.2019.101407, 68, (101407), Online publication date: 1-Feb-2020.

Gonçalves dos Santos G, Delay L, Yaksh T and Corr M (2020) Neuraxial Cytokines in Pain States, Frontiers in Immunology, 10.3389/fimmu.2019.03061, 10

Sheahan T, Sims A, Leist S, Schäfer A, Won J, Brown A, Montgomery S, Hogg A, Babusis D, Clarke M, Spahn J, Bauer L, Sellers S, Porter D, Feng J, Cihlar T, Jordan R, Denison M and Baric R (2020) Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV, Nature Communications, 10.1038/s41467-019-13940-6, 11:1

Chen H, Tas S and de Winther M (2019) Type-I interferons in atherosclerosis, Journal of Experimental Medicine, 10.1084/jem.20190459, 217:1, Online publication date: 6-Jan-2020.

Obayes AL-Khikani F and Hameed R (2020) COVID-19 treatment: Possible role of itraconazole as new therapeutic option, International Journal of Health & Allied Sciences, 10.4103/ijhas.IJHAS_64_20, 9:5, (101), .

Oladunni F, Reedy S, Balasuriya U, Horohov D and Chambers T (2020) The effect of equine herpesvirus type 4 on type-I interferon signaling molecules, Veterinary Immunology and Immunopathology, 10.1016/j.vetimm.2019.109971, 219, (109971), Online publication date: 1-Jan-2020.

Galon J and Bruni D (2020) Tumor Immunology and Tumor Evolution: Intertwined Histories, Immunity, 10.1016/j.immuni.2019.12.018, 52:1, (55-81), Online publication date: 1-Jan-2020.

Rodrigues A (2020) Global players: resources and profits New and Future Developments in Microbial Biotechnology and Bioengineering, 10.1016/B978-0-444-64301-8.00009-3, (187-208), .

Hanson E, Uzel G and Hambleton S (2020) Key pathways in primary immune deficiencies Stiehm's Immune Deficiencies, 10.1016/B978-0-12-816768-7.00003-X, (99-114), .

Oppenheim J (2020) Cytokines, Their Receptors and Signals The Autoimmune Diseases, 10.1016/B978-0-12-812102-3.00015-4, (275-289), .

Peng Y, Yang L, Lo H, Law B and Wong V (2020) Tumor Therapeutic Modes New Nanomaterials and Techniques for Tumor-targeted Systems, 10.1007/978-981-15-5159-8_6, (135-229), .

George S, Deshpande G and Sapkal G (2020) Interferons and Their Role in Viral Infection Dynamics of Immune Activation in Viral Diseases, 10.1007/978-981-15-1045-8_4, (61-80), .

Mathias C (2020) Overview of the Immune System and Its Pharmacological Targets Pharmacology of Immunotherapeutic Drugs, 10.1007/978-3-030-19922-7_1, (1-42), .

Sheppard A and Lysaght J (2020) Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy Immunometabolism, 10.1007/978-1-0716-0802-9_17, (233-263), .

Koehler H and Jacobs B (2020) Subversion of Programed Cell Death by Poxviruses , 10.1007/82_2020_229, .

Tian Y, Jennings J, Gong Y and Sang Y (2019) Xenopus Interferon Complex: Inscribing the Amphibiotic Adaption and Species-Specific Pathogenic Pressure in Vertebrate Evolution?, Cells, 10.3390/cells9010067, 9:1, (67)

Dobosz P and Dzieciątkowski T (2019) The Intriguing History of Cancer Immunotherapy, Frontiers in Immunology, 10.3389/fimmu.2019.02965, 10

Kolb-Mäurer A, Sunderkötter C, Kukowski B and Meuth S (2019) An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists, BMC Neurology, 10.1186/s12883-019-1354-y, 19:1, Online publication date: 1-Dec-2019.

Tan G, Yi Z, Song H, Xu F, Li F, Aliyari R, Zhang H, Du P, Ding Y, Niu J, Wang X, Su L, Qin F and Cheng G (2019) Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation, Cell Reports, 10.1016/j.celrep.2019.11.041, 29:11, (3551-3563.e3), Online publication date: 1-Dec-2019.

Kissová J (2019) Interferon-alpha in the treatment of myeloproliferative diseases, Vnitřní lékařství, 10.36290/vnl.2019.121, 65:11, (699-703), Online publication date: 1-Nov-2019.

Liau N, Laktyushin A, Morris R, Sandow J, Nicola N, Kershaw N and Babon J (2019) Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1, Cancers, 10.3390/cancers11111701, 11:11, (1701)

Hoyer F and Nahrendorf M (2019) Interferon-γ regulates cardiac myeloid cells in myocardial infarction, Cardiovascular Research, 10.1093/cvr/cvz143, 115:13, (1815-1816), Online publication date: 1-Nov-2019.

Rius-Rocabert S, Presa J, Esteban-Rubio S, Ayuso-Sacido A and Nistal-Villan E (2019) A Digital Method to Quantify Type I Interferon, Journal of Interferon & Cytokine Research, 10.1089/jir.2019.0046, 39:11, (711-719), Online publication date: 1-Nov-2019.

Vanpouille-Box C, Hoffmann J and Galluzzi L (2019) Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles, Nature Reviews Drug Discovery, 10.1038/s41573-019-0043-2, 18:11, (845-867), Online publication date: 1-Nov-2019.

Kuka M, De Giovanni M and Iannacone M (2019) The role of type I interferons in CD4+ T cell differentiation, Immunology Letters, 10.1016/j.imlet.2019.01.013, 215, (19-23), Online publication date: 1-Nov-2019.

Litak J, Mazurek M, Grochowski C, Kamieniak P and Roliński J (2019) PD-L1/PD-1 Axis in Glioblastoma Multiforme, International Journal of Molecular Sciences, 10.3390/ijms20215347, 20:21, (5347)

Ginting T, Christian S, Larasati Y, Suryatenggara J, Suriapranata I and Mathew G (2019) Antiviral interferons induced by Newcastle disease virus (NDV) drive a tumor-selective apoptosis, Scientific Reports, 10.1038/s41598-019-51465-6, 9:1

Xu F, Song H, An B, Xiao Q, Cheng G and Tan G (2019) NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication, Frontiers in Microbiology, 10.3389/fmicb.2019.02382, 10

Parekh N, Krouse T, Reider I, Hobbs R, Ward B, Norbury C and DeFilippis V (2019) Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden, PLOS Pathogens, 10.1371/journal.ppat.1007778, 15:10, (e1007778)

Pervolaraki K, Guo C, Albrecht D, Boulant S and Stanifer M (2019) Type-Specific Crosstalk Modulates Interferon Signaling in Intestinal Epithelial Cells, Journal of Interferon & Cytokine Research, 10.1089/jir.2019.0040, 39:10, (650-660), Online publication date: 1-Oct-2019.

Gorlé N and Vandenbroucke R (2019) Interferons: A molecular switch between damage and repair in ageing and Alzheimer’s disease, Mechanisms of Ageing and Development, 10.1016/j.mad.2019.111148, 183, (111148), Online publication date: 1-Oct-2019.

Punnonen J, Rosen D, Zuniga L, Sprogøe K and Tabrizi M (2019) Cytokine Therapeutics in Cancer Immunotherapy: Design and Development, Current Pharmacology Reports, 10.1007/s40495-019-00193-6, 5:5, (377-390), Online publication date: 1-Oct-2019.

Pin A, Monasta L, Taddio A, Piscianz E, Tommasini A and Tesser A (2019) An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers, Diagnostics, 10.3390/diagnostics9030113, 9:3, (113)

Lee C, Tung C, Wu C and Lin T (2019) AVIAN INNATE IMMUNITY WITH AN EMPHASIS ON CHICKEN MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 (MDA5), Taiwan Veterinary Journal, 10.1142/S1682648519300016, 45:03, (43-55), Online publication date: 1-Sep-2019.

Fang P, Yu H, Li M, He R, Zhu Y and Liu S (2019) Rubicon: a facilitator of viral immune evasion, Cellular & Molecular Immunology, 10.1038/s41423-019-0248-7, 16:9, (770-771), Online publication date: 1-Sep-2019.

Quiroga A, Comanzo C, Heit Barbini F, Lucci A, Vera M, Lorenzetti F, Ferretti A, Ceballos M, Alvarez M and Carrillo M (2019) IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice, Toxicology and Applied Pharmacology, 10.1016/j.taap.2019.114650, 379, (114650), Online publication date: 1-Sep-2019.

Gugliotta A, Ceaglio N, Kratje R and Oggero M (2019) Effect of ANITVNITV peptide fusion on the bioactivity and pharmacokinetics of human IFN-α2b and a hyper-N-glycosylated variant, Journal of Biotechnology, 10.1016/j.jbiotec.2019.07.006, 303, (46-52), Online publication date: 1-Sep-2019.

Ershov F, Ospelnikova T and Narovlyansky A (2019) Interferon status as a method of determination of nonspecific biomarkers of human immunopathology, Journal of microbiology, epidemiology and immunobiology, 10.36233/0372-9311-2019-3-91-99, 96:3, (91-99)

De Clercq E (2019) Fifty Years in Search of Selective Antiviral Drugs, Journal of Medicinal Chemistry, 10.1021/acs.jmedchem.9b00175, 62:16, (7322-7339), Online publication date: 22-Aug-2019.

Lück S, Kreszies T, Strickert M, Schweizer P, Kuhlmann M and Douchkov D (2019) siRNA-Finder (si-Fi) Software for RNAi-Target Design and Off-Target Prediction, Frontiers in Plant Science, 10.3389/fpls.2019.01023, 10

Rönnblom L and Leonard D (2019) Interferon pathway in SLE: one key to unlocking the mystery of the disease, Lupus Science & Medicine, 10.1136/lupus-2018-000270, 6:1, (e000270), Online publication date: 1-Aug-2019.

Urin V, Shemesh M and Schreiber G (2019) CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells, Journal of Molecular Biology, 10.1016/j.jmb.2019.06.007, 431:17, (3324-3338), Online publication date: 1-Aug-2019.

Shah M, Bharadwaj M, Gupta A, Kumar R and Kumar S (2019) Chicken viperin inhibits Newcastle disease virus infection in vitro: A possible interaction with the viral matrix protein, Cytokine, 10.1016/j.cyto.2019.04.007, 120, (28-40), Online publication date: 1-Aug-2019.

Takaoka A and Yamada T (2019) Regulation of signaling mediated by nucleic acid sensors for innate interferon-mediated responses during viral infection, International Immunology, 10.1093/intimm/dxz034, 31:8, (477-488), Online publication date: 30-Jul-2019.

Pardy R, Valbon S and Richer M (2019) Running interference: Interplay between Zika virus and the host interferon response, Cytokine, 10.1016/j.cyto.2019.02.009, 119, (7-15), Online publication date: 1-Jul-2019.

Wang W, Chong W, Li C, Chen Z, Wu S, Zhou H, Wan Y, Chen W, Gery I, Liu Y, Caspi R and Chen J (2019) Type I Interferon Therapy Limits CNS Autoimmunity by Inhibiting CXCR3-Mediated Trafficking of Pathogenic Effector T Cells, Cell Reports, 10.1016/j.celrep.2019.06.021, 28:2, (486-497.e4), Online publication date: 1-Jul-2019.

Bradley K, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, Fuchs S, Staeheli P and Wack A (2019) Microbiota-Driven Tonic Interferon Signals in Lung Stromal Cells Protect from Influenza Virus Infection, Cell Reports, 10.1016/j.celrep.2019.05.105, 28:1, (245-256.e4), Online publication date: 1-Jul-2019.

Nazmi A, Field R, Griffin E, Haugh O, Hennessy E, Cox D, Reis R, Tortorelli L, Murray C, Lopez‐Rodriguez A, Jin L, Lavelle E, Dunne A and Cunningham C (2019) Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression, Glia, 10.1002/glia.23592, 67:7, (1254-1276), Online publication date: 1-Jul-2019.

Wilbanks B, Maher L and Rodriguez M (2019) Glial cells as therapeutic targets in progressive multiple sclerosis, Expert Review of Neurotherapeutics, 10.1080/14737175.2019.1614443, 19:6, (481-494), Online publication date: 3-Jun-2019.

Zav'yalov V, Hämäläinen-Laanaya H, Korpela T and Wahlroos T (2019) Interferon-Inducible Myxovirus Resistance Proteins: Potential Biomarkers for Differentiating Viral from Bacterial Infections, Clinical Chemistry, 10.1373/clinchem.2018.292391, 65:6, (739-750), Online publication date: 1-Jun-2019.

Casanova J (2019) Ion Gresser, Journal of Interferon & Cytokine Research, 10.1089/jir.2018.29015.mem, 39:6, (317-320), Online publication date: 1-Jun-2019.

Fish E (2019) Introduction to special issue on interferons, Seminars in Immunology, 10.1016/j.smim.2019.101327, 43, (101327), Online publication date: 1-Jun-2019.

Wang B and Fish E (2019) Global virus outbreaks: Interferons as 1st responders, Seminars in Immunology, 10.1016/j.smim.2019.101300, 43, (101300), Online publication date: 1-Jun-2019.

Saleiro D and Platanias L (2019) Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints, Seminars in Immunology, 10.1016/j.smim.2019.101299, 43, (101299), Online publication date: 1-Jun-2019.

Lukhele S, Boukhaled G and Brooks D (2019) Type I interferon signaling, regulation and gene stimulation in chronic virus infection, Seminars in Immunology, 10.1016/j.smim.2019.05.001, 43, (101277), Online publication date: 1-Jun-2019.

Xie T, Feng M, Dai M, Mo G, Ruan Z, Wang G, Shi M and Zhang X (2019) Cholesterol-25-hydroxylase Is a Chicken ISG That Restricts ALV-J Infection by Producing 25-hydroxycholesterol, Viruses, 10.3390/v11060498, 11:6, (498)

Figueroa J, Cárcamo J, Yañez A, Olavarria V, Ruiz P, Manríquez R, Muñoz C, Romero A and Avendaño‐Herrera R (2019) Addressing viral and bacterial threats to salmon farming in Chile: historical contexts and perspectives for management and control, Reviews in Aquaculture, 10.1111/raq.12333, 11:2, (299-324), Online publication date: 1-May-2019.

Kim J, Yoon J, Nikapitiya C, Kim T, Uddin M, Lee H, Kim Y, Hwang J, Chathuranga K, Chathuranga W, Choi H, Kim C, Jung J, Lee C and Lee J (2019) Small Heterodimer Partner Controls the Virus-Mediated Antiviral Immune Response by Targeting CREB-Binding Protein in the Nucleus, Cell Reports, 10.1016/j.celrep.2019.04.071, 27:7, (2105-2118.e5), Online publication date: 1-May-2019.

Ashraf M, Iman K, Khalid M, Salman H, Shafi T, Rafi M, Javaid N, Hussain R, Ahmad F, Shahzad‐Ul‐Hussan S, Mirza S, Shafiq M, Afzal S, Hamera S, Anwar S, Qazi R, Idrees M, Qureshi S and Chaudhary S (2018) Evolution of efficacious pangenotypic hepatitis C virus therapies, Medicinal Research Reviews, 10.1002/med.21554, 39:3, (1091-1136), Online publication date: 1-May-2019.

Ali S, Mann-Nüttel R, Schulze A, Richter L, Alferink J and Scheu S (2019) Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat, Frontiers in Immunology, 10.3389/fimmu.2019.00778, 10

Becker T, Le-Trilling V and Trilling M (2019) Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses, International Journal of Molecular Sciences, 10.3390/ijms20071636, 20:7, (1636)

Suarez-Kelly L, Levine K, Olencki T, del Campo S, Streacker E, Brooks T, Karpa V, Markowitz J, Bingman A, Geyer S, Kendra K and Carson W (2019) A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma, Cancer Immunology, Immunotherapy, 10.1007/s00262-019-02308-w, 68:4, (619-629), Online publication date: 2-Apr-2019.

Zhang S, Lv X, Deng D, Zeng L, Huang W, Tang D, Zhang L, Xu Q and Wei Q (2019) Gene characterization and expression pattern of Mx and Viperin genes in Dabry’s sturgeon Acipenser dabryanus , Journal of Applied Ichthyology, 10.1111/jai.13876, 35:2, (408-419), Online publication date: 1-Apr-2019.

Mesev E, LeDesma R and Ploss A (2019) Decoding type I and III interferon signalling during viral infection, Nature Microbiology, 10.1038/s41564-019-0421-x, 4:6, (914-924)

Manglani M, Rua R, Hendricksen A, Braunschweig D, Gao Q, Tan W, Houser B, McGavern D and Oh K (2019) Method to quantify cytokines and chemokines in mouse brain tissue using Bio-Plex multiplex immunoassays, Methods, 10.1016/j.ymeth.2019.02.007, 158, (22-26), Online publication date: 1-Apr-2019.

Luna J, Saeed M and Rice C (2019) Taming a beast: lessons from the domestication of hepatitis C virus, Current Opinion in Virology, 10.1016/j.coviro.2019.02.008, 35, (27-34), Online publication date: 1-Apr-2019.

Stanifer M, Pervolaraki K and Boulant S (2019) Differential Regulation of Type I and Type III Interferon Signaling, International Journal of Molecular Sciences, 10.3390/ijms20061445, 20:6, (1445)

Durneva E, Sokolov D, Yarmolinskaya M and Selkov S (2019) Interferons: pathogenetic rationale for the treatment of external genital endometriosis and clinical efficacy, Journal of obstetrics and women's diseases, 10.17816/JOWD68147-58, 68:1, (47-58)

Barcutean L, Maier S, Bajko Z, Motataianu A, Romaniuc A, Andone S and Balasa R (2019) Interferon Beta-1b for the Treatment of Multiple Sclerosis – More than 10 Years of Experience, Acta Medica Marisiensis, 10.2478/amma-2019-0003, 65:1, (12-18), Online publication date: 1-Mar-2019., Online publication date: 1-Mar-2019.

Lebon P, Crow Y, Casanova J and Gresser I (2019) Conséquences pathologiques d’un excès d’interféron in vivo , médecine/sciences, 10.1051/medsci/2019037, 35:3, (232-235), Online publication date: 1-Mar-2019.

He H, Zhai C, Mei M, Rao Y, Liu Y, Wang F, Ma L, Jiang Z, Zhang G and Yi L (2019) Functional expression of porcine interferon-α using a combinational strategy in Pichia pastoris GS115, Enzyme and Microbial Technology, 10.1016/j.enzmictec.2018.12.005, 122, (55-63), Online publication date: 1-Mar-2019.

Wang Y, Zhao H, Liu J, Shao Y and Xing M (2019) Molecular cloning and transcriptional regulation of Indian peafowl (Pavo cristatus) IFN-α gene, Cell Stress and Chaperones, 10.1007/s12192-018-00962-0, 24:2, (323-332), Online publication date: 1-Mar-2019.

Himmerich H, Patsalos O, Lichtblau N, Ibrahim M and Dalton B (2019) Cytokine Research in Depression: Principles, Challenges, and Open Questions, Frontiers in Psychiatry, 10.3389/fpsyt.2019.00030, 10

Thaney V and Kaul M (2019) Type I Interferons in NeuroHIV, Viral Immunology, 10.1089/vim.2018.0085, 32:1, (7-14), Online publication date: 1-Feb-2019.

Samuel C (2019) Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA–triggered innate immune responses, Journal of Biological Chemistry, 10.1074/jbc.TM118.004166, 294:5, (1710-1720), Online publication date: 1-Feb-2019.

Stamatiades E and Li M (2019) Tissue-resident cytotoxic innate lymphoid cells in tumor immunosurveillance, Seminars in Immunology, 10.1016/j.smim.2019.03.001, 41, (101269), Online publication date: 1-Feb-2019.

Wu X, Kwong A and Rice C (2019) Antiviral resistance of stem cells, Current Opinion in Immunology, 10.1016/j.coi.2018.10.004, 56, (50-59), Online publication date: 1-Feb-2019.

Li S, Zhao F, Gong M, Shao J, Xie Y, Chang H and Zhang Y (2018) Antiviral activity of porcine interferon omega 7 against foot‐and‐mouth disease virus in vitro, Journal of Medical Virology, 10.1002/jmv.25272, 91:2, (208-214), Online publication date: 1-Feb-2019.

Chiang H and Liu H (2019) The Molecular Basis of Viral Inhibition of IRF- and STAT-Dependent Immune Responses, Frontiers in Immunology, 10.3389/fimmu.2018.03086, 9

Mogensen T (2019) IRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies, Frontiers in Immunology, 10.3389/fimmu.2018.03047, 9

Scheu S, Ali S, Mann-Nüttel R, Richter L, Arolt V, Dannlowski U, Kuhlmann T, Klotz L and Alferink J (2019) Interferon β-Mediated Protective Functions of Microglia in Central Nervous System Autoimmunity, International Journal of Molecular Sciences, 10.3390/ijms20010190, 20:1, (190)

Celiker H, Kazokoglu H and Direskeneli H (2017) Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet’s Uveitis: A Small Case Series, Ocular Immunology and Inflammation, 10.1080/09273948.2017.1332768, 27:1, (15-22), Online publication date: 2-Jan-2019.

Liu X, Diedrichs-Möhring M and Wildner G (2017) The Role of IFN-alpha in Experimental and Clinical Uveitis, Ocular Immunology and Inflammation, 10.1080/09273948.2017.1298822, 27:1, (23-33), Online publication date: 2-Jan-2019.

Berraondo P, Sanmamed M, Ochoa M, Etxeberria I, Aznar M, Pérez-Gracia J, Rodríguez-Ruiz M, Ponz-Sarvise M, Castañón E and Melero I (2018) Cytokines in clinical cancer immunotherapy, British Journal of Cancer, 10.1038/s41416-018-0328-y, 120:1, (6-15), Online publication date: 1-Jan-2019.

Katla S and Sivaprakasam S (2019) Yeasts as Microbial Factories for Production of Recombinant Human Interferon Alpha 2b of Therapeutic Importance Next Generation Biomanufacturing Technologies, 10.1021/bk-2019-1329.ch003, (41-56), Online publication date: 1-Jan-2019.

Quintans J, Shanmugam S, Heimfarth L, Araújo A, Almeida J, Picot L and Quintans-Júnior L (2019) Monoterpenes modulating cytokines - A review, Food and Chemical Toxicology, 10.1016/j.fct.2018.10.058, 123, (233-257), Online publication date: 1-Jan-2019.

Tsuchida Y and Fujio K (2019) Cytokines and Chemokines Mosaic of Autoimmunity, 10.1016/B978-0-12-814307-0.00015-3, (127-141), .

Newton J, Sikora A and Young S (2019) Materials-Based Cancer Immunotherapies Principles of Regenerative Medicine, 10.1016/B978-0-12-809880-6.00041-2, (715-739), .

Hasselbalch H and Holmström M (2018) Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?, Seminars in Immunopathology, 10.1007/s00281-018-0700-2, 41:1, (5-19), Online publication date: 1-Jan-2019.

Flessa C, Argiriou E and Mavragani C (2019) Type I Interferonopathies: From Pathophysiology to Clinical Expression Auto-Inflammatory Syndromes, 10.1007/978-3-319-96929-9_10, (125-145), .

Niccolai L, Ruddle N and Krause P (2019) Introduction to Immunology, Epidemiology, and Immunoepidemiology Immunoepidemiology, 10.1007/978-3-030-25553-4_1, (3-17), .

Borkar D and Butler N (2019) Interferons and Intravenous Immunoglobulin Treatment of Non-infectious Uveitis, 10.1007/978-3-030-22827-9_10, (113-129), .

Guzman E and Montoya M (2018) Contributions of Farm Animals to Immunology, Frontiers in Veterinary Science, 10.3389/fvets.2018.00307, 5

Manickam C, Shah S, Lucar O, Ram D and Reeves R (2018) Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections, Frontiers in Immunology, 10.3389/fimmu.2018.02862, 9

Negishi H, Taniguchi T and Yanai H (2017) The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family, Cold Spring Harbor Perspectives in Biology, 10.1101/cshperspect.a028423, 10:11, (a028423), Online publication date: 1-Nov-2018.

Jacobs S, Wavreil F, Schepens B, Gad H, Hartmann R, Rocha-Pereira J, Neyts J, Saelens X and Michiels T (2018) Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ, Journal of Interferon & Cytokine Research, 10.1089/jir.2018.0066, 38:11, (469-479), Online publication date: 1-Nov-2018.

Bodewes I and Versnel M (2018) Interferon activation in primary Sjögren’s syndrome: recent insights and future perspective as novel treatment target, Expert Review of Clinical Immunology, 10.1080/1744666X.2018.1519396, 14:10, (817-829), Online publication date: 3-Oct-2018.

Rees P and Lowy R (2018) Measuring type I interferon using reporter gene assays based on readily available cell lines, Journal of Immunological Methods, 10.1016/j.jim.2018.06.007, 461, (63-72), Online publication date: 1-Oct-2018.

Crisler W and Lenz L (2018) Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection, Current Opinion in Immunology, 10.1016/j.coi.2018.05.014, 54, (35-41), Online publication date: 1-Oct-2018.

Haller O, Arnheiter H, Pavlovic J and Staeheli P (2018) The Discovery of the Antiviral Resistance Gene Mx : A Story of Great Ideas, Great Failures, and Some Success , Annual Review of Virology, 10.1146/annurev-virology-092917-043525, 5:1, (33-51), Online publication date: 29-Sep-2018.

Hay A and McCauley J (2018) The WHO global influenza surveillance and response system (GISRS)-A future perspective, Influenza and Other Respiratory Viruses, 10.1111/irv.12565, 12:5, (551-557), Online publication date: 1-Sep-2018.

Oppenheim J (2017) The Future of the Cytokine Discipline, Cold Spring Harbor Perspectives in Biology, 10.1101/cshperspect.a028498, 10:9, (a028498), Online publication date: 1-Sep-2018.

Xia C, Anderson P and Hahm B (2018) Viral dedication to vigorous destruction of interferon receptors, Virology, 10.1016/j.virol.2018.06.017, 522, (19-26), Online publication date: 1-Sep-2018.

Garrido D, Alber A, Kut E, Chanteloup N, Lion A, Trotereau A, Dupont J, Tedin K, Kaspers B, Vervelde L, Trapp S, Schouler C and Guabiraba R (2018) The role of type I interferons (IFNs) in the regulation of chicken macrophage inflammatory response to bacterial challenge, Developmental & Comparative Immunology, 10.1016/j.dci.2018.04.025, 86, (156-170), Online publication date: 1-Sep-2018.

Mochan E, Ackerman E and Shoemaker J (2018) A Systems and Treatment Perspective of Models of Influenza Virus-Induced Host Responses, Processes, 10.3390/pr6090138, 6:9, (138)

Lou H and Pickering M (2018) Extracellular DNA and autoimmune diseases, Cellular & Molecular Immunology, 10.1038/cmi.2017.136, 15:8, (746-755), Online publication date: 1-Aug-2018.

Liu B, Sarhan J and Poltorak A (2018) Host-Intrinsic Interferon Status in Infection and Immunity, Trends in Molecular Medicine, 10.1016/j.molmed.2018.06.004, 24:8, (658-668), Online publication date: 1-Aug-2018.

Zahradník J, Kolářová L, Pařízková H, Kolenko P and Schneider B (2018) Interferons type II and their receptors R1 and R2 in fish species: Evolution, structure, and function, Fish & Shellfish Immunology, 10.1016/j.fsi.2018.05.008, 79, (140-152), Online publication date: 1-Aug-2018.

Arregui M, Mc Callum G, Smith I, Villaverde M, Wolman F, Targovnik A and Miranda M (2018) Production of biologically active feline interferon beta in insect larvae using a recombinant baculovirus, 3 Biotech, 10.1007/s13205-018-1369-x, 8:8, Online publication date: 1-Aug-2018.

Crow Y, Lebon P, Casanova J and Gresser I (2018) A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo, Journal of Clinical Immunology, 10.1007/s10875-018-0543-6, 38:6, (694-698), Online publication date: 1-Aug-2018.

Ahmed D, Jaworski A, Roy D, Willmore W, Golshani A and Cassol E (2018) Transcriptional Profiling Suggests Extensive Metabolic Rewiring of Human and Mouse Macrophages during Early Interferon Alpha Responses, Mediators of Inflammation, 10.1155/2018/5906819, 2018, (1-15), Online publication date: 25-Jul-2018.

Tan G, Song H, Xu F and Cheng G (2018) When Hepatitis B Virus Meets Interferons, Frontiers in Microbiology, 10.3389/fmicb.2018.01611, 9

Gryczan T (2018) Etymologia: Cytokines, Emerging Infectious Diseases, 10.3201/eid2407.ET2407, 24:7, (1227-1227), Online publication date: 1-Jul-2018.

Casanova V, Sousa F, Stevens C and Barlow P (2018) Antiviral therapeutic approaches for human rhinovirus infections, Future Virology, 10.2217/fvl-2018-0016, 13:7, (505-518), Online publication date: 1-Jul-2018.

Lindqvist R, Upadhyay A and Överby A (2018) Tick-Borne Flaviviruses and the Type I Interferon Response, Viruses, 10.3390/v10070340, 10:7, (340)

Mebratu Y and Tesfaigzi Y (2018) IL-17 Plays a Role in Respiratory Syncytial Virus–induced Lung Inflammation and Emphysema in Elastase and LPS-injured Mice, American Journal of Respiratory Cell and Molecular Biology, 10.1165/rcmb.2017-0265OC, 58:6, (717-726), Online publication date: 1-Jun-2018.

Nice T, Robinson B and Van Winkle J (2018) The Role of Interferon in Persistent Viral Infection: Insights from Murine Norovirus, Trends in Microbiology, 10.1016/j.tim.2017.10.010, 26:6, (510-524), Online publication date: 1-Jun-2018.

Fatehi Chenar F, Kyrychko Y and Blyuss K (2018) Mathematical model of immune response to hepatitis B, Journal of Theoretical Biology, 10.1016/j.jtbi.2018.03.025, 447, (98-110), Online publication date: 1-Jun-2018.

Chalan P, Di Dalmazi G, Pani F, De Remigis A, Corsello A and Caturegli P (2017) Thyroid dysfunctions secondary to cancer immunotherapy, Journal of Endocrinological Investigation, 10.1007/s40618-017-0778-8, 41:6, (625-638), Online publication date: 1-Jun-2018.

Wack A (2018) Interfering with transmission, eLife, 10.7554/eLife.37552, 7

Castro F, Cardoso A, Gonçalves R, Serre K and Oliveira M (2018) Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion, Frontiers in Immunology, 10.3389/fimmu.2018.00847, 9

Clercq E and Stewart W (2018) The Breadth of Interferon Action Selective Inhibitors of Viral Functions, 10.1201/9781351076562-4, (81-106)

Liu R, Moss B and Sandri-Goldin R (2018) Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State, Journal of Virology, 10.1128/JVI.00053-18, 92:9, Online publication date: 1-May-2018.

Xia S, Wang H, Hong X, Lu J, Xu D, Jiang Y and Lu L (2018) Identification and characterization of a type I interferon induced by cyprinid herpesvirus 2 infection in crucian carp Carassius auratus gibelio, Fish & Shellfish Immunology, 10.1016/j.fsi.2018.02.043, 76, (35-40), Online publication date: 1-May-2018.

Taylor J, Moore Z, Minter M and Crack P (2017) Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease, Journal of Neural Transmission, 10.1007/s00702-017-1745-4, 125:5, (797-807), Online publication date: 1-May-2018.

Hsu A (2018) Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions, Frontiers in Immunology, 10.3389/fimmu.2018.00743, 9

Muskardin T and Niewold T (2018) Type I interferon in rheumatic diseases, Nature Reviews Rheumatology, 10.1038/nrrheum.2018.31, 14:4, (214-228), Online publication date: 1-Apr-2018.

Picard C and Belot A (2018) Les interféronopathies de type I. Mise au point et revue de la littérature, La Revue de Médecine Interne, 10.1016/j.revmed.2016.08.016, 39:4, (271-278), Online publication date: 1-Apr-2018.

Noël N, Jacquelin B, Huot N, Goujard C, Lambotte O and Müller-Trutwin M (2018) Interferon-associated therapies toward HIV control: The back and forth, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2018.03.004, 40, (99-112), Online publication date: 1-Apr-2018.

Stunnenberg M, Geijtenbeek T and Gringhuis S (2018) DDX3 in HIV-1 infection and sensing: A paradox, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2018.03.001, 40, (32-39), Online publication date: 1-Apr-2018.

Chiba Y, Mizoguchi I, Hasegawa H, Ohashi M, Orii N, Nagai T, Sugahara M, Miyamoto Y, Xu M, Owaki T and Yoshimoto T (2017) Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases, Cellular and Molecular Life Sciences, 10.1007/s00018-017-2724-5, 75:8, (1363-1376), Online publication date: 1-Apr-2018.

Liu W, Qiu X, Song C, Sun Y, Meng C, Liao Y, Tan L, Ding Z, Liu X and Ding C (2018) Deep Sequencing-Based Transcriptome Profiling Reveals Avian Interferon-Stimulated Genes and Provides Comprehensive Insight into Newcastle Disease Virus-Induced Host Responses, Viruses, 10.3390/v10040162, 10:4, (162)

Moyo D, Beattie L, Andrews P, Moore J, Timmis J, Sawtell A, Hoehme S, Sampson A and Kaye P (2018) Macrophage Transactivation for Chemokine Production Identified as a Negative Regulator of Granulomatous Inflammation Using Agent-Based Modeling, Frontiers in Immunology, 10.3389/fimmu.2018.00637, 9

Ruiz-Moreno J, Hamann L, Jin L, Sander L, Puzianowska-Kuznicka M, Cambier J, Witzenrath M, Schumann R, Suttorp N, Opitz B and Freitag N (2018) The cGAS/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans, Infection and Immunity, 10.1128/IAI.00849-17, 86:3, Online publication date: 1-Mar-2018.

Robertsen B (2018) The role of type I interferons in innate and adaptive immunity against viruses in Atlantic salmon, Developmental & Comparative Immunology, 10.1016/j.dci.2017.02.005, 80, (41-52), Online publication date: 1-Mar-2018.

Syinycin V, Oksamytny V, Yanenko U, Zaviriukha H, Yanenko V and Yavorskaya K (2018) Meaning Of Nanoparticipants In Interferon Transport, Naukovì dopovìdì Nacìonalʹnogo unìversitetu bìoresursiv ì prirodokoristuvannâ Ukraïni, 10.31548/dopovidi2018.01.005:1(71)

Ershov F and Narovlyansky A (2018) THEORETICAL AND APPLIED ASPECTS OF THE INTERFERON SYSTEM: TO THE 60TH ANNIVERSARY OF THE DISCOVERY OF INTERFERONS, Problems of Virology, 10.18821/0507-4088-2018-63-1-10-18, 63:1, (10-18)

Nie Z, Aboulnasr F, Natesampillai S, Burke S, Krogman A, Bren G, Chung T, Anderson J, Smart M, Katzmann D, Rajagopalan G, Cummins N and Badley A (2018) Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment, The Journal of Immunology, 10.4049/jimmunol.1701113, 200:3, (1110-1123), Online publication date: 1-Feb-2018.

Maughan A and Ogbuagu O (2018) Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection, Expert Opinion on Drug Metabolism & Toxicology, 10.1080/17425255.2018.1421173, 14:2, (219-227), Online publication date: 1-Feb-2018.

Ahsan F, Gardner Q, Rashid N, Towers G and Akhtar M (2018) Preventing the N-terminal processing of human interferon α-2b and its chimeric derivatives expressed in Escherichia coli, Bioorganic Chemistry, 10.1016/j.bioorg.2017.11.016, 76, (294-302), Online publication date: 1-Feb-2018.

Ingle H, Peterson S and Baldridge M (2018) Distinct Effects of Type I and III Interferons on Enteric Viruses, Viruses, 10.3390/v10010046, 10:1, (46)

Echebli N, Tchitchek N, Dupuy S, Bruel T, Peireira Bittencourt Passaes C, Bosquet N, Le Grand R, Bourgeois C, Favier B, Cheynier R, Lambotte O, Vaslin B and Apetrei C (2018) Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection, PLOS ONE, 10.1371/journal.pone.0190334, 13:1, (e0190334)

Kang S, Brown H and Hwang S (2018) Direct Antiviral Mechanisms of Interferon-Gamma, Immune Network, 10.4110/in.2018.18.e33, 18:5

Malaviya A and Mehra N (2018) A fascinating story of the discovery & development of biologicals for use in clinical medicine, Indian Journal of Medical Research, 10.4103/ijmr.IJMR_1471_18, 148:3, (263), .

Park Y and Cheon J (2018) Updated treatment strategies for intestinal Behçet’s disease, The Korean Journal of Internal Medicine, 10.3904/kjim.2017.377, 33:1, (1-19), Online publication date: 1-Jan-2018.

Gonzalez-Cao M, Karachaliou N, Santarpia M, Viteri S, Meyerhans A and Rosell R (2018) Activation of viral defense signaling in cancer, Therapeutic Advances in Medical Oncology, 10.1177/1758835918793105, 10, (175883591879310), Online publication date: 1-Jan-2018.

Zhao H, Wang Y, Shao Y, Liu J, Li J, Zong H and Xing M (2018) Characterization of Whooper Swan ( Cygnus cygnus ) Interferon α: Prokaryotic Expression, Biological Activities, and Physicochemical Characteristics , Journal of Interferon & Cytokine Research, 10.1089/jir.2017.0089, 38:1, (20-28), Online publication date: 1-Jan-2018.

Bello-Rivero I, Garcia-Vega Y, Duncan-Roberts Y, Vazquez-Blomquistc D, Santana-Milian H, Besada-Perez V and Rios-Cabrera M (2018) HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment, Seminars in Oncology, 10.1053/j.seminoncol.2018.04.007, 45:1-2, (27-33), Online publication date: 1-Jan-2018.

Smith G, Talbot-Cooper C and Lu Y (2018) How Does Vaccinia Virus Interfere With Interferon? , 10.1016/bs.aivir.2018.01.003, (355-378), .

Seelige R, Searles S and Bui J (2017) Mechanisms regulating immune surveillance of cellular stress in cancer, Cellular and Molecular Life Sciences, 10.1007/s00018-017-2597-7, 75:2, (225-240), Online publication date: 1-Jan-2018.

Loo K, Wu C and Daud A (2018) Current Immunotherapy of Melanoma Melanoma, 10.1007/978-3-319-78310-9_35, (567-576), .

Paul E and Agarwala S (2018) Adjuvant Therapy of Melanoma Melanoma, 10.1007/978-3-319-78310-9_29, (483-498), .

Lin F and Young H (2018) Interferon-Gamma Encyclopedia of Signaling Molecules, 10.1007/978-3-319-67199-4_411, (2680-2687), .

Langer J (2018) Type I Interferons Encyclopedia of Signaling Molecules, 10.1007/978-3-319-67199-4_101827, (5787-5794), .

Hutchinson E and Yamauchi Y (2018) Understanding Influenza Influenza Virus, 10.1007/978-1-4939-8678-1_1, (1-21), .

Mojic M, Takeda K and Hayakawa Y (2017) The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion, International Journal of Molecular Sciences, 10.3390/ijms19010089, 19:1, (89)

Zdravkovic N, Rosic M, Lutovac M and Zdravkovic V (2017) Physiology and Pathology of Cytokine: Commercial Production and Medical Use Physiology and Pathology of Immunology, 10.5772/intechopen.72200

Zhang L, Tai Y, Ho M, Qiu L and Anderson K (2017) Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era, Experimental Hematology & Oncology, 10.1186/s40164-017-0081-6, 6:1, Online publication date: 1-Dec-2017.

Li Y, Sun B, Esser S, Jessen H, Streeck H, Widera M, Yang R, Dittmer U and Sutter K (2017) Expression Pattern of Individual IFNA Subtypes in Chronic HIV Infection , Journal of Interferon & Cytokine Research, 10.1089/jir.2017.0076, 37:12, (541-549), Online publication date: 1-Dec-2017.

Zhao H, Wang Y, Liu J, Shao Y, Li J, Chai H and Xing M (2017) Retracted: Molecular Characterization and Biological Activity of Interferon-α in Indian Peafowl ( Pavo cristatus ) , DNA and Cell Biology, 10.1089/dna.2017.3798, 36:12, (e1179-e1187), Online publication date: 1-Dec-2017.

Koo H, Allan R, Howlin R, Stoodley P and Hall-Stoodley L (2017) Targeting microbial biofilms: current and prospective therapeutic strategies, Nature Reviews Microbiology, 10.1038/nrmicro.2017.99, 15:12, (740-755), Online publication date: 1-Dec-2017.

Herrington-Symes A, Choi J and Brocchini S (2017) Interferon dimers: IFN-PEG-IFN, Journal of Drug Targeting, 10.1080/1061186X.2017.1363214, 25:9-10, (881-890), Online publication date: 26-Nov-2017.

Ivin M, Dumigan A, de Vasconcelos F, Ebner F, Borroni M, Kavirayani A, Przybyszewska K, Ingram R, Lienenklaus S, Kalinke U, Stoiber D, Bengoechea J, Kovarik P and Baumler A (2017) Natural killer cell-intrinsic type I IFN signaling controls Klebsiella pneumoniae growth during lung infection, PLOS Pathogens, 10.1371/journal.ppat.1006696, 13:11, (e1006696)

Mahony R, Broadbent L, Maier-Moore J, Power U and Jefferies C (2017) The RNA binding protein La/SS-B promotes RIG-I-mediated type I and type III IFN responses following Sendai viral infection, Scientific Reports, 10.1038/s41598-017-15197-9, 7:1

Ahmed D and Cassol E (2017) Role of cellular metabolism in regulating type I interferon responses: Implications for tumour immunology and treatment, Cancer Letters, 10.1016/j.canlet.2017.08.037, 409, (20-29), Online publication date: 1-Nov-2017.

Selvakumar T, Bhushal S, Kalinke U, Wirth D, Hauser H, Köster M and Hornef M (2017) Identification of a Predominantly Interferon-λ-Induced Transcriptional Profile in Murine Intestinal Epithelial Cells, Frontiers in Immunology, 10.3389/fimmu.2017.01302, 8

De Meyts P (2017) Early Recombinant Protein Therapeutics Protein Therapeutics, 10.1002/9783527699124.ch1, (1-23)

Ouwendijk W, van Veen S, Mahalingam R and Verjans G (2017) Simian varicella virus inhibits the interferon gamma signalling pathway, Journal of General Virology, 10.1099/jgv.0.000925, 98:10, (2582-2588), Online publication date: 1-Oct-2017.

Edwards M, Strong K, Cameron A, Walton R, Jackson D and Johnston S (2017) Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness, Journal of Allergy and Clinical Immunology, 10.1016/j.jaci.2017.07.025, 140:4, (909-920), Online publication date: 1-Oct-2017.

Sandstrom T, Ranganath N and Angel J (2017) Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2017.04.004, 37, (1-16), Online publication date: 1-Oct-2017.

Luecke S and Paludan S (2017) Molecular requirements for sensing of intracellular microbial nucleic acids by the innate immune system, Cytokine, 10.1016/j.cyto.2016.10.003, 98, (4-14), Online publication date: 1-Oct-2017.

Miorin L, Maestre A, Fernandez-Sesma A and García-Sastre A (2017) Antagonism of type I interferon by flaviviruses, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2017.05.146, 492:4, (587-596), Online publication date: 1-Oct-2017.

Andreakos E, Salagianni M, Galani I and Koltsida O (2017) Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract, Frontiers in Immunology, 10.3389/fimmu.2017.01232, 8

Medrano R, Hunger A, Mendonça S, Barbuto J and Strauss B (2017) Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy, Oncotarget, 10.18632/oncotarget.19531, 8:41, (71249-71284), Online publication date: 19-Sep-2017.

Ritchie A, Mallia P and Johnston S Viral infection Acute Exacerbations of Pulmonary Diseases, 10.1183/2312508X.10016116, (76-96)

Domingo-Gonzalez R, Prince O, Cooper A and Khader S (2017) Cytokines and Chemokines in Mycobacterium tuberculosis Infection Tuberculosis and the Tubercle Bacillus, 10.1128/9781555819569.ch2, (33-72)

Huang H, Zhang N, Xiong Q, Chen R, Zhang C, Wang N, Wang L, Ren H, Liu M, Qian M and Du B (2017) Elimination of GPR146-mediated antiviral function through IRF3/HES1-signalling pathway, Immunology, 10.1111/imm.12752, 152:1, (102-114), Online publication date: 1-Sep-2017.

Klotz D, Baumgärtner W and Gerhauser I (2017) Type I interferons in the pathogenesis and treatment of canine diseases, Veterinary Immunology and Immunopathology, 10.1016/j.vetimm.2017.08.006, 191, (80-93), Online publication date: 1-Sep-2017.

Monteiro S, Roque S, Marques F, Correia-Neves M and Cerqueira J (2017) Brain interference: Revisiting the role of IFNγ in the central nervous system, Progress in Neurobiology, 10.1016/j.pneurobio.2017.05.003, 156, (149-163), Online publication date: 1-Sep-2017.

Chen K, Liu J and Cao X (2017) Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review, Journal of Autoimmunity, 10.1016/j.jaut.2017.03.008, 83, (1-11), Online publication date: 1-Sep-2017.

Picard C and Belot A (2017) Does type-I interferon drive systemic autoimmunity?, Autoimmunity Reviews, 10.1016/j.autrev.2017.07.001, 16:9, (897-902), Online publication date: 1-Sep-2017.

Decker W, da Silva R, Sanabria M, Angelo L, Guimarães F, Burt B, Kheradmand F and Paust S (2017) Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models, Frontiers in Immunology, 10.3389/fimmu.2017.00829, 8

Ernstoff M, Gandhi S, Pandey M, Puzanov I, Grivas P, Montero A, Velcheti V, Turk M, Diaz-Montero C, Lewis L and Morrison C (2017) Challenges faced when identifying patients for combination immunotherapy, Future Oncology, 10.2217/fon-2017-0218, 13:18, (1607-1618), Online publication date: 1-Aug-2017.

Ebrahimi S, Ghorbani E, Khazaei M, Avan A, Ryzhikov M, Azadmanesh K and Hassanian S (2017) Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy, Journal of Cellular Biochemistry, 10.1002/jcb.25917, 118:8, (1994-1999), Online publication date: 1-Aug-2017.

Kopitar-Jerala N (2017) The Role of Interferons in Inflammation and Inflammasome Activation, Frontiers in Immunology, 10.3389/fimmu.2017.00873, 8

Encalada-García C (2017) Dendritic cells and interferons in systemic lupus erythematosus, Revista Colombiana de Reumatología (English Edition), 10.1016/j.rcreue.2017.11.002, 24:3, (177-184), Online publication date: 1-Jul-2017.

Encalada-García C (2017) Células dendríticas e interferones en el lupus eritematoso sistémico, Revista Colombiana de Reumatología, 10.1016/j.rcreu.2017.04.002, 24:3, (177-184), Online publication date: 1-Jul-2017.

Guo X and Thomas P (2017) New fronts emerge in the influenza cytokine storm, Seminars in Immunopathology, 10.1007/s00281-017-0636-y, 39:5, (541-550), Online publication date: 1-Jul-2017.

Clark I and Vissel B (2017) The meteorology of cytokine storms, and the clinical usefulness of this knowledge, Seminars in Immunopathology, 10.1007/s00281-017-0628-y, 39:5, (505-516), Online publication date: 1-Jul-2017.

Raftery N and Stevenson N (2017) Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway, Cellular and Molecular Life Sciences, 10.1007/s00018-017-2520-2, 74:14, (2525-2535), Online publication date: 1-Jul-2017.

Fenwick M, Li Y, Cresswell P, Modis Y and Ealick S (2017) Structural studies of viperin, an antiviral radical SAM enzyme, Proceedings of the National Academy of Sciences, 10.1073/pnas.1705402114, 114:26, (6806-6811), Online publication date: 27-Jun-2017.

Kubli-Garfias C, Vázquez-Ramírez R, Trejo-Muñoz C, Berber A and Verma C (2017) Insights on the mechanism of action of immunostimulants in relation to their pharmacological potency. The effects of imidazoquinolines on TLR8, PLOS ONE, 10.1371/journal.pone.0178846, 12:6, (e0178846)

Sell S (2017) Cancer immunotherapy: Breakthrough or “deja vu, all over again”?, Tumor Biology, 10.1177/1010428317707764, 39:6, (101042831770776), Online publication date: 1-Jun-2017.

Villa T, Feijoo-Siota L, Rama J and Ageitos J (2017) Antivirals against animal viruses, Biochemical Pharmacology, 10.1016/j.bcp.2016.09.029, 133, (97-116), Online publication date: 1-Jun-2017.

Kim J, Park M, Nikapitiya C, Kim T, Uddin M, Lee H, Kim E, Ma J, Jung J, Kim C, Lee J and Heise M (2017) FAS-associated factor-1 positively regulates type I interferon response to RNA virus infection by targeting NLRX1, PLOS Pathogens, 10.1371/journal.ppat.1006398, 13:5, (e1006398)

Day P, Thompson C, Lowy D, Schiller J and Banks L (2017) Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism, Journal of Virology, 10.1128/JVI.00168-17, 91:10, Online publication date: 15-May-2017.

Gebhardt A, Laudenbach B and Pichlmair A (2017) Discrimination of Self and Non-Self Ribonucleic Acids, Journal of Interferon & Cytokine Research, 10.1089/jir.2016.0092, 37:5, (184-197), Online publication date: 1-May-2017.

Rodero M, Decalf J, Bondet V, Hunt D, Rice G, Werneke S, McGlasson S, Alyanakian M, Bader-Meunier B, Barnerias C, Bellon N, Belot A, Bodemer C, Briggs T, Desguerre I, Frémond M, Hully M, van den Maagdenberg A, Melki I, Meyts I, Musset L, Pelzer N, Quartier P, Terwindt G, Wardlaw J, Wiseman S, Rieux-Laucat F, Rose Y, Neven B, Hertel C, Hayday A, Albert M, Rozenberg F, Crow Y and Duffy D (2017) Detection of interferon alpha protein reveals differential levels and cellular sources in disease, Journal of Experimental Medicine, 10.1084/jem.20161451, 214:5, (1547-1555), Online publication date: 1-May-2017.

Garcia-Diaz A, Shin D, Moreno B, Saco J, Escuin-Ordinas H, Rodriguez G, Zaretsky J, Sun L, Hugo W, Wang X, Parisi G, Saus C, Torrejon D, Graeber T, Comin-Anduix B, Hu-Lieskovan S, Damoiseaux R, Lo R and Ribas A (2017) Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression, Cell Reports, 10.1016/j.celrep.2017.04.031, 19:6, (1189-1201), Online publication date: 1-May-2017.

Bernichon E, Rancoule C, Vallard A, Langrand-Escure J, Mery B, Guy J and Magné N (2017) Immunothérapie : après le focus sur les voies de signalisation, l’activation d’un système, Bulletin du Cancer, 10.1016/j.bulcan.2017.03.004, 104:5, (462-475), Online publication date: 1-May-2017.

Mahony R, Gargan S, Roberts K, Bourke N, Keating S, Bowie A, O’Farrelly C and Stevenson N (2016) A novel anti-viral role for STAT3 in IFN-α signalling responses, Cellular and Molecular Life Sciences, 10.1007/s00018-016-2435-3, 74:9, (1755-1764), Online publication date: 1-May-2017.

Banchereau R, Cepika A, Banchereau J and Pascual V (2017) Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics, Annual Review of Immunology, 10.1146/annurev-immunol-051116-052225, 35:1, (337-370), Online publication date: 26-Apr-2017.

Chen H, Hu H, Chen D, Tang J, Yu B, Luo J, He J, Luo Y, Yu J and Mao X (2017) Dietary Pectic Oligosaccharide Administration Improves Growth Performance and Immunity in Weaned Pigs Infected by Rotavirus, Journal of Agricultural and Food Chemistry, 10.1021/acs.jafc.7b00039, 65:14, (2923-2929), Online publication date: 12-Apr-2017.

Sanlorenzo M, Vujic I, Carnevale-Schianca F, Quaglino P, Gammaitoni L, Fierro M, Aglietta M and Sangiolo D (2017) Role of interferon in melanoma: old hopes and new perspectives, Expert Opinion on Biological Therapy, 10.1080/14712598.2017.1289169, 17:4, (475-483), Online publication date: 3-Apr-2017.

Giles E and Stagg A (2017) Type 1 Interferon in the Human Intestine—A Co-ordinator of the Immune Response to the Microbiota, Inflammatory Bowel Diseases, 10.1097/MIB.0000000000001078, 23:4, (524-533), Online publication date: 1-Apr-2017.

Müller L, Aigner P and Stoiber D (2017) Type I Interferons and Natural Killer Cell Regulation in Cancer, Frontiers in Immunology, 10.3389/fimmu.2017.00304, 8

Peteranderl C and Herold S (2017) The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond, Frontiers in Immunology, 10.3389/fimmu.2017.00313, 8

Kotenko S and Durbin J (2017) Contribution of type III interferons to antiviral immunity: location, location, location, Journal of Biological Chemistry, 10.1074/jbc.R117.777102, 292:18, (7295-7303), Online publication date: 1-Mar-2017.

Schreiber G (2017) The molecular basis for differential type I interferon signaling, Journal of Biological Chemistry, 10.1074/jbc.R116.774562, 292:18, (7285-7294), Online publication date: 1-Mar-2017.

Kumaki Y, Salazar A, Wandersee M and Barnard D (2017) Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model, Antiviral Research, 10.1016/j.antiviral.2016.12.007, 139, (1-12), Online publication date: 1-Mar-2017.

Hayes C and Chayama K (2016) Interferon stimulated genes and innate immune activation following infection with hepatitis B and C viruses, Journal of Medical Virology, 10.1002/jmv.24659, 89:3, (388-396), Online publication date: 1-Mar-2017.

Fusco D, Pratt H, Kandilas S, Cheon S, Lin W, Cronkite D, Basavappa M, Jeffrey K, Anselmo A, Sadreyev R, Yapp C, Shi X, O'Sullivan J, Gerszten R, Tomaru T, Yoshino S, Satoh T and Chung R (2017) HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus, Frontiers in Microbiology, 10.3389/fmicb.2017.00240, 8

Frabasile S, Koishi A, Kuczera D, Silveira G, Verri W, Duarte dos Santos C and Bordignon J (2017) The citrus flavanone naringenin impairs dengue virus replication in human cells, Scientific Reports, 10.1038/srep41864, 7:1

Majoros A, Platanitis E, Kernbauer-Hölzl E, Rosebrock F, Müller M and Decker T (2017) Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses, Frontiers in Immunology, 10.3389/fimmu.2017.00029, 8

Lu Y, Zuo Q, Zhang Y, Wang Y, Li T and Han J (2017) The expression profile of IFITM family gene in rats, Intractable & Rare Diseases Research, 10.5582/irdr.2017.01066, 6:4, (274-280), .

ZHAO J, YU H, ZHANG J, WANG X, LI J, HU T, HU Y, WANG M, SHEN Y, XU J, HAN G and CHEN J (2017) Pharmacokinetic studies of the recombinant chicken interferon-α in broiler chickens, Journal of Veterinary Medical Science, 10.1292/jvms.15-0681, 79:2, (314-319), .

Xia Y, Cheng X, Blossey C, Wisskirchen K, Esser K and Protzer U (2017) Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro, Journal of Immunology Research, 10.1155/2017/4828936, 2017, (1-12), .

Paueksakon P and Fogo A (2016) Drug-induced nephropathies, Histopathology, 10.1111/his.13064, 70:1, (94-108), Online publication date: 1-Jan-2017.

Almeida G, Silva L, Colson P and Abrahao J (2017) Mimiviruses and the Human Interferon System: Viral Evasion of Classical Antiviral Activities, But Inhibition By a Novel Interferon-β Regulated Immunomodulatory Pathway, Journal of Interferon & Cytokine Research, 10.1089/jir.2016.0097, 37:1, (1-8), Online publication date: 1-Jan-2017.

Mayer-Barber K and Yan B (2016) Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses, Cellular & Molecular Immunology, 10.1038/cmi.2016.25, 14:1, (22-35), Online publication date: 1-Jan-2017.

Brochet B, Lebrun-Frénay C, de Sèze J, Zéphir H, Allart E, Audoin B, Ayrignac X, Bensa C, Blanchard-Dauphin A, Brassat D, Carra-Dallière C, Clavelou P, Cohen M, Créange A, Collongues N, Debouverie M, Defer G, de Sèze M, Donzé C, Edan G, Fromont A, Gamé X, Gout O, Guillon C, Harand C, Jenny B, Labauge P, Lalive P, Le Page E, Marque P, Michel L, Moisset X, Ouallet J, Outteryck O, Pelé F, Pelletier J, Pittion-Vouyovitch S, Ramelli A, Ruet A, Thouvenot E, Veillard D, Vignal-Clermont C and Vukusic S (2017) Thérapeutiques et prise en charge de la sclérose en plaques La Sclérose en Plaques - Clinique et Thérapeutique, 10.1016/B978-2-294-75020-5.00016-8, (145-216), .

Degrave W and Mendonça-Lima L (2017) Interferons Current Developments in Biotechnology and Bioengineering, 10.1016/B978-0-444-63660-7.00003-6, (51-70), .

Crowe J (2017) Host Defense Mechanisms Against Viruses Fetal and Neonatal Physiology, 10.1016/B978-0-323-35214-7.00122-0, (1175-1197.e7), .

Foti M (2017) Introduction to Cytokines as Tissue Regulators in Health and Disease Cytokine Effector Functions in Tissues, 10.1016/B978-0-12-804214-4.00019-1, (3-30), .

Kałużna E (2017) microRNA-155 and microRNA-196b in Hepatitis C Virus Infection Biomarkers in Liver Disease, 10.1007/978-94-007-7675-3_16, (809-836), .

Langer J (2017) Type I Interferons Encyclopedia of Signaling Molecules, 10.1007/978-1-4614-6438-9_101827-1, (1-7), .

Davar D, Appleman L and Kirkwood J (2017) Interferon Alpha Cancer Therapeutic Targets, 10.1007/978-1-4419-0717-2_64, (295-322), .

Kovarik P, Castiglia V, Ivin M and Ebner F (2016) Type I Interferons in Bacterial Infections: A Balancing Act, Frontiers in Immunology, 10.3389/fimmu.2016.00652, 7

Pahari S, Khan N, Aqdas M, Negi S, Kaur J and Agrewala J (2016) Infergen Stimulated Macrophages Restrict Mycobacterium tuberculosis Growth by Autophagy and Release of Nitric Oxide, Scientific Reports, 10.1038/srep39492, 6:1

Li W, Cao F, Li J, Wang Z, Ren Y, Liang Z and Liu P (2016)(2016) Simvastatin exerts anti-hepatitis B virus activity by inhibiting expression of minichromosome maintenance protein 7 in HepG2.2.15 cells, Molecular Medicine Reports, 10.3892/mmr.2016.5868, 14:6, (5334-5342), Online publication date: 1-Dec-2016.

Ku C, Chang Y, Chien Y and Lee T (2016) Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments, Cell & Bioscience, 10.1186/s13578-016-0086-6, 6:1, Online publication date: 1-Dec-2016.

Lund M, Røsæg M, Krasnov A, Timmerhaus G, Nyman I, Aspehaug V, Rimstad E and Dahle M (2016) Experimental Piscine orthoreovirus infection mediates protection against pancreas disease in Atlantic salmon (Salmo salar), Veterinary Research, 10.1186/s13567-016-0389-y, 47:1, Online publication date: 1-Dec-2016.

Giotis E, Robey R, Skinner N, Tomlinson C, Goodbourn S and Skinner M (2016) Chicken interferome: avian interferon-stimulated genes identified by microarray and RNA-seq of primary chick embryo fibroblasts treated with a chicken type I interferon (IFN-α), Veterinary Research, 10.1186/s13567-016-0363-8, 47:1, Online publication date: 1-Dec-2016.

Volpi S, Picco P, Caorsi R, Candotti F and Gattorno M (2016) Type I interferonopathies in pediatric rheumatology, Pediatric Rheumatology, 10.1186/s12969-016-0094-4, 14:1, Online publication date: 1-Dec-2016.

Grassi A, Di Camillo B, Ciccarese F, Agnusdei V, Zanovello P, Amadori A, Finesso L, Indraccolo S and Toffolo G (2016) Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: experimental set-up and inference method, BMC Genomics, 10.1186/s12864-016-2525-5, 17:1, Online publication date: 1-Dec-2016.

Diaz-San Segundo F, Montiel N, Sturza D, Perez-Martin E, Hickman D, Ramirez-Medina E, Grubman M and de los Santos T (2016) Combination of Adt-O1Manisa and Ad5-boIFNλ3 induces early protective immunity against foot-and-mouth disease in cattle, Virology, 10.1016/j.virol.2016.09.027, 499, (340-349), Online publication date: 1-Dec-2016.

Pham E, Perumpail R, Fram B, Glenn J, Ahmed A and Gish R (2016) Future Therapy for Hepatitis B Virus: Role of Immunomodulators, Current Hepatology Reports, 10.1007/s11901-016-0315-9, 15:4, (237-244), Online publication date: 1-Dec-2016.

Rodero M and Crow Y (2016) Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview, Journal of Experimental Medicine, 10.1084/jem.20161596, 213:12, (2527-2538), Online publication date: 14-Nov-2016.

Romanov V, Kostromina T, Miroshnikov A and Feofanov S (2017) Preparative method for obtaining recombinant human interferon α2b from inclusion bodies of Escherichia coli, Russian Journal of Bioorganic Chemistry, 10.1134/S1068162016040154, 42:6, (631-637), Online publication date: 1-Nov-2016.

Xirotagaros G, Hernández-Ostiz S, Aróstegui J and Torrelo A (2016) Newly Described Autoinflammatory Diseases in Pediatric Dermatology, Pediatric Dermatology, 10.1111/pde.12984, 33:6, (602-614), Online publication date: 1-Nov-2016.

Lee K, Um S, Rhee D and Pyo S (2016) Interferon-alpha inhibits adipogenesis via regulation of JAK/STAT1 signaling, Biochimica et Biophysica Acta (BBA) - General Subjects, 10.1016/j.bbagen.2016.07.009, 1860:11, (2416-2427), Online publication date: 1-Nov-2016.

Domingo-Gonzalez R, Prince O, Cooper A, Khader S, Jacobs Jr. W, McShane H, Mizrahi V and Orme I (2016) Cytokines and Chemokines in Mycobacterium tuberculosis Infection , Microbiology Spectrum, 10.1128/microbiolspec.TBTB2-0018-2016, 4:5, Online publication date: 14-Oct-2016.

Porter J, Watson J, Roberts L, Gill S, Groves H, Dhariwal J, Almond M, Wong E, Walton R, Jones L, Tregoning J, Kilty I, Johnston S and Edwards M (2016) Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium, Journal of Antimicrobial Chemotherapy, 10.1093/jac/dkw222, 71:10, (2767-2781), Online publication date: 1-Oct-2016.

Tu Y, Wang G, Wang Y, Chen W, Zhang L, Liu Y, Jiang C, Wang S, Bu Z and Cai X (2016) Extracellular expression and antiviral activity of a bovine interferon-alpha through codon optimization in Pichia pastoris, Microbiological Research, 10.1016/j.micres.2016.05.009, 191, (12-18), Online publication date: 1-Oct-2016.

Rivero-Juárez A, Frias M and Rivero A (2016) Current views on interferon therapy for HIV, Expert Opinion on Biological Therapy, 10.1080/14712598.2016.1196180, 16:9, (1135-1142), Online publication date: 1-Sep-2016.

Cook B, Ranadheera C, Nikiforuk A, Cutts T, Kobasa D, Court D, Theriault S and Singh S (2016) Limited Effects of Type I Interferons on Kyasanur Forest Disease Virus in Cell Culture, PLOS Neglected Tropical Diseases, 10.1371/journal.pntd.0004871, 10:8, (e0004871)

Gao X, Pham T, Feuerbacher L, Chen K, Hays M, Singh G, Rueter C, Hurtado-Guerrero R and Hardwidge P (2016) Citrobacter rodentium NleB Protein Inhibits Tumor Necrosis Factor (TNF) Receptor-associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production, Journal of Biological Chemistry, 10.1074/jbc.M116.738278, 291:35, (18232-18238), Online publication date: 1-Aug-2016.

Kavrochorianou N, Markogiannaki M and Haralambous S (2016) IFN-β differentially regulates the function of T cell subsets in MS and EAE, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2016.03.013, 30, (47-54), Online publication date: 1-Aug-2016.

Schirrmacher V (2016) Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!, Biomedicines, 10.3390/biomedicines4030016, 4:3, (16)

Uchiyama S, Keller N, Schlaepfer E, Grube C, Schuepbach R, Speck R and Zinkernagel A (2016) Interferon α–Enhanced Clearance of Group A Streptococcus Despite Neutropenia, Journal of Infectious Diseases, 10.1093/infdis/jiw157, 214:2, (321-328), Online publication date: 15-Jul-2016.

Lasfar A, Gogas H, Zloza A, Kaufman H and Kirkwood J (2016) IFN-λ cancer immunotherapy: new kid on the block, Immunotherapy, 10.2217/imt-2015-0021, 8:8, (877-888), Online publication date: 1-Jul-2016.

Hastings A, Amato K, Wen S, Peterson L and Williams J (2016) Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation, Virology, 10.1016/j.virol.2016.04.022, 494, (248-256), Online publication date: 1-Jul-2016.

Krause C (2016) Intron loss in interferon genes follows a distinct set of stages, and may confer an evolutionary advantage, Cytokine, 10.1016/j.cyto.2016.04.018, 83, (193-205), Online publication date: 1-Jul-2016.

Schmid E, Pang I, Carrera Silva E, Bosurgi L, Miner J, Diamond M, Iwasaki A and Rothlin C (2016) AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity, eLife, 10.7554/eLife.12414, 5

Chen J, Qiu Y, Zhang S and Gao Y (2015) Dissolving microneedle-based intradermal delivery of interferon-α-2b, Drug Development and Industrial Pharmacy, 10.3109/03639045.2015.1096282, 42:6, (890-896), Online publication date: 2-Jun-2016.

Ben-Ami E and Schachter J (2016) Adjuvant treatment for stage III melanoma in the era of targeted medicine and immunotherapy, Melanoma Management, 10.2217/mmt-2016-0002, 3:2, (137-147), Online publication date: 1-Jun-2016.

Hannoun Z, Maarifi G and Chelbi-Alix M (2016) The implication of SUMO in intrinsic and innate immunity, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2016.04.003, 29, (3-16), Online publication date: 1-Jun-2016.

Saleiro D, Kosciuczuk E and Platanias L (2016) Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2016.03.008, 29, (17-22), Online publication date: 1-Jun-2016.

Green D, Nunes A, Annunziata C and Zoon K (2016) Monocyte and interferon based therapy for the treatment of ovarian cancer, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2016.02.006, 29, (109-115), Online publication date: 1-Jun-2016.

Boxx G and Cheng G (2016) The Roles of Type I Interferon in Bacterial Infection, Cell Host & Microbe, 10.1016/j.chom.2016.05.016, 19:6, (760-769), Online publication date: 1-Jun-2016.

LIU R, ZHAO G, ZHENG M, LIU J, ZHANG J, LI P, LI Q, FENG J, ZHANG M and WEN J (2016) Effect of feeding transgenic cry1Ab/cry1Ac rice on indices of immune function in broilers, Journal of Integrative Agriculture, 10.1016/S2095-3119(15)61281-3, 15:6, (1355-1363), Online publication date: 1-Jun-2016.

Sarkar S, Balasuriya U, Horohov D and Chambers T (2016) Equine herpesvirus-1 infection disrupts interferon regulatory factor-3 (IRF-3) signaling pathways in equine endothelial cells, Veterinary Immunology and Immunopathology, 10.1016/j.vetimm.2016.03.009, 173, (1-9), Online publication date: 1-May-2016.

Meyer B, Ly H and Pierson T (2016) Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses, Journal of Virology, 10.1128/JVI.03049-15, 90:8, (3810-3818), Online publication date: 15-Apr-2016.

Hewitt R, Farne H, Ritchie A, Luke E, Johnston S and Mallia P (2015) The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma, Therapeutic Advances in Respiratory Disease, 10.1177/1753465815618113, 10:2, (158-174), Online publication date: 1-Apr-2016.

Todt D, François C, Anggakusuma , Behrendt P, Engelmann M, Knegendorf L, Vieyres G, Wedemeyer H, Hartmann R, Pietschmann T, Duverlie G and Steinmann E (2016) Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication, Antimicrobial Agents and Chemotherapy, 10.1128/AAC.02427-15, 60:4, (2132-2139), Online publication date: 1-Apr-2016.

Lai Y and Dong C (2015) Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases, International Immunology, 10.1093/intimm/dxv063, 28:4, (181-188), Online publication date: 1-Apr-2016.

Appourchaux R and Cimarelli A (2016) Du nouveau dans la réponse antivirale, médecine/sciences, 10.1051/medsci/20163204003, 32:4, (320-323), Online publication date: 1-Apr-2016.

Huang Y, Jin M, Yin S, Ding Z, Wang W and Ren Q (2016) Responses of three very large inducible GTPases to bacterial and white spot syndrome virus challenges in the giant fresh water prawn Macrobrachium rosenbergii, Fish & Shellfish Immunology, 10.1016/j.fsi.2016.01.037, 51, (77-96), Online publication date: 1-Apr-2016.

Biggadike K, Ahmed M, Ball D, Coe D, Dalmas Wilk D, Edwards C, Gibbon B, Hardy C, Hermitage S, Hessey J, Hillegas A, Hughes S, Lazarides L, Lewell X, Lucas A, Mallett D, Price M, Priest F, Quint D, Shah P, Sitaram A, Smith S, Stocker R, Trivedi N, Tsitoura D and Weller V (2016) Discovery of 6-Amino-2-{[(1 S )-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8 H -purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma , Journal of Medicinal Chemistry, 10.1021/acs.jmedchem.5b01647, 59:5, (1711-1726), Online publication date: 10-Mar-2016.

Ritchie A, Jackson D, Edwards M and Johnston S (2016) Airway Epithelial Orchestration of Innate Immune Function in Response to Virus Infection. A Focus on Asthma, Annals of the American Thoracic Society, 10.1513/AnnalsATS.201507-421MG, 13:Supplement 1, (S55-S63), Online publication date: 1-Mar-2016.

Nascimento-Carvalho C and Ruuskanen O (2016) Clinical Significance of Multiple Respiratory Virus Detection, Pediatric Infectious Disease Journal, 10.1097/INF.0000000000001032, 35:3, (338-339), Online publication date: 1-Mar-2016.

George C, Ramaswami G, Li J and Samuel C (2016) Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses, Journal of Biological Chemistry, 10.1074/jbc.M115.709014, 291:12, (6158-6168), Online publication date: 1-Mar-2016.

Ceaglio N, Gugliotta A, Tardivo M, Cravero D, Etcheverrigaray M, Kratje R and Oggero M (2016) Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit, Journal of Biotechnology, 10.1016/j.jbiotec.2016.01.018, 221, (13-24), Online publication date: 1-Mar-2016.

Asmuth D, Utay N and Pollard R (2016) Peginterferon α-2a for the treatment of HIV infection, Expert Opinion on Investigational Drugs, 10.1517/13543784.2016.1132699, 25:2, (249-257), Online publication date: 1-Feb-2016.

de Winther M (2016) The Plot Thickens Further for Type I Interferons in Atherosclerotic Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 10.1161/ATVBAHA.115.306907, 36:2, (217-218), Online publication date: 1-Feb-2016.

Hofer M and Campbell I (2015) Immunoinflammatory diseases of the central nervous system - the tale of two cytokines, British Journal of Pharmacology, 10.1111/bph.13175, 173:4, (716-728), Online publication date: 1-Feb-2016.

Sarkar S, Balasuriya U, Horohov D and Chambers T (2016) The neuropathogenic T953 strain of equine herpesvirus-1 inhibits type-I IFN mediated antiviral activity in equine endothelial cells, Veterinary Microbiology, 10.1016/j.vetmic.2015.12.011, 183, (110-118), Online publication date: 1-Feb-2016.

Liu Q, Ma J, Wang X, Xiao F, Li L, Zhang J, Lin Y, Du C, He X, Wang X and Zhou J (2016) Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response, Veterinary Immunology and Immunopathology, 10.1016/j.vetimm.2016.01.006, 170, (30-40), Online publication date: 1-Feb-2016.

Teijaro J (2016) Type I interferons in viral control and immune regulation, Current Opinion in Virology, 10.1016/j.coviro.2016.01.001, 16, (31-40), Online publication date: 1-Feb-2016.

Ciancanelli M, Abel L, Zhang S and Casanova J (2016) Host genetics of severe influenza: from mouse Mx1 to human IRF7, Current Opinion in Immunology, 10.1016/j.coi.2015.12.002, 38, (109-120), Online publication date: 1-Feb-2016.

Knight V, Merkel P and O’Sullivan M (2016) Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation, Antibodies, 10.3390/antib5010003, 5:1, (3)

Afarid M, Lashkarizadeh H, Ashraf M, Nowroozzadeh M and Shafiee S (2016) The efficacy of intravitreal interferon alpha-2b for the treatment of experimental endotoxin-induced uveitis, Indian Journal of Ophthalmology, 10.4103/0301-4738.185605, 64:5, (376), .

Kim S and Chung S (2016) Comparison of High Dose Interferon-α2b Immunotherapy and Dacarbazine Chemotherapy as Postoperative Treatment of Malignant Melanoma, Journal of the Korean Orthopaedic Association, 10.4055/jkoa.2016.51.5.426, 51:5, (426), .

Loo S and Wark P (2016) Recent advances in understanding and managing asthma, F1000Research, 10.12688/f1000research.9236.1, 5, (2052)

Lostalé-Seijo I, Martínez-Costas J and Benavente J (2016) Interferon induction by avian reovirus, Virology, 10.1016/j.virol.2015.10.009, 487, (104-111), Online publication date: 1-Jan-2016.

López de Padilla C and Niewold T (2016) The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases, Gene, 10.1016/j.gene.2015.09.058, 576:1, (14-21), Online publication date: 1-Jan-2016.

Kindler E, Thiel V and Weber F (2016) Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response Coronaviruses, 10.1016/bs.aivir.2016.08.006, (219-243), .

Zou J, Castro R and Tafalla C (2016) Antiviral Immunity: Origin and Evolution in Vertebrates The Evolution of the Immune System, 10.1016/B978-0-12-801975-7.00007-4, (173-204), .

(2016) Preface The Innate Immune Response to Noninfectious Stressors, 10.1016/B978-0-12-801968-9.00013-1, (xv-xxvii), .

Razzuoli E, Zanotti C and Amadori M (2016) Modulation of the Interferon Response by Environmental, Noninfectious Stressors The Innate Immune Response to Noninfectious Stressors, 10.1016/B978-0-12-801968-9.00008-8, (191-207), .

Gross R and Lublin F (2016) Interferon β in Multiple Sclerosis Translational Neuroimmunology in Multiple Sclerosis, 10.1016/B978-0-12-801914-6.00016-7, (191-201), .

Dafny N and Lincoln J (2016) The Role of Interferons on the Central Nervous System in Health and Disease☆ Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.99446-7, .

Louten J (2016) The Immune Response to Viruses Essential Human Virology, 10.1016/B978-0-12-800947-5.00006-5, (93-109), .

Moticka E (2016) Intercellular Communication in the Immune System A Historical Perspective on Evidence-Based Immunology, 10.1016/B978-0-12-398381-7.00025-3, (217-226), .

Kramer I (2016) Activating the Adaptive Immune System Signal Transduction, 10.1016/B978-0-12-394803-8.00015-2, (813-848), .

Dhagat U, Nero T, Kan W, Hercus T, Broughton S, de Weerd N, Jenkins B, Mansell A, Guthridge M, Hertzog P, Lopez A and Parker M (2016) Cytokine Receptors and Their Ligands Encyclopedia of Cell Biology, 10.1016/B978-0-12-394447-4.30002-5, (22-36), .

Tarrio M and Biron C (2016) Innate Cytokine Responses and Their Functions during Viral Infections Encyclopedia of Immunobiology, 10.1016/B978-0-12-374279-7.14005-6, (222-234), .

Hertzog P, Bourke N, de Weerd N and Mangan N (2016) New Interferons Encyclopedia of Immunobiology, 10.1016/B978-0-12-374279-7.10007-4, (501-508), .

Landolfo S and De Andrea M (2016) Interferon α/β Encyclopedia of Immunobiology, 10.1016/B978-0-12-374279-7.10005-0, (485-493), .

Kim K, Roh J, Wee H and Kim C (2016) Immunotherapeutic Anticancer Drugs and Other Miscellaneous Anticancer Drugs Cancer Drug Discovery, 10.1007/978-94-024-0844-7_7, (135-153), .

Kałużna E (2016) microRNA-155 and microRNA-196b in Hepatitis C Virus Infection Biomarkers in Liver Disease, 10.1007/978-94-007-7742-2_16-1, (1-28), .

Rotte A and Bhandaru M (2016) Interferon-α2b Immunotherapy of Melanoma, 10.1007/978-3-319-48066-4_9, (235-256), .

Reiss C (2016) Innate Immunity in Viral Encephalitis Neurotropic Viral Infections, 10.1007/978-3-319-33189-8_8, (251-303), .

Khan M (2016) Role of Cytokines Immunopharmacology, 10.1007/978-3-319-30273-7_2, (57-92), .

Villa T, Sánchez-Pérez A and Viñas M (2016) The Biological Fight Against Pathogenic Bacteria and Protozoa New Weapons to Control Bacterial Growth, 10.1007/978-3-319-28368-5_19, (509-556), .

Secombes C and Belmonte R (2016) Overview of the Fish Adaptive Immune System Fish Vaccines, 10.1007/978-3-0348-0980-1_2, (35-52), .

Work T, Dagenais J, Breeden R, Schneemann A, Sung J, Hew B, Balazs G and Berestecky J (2015) Green Turtles ( Chelonia mydas ) Have Novel Asymmetrical Antibodies , The Journal of Immunology, 10.4049/jimmunol.1501332, 195:11, (5452-5460), Online publication date: 1-Dec-2015.

Laurie K, Guarnaccia T, Carolan L, Yan A, Aban M, Petrie S, Cao P, Heffernan J, McVernon J, Mosse J, Kelso A, McCaw J and Barr I (2015) Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model, Journal of Infectious Diseases, 10.1093/infdis/jiv260, 212:11, (1701-1710), Online publication date: 1-Dec-2015.

Zanotti C, Razzuoli E, Crooke H, Soule O, Pezzoni G, Ferraris M, Ferrari A and Amadori M (2015) Differential Biological Activities of Swine Interferon-α Subtypes, Journal of Interferon & Cytokine Research, 10.1089/jir.2015.0076, 35:12, (990-1002), Online publication date: 1-Dec-2015.

Annamalai T, Saif L, Lu Z and Jung K (2015) Age-dependent variation in innate immune responses to porcine epidemic diarrhea virus infection in suckling versus weaned pigs, Veterinary Immunology and Immunopathology, 10.1016/j.vetimm.2015.09.006, 168:3-4, (193-202), Online publication date: 1-Dec-2015.

El-Baky N, Uversky V and Redwan E (2015) Human consensus interferons: Bridging the natural and artificial cytokines with intrinsic disorder, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2015.07.012, 26:6, (637-645), Online publication date: 1-Dec-2015.

Avau A and Matthys P (2015) Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome, Pharmaceuticals, 10.3390/ph8040793, 8:4, (793-815)

Fensterl V, Chattopadhyay S and Sen G (2015) No Love Lost Between Viruses and Interferons, Annual Review of Virology, 10.1146/annurev-virology-100114-055249, 2:1, (549-572), Online publication date: 9-Nov-2015.

Ritchie A, Farne H, Singanayagam A, Jackson D, Mallia P and Johnston S (2015) Pathogenesis of Viral Infection in Exacerbations of Airway Disease, Annals of the American Thoracic Society, 10.1513/AnnalsATS.201503-151AW, 12:Supplement 2, (S115-S132), Online publication date: 1-Nov-2015.

Rautela J, Baschuk N, Slaney C, Jayatilleke K, Xiao K, Bidwell B, Lucas E, Hawkins E, Lock P, Wong C, Chen W, Anderson R, Hertzog P, Andrews D, Möller A and Parker B (2015) Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer, Cancer Immunology Research, 10.1158/2326-6066.CIR-15-0065, 3:11, (1207-1217), Online publication date: 1-Nov-2015.

Haller O (2015) A tribute to Jean Lindenmann, co-discoverer of interferon (1924–2015), Cytokine, 10.1016/j.cyto.2015.02.029, 76:1, (113-115), Online publication date: 1-Nov-2015.

Heim M (2015) Interferon signaling Signaling Pathways in Liver Diseases, 10.1002/9781118663387.ch16, (214-225)

Diner B, Lum K and Cristea I (2015) The Emerging Role of Nuclear Viral DNA Sensors, Journal of Biological Chemistry, 10.1074/jbc.R115.652289, 290:44, (26412-26421), Online publication date: 1-Oct-2015.

Sarkar S, Balasuriya U, Horohov D and Chambers T (2015) Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells, Veterinary Immunology and Immunopathology, 10.1016/j.vetimm.2015.07.015, 167:3-4, (122-129), Online publication date: 1-Oct-2015.

Pateras I, Havaki S, Nikitopoulou X, Vougas K, Townsend P, Panayiotidis M, Georgakilas A and Gorgoulis V (2015) The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2015.06.011, 154, (36-56), Online publication date: 1-Oct-2015.

Chen R, Su Y, Wang J, Liu M, Qiao Y, Mao Y, Ke Q, Han K, Zheng W, Zhang J and Wu C (2015) Molecular characterization and expression analysis of interferon-gamma in the large yellow croaker Larimichthys crocea, Fish & Shellfish Immunology, 10.1016/j.fsi.2015.07.008, 46:2, (596-602), Online publication date: 1-Oct-2015.

Spaccarelli N and Rook A (2015) The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma, Dermatologic Clinics, 10.1016/j.det.2015.05.008, 33:4, (731-745), Online publication date: 1-Oct-2015.

Isorce N, Lucifora J, Zoulim F and Durantel D (2015) Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies, Antiviral Research, 10.1016/j.antiviral.2015.08.008, 122, (69-81), Online publication date: 1-Oct-2015.

Wang A, Liu F, Chen S, Wang M, Jia R, Zhu D, Liu M, Sun K, Wu Y, Chen X and Cheng A (2015) Transcriptome Analysis and Identification of Differentially Expressed Transcripts of Immune-Related Genes in Spleen of Gosling and Adult Goose, International Journal of Molecular Sciences, 10.3390/ijms160922904, 16:9, (22904-22926)

Hammerstad S, Grock S, Lee H, Hasham A, Sundaram N and Tomer Y (2015) Diabetes and Hepatitis C: A Two-Way Association, Frontiers in Endocrinology, 10.3389/fendo.2015.00134, 6

Gale M (2015) Interference with Virus Infection, The Journal of Immunology, 10.4049/jimmunol.1501575, 195:5, (1909-1910), Online publication date: 1-Sep-2015.

Hagberg N and Rönnblom L (2015) Systemic Lupus Erythematosus - A Disease with A Dysregulated Type I Interferon System, Scandinavian Journal of Immunology, 10.1111/sji.12330, 82:3, (199-207), Online publication date: 1-Sep-2015.

Wiley C, Bhardwaj N, Ross T and Bissel S (2015) Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus, Brain Pathology, 10.1111/bpa.12281, 25:5, (634-650), Online publication date: 1-Sep-2015.

Sehgal M, Zeremski M, Talal A, Ginwala R, Elrod E, Grakoui A, Li Q, Philip R, Khan Z and Jain P (2015) IFN-α-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment, Journal of Interferon & Cytokine Research, 10.1089/jir.2014.0211, 35:9, (698-709), Online publication date: 1-Sep-2015.

McGlasson S, Jury A, Jackson A and Hunt D (2015) Type I interferon dysregulation and neurological disease, Nature Reviews Neurology, 10.1038/nrneurol.2015.143, 11:9, (515-523), Online publication date: 1-Sep-2015.

Ignatius Irudayam J, Contreras D, Spurka L, Subramanian A, Allen J, Ren S, Kanagavel V, Nguyen Q, Ramaiah A, Ramamoorthy K, French S, Klein A, Funari V and Arumugaswami V (2015) Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection, Stem Cell Research, 10.1016/j.scr.2015.08.003, 15:2, (354-364), Online publication date: 1-Sep-2015.

Song J, Guan M, Zhao Z, Zhang J and Jin D (2015) Type I Interferons Function as Autocrine and Paracrine Factors to Induce Autotaxin in Response to TLR Activation, PLOS ONE, 10.1371/journal.pone.0136629, 10:8, (e0136629)

Gonzales-van Horn S and Farrar J (2015) Interferon at the crossroads of allergy and viral infections, Journal of Leukocyte Biology, 10.1189/jlb.3RU0315-099R, 98:2, (185-194), Online publication date: 1-Aug-2015.

Paul F, Pellegrini S and Uzé G (2015) IFNA2: The prototypic human alpha interferon, Gene, 10.1016/j.gene.2015.04.087, 567:2, (132-137), Online publication date: 1-Aug-2015.

Urin V, Levin D, Sharma N, Harari D, Schreiber G and Fernandez-Zapico M (2015) Fine Tuning of a Type 1 Interferon Antagonist, PLOS ONE, 10.1371/journal.pone.0130797, 10:7, (e0130797)

Blondel D, Maarifi G, Nisole S and Chelbi-Alix M (2015) Resistance to Rhabdoviridae Infection and Subversion of Antiviral Responses, Viruses, 10.3390/v7072794, 7:7, (3675-3702)

Markowitz G, Bomback A and Perazella M (2015) Drug-Induced Glomerular Disease, Clinical Journal of the American Society of Nephrology, 10.2215/CJN.00860115, 10:7, (1291-1299), Online publication date: 1-Jul-2015.

Boshuizen M and de Winther M (2015) Interferons as Essential Modulators of Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, 10.1161/ATVBAHA.115.305464, 35:7, (1579-1588), Online publication date: 1-Jul-2015.

Zitvogel L, Galluzzi L, Kepp O, Smyth M and Kroemer G (2015) Type I interferons in anticancer immunity, Nature Reviews Immunology, 10.1038/nri3845, 15:7, (405-414), Online publication date: 1-Jul-2015.

Lazear H, Nice T and Diamond M (2015) Interferon-λ: Immune Functions at Barrier Surfaces and Beyond, Immunity, 10.1016/j.immuni.2015.07.001, 43:1, (15-28), Online publication date: 1-Jul-2015.

Antonelli G and Turriziani O (2015) Mechanisms of Action of Antiviral Agents Practical Handbook of Microbiology, Third Edition, 10.1201/b17871-15, (197-210), Online publication date: 15-Jun-2015.

Moore T, Vogel A, Petro T and Brown D (2015) IRF3 deficiency impacts granzyme B expression and maintenance of memory T cell function in response to viral infection, Microbes and Infection, 10.1016/j.micinf.2015.03.001, 17:6, (426-439), Online publication date: 1-Jun-2015.

Zhang R, Liu R, Wang W, Xin L, Wang L, Li C and Song L (2015) Identification and functional analysis of a novel IFN-like protein (CgIFNLP) in Crassostrea gigas, Fish & Shellfish Immunology, 10.1016/j.fsi.2015.03.015, 44:2, (547-554), Online publication date: 1-Jun-2015.

Kotzamanis K, Angulo A and Ghazal P (2015) Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection, Medical Microbiology and Immunology, 10.1007/s00430-015-0402-5, 204:3, (395-407), Online publication date: 1-Jun-2015.

Sheehan K, Lazear H, Diamond M, Schreiber R and Aldabe R (2015) Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection, PLOS ONE, 10.1371/journal.pone.0128636, 10:5, (e0128636)

Baharom F, Thomas S, Bieder A, Hellmér M, Volz J, Sandgren K, McInerney G, Karlsson Hedestam G, Mellman I and Smed-Sörensen A (2015) Protection of Human Myeloid Dendritic Cell Subsets against Influenza A Virus Infection Is Differentially Regulated upon TLR Stimulation, The Journal of Immunology, 10.4049/jimmunol.1402671, 194:9, (4422-4430), Online publication date: 1-May-2015.

Dhama K, Saminathan M, Jacob S, Singh M, Karthik K, . A, Tiwari R, Sunkara L, Malik Y and Singh R (2015) Effect of Immunomodulation and Immunomodulatory Agents on Health with some Bioactive Principles, Modes of Action and Potent Biomedical Applications, International Journal of Pharmacology, 10.3923/ijp.2015.253.290, 11:4, (253-290), Online publication date: 1-May-2015.

Barjesteh N, Brisbin J, Behboudi S, Nagy É and Sharif S (2015) Induction of Antiviral Responses Against Avian Influenza Virus in Embryonated Chicken Eggs with Toll-Like Receptor Ligands, Viral Immunology, 10.1089/vim.2014.0145, 28:4, (192-200), Online publication date: 1-May-2015.

Booy S, Hofland L and van Eijck C (2015) Potentials of Interferon Therapy in the Treatment of Pancreatic Cancer, Journal of Interferon & Cytokine Research, 10.1089/jir.2014.0157, 35:5, (327-339), Online publication date: 1-May-2015.

Li Y, Wen B, Chen R, Jiang F, Zhao X and Deng X (2015) Promotion of expression of interferon-stimulated genes in U937 monocytic cells by HIV RNAs, measured using stable isotope labeling with amino acids in cell culture (SILAC), Archives of Virology, 10.1007/s00705-015-2372-8, 160:5, (1249-1258), Online publication date: 1-May-2015.

Cavaillon J (2015) Molecular Mediators: Cytokines Reviews in Cell Biology and Molecular Medicine, 10.1002/3527600906.mcb.200400134.pub2, (1-37)

Lu J, Yi L, Ke C, Zhang Y, Liu R, Chen J, Kung H and He M (2013) The interaction between human enteroviruses and type I IFN signaling pathway, Critical Reviews in Microbiology, 10.3109/1040841X.2013.813903, 41:2, (201-207), Online publication date: 3-Apr-2015.

Davidson S, Maini M and Wack A (2015) Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections, Journal of Interferon & Cytokine Research, 10.1089/jir.2014.0227, 35:4, (252-264), Online publication date: 1-Apr-2015.

Crouse J, Kalinke U and Oxenius A (2015) Regulation of antiviral T cell responses by type I interferons, Nature Reviews Immunology, 10.1038/nri3806, 15:4, (231-242), Online publication date: 1-Apr-2015.

Antonelli G, Scagnolari C, Moschella F and Proietti E (2015) Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2014.12.006, 26:2, (121-131), Online publication date: 1-Apr-2015.

Gresser I (2015) On intuition and the discovery of interferon, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2014.11.006, 26:2, (99-101), Online publication date: 1-Apr-2015.

Severa M, Rizzo F, Giacomini E, Salvetti M and Coccia E (2015) IFN-β and multiple sclerosis: Cross-talking of immune cells and integration of immunoregulatory networks, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2014.11.005, 26:2, (229-239), Online publication date: 1-Apr-2015.

Capobianchi M, Uleri E, Caglioti C and Dolei A (2015) Type I IFN family members: Similarity, differences and interaction, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2014.10.011, 26:2, (103-111), Online publication date: 1-Apr-2015.

Annibali V, Mechelli R, Romano S, Buscarinu M, Fornasiero A, Umeton R, Ricigliano V, Orzi F, Coccia E, Salvetti M and Ristori G (2015) IFN-β and multiple sclerosis: From etiology to therapy and back, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2014.10.010, 26:2, (221-228), Online publication date: 1-Apr-2015.

Cerdeira A and Thadhani R (2015) Editorial: “Interfering” With Preeclampsia, Arthritis & Rheumatology, 10.1002/art.39028, 67:4, (862-864), Online publication date: 1-Apr-2015.

Stifter S and Feng C (2015) Interfering with Immunity: Detrimental Role of Type I IFNs during Infection, The Journal of Immunology, 10.4049/jimmunol.1402794, 194:6, (2455-2465), Online publication date: 15-Mar-2015.

Haller O, Staeheli P, Schwemmle M and Kochs G (2015) Mx GTPases: dynamin-like antiviral machines of innate immunity, Trends in Microbiology, 10.1016/j.tim.2014.12.003, 23:3, (154-163), Online publication date: 1-Mar-2015.

El-Baky N and Redwan E (2014) Therapeutic Alpha-Interferons Protein: Structure, Production, and Biosimilar, Preparative Biochemistry and Biotechnology, 10.1080/10826068.2014.907175, 45:2, (109-127), Online publication date: 17-Feb-2015.

Cheluvappa R, Eri R, Luo A and Grimm M (2015) Modulation of Interferon Activity-Associated Soluble Molecules by Appendicitis and Appendectomy Limits Colitis–Identification of Novel Anti-Colitic Targets, Journal of Interferon & Cytokine Research, 10.1089/jir.2014.0091, 35:2, (108-115), Online publication date: 1-Feb-2015.

Grine L, Dejager L, Libert C and Vandenbroucke R (2015) An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2014.10.009, 26:1, (25-33), Online publication date: 1-Feb-2015.

Pandey A, Kondabattula G, Dechamma H, Pandey A and Reddy G (2014) Phylogenetic Analysis of Bovine Interferon α, National Academy Science Letters, 10.1007/s40009-014-0291-y, 38:1, (75-79), Online publication date: 1-Feb-2015.

Ng S and Galipeau J (2014) Concise Review: Engineering the Fusion of Cytokines for the Modulation of Immune Cellular Responses in Cancer and Autoimmune Disorders, Stem Cells Translational Medicine, 10.5966/sctm.2014-0145, 4:1, (66-73), Online publication date: 1-Jan-2015.

Mihm S (2015) Activation of Type I and Type III Interferons in Chronic Hepatitis C, Journal of Innate Immunity, 10.1159/000369973, 7:3, (251-259), .

De Clercq E (2015) Ebola virus (EBOV) infection: Therapeutic strategies, Biochemical Pharmacology, 10.1016/j.bcp.2014.11.008, 93:1, (1-10), Online publication date: 1-Jan-2015.

(2015) References The Origin of Chronic Inflammatory Systemic Diseases and their Sequelae, 10.1016/B978-0-12-803321-0.09996-1, (261-355), .

Straub R (2015) Energy and Volume Regulation The Origin of Chronic Inflammatory Systemic Diseases and their Sequelae, 10.1016/B978-0-12-803321-0.00003-3, (131-149), .

Straub R (2015) History of Immunology Research The Origin of Chronic Inflammatory Systemic Diseases and their Sequelae, 10.1016/B978-0-12-803321-0.00001-X, (1-58), .

Arbuthnot P (2015) Essentials of Viruses and their Suitability for Treatment Using Gene Therapy Gene Therapy for Viral Infections, 10.1016/B978-0-12-410518-8.00001-6, (1-28), .

Weber G (2015) Immunotherapy Molecular Therapies of Cancer, 10.1007/978-3-319-13278-5_11, (333-351), .

Edwards C, Best S, Gun S, Claser C, James K, de Oca M, Sebina I, Rivera F, Amante F, Hertzog P, Engwerda C, Renia L and Haque A (2014) Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection , European Journal of Immunology, 10.1002/eji.201444824, 45:1, (130-141), Online publication date: 1-Jan-2015.

Lin S, Chen T, Lu P, Lin C, Lin W, Yang Y and Chen Y (2014) Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan, BMC Infectious Diseases, 10.1186/s12879-014-0705-y, 14:1, Online publication date: 1-Dec-2014.

Alfonso-Trujillo I, López Saura P, Toledo García M and Hernández Pavón Y (2014) Tratamiento del condiloma acuminado con interferón, Piel, 10.1016/j.piel.2014.05.006, 29:10, (660-670), Online publication date: 1-Dec-2014.

Alfonso Trujillo I, López Saura P, Nodarse Cuní H, Toledo García M and Hernández Pavón Y (2014) Terapia combinada de criocirugía e interferón alfa-2b humano recombinante frente a criocirugía en el condiloma acuminado, Piel, 10.1016/j.piel.2014.02.012, 29:9, (536-545), Online publication date: 1-Nov-2014.

Kuruganti S, Accavitti-Loper M and Walter M (2014) Production and characterization of thirteen human type-I interferon-α subtypes, Protein Expression and Purification, 10.1016/j.pep.2014.08.010, 103, (75-83), Online publication date: 1-Nov-2014.

Turner M, Nedjai B, Hurst T and Pennington D (2014) Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 10.1016/j.bbamcr.2014.05.014, 1843:11, (2563-2582), Online publication date: 1-Nov-2014.

Abdel-Mohsen M, Deng X, Danesh A, Liegler T, Jacobs E, Rauch A, Ledergerber B, Norris P, Günthard H, Wong J, Pillai S and Ho W (2014) Role of MicroRNA Modulation in the Interferon-α/Ribavirin Suppression of HIV-1 In Vivo, PLoS ONE, 10.1371/journal.pone.0109220, 9:10, (e109220)

Beiting D (2014) Protozoan parasites and type I interferons: a cold case reopened, Trends in Parasitology, 10.1016/j.pt.2014.07.007, 30:10, (491-498), Online publication date: 1-Oct-2014.

Abe H, Hayes C and Chayama K (2014) New insight into the enhanced effect of pegylated interferon-α, Hepatology, 10.1002/hep.27269, 60:4, (1435-1437), Online publication date: 1-Oct-2014.

Siciliano N, Hersperger A, Lacuanan A, Xu R, Sidney J, Sette A, Sigal L, Eisenlohr L and McFadden G (2014) Impact of Distinct Poxvirus Infections on the Specificities and Functionalities of CD4 + T Cell Responses , Journal of Virology, 10.1128/JVI.01150-14, 88:17, (10078-10091), Online publication date: 1-Sep-2014.

Reid E and Charleston B (2014) Type I and III Interferon Production in Response to RNA Viruses, Journal of Interferon & Cytokine Research, 10.1089/jir.2014.0066, 34:9, (649-658), Online publication date: 1-Sep-2014.

Freaney J, Zhang Q, Yigit E, Kim R, Widom J, Wang J and Horvath C (2014) High-Density Nucleosome Occupancy Map of Human Chromosome 9p21–22 Reveals Chromatin Organization of the Type I Interferon Gene Cluster, Journal of Interferon & Cytokine Research, 10.1089/jir.2013.0118, 34:9, (676-685), Online publication date: 1-Sep-2014.

Liu Y, Jesus A, Marrero B, Yang D, Ramsey S, Montealegre Sanchez G, Tenbrock K, Wittkowski H, Jones O, Kuehn H, Lee C, DiMattia M, Cowen E, Gonzalez B, Palmer I, DiGiovanna J, Biancotto A, Kim H, Tsai W, Trier A, Huang Y, Stone D, Hill S, Kim H, St. Hilaire C, Gurprasad S, Plass N, Chapelle D, Horkayne-Szakaly I, Foell D, Barysenka A, Candotti F, Holland S, Hughes J, Mehmet H, Issekutz A, Raffeld M, McElwee J, Fontana J, Minniti C, Moir S, Kastner D, Gadina M, Steven A, Wingfield P, Brooks S, Rosenzweig S, Fleisher T, Deng Z, Boehm M, Paller A and Goldbach-Mansky R (2014) Activated STING in a Vascular and Pulmonary Syndrome, New England Journal of Medicine, 10.1056/NEJMoa1312625, 371:6, (507-518), Online publication date: 7-Aug-2014.

Ahsan F, Arif A, Mahmood N, Gardner Q, Rashid N and Akhtar M (2014) Characterization and bioassay of post-translationally modified interferon α-2b expressed in Escherichia coli, Journal of Biotechnology, 10.1016/j.jbiotec.2014.05.001, 184, (11-16), Online publication date: 1-Aug-2014.

Lee M, Seo D, Kang J, Oh S and Choi C (2014) Expression of antiviral cytokines in Crandell-Reese feline kidney cells pretreated with Korean red ginseng extract or ginsenosides, Food and Chemical Toxicology, 10.1016/j.fct.2014.04.034, 70, (19-25), Online publication date: 1-Aug-2014.

Xu Z, Shan F, Shan F, Meng C, Zhou X, Zhang X, Chen X and Jiao X (2014) Generation and application of a 293 cell line stably expressing bovine interferon-gamma, Protein Expression and Purification, 10.1016/j.pep.2014.04.012, 99, (131-137), Online publication date: 1-Jul-2014.

Bis R, Stauffer T, Singh S, Lavoie T and Mallela K (2014) High yield soluble bacterial expression and streamlined purification of recombinant human interferon α-2a, Protein Expression and Purification, 10.1016/j.pep.2014.04.010, 99, (138-146), Online publication date: 1-Jul-2014.

Peciak K, Tommasi R, Choi J, Brocchini S and Laurine E (2014) Expression of soluble and active interferon consensus in SUMO fusion expression system in E. coli, Protein Expression and Purification, 10.1016/j.pep.2014.03.009, 99, (18-26), Online publication date: 1-Jul-2014.

Paulmann D, Bortmann S, Grimm F, Berk I, Kraemer L, Vallbracht A and Dotzauer A (2014) NF-κB activation induced by hepatitis A virus and Newcastle disease virus occurs by different pathways depending on the structural pattern of viral nucleic acids, Archives of Virology, 10.1007/s00705-014-1993-7, 159:7, (1723-1733), Online publication date: 1-Jul-2014.

Buchbinder E and McDermott D (2014) Interferon, Interleukin-2, and Other Cytokines, Hematology/Oncology Clinics of North America, 10.1016/j.hoc.2014.02.001, 28:3, (571-583), Online publication date: 1-Jun-2014.

Lu D, Leng T, Ding X, Peng W, Yao M, Li S, Lin H and Zhang Y (2014) Two IFNGR1 homologues in Tetraodon nigroviridis: Origin, expression analysis and ligand-binding preference, Developmental & Comparative Immunology, 10.1016/j.dci.2014.01.001, 44:2, (270-279), Online publication date: 1-Jun-2014.

Frieman M (2014) The art of war: battles between virus and host, Current Opinion in Virology, 10.1016/j.coviro.2014.05.001, 6, (76-77), Online publication date: 1-Jun-2014.

Cofre C, Gonzalez R, Moya J and Vidal R (2013) Phenotype gene expression differences between resistant and susceptible salmon families to IPNV, Fish Physiology and Biochemistry, 10.1007/s10695-013-9894-3, 40:3, (887-896), Online publication date: 1-Jun-2014.

Davidson S, Crotta S, McCabe T and Wack A (2014) Pathogenic potential of interferon αβ in acute influenza infection, Nature Communications, 10.1038/ncomms4864, 5:1

Bauer E, Zheng H, Lotze M, Bauer P and Zhao Y (2014) Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension, PLoS ONE, 10.1371/journal.pone.0096720, 9:5, (e96720)

Savan R (2014) Post-Transcriptional Regulation of Interferons and Their Signaling Pathways, Journal of Interferon & Cytokine Research, 10.1089/jir.2013.0117, 34:5, (318-329), Online publication date: 1-May-2014.

Pennell L and Fish E (2014) Immunoregulatory Effects of Interferon-β in Suppression of Th17 cells, Journal of Interferon & Cytokine Research, 10.1089/jir.2013.0088, 34:5, (330-341), Online publication date: 1-May-2014.

Liu X, Huang J, Yang S, Zhao Y, Xiang A, Cao J, Fan B, Wu Z, Zhao J, Zhao S and Zhu M (2014) Whole blood transcriptome comparison of pigs with extreme production of in vivo dsRNA-induced serum IFN-a, Developmental & Comparative Immunology, 10.1016/j.dci.2013.11.008, 44:1, (35-43), Online publication date: 1-May-2014.

Dussurget O, Bierne H and Cossart P (2014) The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons, Frontiers in Cellular and Infection Microbiology, 10.3389/fcimb.2014.00050, 4

Pinto A, Ramos H, Wu X, Aggarwal S, Shrestha B, Gorman M, Kim K, Suthar M, Atkinson J, Gale Jr M, Diamond M and Gack M (2014) Deficient IFN Signaling by Myeloid Cells Leads to MAVS-Dependent Virus-Induced Sepsis, PLoS Pathogens, 10.1371/journal.ppat.1004086, 10:4, (e1004086)

DeKelver R, Lewin B, Weng S, Yan M, Biggs J and Zhang D (2013) RUNX1–ETO induces a type I interferon response which negatively effects t(8;21)-induced increased self-renewal and leukemia development, Leukemia & Lymphoma, 10.3109/10428194.2013.815351, 55:4, (884-891), Online publication date: 1-Apr-2014.

Brkic Z and Versnel M (2014) Type I IFN signature in primary Sjögren’s syndrome patients, Expert Review of Clinical Immunology, 10.1586/1744666X.2014.876364, 10:4, (457-467), Online publication date: 1-Apr-2014.

Kroczynska B, Mehrotra S, Arslan A, Kaur S and Platanias L (2014) Regulation of Interferon-Dependent mRNA Translation of Target Genes, Journal of Interferon & Cytokine Research, 10.1089/jir.2013.0148, 34:4, (289-296), Online publication date: 1-Apr-2014.

Thompson J and Lake J (2014) Interferon graft dysfunction: a final chapter for interferon and hepatitis C, Hepatology International, 10.1007/s12072-014-9535-7, 8:2, (155-157), Online publication date: 1-Apr-2014.

Schneider W, Chevillotte M and Rice C (2014) Interferon-Stimulated Genes: A Complex Web of Host Defenses, Annual Review of Immunology, 10.1146/annurev-immunol-032713-120231, 32:1, (513-545), Online publication date: 21-Mar-2014.

Burke J, Platanias L, Fish E and Diamond M (2014) Beta Interferon Regulation of Glucose Metabolism Is PI3K/Akt Dependent and Important for Antiviral Activity against Coxsackievirus B3, Journal of Virology, 10.1128/JVI.02649-13, 88:6, (3485-3495), Online publication date: 15-Mar-2014.

Vitour D, Doceul V, Ruscanu S, Chauveau E, Schwartz-Cornil I and Zientara S (2014) Induction and control of the type I interferon pathway by Bluetongue virus, Virus Research, 10.1016/j.virusres.2013.10.027, 182, (59-70), Online publication date: 1-Mar-2014.

Silva L, Almeida G, Oliveira D, Dornas F, Campos R, La Scola B, Ferreira P, Kroon E and Abrahão J (2014) A resourceful giant: APMV is able to interfere with the human type I interferon system, Microbes and Infection, 10.1016/j.micinf.2013.11.011, 16:3, (187-195), Online publication date: 1-Mar-2014.

Owens T, Khorooshi R, Wlodarczyk A and Asgari N (2013) Interferons in the central nervous system: A few instruments play many tunes, Glia, 10.1002/glia.22608, 62:3, (339-355), Online publication date: 1-Mar-2014.

Ooi E, Chan S, Cho N, Wilkins C, Woodward J, Li M, Kikkawa U, Tellinghuisen T, Gale M and Saito T (2014) Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1, Proceedings of the National Academy of Sciences, 10.1073/pnas.1314268111, 111:5, (1909-1914), Online publication date: 4-Feb-2014.

Stifter S, Gould J, Mangan N, Reid H, Rossjohn J, Hertzog P and de Weerd N (2014) Purification and biological characterization of soluble, recombinant mouse IFNβ expressed in insect cells, Protein Expression and Purification, 10.1016/j.pep.2013.10.019, 94, (7-14), Online publication date: 1-Feb-2014.

Wang D, Zhong X, Huang D, Chen R, Bai G, Li Q, Yu B, Fan Y, Sun X and Caldwell C (2014) Functional Polymorphisms of Interferon-gamma Affect Pneumonia-Induced Sepsis, PLoS ONE, 10.1371/journal.pone.0087049, 9:1, (e87049)

Wiktor S, Ford N, Ball A and Hirnschall G (2014) HIV and HCV: distinct infections with important overlapping challenges, Journal of the International AIDS Society, 10.7448/IAS.17.1.19323, 17:1, (19323), Online publication date: 1-Jan-2014.

Trilling M, Le V, Rashidi-Alavijeh J, Katschinski B, Scheller J, Rose-John S, Androsiac G, Jonjić S, Poli V, Pfeffer K and Hengel H (2014) “Activated” STAT Proteins: A Paradoxical Consequence of Inhibited JAK-STAT Signaling in Cytomegalovirus-Infected Cells, The Journal of Immunology, 10.4049/jimmunol.1203516, 192:1, (447-458), Online publication date: 1-Jan-2014.

Micallef A, Grech N, Farrugia F, Schembri-Wismayer P and Calleja-Agius J (2013) The role of interferons in early pregnancy, Gynecological Endocrinology, 10.3109/09513590.2012.743011, 30:1, (1-6), Online publication date: 1-Jan-2014.

Ostler N, Britzen-Laurent N, Liebl A, Naschberger E, Lochnit G, Ostler M, Forster F, Kunzelmann P, Ince S, Supper V, Praefcke G, Schubert D, Stockinger H, Herrmann C and Stürzl M (2023) Gamma Interferon-Induced Guanylate Binding Protein 1 Is a Novel Actin Cytoskeleton Remodeling Factor, Molecular and Cellular Biology, 10.1128/MCB.00664-13, 34:2, (196-209), Online publication date: 1-Jan-2014.

Abdel-Mohsen M, Deng X, Liegler T, Guatelli J, Salama M, Ghanem H, Rauch A, Ledergerber B, Deeks S, Günthard H, Wong J and Pillai S (2014) Effects of Alpha Interferon Treatment on Intrinsic Anti-HIV-1 Immunity In Vivo , Journal of Virology, 10.1128/JVI.02687-13, 88:1, (763-767), Online publication date: 1-Jan-2014.

Wallach D, Kang T and Kovalenko A (2013) Concepts of tissue injury and cell death in inflammation: a historical perspective, Nature Reviews Immunology, 10.1038/nri3561, 14:1, (51-59), Online publication date: 1-Jan-2014.

Egli A, Santer D, O’Shea D, Tyrrell D and Houghton M (2019) The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections, Emerging Microbes & Infections, 10.1038/emi.2014.51, 3:1, (1-12), Online publication date: 1-Jan-2014.

Barnes M, Roychowdhury S and Nagy L (2014) Innate immunity and cell death in alcoholic liver disease: Role of cytochrome P4502E1, Redox Biology, 10.1016/j.redox.2014.07.007, 2, (929-935), .

Farrar J (2014) Type I Interferons in Immunity Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.00120-3, .

Moraga I, Spangler J, Mendoza J and Garcia K (2014) Multifarious Determinants of Cytokine Receptor Signaling Specificity , 10.1016/B978-0-12-800100-4.00001-5, (1-39), .

Hambleton S (2014) STAT2 Stiehm's Immune Deficiencies, 10.1016/B978-0-12-405546-9.00036-4, (721-725), .

Schultz U and Magor K (2014) Comparative Immunology of Agricultural Birds Avian Immunology, 10.1016/B978-0-12-396965-1.00021-2, (363-389), .

Oppenheim J (2014) Cytokines, their Receptors and Signals The Autoimmune Diseases, 10.1016/B978-0-12-384929-8.00016-2, (229-241), .

Vähä-Koskela M (2014) Antiviral Defenses Encyclopedia of Cancer, 10.1007/978-3-662-46875-3_7161, (298-304), .

Ma Y, Long M and Diao A (2014) Expression, Purification, and Activity Assay of Chicken Interferon-Alpha Proceedings of the 2012 International Conference on Applied Biotechnology (ICAB 2012), 10.1007/978-3-642-37922-2_76, (741-747), .

Vähä-Koskela M (2014) Antiviral Defenses Encyclopedia of Cancer, 10.1007/978-3-642-27841-9_7161-5, (1-7), .

Hertzog P (2014) Production and Action of Type I Interferons in Host Defense Bacterial Activation of Type I Interferons, 10.1007/978-3-319-09498-4_1, (1-15), .

Rammensee H (2014) From Basic Immunology to New Therapies for Cancer Patients Cancer Immunotherapy Meets Oncology, 10.1007/978-3-319-05104-8_1, (3-11), .

Lee J and Hoang M (2014) Cutaneous Lymphoid Infiltrates in Patients Receiving Biologic Modifiers Cutaneous Hematopathology, 10.1007/978-1-4939-0950-6_15, (471-491), .

Cudris J and Merchan J (2014) Immunotherapy in Renal Cell Carcinoma Advances in Tumor Immunology and Immunotherapy, 10.1007/978-1-4614-8809-5_8, (125-147), .

Ayllon J and García-Sastre A (2014) The NS1 Protein: A Multitasking Virulence Factor Influenza Pathogenesis and Control - Volume II, 10.1007/82_2014_400, (73-107), .

Xue M, Shi X, Zhao Y, Cui H, Hu S, Cui X, Wang Y and Murthy A (2013) Effects of Reticuloendotheliosis Virus Infection on Cytokine Production in SPF Chickens, PLoS ONE, 10.1371/journal.pone.0083918, 8:12, (e83918)

Cachat A, Chevalier S, Alais S, Ko N, Ratner L, Journo C, Dutartre H and Mahieux R (2013) Alpha Interferon Restricts Human T-Lymphotropic Virus Type 1 and 2 De Novo Infection through PKR Activation , Journal of Virology, 10.1128/JVI.02758-13, 87:24, (13386-13396), Online publication date: 15-Dec-2013.

Imran M, Manzoor S, Ashraf J, Khalid M, Tariq M, Khaliq H and Azam S (2013) Role of viral and host factors in interferon based therapy of hepatitis C virus infection, Virology Journal, 10.1186/1743-422X-10-299, 10:1, Online publication date: 1-Dec-2013.

Voigt E, İnankur B, Baltes A and Yin J (2013) A quantitative infection assay for human type I, II, and III interferon antiviral activities, Virology Journal, 10.1186/1743-422X-10-224, 10:1, Online publication date: 1-Dec-2013.

Li X, Xu X, Jin A, Jia Q, Zhou H, Kang S, Lou Y, Gao J and Lu J (2013) Self-assembled HCV core virus-like particles targeted and inhibited tumor cell migration and invasion, Nanoscale Research Letters, 10.1186/1556-276X-8-401, 8:1, Online publication date: 1-Dec-2013.

Bean A, Baker M, Stewart C, Cowled C, Deffrasnes C, Wang L and Lowenthal J (2013) Studying immunity to zoonotic diseases in the natural host — keeping it real, Nature Reviews Immunology, 10.1038/nri3551, 13:12, (851-861), Online publication date: 1-Dec-2013.

Wilson E and Brooks D (2013) Decoding the complexity of type I interferon to treat persistent viral infections, Trends in Microbiology, 10.1016/j.tim.2013.10.003, 21:12, (634-640), Online publication date: 1-Dec-2013.

Lin Y, Ooi C, Tan J, Show P, Ariff A and Ling T (2013) Recovery of human interferon alpha-2b from recombinant Escherichia coli using alcohol/salt-based aqueous two-phase systems, Separation and Purification Technology, 10.1016/j.seppur.2013.09.038, 120, (362-366), Online publication date: 1-Dec-2013.

Sedger L (2013) microRNA control of interferons and interferon induced anti-viral activity, Molecular Immunology, 10.1016/j.molimm.2013.07.009, 56:4, (781-793), Online publication date: 1-Dec-2013.

Langevin C, Aleksejeva E, Passoni G, Palha N, Levraud J and Boudinot P (2013) The Antiviral Innate Immune Response in Fish: Evolution and Conservation of the IFN System, Journal of Molecular Biology, 10.1016/j.jmb.2013.09.033, 425:24, (4904-4920), Online publication date: 1-Dec-2013.

Chen Y, Zhang Y, Huang Z, Xu Q, Zhu Z, Tong Y, Yu Q, Ding J and Chen G (2013) Molecular characterization, expression patterns, and subcellular localization of RIG-I in the Jinding Duck (Anas platyrhynchos domesticus), Developmental & Comparative Immunology, 10.1016/j.dci.2013.07.018, 41:4, (766-771), Online publication date: 1-Dec-2013.

Rice G, Forte G, Szynkiewicz M, Chase D, Aeby A, Abdel-Hamid M, Ackroyd S, Allcock R, Bailey K, Balottin U, Barnerias C, Bernard G, Bodemer C, Botella M, Cereda C, Chandler K, Dabydeen L, Dale R, De Laet C, De Goede C, del Toro M, Effat L, Enamorado N, Fazzi E, Gener B, Haldre M, Lin J, Livingston J, Lourenco C, Marques W, Oades P, Peterson P, Rasmussen M, Roubertie A, Schmidt J, Shalev S, Simon R, Spiegel R, Swoboda K, Temtamy S, Vassallo G, Vilain C, Vogt J, Wermenbol V, Whitehouse W, Soler D, Olivieri I, Orcesi S, Aglan M, Zaki M, Abdel-Salam G, Vanderver A, Kisand K, Rozenberg F, Lebon P and Crow Y (2013) Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study, The Lancet Neurology, 10.1016/S1474-4422(13)70258-8, 12:12, (1159-1169), Online publication date: 1-Dec-2013.

Hillyer P, Raviv N, Gold D, Dougherty D, Liu J, Johnson T, Graham B and Rabin R (2013) Subtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4 + T cells , European Journal of Immunology, 10.1002/eji.201243288, 43:12, (3197-3208), Online publication date: 1-Dec-2013.

Crotta S, Davidson S, Mahlakoiv T, Desmet C, Buckwalter M, Albert M, Staeheli P, Wack A and Kawaoka Y (2013) Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia, PLoS Pathogens, 10.1371/journal.ppat.1003773, 9:11, (e1003773)

(2013) CYTOKINES AND INTERFERONS Biotechnology and Biopharmaceuticals, 10.1002/9781118660485.ch11, (251-305)

Furuya Y and Müllbacher A (2013) Type I IFN Exhaustion is a Host Defence Protecting Against Secondary Bacterial Infections, Scandinavian Journal of Immunology, 10.1111/sji.12107, 78:5, (395-400), Online publication date: 1-Nov-2013.

Smith G, Benfield C, Maluquer de Motes C, Mazzon M, Ember S, Ferguson B and Sumner R (2013) Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity, Journal of General Virology, 10.1099/vir.0.055921-0, 94:11, (2367-2392), Online publication date: 1-Nov-2013.

Lowenthal J, Bean A and Kogut M (2013) What’s so special about chicken immunology?, Developmental & Comparative Immunology, 10.1016/j.dci.2013.07.012, 41:3, (307-309), Online publication date: 1-Nov-2013.

Goossens K, Ward A, Lowenthal J and Bean A (2013) Chicken interferons, their receptors and interferon-stimulated genes, Developmental & Comparative Immunology, 10.1016/j.dci.2013.05.020, 41:3, (370-376), Online publication date: 1-Nov-2013.

Ahmed C and Johnson H (2014) The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis, JAK-STAT, 10.4161/jkst.26227, 2:4, (e26227), Online publication date: 16-Oct-2013.

Whitehead P, Drouet B, Zagury D and Bensussan A (2013) Traitement antiviral, médecine/sciences, 10.1051/medsci/20132910008, 29:10, (836-839), Online publication date: 1-Oct-2013.

Ito F and Chang A (2013) Cancer Immunotherapy, Surgical Oncology Clinics of North America, 10.1016/j.soc.2013.06.005, 22:4, (765-783), Online publication date: 1-Oct-2013.

Prakash S, Agrawal S, Cao J, Gupta S and Agrawal A (2012) Impaired secretion of interferons by dendritic cells from aged subjects to influenza, AGE, 10.1007/s11357-012-9477-8, 35:5, (1785-1797), Online publication date: 1-Oct-2013.

Iwasaki A and Peiris M (2013) Innate immunity Textbook of Influenza, 10.1002/9781118636817.ch17, (267-282)

Durbin R, Kotenko S and Durbin J (2013) Interferon induction and function at the mucosal surface, Immunological Reviews, 10.1111/imr.12101, 255:1, (25-39), Online publication date: 1-Sep-2013.

Trilling M, Bellora N, Rutkowski A, de Graaf M, Dickinson P, Robertson K, Prazeres da Costa O, Ghazal P, Friedel C, Albà M and Dölken L (2013) Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis, Nucleic Acids Research, 10.1093/nar/gkt589, 41:17, (8107-8125), Online publication date: 1-Sep-2013., Online publication date: 1-Sep-2013.

Rotondi M, Coperchini F, Sideri R, Groppelli G, de Martinis L, Villani L, Pignatti P, Magri F and Chiovato L (2013) Type I and Type II Interferons Inhibit Both Basal and Tumor Necrosis Factor-α-Induced CXCL8 Secretion in Primary Cultures of Human Thyrocytes, Journal of Interferon & Cytokine Research, 10.1089/jir.2012.0080, 33:9, (508-513), Online publication date: 1-Sep-2013.

Weh J, Antoni C, Weiß C, Findeisen P, Ebert M and Böcker U (2013) Discriminatory potential of C-reactive protein, cytokines, and fecal markers in infectious gastroenteritis in adults, Diagnostic Microbiology and Infectious Disease, 10.1016/j.diagmicrobio.2013.05.005, 77:1, (79-84), Online publication date: 1-Sep-2013.

Thillier Y, Stevens S, Moy C, Taylor J, Vasseur J, Beigelman L and Debart F (2013) Solid-phase synthesis of 5′-triphosphate 2′-5′-oligoadenylates analogs with 3′-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs, Bioorganic & Medicinal Chemistry, 10.1016/j.bmc.2013.06.008, 21:17, (5461-5469), Online publication date: 1-Sep-2013.

Derkow K, Bauer J, Hecker M, Paap B, Thamilarasan M, Koczan D, Schott E, Deuschle K, Bellmann-Strobl J, Paul F, Zettl U, Ruprecht K, Lehnardt S and Alexopoulou L (2013) Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells, PLoS ONE, 10.1371/journal.pone.0070626, 8:8, (e70626)

Hermant P, Francius C, Clotman F, Michiels T and Thiel V (2013) IFN-ε Is Constitutively Expressed by Cells of the Reproductive Tract and Is Inefficiently Secreted by Fibroblasts and Cell Lines, PLoS ONE, 10.1371/journal.pone.0071320, 8:8, (e71320)

WANG L and WU X (2013) Cytokines of defender against cell death 1 and allograft inflammatory factor-1 with regard to innate immunity of fish, Journal of Fishery Sciences of China, 10.3724/SP.J.1118.2011.00237, 18:1, (237-242), Online publication date: 8-Aug-2013.

Rehwinkel J and Reis e Sousa C (2013) Targeting the viral Achilles’ heel: recognition of 5′-triphosphate RNA in innate anti-viral defence, Current Opinion in Microbiology, 10.1016/j.mib.2013.04.009, 16:4, (485-492), Online publication date: 1-Aug-2013.

Kuss S, Mata M, Zhang L and Fontoura B (2013) Nuclear Imprisonment: Viral Strategies to Arrest Host mRNA Nuclear Export, Viruses, 10.3390/v5071824, 5:7, (1824-1849)

Vazquez-Lombardi R, Roome B and Christ D (2013) Molecular Engineering of Therapeutic Cytokines, Antibodies, 10.3390/antib2030426, 2:4, (426-451)

Lind K, Richardson S, Leete P, Morgan N, Korsgren O and Flodström-Tullberg M (2013) Induction of an Antiviral State and Attenuated Coxsackievirus Replication in Type III Interferon-Treated Primary Human Pancreatic Islets, Journal of Virology, 10.1128/JVI.03431-12, 87:13, (7646-7654), Online publication date: 1-Jul-2013.

Demers K, Reuter M and Betts M (2013) CD8 + T-cell effector function and transcriptional regulation during HIV pathogenesis , Immunological Reviews, 10.1111/imr.12069, 254:1, (190-206), Online publication date: 1-Jul-2013.

Heim M (2013) 25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end, Nature Reviews Immunology, 10.1038/nri3463, 13:7, (535-542), Online publication date: 1-Jul-2013.

Pelka K and Latz E (2013) IRF5, IRF8, and IRF7 in human pDCs - the good, the bad, and the insignificant?, European Journal of Immunology, 10.1002/eji.201343739, 43:7, (1693-1697), Online publication date: 1-Jul-2013.

MacLeod D, Nakatsuji T, Yamasaki K, Kobzik L and Gallo R (2013) HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection, Nature Communications, 10.1038/ncomms2963, 4:1

Fusco D, Brisac C, John S, Huang Y, Chin C, Xie T, Zhao H, Jilg N, Zhang L, Chevaliez S, Wambua D, Lin W, Peng L, Chung R and Brass A (2013) A Genetic Screen Identifies Interferon-α Effector Genes Required to Suppress Hepatitis C Virus Replication, Gastroenterology, 10.1053/j.gastro.2013.02.026, 144:7, (1438-1449.e9), Online publication date: 1-Jun-2013.

Hertzog P and Williams B (2013) Fine tuning type I interferon responses, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2013.04.002, 24:3, (217-225), Online publication date: 1-Jun-2013.

Hofer M and Campbell I (2013) Type I interferon in neurological disease—The devil from within, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2013.03.006, 24:3, (257-267), Online publication date: 1-Jun-2013.

Nicola N (2013) A (selective) history of Australian involvement in cytokine biology, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2013.03.004, 24:3, (179-187), Online publication date: 1-Jun-2013.

Scagnolari C and Antonelli G (2013) Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C, Expert Opinion on Biological Therapy, 10.1517/14712598.2013.764409, 13:5, (693-711), Online publication date: 1-May-2013.

Szczerba B, Rybakowska P, Dey P, Payerhin K, Peck A, Bagavant H and Deshmukh U (2013) Type I Interferon Receptor Deficiency Prevents Murine Sjögren’s Syndrome, Journal of Dental Research, 10.1177/0022034513483315, 92:5, (444-449), Online publication date: 1-May-2013.

Hong X and Carmichael G (2013) Innate Immunity in Pluripotent Human Cells, Journal of Biological Chemistry, 10.1074/jbc.M112.435461, 288:22, (16196-16205), Online publication date: 1-May-2013.

Goubau D, Deddouche S and Reis e Sousa C (2013) Cytosolic Sensing of Viruses, Immunity, 10.1016/j.immuni.2013.05.007, 38:5, (855-869), Online publication date: 1-May-2013.

Xu L, Yang L and Liu W (2013) Distinct evolution process among type I interferon in mammals, Protein & Cell, 10.1007/s13238-013-3021-1, 4:5, (383-392), Online publication date: 1-May-2013.

Cavlar T, Deimling T, Ablasser A, Hopfner K and Hornung V (2013)(2013) Species-specific detection of the antiviral small-molecule compound CMA by STING, The EMBO Journal, 10.1038/emboj.2013.86, 32:10, (1440-1450)

Teijaro J, Ng C, Lee A, Sullivan B, Sheehan K, Welch M, Schreiber R, Carlos de la Torre J and Oldstone M (2013) Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling, Science, 10.1126/science.1235214, 340:6129, (207-211), Online publication date: 12-Apr-2013.

Bekisz J, Sato Y, Johnson C, Husain S, Puri R and Zoon K (2013) Immunomodulatory Effects of Interferons in Malignancies, Journal of Interferon & Cytokine Research, 10.1089/jir.2012.0167, 33:4, (154-161), Online publication date: 1-Apr-2013.

Qu H, Yang L, Meng S, Xu L, Bi Y, Jia X, Li J, Sun L, Liu W and Valledor A (2013) The Differential Antiviral Activities of Chicken Interferon α (ChIFN-α) and ChIFN-β are Related to Distinct Interferon-Stimulated Gene Expression, PLoS ONE, 10.1371/journal.pone.0059307, 8:3, (e59307)

Fioravanti J, Prieto J and Berraondo P (2013) Targeting Interferon-α to the Liver: Apolipoprotein A-I as a Scaffold for Protein Delivery Fusion Protein Technologies for Biopharmaceuticals, 10.1002/9781118354599.ch29, (441-452)

Hussmann K, Samuel M, Kim K, Diamond M and Fredericksen B (2013) Differential Replication of Pathogenic and Nonpathogenic Strains of West Nile Virus within Astrocytes, Journal of Virology, 10.1128/JVI.02577-12, 87:5, (2814-2822), Online publication date: 1-Mar-2013.

Cordeil S, Nguyen X, Berger G, Durand S, Ainouze M and Cimarelli A (2013) Evidence for a Different Susceptibility of Primate Lentiviruses to Type I Interferons, Journal of Virology, 10.1128/JVI.02553-12, 87:5, (2587-2596), Online publication date: 1-Mar-2013.

Fung K, Mangan N, Cumming H, Horvat J, Mayall J, Stifter S, De Weerd N, Roisman L, Rossjohn J, Robertson S, Schjenken J, Parker B, Gargett C, Nguyen H, Carr D, Hansbro P and Hertzog P (2013) Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection, Science, 10.1126/science.1233321, 339:6123, (1088-1092), Online publication date: 1-Mar-2013.

Gibbert K, Schlaak J, Yang D and Dittmer U (2013) IFN-α subtypes: distinct biological activities in anti-viral therapy, British Journal of Pharmacology, 10.1111/bph.12010, 168:5, (1048-1058), Online publication date: 1-Mar-2013.

Sykes A (2013) Asthma and Infections, Clinical Pulmonary Medicine, 10.1097/CPM.0b013e318285c4e0, 20:2, (56-60), Online publication date: 1-Mar-2013.

Ngunjiri J, Buchek G, Mohni K, Sekellick M and Marcus P (2013) Influenza Virus Subpopulations: Exchange of Lethal H5N1 Virus NS for H1N1 Virus NS Triggers De Novo Generation of Defective-Interfering Particles and Enhances Interferon-Inducing Particle Efficiency , Journal of Interferon & Cytokine Research, 10.1089/jir.2012.0070, 33:3, (99-107), Online publication date: 1-Mar-2013.

Lee C, Collichio F, Ollila D and Moschos S (2013) Historical review of melanoma treatment and outcomes, Clinics in Dermatology, 10.1016/j.clindermatol.2012.08.015, 31:2, (141-147), Online publication date: 1-Mar-2013.

De Clercq E (2013) Antivirals: Past, present and future, Biochemical Pharmacology, 10.1016/j.bcp.2012.12.011, 85:6, (727-744), Online publication date: 1-Mar-2013.

Pan C, Zhang C and Huang J (2013) Advances in individual markers of interferon in anti-cancer therapy, The Chinese-German Journal of Clinical Oncology, 10.1007/s10330-012-1129-z, 12:3, (129-132), Online publication date: 1-Mar-2013.

Raaijmakers M, Rozati S, Goldinger S, Widmer D, Dummer R and Levesque M (2013) Melanoma immunotherapy: historical precedents, recent successes and future prospects, Immunotherapy, 10.2217/imt.12.162, 5:2, (169-182), Online publication date: 1-Feb-2013.

Burke D and Meager T (2013) Norman B. Finter, MD (1924–2012), Journal of Interferon & Cytokine Research, 10.1089/jir.2012.1501, 33:2, (49-51), Online publication date: 1-Feb-2013.

Malinoski C and Marcus P (2013) Influenza Virus Subpopulations: Interferon Induction-Suppressing Particles Require Expression of NS1 and Act Globally in Cells; UV Irradiation of Interferon-Inducing Particles Blocks Global Shut-Off and Enhances Interferon Production, Journal of Interferon & Cytokine Research, 10.1089/jir.2012.0075, 33:2, (72-79), Online publication date: 1-Feb-2013.

Suthar M, Diamond M and Gale Jr M (2013) West Nile virus infection and immunity, Nature Reviews Microbiology, 10.1038/nrmicro2950, 11:2, (115-128), Online publication date: 1-Feb-2013.

Ottman C (2013) Protein-Protein Interactions: An Overview Protein-Protein Interactions in Drug Discovery, 10.1002/9783527648207.ch1, (1-19)

Cavaillon J (2013) Sir Marc Armand Ruffer and Giulio Bizzozero: the first reports on efferocytosis, Journal of Leukocyte Biology, 10.1189/jlb.0712361, 93:1, (39-43), Online publication date: 1-Jan-2013.

Yoo E, Crall B, Balakrishna R, Malladi S, Fox L, Hermanson A and David S (2013) Structure–activity relationships in Toll-like receptor 7 agonistic 1H-imidazo[4,5-c]pyridines, Organic & Biomolecular Chemistry, 10.1039/c3ob40816g, 11:38, (6526), .

Aguiar F, Moraes de Oliveira A and Masetto de Gaitani C (2013) Development, validation, and application of a capillary electrophoresis method for analysis of cytokine interferon alpha-2a in pharmaceutical formulations, Analytical Methods, 10.1039/c3ay26582j, 5:19, (5215), .

Peterhans E and Schweizer M (2013) BVDV: A pestivirus inducing tolerance of the innate immune response, Biologicals, 10.1016/j.biologicals.2012.07.006, 41:1, (39-51), Online publication date: 1-Jan-2013.

Pawlotsky J (2013) Hepatitis C Virus Antiviral Agents, 10.1016/B978-0-12-405880-4.00005-6, (169-215), .

Price K and Rao G (2013) Biological Therapies for Cancer Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics, 10.1016/B978-0-12-394810-6.00013-7, (303-342), .

Limmroth V (2013) Betaferon® – Ab Ovo Betaferon®, 10.1007/978-3-7091-1766-8_1, (1-12), .

Widman D (2013) Bioassay for the Measurement of Type-I Interferon Activity Mouse Models of Innate Immunity, 10.1007/978-1-62703-481-4_11, (91-96), .

Abdulla F, Duvic M and Kim Y (2013) Cutaneous T-Cell Lymphomas T-Cell Lymphomas, 10.1007/978-1-62703-170-7_10, (155-177), .

Davar D, Appleman L and Kirkwood J (2013) Interferon Alpha Cancer Therapeutic Targets, 10.1007/978-1-4614-6613-0_64-3, (1-28), .

Ryff J and Pestka S (2013) Interferons and Interleukins Pharmaceutical Biotechnology, 10.1007/978-1-4614-6486-0_21, (413-437), .

Moens B, Pannecouque C, López G, Talledo M, Gotuzzo E, Khouri R, Bittencourt A, Farré L, Galvão-Castro B, Vandamme A and Van Weyenbergh J (2012) Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines, Virology Journal, 10.1186/1743-422X-9-171, 9:1, Online publication date: 1-Dec-2012.

Mi Z, Ma Y and Tong Y (2012) Avian influenza virus H5N1 induces rapid interferon-beta production but shows more potent inhibition to retinoic acid-inducible gene I expression than H1N1 in vitro, Virology Journal, 10.1186/1743-422X-9-145, 9:1, Online publication date: 1-Dec-2012.

Asselah T (2012) Interferon Stimulated Genes and Hepatitis C Virus Infection, Journal of Interferon & Cytokine Research, 10.1089/jir.2012.0059, 32:12, (557-562), Online publication date: 1-Dec-2012.

Manry J and Quintana-Murci L (2012) Génétique des populations et immunité chez l’homme, médecine/sciences, 10.1051/medsci/20122812020, 28:12, (1095-1101), Online publication date: 1-Dec-2012.

Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, Chapman R and Hertzog P (2012) INTERFEROME v2.0: an updated database of annotated interferon-regulated genes, Nucleic Acids Research, 10.1093/nar/gks1215, 41:D1, (D1040-D1046)

Trilling M, Le V and Hengel H (2012) Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention, Future Microbiology, 10.2217/fmb.12.109, 7:11, (1269-1282), Online publication date: 1-Nov-2012.

Hey Y and O'Neill H (2012) Murine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function, Journal of Cellular and Molecular Medicine, 10.1111/j.1582-4934.2012.01608.x, 16:11, (2611-2619), Online publication date: 1-Nov-2012.

Epperson M, Lee C and Fremont D (2012) Subversion of cytokine networks by virally encoded decoy receptors, Immunological Reviews, 10.1111/imr.12009, 250:1, (199-215), Online publication date: 1-Nov-2012.

Piehler J, Thomas C, Garcia K and Schreiber G (2012) Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation, Immunological Reviews, 10.1111/imr.12001, 250:1, (317-334), Online publication date: 1-Nov-2012.

Mayes M (2012) The genetics of scleroderma, Current Opinion in Rheumatology, 10.1097/BOR.0b013e328358575b, 24:6, (677-684), Online publication date: 1-Nov-2012.

Xi Y, Day S, Jackson R and Ranasinghe C (2012) Role of novel type I interferon epsilon in viral infection and mucosal immunity, Mucosal Immunology, 10.1038/mi.2012.35, 5:6, (610-622), Online publication date: 1-Nov-2012.

Rahman M and Eo S (2012) Prospects and challenges of using chicken cytokines in disease prevention, Vaccine, 10.1016/j.vaccine.2012.10.011, 30:50, (7165-7173), Online publication date: 1-Nov-2012.

Tarhini A, Gogas H and Kirkwood J (2012) IFN-α in the Treatment of Melanoma, The Journal of Immunology, 10.4049/jimmunol.1290060, 189:8, (3789-3793), Online publication date: 15-Oct-2012.

Ernstoff M (2012) Overcoming the logistics of immune monitoring of cancer patients during clinical trials, Clinical Investigation, 10.4155/cli.12.90, 2:10, (953-955), Online publication date: 1-Oct-2012.

Hillyer P, Mane V, Schramm L, Puig M, Verthelyi D, Chen A, Zhao Z, Navarro M, Kirschman K, Bykadi S, Jubin R and Rabin R (2012) Expression profiles of human interferon‐alpha and interferon‐lambda subtypes are ligand‐ and cell‐dependent, Immunology & Cell Biology, 10.1038/icb.2011.109, 90:8, (774-783), Online publication date: 1-Sep-2012.

Sin W, Li P, Yeong J and Chin K (2012) Activation and regulation of interferon-β in immune responses, Immunologic Research, 10.1007/s12026-012-8293-7, 53:1-3, (25-40), Online publication date: 1-Sep-2012.

Axtell R and Raman C (2012) Janus-like effects of type I interferon in autoimmune diseases, Immunological Reviews, 10.1111/j.1600-065X.2012.01131.x, 248:1, (23-35), Online publication date: 1-Jul-2012.

George P, Badiger R, Alazawi W, Foster G and Mitchell J (2012) Pharmacology and therapeutic potential of interferons, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2012.03.006, 135:1, (44-53), Online publication date: 1-Jul-2012.

Cowling B, Fang V, Nishiura H, Chan K, Ng S, Ip D, Chiu S, Leung G and Peiris J (2012) Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine, Clinical Infectious Diseases, 10.1093/cid/cis307, 54:12, (1778-1783), Online publication date: 15-Jun-2012., Online publication date: 15-Jun-2012.

Robb R and Hill G (2012) The interferon-dependent orchestration of innate and adaptive immunity after transplantation, Blood, 10.1182/blood-2012-02-368076, 119:23, (5351-5358), Online publication date: 7-Jun-2012.

Hubbard J, Greenwell-Wild T, Barrett L, Yang J, Lempicki R, Wahl S, Asmuth D, Murphy R, Pollard R and Kottilil S (2012) Host Gene Expression Changes Correlating With Anti–HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2a, The Journal of Infectious Diseases, 10.1093/infdis/jis211, 205:9, (1443-1447), Online publication date: 1-May-2012., Online publication date: 1-May-2012.

Byrnes-Blake K, Pederson S, Klucher K, Anderson-Haley M, Miller D, Lopez-Talavera J and Freeman J (2012) Pharmacokinetics and Pharmacodynamics of Pegylated Interferon Lambda-1 in Cynomolgus Monkeys, Journal of Interferon & Cytokine Research, 10.1089/jir.2011.0075, 32:5, (198-206), Online publication date: 1-May-2012.

Weerd N and Nguyen T (2012) The interferons and their receptors—distribution and regulation, Immunology & Cell Biology, 10.1038/icb.2012.9, 90:5, (483-491), Online publication date: 1-May-2012.

Tough D (2012) Modulation of T‐cell function by type I interferon, Immunology & Cell Biology, 10.1038/icb.2012.7, 90:5, (492-497), Online publication date: 1-May-2012.

Cavlar T, Ablasser A and Hornung V (2012) Induction of type I IFNs by intracellular DNA‐sensing pathways, Immunology & Cell Biology, 10.1038/icb.2012.11, 90:5, (474-482), Online publication date: 1-May-2012.

Fioravanti J, Medina-Echeverz J, Ardaiz N, Gomar C, Parra-Guillén Z, Prieto J and Berraondo P (2012) The Fusion Protein of IFN-α and Apolipoprotein A-I Crosses the Blood–Brain Barrier by a Saturable Transport Mechanism, The Journal of Immunology, 10.4049/jimmunol.1101598, 188:8, (3988-3992), Online publication date: 15-Apr-2012.

Willmes C, Adam C, Alb M, Völkert L, Houben R, Becker J and Schrama D (2012) Type I and II IFNs Inhibit Merkel Cell Carcinoma via Modulation of the Merkel Cell Polyomavirus T Antigens, Cancer Research, 10.1158/0008-5472.CAN-11-2651, 72:8, (2120-2128), Online publication date: 15-Apr-2012.

Burlone M, Minisini R and Pirisi M (2012) Interferon-stimulated gene pathways in the treatment of viral hepatitis, Future Virology, 10.2217/fvl.12.21, 7:4, (361-369), Online publication date: 1-Apr-2012.

Berry C, Hertzog P and Mangan N (2012) Interferons as biomarkers and effectors: lessons learned from animal models, Biomarkers in Medicine, 10.2217/bmm.12.10, 6:2, (159-176), Online publication date: 1-Apr-2012.

Lin Y, Ooi C, Ramanan R, Ariff A and Ling T (2012) Recovery of Human Interferon Alpha-2b from Recombinant Escherichia coli by Aqueous Two-Phase System , Separation Science and Technology, 10.1080/01496395.2011.644018, 47:7, (1023-1030), Online publication date: 1-Apr-2012.

Pulit-Penaloza J, Scherbik S and Brinton M (2012) Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells, Virology, 10.1016/j.virol.2012.01.006, 425:2, (82-94), Online publication date: 1-Apr-2012.

Stark G and Darnell J (2012) The JAK-STAT Pathway at Twenty, Immunity, 10.1016/j.immuni.2012.03.013, 36:4, (503-514), Online publication date: 1-Apr-2012.

Kaiser M and Ottmann C (2012) In Silico Identification of an Interferon Inhibitor, ChemMedChem, 10.1002/cmdc.201100579, 7:4, (555-557), Online publication date: 1-Apr-2012.

Quetglas J, Fioravanti J, Ardaiz N, Medina-Echeverz J, Baraibar I, Prieto J, Smerdou C and Berraondo P (2011) A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumors, Gene Therapy, 10.1038/gt.2011.99, 19:3, (271-278), Online publication date: 1-Mar-2012.

Touzot M, Soumelis V and Asselah T (2012) A dive into the complexity of type I interferon antiviral functions, Journal of Hepatology, 10.1016/j.jhep.2011.07.009, 56:3, (726-728), Online publication date: 1-Mar-2012.

Reyes-Vázquez C, Prieto-Gómez B and Dafny N (2012) Interferon modulates central nervous system function, Brain Research, 10.1016/j.brainres.2011.09.061, 1442, (76-89), Online publication date: 1-Mar-2012.

Pillai S, Abdel-Mohsen M, Guatelli J, Skasko M, Monto A, Fujimoto K, Yukl S, Greene W, Kovari H, Rauch A, Fellay J, Battegay M, Hirschel B, Witteck A, Bernasconi E, Ledergerber B, Günthard H, Wong J, Barth J, Battegay M, Bernasconi E, Böni J, Bucher H, Burton-Jeangros C, Calmy A, Cavassini M, Cellerai C, Egger M, Elzi L, Fehr J, Fellay J, Flepp M, Francioli P, Furrer H, Fux C, Gorgievski M, Günthard H, Haerry D, Hasse B, Hirsch H, Hirschel B, Hösli I, Kahlert C, Kaiser L, Keiser O, Kind C, Klimkait T, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Müller N, Nadal D, Pantaleo G, Rauch A, Regenass S, Rickenbach M, Rudin C, Schmid P, Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Tarr P, Telenti A, Trkola A, Vernazza P, Weber R and Yerly S (2012) Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo, Proceedings of the National Academy of Sciences, 10.1073/pnas.1111573109, 109:8, (3035-3040), Online publication date: 21-Feb-2012.

Robinson B, Estep R, Messaoudi I, Rogers K and Wong S (2012) Viral Interferon Regulatory Factors Decrease the Induction of Type I and Type II Interferon during Rhesus Macaque Rhadinovirus Infection, Journal of Virology, 10.1128/JVI.05047-11, 86:4, (2197-2211), Online publication date: 15-Feb-2012.

González-Navajas J, Lee J, David M and Raz E (2012) Immunomodulatory functions of type I interferons, Nature Reviews Immunology, 10.1038/nri3133, 12:2, (125-135), Online publication date: 1-Feb-2012.

Cook B, Cutts T, Court D and Theriault S (2012) The generation of a reverse genetics system for Kyasanur Forest Disease Virus and the ability to antagonize the induction of the antiviral state in vitro, Virus Research, 10.1016/j.virusres.2011.11.002, 163:2, (431-438), Online publication date: 1-Feb-2012.

Kurche J, Haluszczak C, McWilliams J, Sanchez P and Kedl R (2012) Type I IFN-Dependent T Cell Activation Is Mediated by IFN-Dependent Dendritic Cell OX40 Ligand Expression and Is Independent of T Cell IFNR Expression, The Journal of Immunology, 10.4049/jimmunol.1102550, 188:2, (585-593), Online publication date: 15-Jan-2012.

Koppe U, Högner K, Doehn J, Müller H, Witzenrath M, Gutbier B, Bauer S, Pribyl T, Hammerschmidt S, Lohmeyer J, Suttorp N, Herold S and Opitz B (2012) Streptococcus pneumoniae Stimulates a STING- and IFN Regulatory Factor 3-Dependent Type I IFN Production in Macrophages, which Regulates RANTES Production in Macrophages, Cocultured Alveolar Epithelial Cells, and Mouse Lungs , The Journal of Immunology, 10.4049/jimmunol.1004143, 188:2, (811-817), Online publication date: 15-Jan-2012.

DeCarlo C, Rosa B, Jackson R, Niccoli S, Escott N and Zehbe I (2012) Toll-Like Receptor Transcriptome in the HPV-Positive Cervical Cancer Microenvironment, Clinical and Developmental Immunology, 10.1155/2012/785825, 2012, (1-9), .

Savaskan N, Fingerle-Rowson G, Buchfelder M and Eyüpoglu I (2012) Brain Miffed by Macrophage Migration Inhibitory Factor, International Journal of Cell Biology, 10.1155/2012/139573, 2012, (1-11), .

Liu X, Wei G, Yang D, Liu L, Ma L, Li X, OuYang J, Li C, Zhang K, Wang J, Chu L, Gu J, Li H, Ding J, Wei N, Cai Y, Liu X, Cao X, Chen Y, Wu Z, Ding M and Zuo M (2012) Possibility to Partly Win the War Against Cancer Recent Advances in Cancer Research and Therapy, 10.1016/B978-0-12-397833-2.00021-2, (617-671), .

Arens R (2012) Rational Design of Vaccines Synthetic Vaccines, 10.1016/B978-0-12-396548-6.00009-3, (217-243), .

Simbirtsev A and Kozlov I (2012) Cytokine System Mechanical Stretch and Cytokines, 10.1007/978-94-007-2004-6_1, (1-33), .

Abdul-Sater A and Schindler C (2012) Interferon Regulation of the Innate Response to Bacteria Jak-Stat Signaling : From Basics to Disease, 10.1007/978-3-7091-0891-8_22, (425-441), .

Murphy C and O’Neill L (2012) Negative Regulators of NF-κB Activation and Type I Interferon Pathways Innate Immune Regulation and Cancer Immunotherapy, 10.1007/978-1-4419-9914-6_15, (267-287), .

Kaur B, Lesinski G and Chaudhary A (2011) From Concept to the Clinics: Development of Cancer Therapeutics Pharmaceutical Sciences Encyclopedia, 10.1002/9780470571224.pse421

Foo S, Chen W, Herrero L, Bettadapura J, Narayan J, Dar L, Broor S and Mahalingam S (2011) The genetics of alphaviruses, Future Virology, 10.2217/fvl.11.123, 6:12, (1407-1422), Online publication date: 1-Dec-2011.

Hasselbalch H (2014) A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms, Expert Review of Hematology, 10.1586/ehm.11.63, 4:6, (637-655), Online publication date: 1-Dec-2011.

Pinto A, Daffis S, Brien J, Gainey M, Yokoyama W, Sheehan K, Murphy K, Schreiber R, Diamond M and Basler C (2011) A Temporal Role Of Type I Interferon Signaling in CD8+ T Cell Maturation during Acute West Nile Virus Infection, PLoS Pathogens, 10.1371/journal.ppat.1002407, 7:12, (e1002407)

Jiang H, Yang H and Kapczynski D (2011) Chicken interferon alpha pretreatment reduces virus replication of pandemic H1N1 and H5N9 avian influenza viruses in lung cell cultures from different avian species, Virology Journal, 10.1186/1743-422X-8-447, 8:1, Online publication date: 1-Dec-2011.

Zhao L, Hua X, He S, Ren H and Qi Z (2011) Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells, Virology Journal, 10.1186/1743-422X-8-157, 8:1, Online publication date: 1-Dec-2011.

Jie H and Liu Y (2019) Breeding for disease resistance in poultry: opportunities with challenges, World's Poultry Science Journal, 10.1017/S0043933911000766, 67:4, (687-696), Online publication date: 1-Dec-2011.

Verrier E, Langevin C, Benmansour A and Boudinot P (2011) Early antiviral response and virus-induced genes in fish, Developmental & Comparative Immunology, 10.1016/j.dci.2011.03.012, 35:12, (1204-1214), Online publication date: 1-Dec-2011.

Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang S and Casanova J (2011) Inborn errors of anti-viral interferon immunity in humans, Current Opinion in Virology, 10.1016/j.coviro.2011.10.016, 1:6, (487-496), Online publication date: 1-Dec-2011.

Rönnblom L (2011) The type I interferon system in the etiopathogenesis of autoimmune diseases, Upsala Journal of Medical Sciences, 10.3109/03009734.2011.624649, 116:4, (227-237), Online publication date: 1-Nov-2011.

Crow Y (2011) Type I interferonopathies: a novel set of inborn errors of immunity, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.2011.06220.x, 1238:1, (91-98), Online publication date: 1-Nov-2011.

Wilke C, Wei S, Wang L, Kryczek I, Kao J and Zou W (2011) Dual biological effects of the cytokines interleukin-10 and interferon-γ, Cancer Immunology, Immunotherapy, 10.1007/s00262-011-1104-5, 60:11, Online publication date: 1-Nov-2011.

Lee S and Margolin K (2011) Cytokines in Cancer Immunotherapy, Cancers, 10.3390/cancers3043856, 3:4, (3856-3893)

Hussain K and Chu J (2011) Insights into the interplay between chikungunya virus and its human host, Future Virology, 10.2217/fvl.11.101, 6:10, (1211-1223), Online publication date: 1-Oct-2011.

Ibrahim S, Sambandan D and Ratner D (2011) Immunotherapy for Cutaneous Malignancy, Dermatologic Surgery, 10.1111/j.1524-4725.2011.02070.x, 37:10, (1377-1393), Online publication date: 1-Oct-2011.

Apostolidis S, Lieberman L, Kis-Toth K, Crispín J and Tsokos G (2011) The Dysregulation of Cytokine Networks in Systemic Lupus Erythematosus, Journal of Interferon & Cytokine Research, 10.1089/jir.2011.0029, 31:10, (769-779), Online publication date: 1-Oct-2011.

Pfaller C, Li Z, George C and Samuel C (2011) Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response, Current Opinion in Immunology, 10.1016/j.coi.2011.08.009, 23:5, (573-582), Online publication date: 1-Oct-2011.

Robb R, Kreijveld E, Kuns R, Wilson Y, Olver S, Don A, Raffelt N, De Weerd N, Lineburg K, Varelias A, Markey K, Koyama M, Clouston A, Hertzog P, MacDonald K and Hill G (2011) Type I-IFNs control GVHD and GVL responses after transplantation, Blood, 10.1182/blood-2010-12-325746, 118:12, (3399-3409), Online publication date: 22-Sep-2011.

Benitah N, Sobrin L and Papaliodis G (2011) The Use of Biologic Agents in the Treatment of Ocular Manifestations of Behcet’s Disease, Seminars in Ophthalmology, 10.3109/08820538.2011.588665, 26:4-5, (295-303), Online publication date: 1-Sep-2011.

Nakamura S, Davis K and Weiser J (2011) Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice, Journal of Clinical Investigation, 10.1172/JCI57762, 121:9, (3657-3665), Online publication date: 1-Sep-2011.

Gerlier D and Lyles D (2011) Interplay between Innate Immunity and Negative-Strand RNA Viruses: towards a Rational Model, Microbiology and Molecular Biology Reviews, 10.1128/MMBR.00007-11, 75:3, (468-490), Online publication date: 1-Sep-2011.

Sears N, Sen G, Stark G and Chattopadhyay S (2011) Caspase-8-mediated Cleavage Inhibits IRF-3 Protein by Facilitating Its Proteasome-mediated Degradation, Journal of Biological Chemistry, 10.1074/jbc.M111.257022, 286:38, (33037-33044), Online publication date: 1-Sep-2011.

Wack A, Openshaw P and O’Garra A (2011) Contribution of cytokines to pathology and protection in virus infection, Current Opinion in Virology, 10.1016/j.coviro.2011.05.015, 1:3, (184-195), Online publication date: 1-Sep-2011.

Diaz Ochoa J, Voigt A, Briesen H and Sundmacher K (2011) Modeling of innate immune responses of cells for vaccine production, Chemical Engineering Science, 10.1016/j.ces.2011.05.030, 66:17, (3954-3961), Online publication date: 1-Sep-2011.

Haque A, Best S, Ammerdorffer A, Desbarrieres L, de Oca M, Amante F, de Labastida Rivera F, Hertzog P, Boyle G, Hill G and Engwerda C (2011) Type I interferons suppress CD4+ T-cell-dependent parasite control during blood-stage Plasmodium infection, European Journal of Immunology, 10.1002/eji.201141539, 41:9, (2688-2698), Online publication date: 1-Sep-2011.

Schusser B, Reuter A, von der Malsburg A, Penski N, Weigend S, Kaspers B, Staeheli P and Härtle S (2011) Mx Is Dispensable for Interferon-Mediated Resistance of Chicken Cells against Influenza A Virus, Journal of Virology, 10.1128/JVI.00535-11, 85:16, (8307-8315), Online publication date: 15-Aug-2011.

Hamming O, Lutfalla G, Levraud J and Hartmann R (2011) Crystal Structure of Zebrafish Interferons I and II Reveals Conservation of Type I Interferon Structure in Vertebrates, Journal of Virology, 10.1128/JVI.00521-11, 85:16, (8181-8187), Online publication date: 15-Aug-2011.

Penski N, Härtle S, Rubbenstroth D, Krohmann C, Ruggli N, Schusser B, Pfann M, Reuter A, Gohrbandt S, Hundt J, Veits J, Breithaupt A, Kochs G, Stech J, Summerfield A, Vahlenkamp T, Kaspers B and Staeheli P (2011) Highly Pathogenic Avian Influenza Viruses Do Not Inhibit Interferon Synthesis in Infected Chickens but Can Override the Interferon-Induced Antiviral State, Journal of Virology, 10.1128/JVI.00063-11, 85:15, (7730-7741), Online publication date: 1-Aug-2011.

Xu Q, Nomura T, Ikeda M, Ohta M, Kameyama K, Konishi M, Wu D, Inumaru S and Murakami K (2011) Stability of recombinant bovine interferon-γ antiviral activity in the absence of stabilizing additives, Microbiology and Immunology, 10.1111/j.1348-0421.2011.00349.x, 55:8, (595-598), Online publication date: 1-Aug-2011.

Scott R, Siegrist F, Foser S and Certa U (2011) Interferon-Alpha Induces Reversible DNA Demethylation of the Interferon-Induced Transmembrane Protein-3 Core Promoter in Human Melanoma Cells, Journal of Interferon & Cytokine Research, 10.1089/jir.2010.0134, 31:8, (601-608), Online publication date: 1-Aug-2011.

Thomas C, Moraga I, Levin D, Krutzik P, Podoplelova Y, Trejo A, Lee C, Yarden G, Vleck S, Glenn J, Nolan G, Piehler J, Schreiber G and Garcia K (2011) Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons, Cell, 10.1016/j.cell.2011.06.048, 146:4, (621-632), Online publication date: 1-Aug-2011.

Santos C and Costa-Pereira A (2011) Signal transducers and activators of transcription—from cytokine signalling to cancer biology, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 10.1016/j.bbcan.2011.03.003, 1816:1, (38-49), Online publication date: 1-Aug-2011.

Lazear H, Pinto A, Vogt M, Gale M and Diamond M (2011) Beta Interferon Controls West Nile Virus Infection and Pathogenesis in Mice, Journal of Virology, 10.1128/JVI.00396-11, 85:14, (7186-7194), Online publication date: 15-Jul-2011.

Iwami K, Natsume A and Wakabayashi T (2011) Cytokine networks in glioma, Neurosurgical Review, 10.1007/s10143-011-0320-y, 34:3, (253-264), Online publication date: 1-Jul-2011.

Krauze M, Tarhini A, Gogas H and Kirkwood J (2011) Prognostic significance of autoimmunity during treatment of melanoma with interferon, Seminars in Immunopathology, 10.1007/s00281-011-0247-y, 33:4, (385-391), Online publication date: 1-Jul-2011.

Roos W, Jöst E, Belohlavek C, Nagel G, Fritz G and Kaina B (2011) Intrinsic Anticancer Drug Resistance of Malignant Melanoma Cells Is Abrogated by IFN-β and Valproic Acid, Cancer Research, 10.1158/0008-5472.CAN-10-3498, 71:12, (4150-4160), Online publication date: 15-Jun-2011.

Harris J and Marshak-Rothstein A (2011) Editorial: Interfering with B cell immunity, Journal of Leukocyte Biology, 10.1189/jlb.0111042, 89:6, (805-806), Online publication date: 1-Jun-2011.

Rácz Z, Godó M, Révész C and Hamar P (2011) Immune Activation and Target Organ Damage Are Consequences of Hydrodynamic Treatment but Not Delivery of Naked siRNAs in Mice, Nucleic Acid Therapeutics, 10.1089/nat.2010.0248, 21:3, (215-224), Online publication date: 1-Jun-2011.

Lu M and Liao F (2010) Interferon-stimulated gene ISG12b2 is localized to the inner mitochondrial membrane and mediates virus-induced cell death, Cell Death & Differentiation, 10.1038/cdd.2010.160, 18:6, (925-936), Online publication date: 1-Jun-2011.

Axtell R, Raman C and Steinman L (2011) Interferon-β exacerbates Th17-mediated inflammatory disease, Trends in Immunology, 10.1016/j.it.2011.03.008, 32:6, (272-277), Online publication date: 1-Jun-2011.

Fioravanti J, González I, Medina‐Echeverz J, Larrea E, Ardaiz N, González‐Aseguinolaza G, Prieto J and Berraondo P (2011) Anchoring interferon alpha to apolipoprotein A‐I reduces hematological toxicity while enhancing immunostimulatory properties, Hepatology, 10.1002/hep.24306, 53:6, (1864-1873), Online publication date: 1-Jun-2011.

Ying F, Chalise J, Narendra S and Magnusson M (2011) Type I IFN protects against antigen-induced arthritis, European Journal of Immunology, 10.1002/eji.201040956, 41:6, (1687-1695), Online publication date: 1-Jun-2011.

Russo C, Cornella-Taracido I, Galli-Stampino L, Jain R, Harrington E, Isome Y, Tavarini S, Sammicheli C, Nuti S, Mbow M, Valiante N, Tallarico J, De Gregorio E and Soldaini E (2011) Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells, Blood, 10.1182/blood-2010-12-328138, 117:21, (5683-5691), Online publication date: 26-May-2011.

Nicholas C and Lesinski G (2011) Immunomodulatory cytokines as therapeutic agents for melanoma, Immunotherapy, 10.2217/imt.11.45, 3:5, (673-690), Online publication date: 1-May-2011.

Hervas-Stubbs S, Perez-Gracia J, Rouzaut A, Sanmamed M, Le Bon A and Melero I (2011) Direct Effects of Type I Interferons on Cells of the Immune System, Clinical Cancer Research, 10.1158/1078-0432.CCR-10-1114, 17:9, (2619-2627), Online publication date: 1-May-2011.

Erdmann J, Vitale G, van Koetsveld P, Croze E, Sprij-Mooij D, Hofland L and van Eijck C (2011) Effects of Interferons α/β on the Proliferation of Human Micro- and Macrovascular Endothelial Cells, Journal of Interferon & Cytokine Research, 10.1089/jir.2009.0103, 31:5, (451-458), Online publication date: 1-May-2011.

Schoggins J, Wilson S, Panis M, Murphy M, Jones C, Bieniasz P and Rice C (2011) A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, 10.1038/nature09907, 472:7344, (481-485), Online publication date: 28-Apr-2011.

Huber J and David Farrar J (2011) Regulation of effector and memory T-cell functions by type I interferon, Immunology, 10.1111/j.1365-2567.2011.03412.x, 132:4, (466-474), Online publication date: 1-Apr-2011.

Gregory S, Nazir S and Metcalf J (2011) Implications of the innate immune response to adenovirus and adenoviral vectors, Future Virology, 10.2217/fvl.11.6, 6:3, (357-374), Online publication date: 1-Mar-2011.

Blair C (2011) Mosquito RNAi is the major innate immune pathway controlling arbovirus infection and transmission, Future Microbiology, 10.2217/fmb.11.11, 6:3, (265-277), Online publication date: 1-Mar-2011.

Thompson M, Dar M and Monga S (2011) Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin, Journal of Hepatology, 10.1016/j.jhep.2010.07.020, 54:3, (506-512), Online publication date: 1-Mar-2011.

Stübiger N, Winterhalter S, Pleyer U, Doycheva D, Zierhut M and Deuter C (2011) Ein Januskopf?Janus-faced?, Der Ophthalmologe, 10.1007/s00347-010-2261-1, 108:3, (204-212), Online publication date: 1-Mar-2011.

De Clercq E (2011) A 40-Year Journey in Search of Selective Antiviral Chemotherapy*, Annual Review of Pharmacology and Toxicology, 10.1146/annurev-pharmtox-010510-100228, 51:1, (1-24), Online publication date: 10-Feb-2011.

Sauer J, Sotelo-Troha K, von Moltke J, Monroe K, Rae C, Brubaker S, Hyodo M, Hayakawa Y, Woodward J, Portnoy D, Vance R and Flynn J (2011) The N -Ethyl- N -Nitrosourea-Induced Goldenticket Mouse Mutant Reveals an Essential Function of Sting in the In Vivo Interferon Response to Listeria monocytogenes and Cyclic Dinucleotides , Infection and Immunity, 10.1128/IAI.00999-10, 79:2, (688-694), Online publication date: 1-Feb-2011.

Joshi S, Sharma B, Kaur S, Majchrzak B, Ueda T, Fukunaga R, Verma A, Fish E and Platanias L (2011) Essential Role for Mnk Kinases in Type II Interferon (IFNγ) Signaling and Its Suppressive Effects on Normal Hematopoiesis, Journal of Biological Chemistry, 10.1074/jbc.M110.197921, 286:8, (6017-6026), Online publication date: 1-Feb-2011.

Baldridge M, King K and Goodell M (2011) Inflammatory signals regulate hematopoietic stem cells, Trends in Immunology, 10.1016/j.it.2010.12.003, 32:2, (57-65), Online publication date: 1-Feb-2011.

Seeds R and Miller J (2011) Measurement of Type I Interferon Production, Current Protocols in Immunology, 10.1002/0471142735.im1421s92, 92:1, Online publication date: 1-Feb-2011.

Ward S, George C, Welch M, Liou L, Hahm B, Lewicki H, de la Torre J, Samuel C and Oldstone M (2010) RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis, Proceedings of the National Academy of Sciences, 10.1073/pnas.1017241108, 108:1, (331-336), Online publication date: 4-Jan-2011.

Moll H, Maier T, Zommer A, Lavoie T and Brostjan C (2011) The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types, Cytokine, 10.1016/j.cyto.2010.09.006, 53:1, (52-59), Online publication date: 1-Jan-2011.

Liu Y, Wylie D, Zhao J, Cure R, Cutler C, Cannon-Carlson S, Yang X, Nagabhushan T and Pramanik B (2011) Mass spectrometric characterization of the isoforms in Escherichia coli recombinant DNA-derived interferon alpha-2b, Analytical Biochemistry, 10.1016/j.ab.2010.08.033, 408:1, (105-117), Online publication date: 1-Jan-2011.

Brad Guffey M and Kimberlin D (2011) Host Defense Mechanisms Against Viruses Fetal and Neonatal Physiology, 10.1016/B978-1-4160-3479-7.10150-8, (1570-1595), .

Rieder M and Conzelmann K (2011) Interferon in Rabies Virus Infection Research Advances in Rabies, 10.1016/B978-0-12-387040-7.00006-8, (91-114), .

Crow M (2011) Interferon-Alpha in Systemic Lupus Erythematosus Systemic Lupus Erythematosus, 10.1016/B978-0-12-374994-9.10018-X, (307-320), .

Albergotti L and Guillette Jr. L (2011) Viviparity in Reptiles Hormones and Reproduction of Vertebrates, 10.1016/B978-0-12-374932-1.00033-0, (247-275), .

Albergotti L and Guillette Jr. L (2011) Viviparity in Reptiles Hormones and Reproduction of Vertebrates, 10.1016/B978-0-12-374930-7.10009-3, (247-275), .

Samuel C (2011) ADARs: Viruses and Innate Immunity Adenosine Deaminases Acting on RNA (ADARs) and A-to-I Editing, 10.1007/82_2011_148, (163-195), .

Li X, Ezelle H, Hsi T and Hassel B (2010) A central role for RNA in the induction and biological activities of type 1 interferons, Wiley Interdisciplinary Reviews: RNA, 10.1002/wrna.32, 2:1, (58-78), Online publication date: 1-Jan-2011.

Skjesol A, Hansen T, Shi C, Thim H and Jørgensen J (2010) Structural and functional studies of STAT1 from Atlantic salmon (Salmo salar), BMC Immunology, 10.1186/1471-2172-11-17, 11:1, Online publication date: 1-Dec-2010.

Onomoto K, Onoguchi K, Takahasi K and Fujita T (2010) Type I Interferon Production Induced by RIG-I-Like Receptors, Journal of Interferon & Cytokine Research, 10.1089/jir.2010.0117, 30:12, (875-881), Online publication date: 1-Dec-2010.

Clark I, Alleva L and Vissel B (2010) The roles of TNF in brain dysfunction and disease, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2010.08.007, 128:3, (519-548), Online publication date: 1-Dec-2010.

Wiltshire S, Watkins D, Skamene E and Vidal S (2014) Immunogenetics of Virus Pathogenesis The Immune Response to Infection, 10.1128/9781555816872.ch39, (491-508)

Shirey K, Nhu Q, Yim K, Roberts Z, Teijaro J, Farber D, Blanco J and Vogel S (2010) The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-β-mediated antiviral activity in vitro and in vivo, Journal of Leukocyte Biology, 10.1189/jlb.0410216, 89:3, (351-357), Online publication date: 17-Nov-2010.

Chen N and Szalay A (2010) Oncolytic vaccinia virus: a theranostic agent for cancer, Future Virology, 10.2217/fvl.10.58, 5:6, (763-784), Online publication date: 1-Nov-2010.

Bagashev A, Fitzgerald M, LaRosa D, Rose P, Cherry S, Johnson A and Sullivan K (2010) Leucine-Rich Repeat (in Flightless I) Interacting Protein-1 Regulates a Rapid Type I Interferon Response, Journal of Interferon & Cytokine Research, 10.1089/jir.2010.0017, 30:11, (843-852), Online publication date: 1-Nov-2010.

Toledo J, Barrera M, Farnós O, Gómez S, Rodríguez M, Aguero F, Ormazabal V, Parra N, Suárez L and Sánchez O (2010) Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs, Vaccine, 10.1016/j.vaccine.2010.09.073, 28:50, (7907-7914), Online publication date: 1-Nov-2010.

Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, Bourdieu C, Decamps L, Dhorne-Pollet S and Delmas B (2010) Influenza A Virus Protein PB1-F2 Exacerbates IFN-β Expression of Human Respiratory Epithelial Cells, The Journal of Immunology, 10.4049/jimmunol.0903952, 185:8, (4812-4823), Online publication date: 15-Oct-2010.

Toporovski R, Morrow M and Weiner D (2010) Interferons as potential adjuvants in prophylactic vaccines, Expert Opinion on Biological Therapy, 10.1517/14712598.2010.521495, 10:10, (1489-1500), Online publication date: 1-Oct-2010.

Workenhe S, Rise M, Kibenge M and Kibenge F (2010) The fight between the teleost fish immune response and aquatic viruses, Molecular Immunology, 10.1016/j.molimm.2010.06.009, 47:16, (2525-2536), Online publication date: 1-Oct-2010.

Yoo J, Baker D and Fish E (2010) Interferon-β modulates type 1 immunity during influenza virus infection, Antiviral Research, 10.1016/j.antiviral.2010.07.006, 88:1, (64-71), Online publication date: 1-Oct-2010.

Murube J (2010) The Second Definition of Sjögren's Syndrome as an Autoimmune Disorder, The Ocular Surface, 10.1016/S1542-0124(12)70231-8, 8:4, (163-172), Online publication date: 1-Oct-2010.

Frenz T, Waibler Z, Hofmann J, Hamdorf M, Lantermann M, Reizis B, Tovey M, Aichele P, Sutter G and Kalinke U (2010) Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion, European Journal of Immunology, 10.1002/eji.201040453, 40:10, (2769-2777), Online publication date: 1-Oct-2010.

Trinchieri G (2010) Type I interferon: friend or foe?, Journal of Experimental Medicine, 10.1084/jem.20101664, 207:10, (2053-2063), Online publication date: 27-Sep-2010.

Lee H, Lee S, Chaudhary P, Gill P and Jung J (2010) Immune evasion by Kaposi’s sarcoma-associated herpesvirus, Future Microbiology, 10.2217/fmb.10.105, 5:9, (1349-1365), Online publication date: 1-Sep-2010.

Kopf M, Bachmann M and Marsland B (2010) Averting inflammation by targeting the cytokine environment, Nature Reviews Drug Discovery, 10.1038/nrd2805, 9:9, (703-718), Online publication date: 1-Sep-2010.

Gad H, Hamming O and Hartmann R (2010) The Structure of Human Interferon Lambda and What It Has Taught Us, Journal of Interferon & Cytokine Research, 10.1089/jir.2010.0062, 30:8, (565-571), Online publication date: 1-Aug-2010.

Prinz M and Kalinke U (2010) New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS, Trends in Molecular Medicine, 10.1016/j.molmed.2010.06.001, 16:8, (379-386), Online publication date: 1-Aug-2010.

Ceaglio N, Etcheverrigaray M, Kratje R and Oggero M (2010) Influence of carbohydrates on the stability and structure of a hyperglycosylated human interferon alpha mutein, Biochimie, 10.1016/j.biochi.2010.04.004, 92:8, (971-978), Online publication date: 1-Aug-2010.

Schwartz O and Albert M (2010) Biology and pathogenesis of chikungunya virus, Nature Reviews Microbiology, 10.1038/nrmicro2368, 8:7, (491-500), Online publication date: 1-Jul-2010.

Kaur B, Lesinski G and Chaudhury A (2010) From Concept to the Clinics: Development of Novel Large Molecule Cancer Therapeutics Pharmaceutical Sciences Encyclopedia, 10.1002/9780470571224.pse402

Berencsi G, Kapusinszky B, Rigó Z and Szomor K (2010) Interference among viruses circulating and administered in Hungary from 1931 to 2008, Acta Microbiologica et Immunologica Hungarica, 10.1556/AMicr.57.2010.2.1, 57:2, (73-86), Online publication date: 1-Jun-2010.

Dhillon S, Kaker A, Dosanjh A, Japra D and VanThiel D (2010) Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C, Digestive Diseases and Sciences, 10.1007/s10620-010-1220-7, 55:6, (1785-1790), Online publication date: 1-Jun-2010.

Antonelli L, Gigliotti Rothfuchs A, Gonçalves R, Roffê E, Cheever A, Bafica A, Salazar A, Feng C and Sher A (2010) Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population, Journal of Clinical Investigation, 10.1172/JCI40817, 120:5, (1674-1682), Online publication date: 3-May-2010.

Conigliaro P, Perricone C, Benson R, Garside P, Brewer J, Perricone R and Valesini G (2010) The type I IFN system in rheumatoid arthritis, Autoimmunity, 10.3109/08916930903510914, 43:3, (220-225), Online publication date: 1-May-2010.

Sozzani S, Bosisio D, Scarsi M and Tincani A (2010) Type I interferons in systemic autoimmunity, Autoimmunity, 10.3109/08916930903510872, 43:3, (196-203), Online publication date: 1-May-2010.

DeWitte-Orr S and Mossman K (2010) dsRNA and the innate antiviral immune response, Future Virology, 10.2217/fvl.10.18, 5:3, (325-341), Online publication date: 1-May-2010.

Andrade F (2010) Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state, Immunological Reviews, 10.1111/j.0105-2896.2010.00909.x, 235:1, (128-146), Online publication date: 1-May-2010.

Kumanogoh A and Ogata M (2010) The study of cytokines by Japanese researchers: a historical perspective, International Immunology, 10.1093/intimm/dxq022, 22:5, (341-345), Online publication date: 1-May-2010.

Jeon Y, Yoo H and Chung C (2010) ISG15 and immune diseases, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 10.1016/j.bbadis.2010.02.006, 1802:5, (485-496), Online publication date: 1-May-2010.

Canaday D, Amponsah N, Jones L, Tisch D, Hornick T and Ramachandra L (2010) Influenza-Induced Production of Interferon-Alpha is Defective in Geriatric Individuals, Journal of Clinical Immunology, 10.1007/s10875-010-9374-9, 30:3, (373-383), Online publication date: 1-May-2010.

Baum A and García-Sastre A (2009) Induction of type I interferon by RNA viruses: cellular receptors and their substrates, Amino Acids, 10.1007/s00726-009-0374-0, 38:5, (1283-1299), Online publication date: 1-May-2010.

Brod S (2010) Ingested Type I Interferon—State of the Art as Treatment for Autoimmunity Part 2, Pharmaceuticals, 10.3390/ph3041108, 3:4, (1108-1121)

Henry T, Kirimanjeswara G, Ruby T, Jones J, Peng K, Perret M, Ho L, Sauer J, Iwakura Y, Metzger D and Monack D (2010) Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections, The Journal of Immunology, 10.4049/jimmunol.0902065, 184:7, (3755-3767), Online publication date: 1-Apr-2010.

Markowitz G, Nasr S, Stokes M and D'Agati V (2010) Treatment with IFN-α, -β, or -γ Is Associated with Collapsing Focal Segmental Glomerulosclerosis, Clinical Journal of the American Society of Nephrology, 10.2215/CJN.07311009, 5:4, (607-615), Online publication date: 1-Apr-2010.

Bekisz J, Baron S, Balinsky C, Morrow A and Zoon K (2010) Antiproliferative Properties of Type I and Type II Interferon, Pharmaceuticals, 10.3390/ph3040994, 3:4, (994-1015)

Barber M, Aldridge J, Webster R and Magor K (2010) Association of RIG-I with innate immunity of ducks to influenza, Proceedings of the National Academy of Sciences, 10.1073/pnas.1001755107, 107:13, (5913-5918), Online publication date: 30-Mar-2010.

Collier L (2010) A Short History of Research on Viruses Topley & Wilson's Microbiology and Microbial Infections, 10.1002/9780470688618.taw0207

Pestka S (2010) Type I Interferons and Receptors Topley & Wilson's Microbiology and Microbial Infections, 10.1002/9780470688618.taw0095

Materi W, Gombos Z and Wishart D (2010) Proteins: Hormones, Enzymes, and Monoclonal Antibodies-Background Pharmaceutical Sciences Encyclopedia, 10.1002/9780470571224.pse312

Domingo-Gil E, González J and Esteban M (2010) Identification of Cellular Genes Induced in Human Cells After Activation of the OAS/RNaseL Pathway by Vaccinia Virus Recombinants Expressing These Antiviral Enzymes, Journal of Interferon & Cytokine Research, 10.1089/jir.2009.0037, 30:3, (171-188), Online publication date: 1-Mar-2010.

Kalaaji A, Lu J, Markovic S, Celis E and Pittelkow M (2010) Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model, Cytokine, 10.1016/j.cyto.2009.11.016, 49:3, (287-293), Online publication date: 1-Mar-2010.

De Clercq E (2009) Highlights in the Discovery of Antiviral Drugs: A Personal Retrospective, Journal of Medicinal Chemistry, 10.1021/jm900932g, 53:4, (1438-1450), Online publication date: 25-Feb-2010.

Tachikawa E, Itho K, Kudo K, Harada K, Kashimoto T and Hirota Y (2010) Effects of Interferons on Cortisol Production in Bovine Adrenal Fasciculata Cells Stimulated by Adrenocorticotropin, Journal of Pharmacy and Pharmacology, 10.1211/0022357991772529, 51:4, (465-473), Online publication date: 18-Feb-2010.

Katsoulidis E, Kaur S and Platanias L (2010) Deregulation of Interferon Signaling in Malignant Cells, Pharmaceuticals, 10.3390/ph3020406, 3:2, (406-418)

Trachtman J (2010) Vision and the hypothalamus, Optometry - Journal of the American Optometric Association, 10.1016/j.optm.2009.07.016, 81:2, (100-115), Online publication date: 1-Feb-2010.

Rehwinkel J, Tan C, Goubau D, Schulz O, Pichlmair A, Bier K, Robb N, Vreede F, Barclay W, Fodor E and Reis e Sousa C (2010) RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection, Cell, 10.1016/j.cell.2010.01.020, 140:3, (397-408), Online publication date: 1-Feb-2010.

Rehwinkel J and Reis e Sousa C (2010) RIGorous Detection: Exposing Virus Through RNA Sensing, Science, 10.1126/science.1185068, 327:5963, (284-286), Online publication date: 15-Jan-2010.

Namba M (2010) Contribution of cell cultures to the Nobel Prize, Okayama Igakkai Zasshi (Journal of Okayama Medical Association), 10.4044/joma.122.33, 122:1, (33-38), .

Hale B, Albrecht R and García-Sastre A (2010) Innate immune evasion strategies of influenza viruses, Future Microbiology, 10.2217/fmb.09.108, 5:1, (23-41), Online publication date: 1-Jan-2010.

Kostanyan I, Vonarshenko A and Lipkin V (2010) STAT1: A many-sided transcription factor, Russian Journal of Bioorganic Chemistry, 10.1134/S1068162010010024, 36:1, (11-23), Online publication date: 1-Jan-2010.

Tatsugami K, Eto M and Naito S (2010) Influence of Immunotherapy With Interferon-α on Regulatory T Cells in Renal Cell Carcinoma Patients, Journal of Interferon & Cytokine Research, 10.1089/jir.2009.0014, 30:1, (43-48), Online publication date: 1-Jan-2010.

Bracarda S, Eggermont A and Samuelsson J (2010) Redefining the role of interferon in the treatment of malignant diseases, European Journal of Cancer, 10.1016/j.ejca.2009.10.013, 46:2, (284-297), Online publication date: 1-Jan-2010.

De Clercq E (2010) In search of a selective therapy of viral infections, Antiviral Research, 10.1016/j.antiviral.2009.10.005, 85:1, (19-24), Online publication date: 1-Jan-2010.

Jiménez-Méndez R and Castañeda-Hernández G (2010) Characteristics of hepatitis C treatment with pegylated interferons and ribavirin, Annals of Hepatology, 10.1016/S1665-2681(19)31726-0, 9, (S61-S64), .

Pagnoux C and Mallet V (2010) Interférons Les Uvéites, 10.1016/B978-2-294-71107-7.50058-5, (661-665), .

Herold T and Hintschich C (2009) Interferon α for the treatment of melanocytic conjunctival lesions, Graefe's Archive for Clinical and Experimental Ophthalmology, 10.1007/s00417-009-1189-0, 248:1, (111-115), Online publication date: 1-Jan-2010.

Guggenheim M, Giovanoli P, Baumert B, Eigentler T, Garbe C, Mangana J and Dummer R (2010) Melanoma Skin Cancer - A World-Wide Perspective, 10.1007/978-3-642-05072-5_23, (307-341), .

Yoneyama M and Fujita T (2009) Recognition of viral nucleic acids in innate immunity, Reviews in Medical Virology, 10.1002/rmv.633, 20:1, (4-22), Online publication date: 1-Jan-2010.

Friedman R and Contente S (2009) Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon, Pharmaceuticals, 10.3390/ph2030206, 2:3, (206-216)

Prchal M, Pilz A, Simma O, Lingnau K, von Gabain A, Strobl B, Müller M and Decker T (2009) Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity, Vaccine, 10.1016/j.vaccine.2009.10.016, 27, (G17-G20), Online publication date: 1-Dec-2009.

Tirone N, Peghini B, Barcelos A, Murta E and Michelin M (2009) Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia, Cancer Immunology, Immunotherapy, 10.1007/s00262-009-0707-6, 58:12, (2003-2010), Online publication date: 1-Dec-2009.

Heim M (2009) HCV Innate Immune Responses, Viruses, 10.3390/v1031073, 1:3, (1073-1088)

Faul E, Lyles D and Schnell M (2009) Interferon Response and Viral Evasion by Members of the Family Rhabdoviridae, Viruses, 10.3390/v1030832, 1:3, (832-851)

Roescher N, Tak P and Illei G (2009) Cytokines in Sjögren’s syndrome, Oral Diseases, 10.1111/j.1601-0825.2009.01582.x, 15:8, (519-526), Online publication date: 1-Nov-2009.

Barral P, Sarkar D, Su Z, Barber G, DeSalle R, Racaniello V and Fisher P (2009) Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2009.06.012, 124:2, (219-234), Online publication date: 1-Nov-2009.

Baranek T, Zucchini N and Dalod M (2009) Plasmacytoid Dendritic Cells and the Control of Herpesvirus Infections, Viruses, 10.3390/v1030383, 1:3, (383-419)

Watanuki H, Chakraborty G, Korenaga H, Kono T, Shivappa R and Sakai M (2009) Immunostimulatory effects of natural human interferon-alpha (huIFN-α) on carps Cyprinus carpio L., Veterinary Immunology and Immunopathology, 10.1016/j.vetimm.2009.04.005, 131:3-4, (273-277), Online publication date: 1-Oct-2009.

Allison A (2009) Genetic control of resistance to human malaria, Current Opinion in Immunology, 10.1016/j.coi.2009.04.001, 21:5, (499-505), Online publication date: 1-Oct-2009.

Sarasin-Filipowicz M, Wang X, Yan M, Duong F, Poli V, Hilton D, Zhang D and Heim M (2023) Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43, Molecular and Cellular Biology, 10.1128/MCB.00224-09, 29:17, (4841-4851), Online publication date: 1-Sep-2009.

Perdiguero B and Esteban M (2009) The Interferon System and Vaccinia Virus Evasion Mechanisms, Journal of Interferon & Cytokine Research, 10.1089/jir.2009.0073, 29:9, (581-598), Online publication date: 1-Sep-2009.

Lee H, Kim M, Lee J, Liang C and Jung J (2009) Viral Interferon Regulatory Factors, Journal of Interferon & Cytokine Research, 10.1089/jir.2009.0067, 29:9, (621-627), Online publication date: 1-Sep-2009.

Wolff T and Ludwig S (2009) Influenza Viruses Control the Vertebrate Type I Interferon System: Factors, Mechanisms, and Consequences, Journal of Interferon & Cytokine Research, 10.1089/jir.2009.0066, 29:9, (549-558), Online publication date: 1-Sep-2009.

George C, Li Z, Okonski K, Toth A, Wang Y and Samuel C (2009) Tipping the Balance: Antagonism of PKR Kinase and ADAR1 Deaminase Functions by Virus Gene Products, Journal of Interferon & Cytokine Research, 10.1089/jir.2009.0065, 29:9, (477-487), Online publication date: 1-Sep-2009.

McFadden G, Mohamed M, Rahman M and Bartee E (2009) Cytokine determinants of viral tropism, Nature Reviews Immunology, 10.1038/nri2623, 9:9, (645-655), Online publication date: 1-Sep-2009.

Clark V and Nelson D (2009) Novel Interferons for Treatment of Hepatitis C Virus, Clinics in Liver Disease, 10.1016/j.cld.2009.05.004, 13:3, (351-363), Online publication date: 1-Aug-2009.

PEYMAN G, LAD E and MOSHFEGHI D (2009) INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS, Retina, 10.1097/IAE.0b013e3181a94f01, 29:7, (875-912), Online publication date: 1-Jul-2009.

De Clercq E (2009) Antiviral drug discovery: Ten more compounds, and ten more stories (part B), Medicinal Research Reviews, 10.1002/med.20149, 29:4, (571-610), Online publication date: 1-Jul-2009.

Szretter K, Gangappa S, Belser J, Zeng H, Chen H, Matsuoka Y, Sambhara S, Swayne D, Tumpey T and Katz J (2009) Early Control of H5N1 Influenza Virus Replication by the Type I Interferon Response in Mice, Journal of Virology, 10.1128/JVI.02144-08, 83:11, (5825-5834), Online publication date: 1-Jun-2009.

Zídek Z, Anzenbacher P and Kmoníčková E (2009) Current status and challenges of cytokine pharmacology, British Journal of Pharmacology, 10.1111/j.1476-5381.2009.00206.x, 157:3, (342-361)

Medzhitov R (2009) Approaching the Asymptote: 20 Years Later, Immunity, 10.1016/j.immuni.2009.06.004, 30:6, (766-775), Online publication date: 1-Jun-2009.

Robek M (2014) Targeting the Interferon Response for Antiviral Therapy Antiviral Research, 10.1128/9781555815493.ch18, (317-332)

Boasso A (2009) Type I interferon in HIV treatment: from antiviral drug to therapeutic target, HIV Therapy, 10.2217/hiv.09.8, 3:3, (269-282), Online publication date: 1-May-2009.

Ludwig S and Wolff T (2009) Influenza A Virus TRIMs the Type I Interferon Response, Cell Host & Microbe, 10.1016/j.chom.2009.05.004, 5:5, (420-421), Online publication date: 1-May-2009.

Hance K, Rogers C, Zaharoff D, Canter D, Schlom J and Greiner J (2009) The Antitumor and Immunoadjuvant Effects of IFN-α in Combination with Recombinant Poxvirus Vaccines, Clinical Cancer Research, 10.1158/1078-0432.CCR-08-1752, 15:7, (2387-2396), Online publication date: 1-Apr-2009.

Mogensen T (2009) Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses, Clinical Microbiology Reviews, 10.1128/CMR.00046-08, 22:2, (240-273), Online publication date: 1-Apr-2009.

Meager A (2009) The interferons: Past, present and future, Digestive and Liver Disease Supplements, 10.1016/S1594-5804(09)60008-5, 3:1, (3-8), Online publication date: 1-Apr-2009.

Li M, Liu X, Zhou Y and Su S (2009) Interferon-λs: the modulators of antivirus, antitumor, and immune responses, Journal of Leukocyte Biology, 10.1189/jlb.1208761, 86:1, (23-32), Online publication date: 20-Mar-2009.

Detje C, Meyer T, Schmidt H, Kreuz D, Rose J, Bechmann I, Prinz M and Kalinke U (2009) Local Type I IFN Receptor Signaling Protects against Virus Spread within the Central Nervous System, The Journal of Immunology, 10.4049/jimmunol.0800596, 182:4, (2297-2304), Online publication date: 15-Feb-2009.

Waibler Z, Anzaghe M, Frenz T, Schwantes A, Pöhlmann C, Ludwig H, Palomo-Otero M, Alcamí A, Sutter G and Kalinke U (2009) Vaccinia Virus-Mediated Inhibition of Type I Interferon Responses Is a Multifactorial Process Involving the Soluble Type I Interferon Receptor B18 and Intracellular Components, Journal of Virology, 10.1128/JVI.01617-08, 83:4, (1563-1571), Online publication date: 15-Feb-2009.

Giannakopoulos N, Arutyunova E, Lai C, Lenschow D, Haas A and Virgin H (2009) ISG15 Arg151 and the ISG15-Conjugating Enzyme UbE1L Are Important for Innate Immune Control of Sindbis Virus, Journal of Virology, 10.1128/JVI.01590-08, 83:4, (1602-1610), Online publication date: 15-Feb-2009.

Berraondo P, Crettaz J, Ochoa L, Vales A, Ruiz J, Prieto J, Martinez-Ansó E and González-Aseguinolaza G (2009) Production of Recombinant Woodchuck IFNα and Development of Monoclonal Antibodies, Journal of Interferon & Cytokine Research, 10.1089/jir.2008.0012, 29:2, (75-82), Online publication date: 1-Feb-2009.

Gaertner F, Babiuk L, Mutwiri G, Armstrong J and Griebel P (2009) Amended recombinant cells (ARCs™) expressing bovine IFN-γ: An economical and highly effective adjuvant system, Vaccine, 10.1016/j.vaccine.2008.12.049, 27:9, (1377-1385), Online publication date: 1-Feb-2009.

Lang P, Cervantes-Barragan L, Verschoor A, Navarini A, Recher M, Pellegrini M, Flatz L, Bergthaler A, Honda K, Ludewig B, Ohashi P and Lang K (2009) Hematopoietic cell–derived interferon controls viral replication and virus-induced disease, Blood, 10.1182/blood-2007-10-117861, 113:5, (1045-1052), Online publication date: 29-Jan-2009.

(2014) Alick Isaacs and Interferon Animalcules, 10.1128/9781555817442.ch50, (233-237)

Yoneyama M and Fujita T (2009) RNA recognition and signal transduction by RIG-I-like receptors, Immunological Reviews, 10.1111/j.1600-065X.2008.00727.x, 227:1, (54-65), Online publication date: 1-Jan-2009.

Loke Y, Somogyi A, Lewis L, Schachter M, Cohen A and Ritter J (2009) Looking back: editors' pick of 2008, British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.2008.03354.x, 67:1, (1-4), Online publication date: 1-Jan-2009.

De Luján Alvarez* M, Quiroga* A, Parody J, Ronco M, Francés D, Carnovale C and Carrillo M (2009) Cross-talk between IFN-α and TGF-β 1 signaling pathways in preneoplastic rat liver , Growth Factors, 10.1080/08977190802547357, 27:1, (1-11), Online publication date: 1-Jan-2009.

Bonjardim C, Ferreira P and Kroon E (2009) Interferons: Signaling, antiviral and viral evasion, Immunology Letters, 10.1016/j.imlet.2008.11.002, 122:1, (1-11), Online publication date: 1-Jan-2009.

Funk D, Parrillo J and Kumar A (2009) Sepsis and Septic Shock: A History, Critical Care Clinics, 10.1016/j.ccc.2008.12.003, 25:1, (83-101), Online publication date: 1-Jan-2009.

Clercq E (2009) Chapter 1 Looking Back in 2009 at the Dawning of Antiviral Therapy Now 50 Years Ago , 10.1016/S0065-3527(09)73001-5, (1-53), .

Gomperts B, Kramer I and Tatham P (2009) Tyrosine Protein Kinases and Adaptive Immunity: TCR, BCR, Soluble Tyrosine Kinases and NFAT Signal Transduction, 10.1016/B978-0-12-369441-6.00017-9, (513-542), .

Van Hateren N, Jones R and Wilson S (2009) RNA Interference in Chicken Embryos Electroporation and Sonoporation in Developmental Biology, 10.1007/978-4-431-09427-2_26, (295-314), .

Wang J Interferon-α, Molecular Signaling Pathways and Behavior The Neuroimmunological Basis of Behavior and Mental Disorders, 10.1007/978-0-387-84851-8_5, (71-85)

Guan H, Dower S and Kiss-Toth E (2009) Immunomics: At the Forefront of Innate Immunity Research Clinical Applications of Immunomics, 10.1007/978-0-387-79208-8_2, (15-38), .

Fensterl V and Sen G (2009) Interferons and viral infections, BioFactors, 10.1002/biof.6, 35:1, (14-20), Online publication date: 1-Jan-2009.

Frieman M and Baric R (2008) Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation, Microbiology and Molecular Biology Reviews, 10.1128/MMBR.00015-08, 72:4, (672-685), Online publication date: 1-Dec-2008.

Lienenklaus S, Walisko R, Boekhorst A, May T, Samuelsson C, Michiels T and Weiss S (2008) PCR-Based Simultaneous Analysis of the Interferon-Alpha Family Reveals Distinct Kinetics for Early Interferons, Journal of Interferon & Cytokine Research, 10.1089/jir.2008.0082, 28:11, (653-660), Online publication date: 1-Nov-2008.

Kiladjian J, Chomienne C and Fenaux P (2008) Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms, Leukemia, 10.1038/leu.2008.280, 22:11, (1990-1998), Online publication date: 1-Nov-2008.

Sandbulte M, Boon A, Webby R and Riberdy J (2008) Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses, Virology, 10.1016/j.virol.2008.08.018, 381:1, (22-28), Online publication date: 1-Nov-2008.

Moschen A, Geiger S, Krehan I, Kaser A and Tilg H (2008) Interferon-alpha controls IL-17 expression in vitro and in vivo, Immunobiology, 10.1016/j.imbio.2008.07.022, 213:9-10, (779-787), Online publication date: 1-Nov-2008.

Reiss C (2008) Innate immunity in viral encephalitis Neurotropic Viral Infections, 10.1017/CBO9780511541728.019, (265-291)

Reiss C (2008) Introduction: immunity, diagnosis, vector, and beneficial uses of neurotropic viruses Neurotropic Viral Infections, 10.1017/CBO9780511541728.018, (263-264)

Wolff T, Zielecki F, Abt M, Voss D, Semmler I and Matthaei M (2008) Sabotage of antiviral signaling and effectors by influenza viruses, bchm, 10.1515/BC.2008.146, 389:10, (1299-1305), Online publication date: 1-Oct-2008.

Bisbal C and Salehzada T (2008) La RNase L, un acteur essentiel de la réponse cellulaire antivirale, médecine/sciences, 10.1051/medsci/20082410859, 24:10, (859-864), Online publication date: 1-Oct-2008.

George C, Das S and Samuel C (2008) Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5′-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon, Virology, 10.1016/j.virol.2008.07.029, 380:2, (338-343), Online publication date: 1-Oct-2008.

Gough D, Levy D, Johnstone R and Clarke C (2008) IFNγ signaling—Does it mean JAK–STAT?, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2008.08.004, 19:5-6, (383-394), Online publication date: 1-Oct-2008.

Ramachandran A, Parisien J and Horvath C (2008) STAT2 Is a Primary Target for Measles Virus V Protein-Mediated Alpha/Beta Interferon Signaling Inhibition, Journal of Virology, 10.1128/JVI.00831-08, 82:17, (8330-8338), Online publication date: 1-Sep-2008.

Thompson J, Whitmore A, Staats H and Johnston R (2008) The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines, Vaccine, 10.1016/j.vaccine.2008.07.011, 26:39, (4998-5003), Online publication date: 1-Sep-2008.

Mo W, Zhang L, Yang G, Zhai J, Hu Z, Chen Y, Chen X, Hui L, Huang R and Hu G (2008) Nuclear β-Arrestin1 Functions as a Scaffold for the Dephosphorylation of STAT1 and Moderates the Antiviral Activity of IFN-γ, Molecular Cell, 10.1016/j.molcel.2008.06.017, 31:5, (695-707), Online publication date: 1-Sep-2008.

Caparrós S and López D (2008) Insuficiencia renal aguda en un paciente de 64 años con hepatitis crónica, Medicina Clínica, 10.1016/S0025-7753(08)72275-9, 131:9, (349-354), Online publication date: 1-Sep-2008.

Cheng Z, Cheng A, Wang M, Chen B, Liu C, Duan K, Zhou X and Chen X (2008) Effect of cell mediated immunity regulation of duck enhanced by duck IFN-α eukaryon expression plasmid and inoculated with DPV attenuated vaccine by gene-gun, Frontiers of Agriculture in China, 10.1007/s11703-008-0055-x, 2:3, (343-347), Online publication date: 1-Sep-2008.

Narayanan K and Makino S (2014) Coronaviruses and Arteriviruses Cellular Signaling and Innate Immune Responses to RNA Virus Infections, 10.1128/9781555815561.ch23, (373-387)

Tatsugami K, Eto M, Harano M, Hamaguchi M, Miyamoto T, Morisaki T, Furue M, Akashi K and Naito S (2008) Dendritic cell therapy in combination with interferon-α for the treatment of metastatic renal cell carcinoma, International Journal of Urology, 10.1111/j.1442-2042.2008.02088.x, 15:8, (694-698), Online publication date: 1-Aug-2008.

Schindler C and Plumlee C (2008) Inteferons pen the JAK–STAT pathway, Seminars in Cell & Developmental Biology, 10.1016/j.semcdb.2008.08.010, 19:4, (311-318), Online publication date: 1-Aug-2008.

Schechter B, Koreishi A, Karp C and Feuer W (2008) Long-term Follow-up of Conjunctival and Corneal Intraepithelial Neoplasia Treated with Topical Interferon Alfa-2b, Ophthalmology, 10.1016/j.ophtha.2007.10.039, 115:8, (1291-1296.e1), Online publication date: 1-Aug-2008.

Ludlow L, Lo M, Rodriguez J, Rota P and Horvath C (2008) Henipavirus V Protein Association with Polo-Like Kinase Reveals Functional Overlap with STAT1 Binding and Interferon Evasion , Journal of Virology, 10.1128/JVI.00409-08, 82:13, (6259-6271), Online publication date: 1-Jul-2008.

Sadler A and Williams B (2008) Interferon-inducible antiviral effectors, Nature Reviews Immunology, 10.1038/nri2314, 8:7, (559-568), Online publication date: 1-Jul-2008.

Day S, Ramshaw I, Ramsay A and Ranasinghe C (2008) Differential Effects of the Type I Interferons α4, β, and ε on Antiviral Activity and Vaccine Efficacy, The Journal of Immunology, 10.4049/jimmunol.180.11.7158, 180:11, (7158-7166), Online publication date: 1-Jun-2008.

Higgs R and Jefferies C (2008) Targeting IRFs by ubiquitination: regulating antiviral responses, Biochemical Society Transactions, 10.1042/BST0360453, 36:3, (453-458), Online publication date: 1-Jun-2008.

Kumaki Y, Day C, Wandersee M, Schow B, Madsen J, Grant D, Roth J, Smee D, Blatt L and Barnard D (2008) Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2008.04.006, 371:1, (110-113), Online publication date: 1-Jun-2008.

Neuman M, Sha K, Esguerra R, Zakhari S, Winkler R, Hilzenrat N, Wyse J, Cooper C, Seth D, Gorrell M, Haber P, McCaughan G, Leo M, Lieber C, Voiculescu M, Buzatu E, Ionescu C, Dudas J, Saile B and Ramadori G (2007) Inflammation and Repair in Viral Hepatitis C, Digestive Diseases and Sciences, 10.1007/s10620-007-0047-3, 53:6, Online publication date: 1-Jun-2008.

Rehman J (2008) An Inconvenient Truth, Circulation Research, 10.1161/CIRCRESAHA.108.177311, 102:10, (1146-1147), Online publication date: 23-May-2008.

Colonna M and Gitlin L (2008) Helicases at Frontline of RNA Virus Recognition Nucleic Acids in Innate Immunity, 10.1201/9781420068269.ch17, (241-272), Online publication date: 22-May-2008.

Ablasser A, Hartmann G and Hornung V (2008) RNA Interference in Scope of Immune System Nucleic Acids in Innate Immunity, 10.1201/9781420068269.ch15, (207-226), Online publication date: 22-May-2008.

(2008) Helicases at Frontline of RNA Virus Recognition Nucleic Acids in Innate Immunity, 10.1201/9781420068269-23, (257-288)

Le V, Trilling M, Zimmermann A and Hengel H (2008) Mouse cytomegalovirus inhibits beta interferon (IFN-β) gene expression and controls activation pathways of the IFN-β enhanceosome, Journal of General Virology, 10.1099/vir.0.83538-0, 89:5, (1131-1141), Online publication date: 1-May-2008.

Lengyel P (2008) From RNase L to the Multitalented p200 Family Proteins: An Exploration of the Modes of Interferon Action, Journal of Interferon & Cytokine Research, 10.1089/jir.2008.3993.HP, 28:5, (273-281), Online publication date: 1-May-2008.

Zitvogel L, Mignot G, Bonmort M, Ullrich E and Chaput N (2008) Les IKDC, médecine/sciences, 10.1051/medsci/2008245525, 24:5, (525-528), Online publication date: 1-May-2008.

Michallet M, Meylan E, Ermolaeva M, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, König M, Kalinke U, Pasparakis M and Tschopp J (2008) TRADD Protein Is an Essential Component of the RIG-like Helicase Antiviral Pathway, Immunity, 10.1016/j.immuni.2008.03.013, 28:5, (651-661), Online publication date: 1-May-2008.

Ooi E, Verjan N, Hirono I, Nochi T, Kondo H, Aoki T, Kiyono H and Yuki Y (2008) Biological characterisation of a recombinant Atlantic salmon type I interferon synthesized in Escherichia coli, Fish & Shellfish Immunology, 10.1016/j.fsi.2007.10.004, 24:5, (506-513), Online publication date: 1-May-2008.

Zhao W, Lee C, Piganis R, Plumlee C, de Weerd N, Hertzog P and Schindler C (2008) A Conserved IFN-α Receptor Tyrosine Motif Directs the Biological Response to Type I IFNs, The Journal of Immunology, 10.4049/jimmunol.180.8.5483, 180:8, (5483-5489), Online publication date: 15-Apr-2008.

Loppnow H, Werdan K and Buerke M (2008) Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms, Innate Immunity, 10.1177/1753425908091246, 14:2, (63-87), Online publication date: 1-Apr-2008.

Nichols W, Peck Campbell A and Boeckh M (2008) Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances, Clinical Microbiology Reviews, 10.1128/CMR.00045-07, 21:2, (274-290), Online publication date: 1-Apr-2008.

Frieman M, Heise M and Baric R (2008) SARS coronavirus and innate immunity, Virus Research, 10.1016/j.virusres.2007.03.015, 133:1, (101-112), Online publication date: 1-Apr-2008.

Hooks J, Nagineni C, Hooper L, Hayashi K and Detrick B (2008) IFN-β Provides Immuno-Protection in the Retina by Inhibiting ICAM-1 and CXCL9 in Retinal Pigment Epithelial Cells, The Journal of Immunology, 10.4049/jimmunol.180.6.3789, 180:6, (3789-3796), Online publication date: 15-Mar-2008.

Sommereyns C, Paul S, Staeheli P, Michiels T and Buchmeier M (2008) IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo, PLoS Pathogens, 10.1371/journal.ppat.1000017, 4:3, (e1000017)

Sanchez D, Miranda D, Arumugaswami V, Hwang S, Singer A, Senaati A, Shahangian A, Song M, Sun R and Cheng G (2008) A Repetitive Region of Gammaherpesvirus Genomic DNA Is a Ligand for Induction of Type I Interferon, Journal of Virology, 10.1128/JVI.01718-07, 82:5, (2208-2217), Online publication date: 1-Mar-2008.

Alsharifi M, Müllbacher A and Regner M (2008) Interferon type I responses in primary and secondary infections, Immunology & Cell Biology, 10.1038/sj.icb.7100159, 86:3, (239-245), Online publication date: 1-Mar-2008.

Ceaglio N, Etcheverrigaray M, Kratje R and Oggero M (2008) Novel long-lasting interferon alpha derivatives designed by glycoengineering, Biochimie, 10.1016/j.biochi.2007.10.013, 90:3, (437-449), Online publication date: 1-Mar-2008.

Ank N, Iversen M, Bartholdy C, Staeheli P, Hartmann R, Jensen U, Dagnaes-Hansen F, Thomsen A, Chen Z, Haugen H, Klucher K and Paludan S (2008) An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity, The Journal of Immunology, 10.4049/jimmunol.180.4.2474, 180:4, (2474-2485), Online publication date: 15-Feb-2008.

Detrick B, Nagineni C and Hooks J (2008) Cytokines Handbook of Human Immunology, Second Edition, 10.1201/9781420003710.ch16, (495-516), Online publication date: 15-Feb-2008.

Nagy Z, Gergely P, Donáth J, Borgulya G, Csanád M and Poór G (2007) Gene Expression Profiling in Paget's Disease of Bone: Upregulation of Interferon Signaling Pathways in Pagetic Monocytes and Lymphocytes, Journal of Bone and Mineral Research, 10.1359/jbmr.071021, 23:2, (253-259)

Ritter J (2008) Sensitivity: real (interferons, odorants) and imagined (homeopathy), British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.2007.03100.x, 65:2, (151-153), Online publication date: 1-Feb-2008.

Friedman R (2008) Clinical uses of interferons, British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.2007.03055.x, 65:2, (158-162), Online publication date: 1-Feb-2008.

Tanaka J, Sugimoto K, Shiraki K, Beppu T, Yoneda K, Fuke H, Yamamoto N, Ito K and Takei Y (2008) Type 1 Diabetes Mellitus Provoked by Peginterferon .ALPHA.-2b Plus Ribavirin Treatment for Chronic Hepatitis C, Internal Medicine, 10.2169/internalmedicine.47.0653, 47:8, (747-749), .

Randall R and Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures, Journal of General Virology, 10.1099/vir.0.83391-0, 89:1, (1-47), Online publication date: 1-Jan-2008.

Laver T, Nozell S and Benveniste E (2008) IFN- β -Mediated Inhibition of IL-8 Expression Requires the ISGF3 Components Stat1, Stat2, and IRF-9 , Journal of Interferon & Cytokine Research, 10.1089/jir.2007.0062, 28:1, (13-23), Online publication date: 1-Jan-2008.

Bisbal C (2008) Cliver les ARN du soi donne du punch à la réponse innée antivirale, médecine/sciences, 10.1051/medsci/200824123, 24:1, (23-25), Online publication date: 1-Jan-2008.

Kovarik P, Sauer I and Schaljo B (2008) Molecular mechanisms of the anti-inflammatory functions of interferons, Immunobiology, 10.1016/j.imbio.2007.09.011, 212:9-10, (895-901), Online publication date: 1-Jan-2008.

Tayal V and Kalra B (2008) Cytokines and anti-cytokines as therapeutics — An update, European Journal of Pharmacology, 10.1016/j.ejphar.2007.10.049, 579:1-3, (1-12), Online publication date: 1-Jan-2008.

Foster C and Klisovic D (2008) Adamantiades–Behçet's Disease Albert &amp Jakobiec's Principles &amp Practice of Ophthalmology, 10.1016/B978-1-4160-0016-7.50331-3, (4469-4481), .

Tam R, Hong Z, Moran M, Varnavski A and Kim S (2008) Therapeutic Strategies Targeting the Innate Antiviral Immune Response Biopharmaceutical Drug Design and Development, 10.1007/978-1-59745-532-9_11, (223-251), .

Khan M (2008) Role of Cytokines Immunopharmacology, 10.1007/978-0-387-77976-8_2, (33-59), .

Silverman R (2007) Viral Encounters with 2′,5′-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral Response, Journal of Virology, 10.1128/JVI.01471-07, 81:23, (12720-12729), Online publication date: 1-Dec-2007.

Rudd B, Luker G, Luker K, Peebles R and Lukacs N (2007) Type I Interferon Regulates Respiratory Virus Infected Dendritic Cell Maturation and Cytokine Production, Viral Immunology, 10.1089/vim.2007.0057, 20:4, (531-540), Online publication date: 1-Dec-2007.

Marcus P (2007) Time, Travels, and Travails with the Interferon System, Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9969, 27:12, (971-983), Online publication date: 1-Dec-2007.

Borden E, Sen G, Uze G, Silverman R, Ransohoff R, Foster G and Stark G (2007) Interferons at age 50: past, current and future impact on biomedicine, Nature Reviews Drug Discovery, 10.1038/nrd2422, 6:12, (975-990), Online publication date: 1-Dec-2007.

Subramanian G, Fiscella M, Lamousé-Smith A, Zeuzem S and McHutchison J (2007) Albinterferon α-2b: a genetic fusion protein for the treatment of chronic hepatitis C, Nature Biotechnology, 10.1038/nbt1364, 25:12, (1411-1419), Online publication date: 1-Dec-2007.

Sriram U, Biswas C, Behrens E, Dinnall J, Shivers D, Monestier M, Argon Y and Gallucci S (2007) IL-4 Suppresses Dendritic Cell Response to Type I Interferons, The Journal of Immunology, 10.4049/jimmunol.179.10.6446, 179:10, (6446-6455), Online publication date: 15-Nov-2007.

Alexander D, Ward S, Mizushima N, Levine B and Leib D (2007) Analysis of the Role of Autophagy in Replication of Herpes Simplex Virus in Cell Culture, Journal of Virology, 10.1128/JVI.01356-07, 81:22, (12128-12134), Online publication date: 15-Nov-2007.

Chany C (2007) My Tortuous Journey to a Life in Interferon Research, Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9972, 27:11, (897-900), Online publication date: 1-Nov-2007.

Howard J (2007) Introduction: cell-autonomous immunity, Microbes and Infection, 10.1016/j.micinf.2007.09.003, 9:14-15, (1633-1635), Online publication date: 1-Nov-2007.

Bermel R and Rudick R (2007) Interferon-β treatment for multiple sclerosis, Neurotherapeutics, 10.1016/j.nurt.2007.07.001, 4:4, (633-646), Online publication date: 1-Oct-2007.

Rubinstein M (2007) The purification and characterization of alpha interferons and related cytokine receptors—A personal account, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2007.06.011, 18:5-6, (519-524), Online publication date: 1-Oct-2007.

Krause C and Pestka S (2007) Historical developments in the research of interferon receptors, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2007.06.009, 18:5-6, (473-482), Online publication date: 1-Oct-2007.

Keller B, Johnson C, Erickson A and Gale M (2007) Innate immune evasion by hepatitis C virus and West Nile virus, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2007.06.006, 18:5-6, (535-544), Online publication date: 1-Oct-2007.

Hovanessian A (2007) On the discovery of interferon-inducible, double-stranded RNA activated enzymes: The 2′–5′oligoadenylate synthetases and the protein kinase PKR, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2007.06.003, 18:5-6, (351-361), Online publication date: 1-Oct-2007.

Chevaliez S and Pawlotsky J (2007) Interferon-based therapy of hepatitis C, Advanced Drug Delivery Reviews, 10.1016/j.addr.2007.07.002, 59:12, (1222-1241), Online publication date: 1-Oct-2007.

Zinkernagel R (2007) Immunology and Immunity Studied with Viruses Ciba Foundation Symposium 204 - The Molecular Basis of Cellular Defence Mechanisms, 10.1002/9780470515280.ch8, (105-129)

Langer J (2007) Interferon at 50: New Molecules, New Potential, New (and Old) Questions, Science's STKE, 10.1126/stke.4052007pe53, 2007:405, Online publication date: 25-Sep-2007.

(2007) Interferon discovery and ferret flu, Nature, 10.1038/449126a, 449:7159, (126-126), Online publication date: 13-Sep-2007.

Fehér J and Lengyel G (2007) Interferon in the Treatment of Viral Hepatitis. On the 50th Anniversary of Interferon’s Discovery, Hungarian Medical Journal, 10.1556/OH-HMJ.2007.28194, 1:3, (271-279), Online publication date: 1-Sep-2007.

Finter N (2007) A Lifetime with Interferon, Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9975, 27:9, (745-750), Online publication date: 1-Sep-2007.

Kyogoku C and Tsuchiya N (2007) A compass that points to lupus: genetic studies on type I interferon pathway, Genes & Immunity, 10.1038/sj.gene.6364409, 8:6, (445-455), Online publication date: 1-Sep-2007.

Pichlmair A and Reis e Sousa C (2007) Innate Recognition of Viruses, Immunity, 10.1016/j.immuni.2007.08.012, 27:3, (370-383), Online publication date: 1-Sep-2007.

Fehér J and Lengyel G Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago, Orvosi Hetilap, 10.1556/oh.2007.28194, 148:33, (1539-1543)

Jaitin D and Schreiber G (2007) Upregulation of a Small Subset of Genes Drives Type I Interferon-Induced Antiviral Memory, Journal of Interferon & Cytokine Research, 10.1089/jir.2006.0162, 27:8, (653-664), Online publication date: 1-Aug-2007.

Kirou K, Mavragani C and Crow M (2014) Activation of type I interferon in systemic lupus erythematosus, Expert Review of Clinical Immunology, 10.1586/1744666X.3.4.579, 3:4, (579-588), Online publication date: 1-Jul-2007.

Vilcek J (2007) My Fifty Years with Interferon, Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9984, 27:7, (535-542), Online publication date: 1-Jul-2007.

Schindler C, Levy D and Decker T (2007) JAK-STAT Signaling: From Interferons to Cytokines, Journal of Biological Chemistry, 10.1074/jbc.R700016200, 282:28, (20059-20063), Online publication date: 1-Jul-2007.

Pestka S (2007) The Interferons: 50 Years after Their Discovery, There Is Much More to Learn, Journal of Biological Chemistry, 10.1074/jbc.R700004200, 282:28, (20047-20051), Online publication date: 1-Jul-2007.

Cheng G, Zhao X, Yan W, Wang W, Zuo X, Huang K, Liu Y, Chen J, Wang J, Cong W, Liu M, Gao H, Chen J, Lu Y and Zheng Z (2007) Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response, Vaccine, 10.1016/j.vaccine.2007.04.089, 25:28, (5199-5208), Online publication date: 1-Jul-2007.

Swann J, Hayakawa Y, Zerafa N, Sheehan K, Scott B, Schreiber R, Hertzog P and Smyth M (2007) Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function, The Journal of Immunology, 10.4049/jimmunol.178.12.7540, 178:12, (7540-7549), Online publication date: 15-Jun-2007.

Jaworska J, Gravel A, Fink K, Grandvaux N and Flamand L (2007) Inhibition of Transcription of the Beta Interferon Gene by the Human Herpesvirus 6 Immediate-Early 1 Protein, Journal of Virology, 10.1128/JVI.02443-06, 81:11, (5737-5748), Online publication date: 1-Jun-2007.

Gresser I (2007) Interferon: An Unfolding Tale, Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9986, 27:6, (447-452), Online publication date: 1-Jun-2007.

Chelbi-Alix M and Wietzerbin J (2007) Interferon, a growing cytokine family: 50 years of interferon research, Biochimie, 10.1016/j.biochi.2007.05.001, 89:6-7, (713-718), Online publication date: 1-Jun-2007.

Fitzgerald-Bocarsly P and Feng D (2007) The role of type I interferon production by dendritic cells in host defense, Biochimie, 10.1016/j.biochi.2007.04.018, 89:6-7, (843-855), Online publication date: 1-Jun-2007.

Jouanguy E, Zhang S, Chapgier A, Sancho-Shimizu V, Puel A, Picard C, Boisson-Dupuis S, Abel L and Casanova J (2007) Human primary immunodeficiencies of type I interferons, Biochimie, 10.1016/j.biochi.2007.04.016, 89:6-7, (878-883), Online publication date: 1-Jun-2007.

Gottenberg J and Chiocchia G (2007) Dendritic cells and interferon-mediated autoimmunity, Biochimie, 10.1016/j.biochi.2007.04.013, 89:6-7, (856-871), Online publication date: 1-Jun-2007.

Chany C (2007) Early days in interferon research, Biochimie, 10.1016/j.biochi.2007.04.012, 89:6-7, (721-722), Online publication date: 1-Jun-2007.

Lindenmnann J (2007) 50 years ago: How prepared were our minds?, Biochimie, 10.1016/j.biochi.2007.04.007, 89:6-7, (719-720), Online publication date: 1-Jun-2007.

Claudinon J, Monier M and Lamaze C (2007) Interfering with interferon receptor sorting and trafficking: Impact on signaling, Biochimie, 10.1016/j.biochi.2007.03.014, 89:6-7, (735-743), Online publication date: 1-Jun-2007.

Uzé G and Monneron D (2007) IL-28 and IL-29: Newcomers to the interferon family, Biochimie, 10.1016/j.biochi.2007.01.008, 89:6-7, (729-734), Online publication date: 1-Jun-2007.

Weber F and Haller O (2007) Viral suppression of the interferon system, Biochimie, 10.1016/j.biochi.2007.01.005, 89:6-7, (836-842), Online publication date: 1-Jun-2007.

Bode J, Brenndörfer E and Häussinger D (2007) Subversion of innate host antiviral strategies by the hepatitis C virus, Archives of Biochemistry and Biophysics, 10.1016/j.abb.2007.03.033, 462:2, (254-265), Online publication date: 1-Jun-2007.

Bin F, Bu-feng L and Guang-yuan H (2008) Synonymous codon usage bias and overexpression of a synthetic gene encoding Interferon α2b in yeast, Virologica Sinica, 10.1007/s12250-007-0026-z, 22:3, (226-232), Online publication date: 1-Jun-2007.

Ozato K, Uno K and Iwakura Y (2007) Another Road to Interferon: Yasuichi Nagano's Journey, Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9988, 27:5, (349-352), Online publication date: 1-May-2007.

Uematsu S and Akira S (2007) Toll-like Receptors and Type I Interferons, Journal of Biological Chemistry, 10.1074/jbc.R700009200, 282:21, (15319-15323), Online publication date: 1-May-2007.

Herbeuval J and Shearer G (2007) HIV-1 immunopathogenesis: How good interferon turns bad, Clinical Immunology, 10.1016/j.clim.2006.09.016, 123:2, (121-128), Online publication date: 1-May-2007.

Li J, Chen M, Liu X, Zhang H, Shen F and Wang G (2007) Transient expression of an active human interferon-beta in lettuce, Scientia Horticulturae, 10.1016/j.scienta.2006.12.047, 112:3, (258-265), Online publication date: 1-Apr-2007.

Hamidi M, Zarrin A, Foroozesh M and Mohammadi-Samani S (2007) Applications of carrier erythrocytes in delivery of biopharmaceuticals, Journal of Controlled Release, 10.1016/j.jconrel.2006.06.032, 118:2, (145-160), Online publication date: 1-Apr-2007.

Liu L, Li P, Jiang L, Dong C, Wang L, Che Y, Zhao H, Dong S and Li Q (2007) Using Interferon-α to Block Expression of Cellular Ribosome Subunit S24 Variant 2 in Human Fibroblasts Inhibits Translation of The Poliovirus Genome, Viral Immunology, 10.1089/vim.2006.0058, 20:1, (142-149), Online publication date: 1-Mar-2007.

Amadori M (2007) The Role of IFN- α as Homeostatic Agent in The Inflammatory Response: A Balance between Danger and Response? , Journal of Interferon & Cytokine Research, 10.1089/jir.2006.0110, 27:3, (181-190), Online publication date: 1-Mar-2007.

Burke D (2007) Early Days with Interferon, Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9998, 27:2, (91-96), Online publication date: 1-Feb-2007.

Marcus P (2007) Celebrating the 50 th Anniversary of the Discovery of Interferon , Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9997, 27:2, (87-90), Online publication date: 1-Feb-2007.

Hackett C, Rotrosen D, Auchincloss H and Fauci A (2007) Immunology research: challenges and opportunities in a time of budgetary constraint, Nature Immunology, 10.1038/ni0207-114, 8:2, (114-117), Online publication date: 1-Feb-2007.

Tsang S, Leung P, Leung K, Yau W, Hardy M, Mak N, Leung K and Fung M (2007) Characterization of murine interferon-alpha 12 (MuIFN-α12): Biological activities and gene expression, Cytokine, 10.1016/j.cyto.2007.03.002, 37:2, (138-149), Online publication date: 1-Feb-2007.

Lindenmann J (2007) Interferon and Before, Journal of Interferon & Cytokine Research, 10.1089/jir.2007.9995, 27:1, (3-5), Online publication date: 1-Jan-2007.

Karauzum S, Yasar D, Dirice E, Imir N, Luleci G and Ozes O (2009) Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas, Growth Factors, 10.1080/08977190701345515, 25:2, (94-100), Online publication date: 1-Jan-2007.

Burleson G and Burleson F (2007) Influenza virus host resistance model, Methods, 10.1016/j.ymeth.2006.09.007, 41:1, (31-37), Online publication date: 1-Jan-2007.

Aguzzi A (2007) Chapter 7 A Neuropathologist's Diary Stories of Success - Personal Recollections. X, 10.1016/S0069-8032(07)45007-0, (257-355), .

Fujii S and Lotze M Interleukin-10 (IL-10) Cytokines in the Genesis and Treatment of Cancer, 10.1007/978-1-59745-455-1_9, (165-179)

Moschos S, Lesinski G, Carson W and Kirkwood J (2007) The Type I Interferon System With Emphasis on Its Role in Malignancies Cytokines in the Genesis and Treatment of Cancer, 10.1007/978-1-59745-455-1_19, (339-372), .

Ergonul O, Mirazimi A and Dimitrov D (2007) Treatment of Crimean-Congo Hemorrhagic Fever Crimean-Congo Hemorrhagic Fever, 10.1007/978-1-4020-6106-6_19, (245-269), .

Moschos S and Kirkwood J Interferon Therapy General Principles of Tumor Immunotherapy, 10.1007/978-1-4020-6087-8_18, (405-430)

Qu K and Brooijmans N (2007) Structure-Based Drug Design Computational Methods for Protein Structure Prediction and Modeling, 10.1007/978-0-387-68825-1_5, (135-176), .

Schmidt B, Kittan N, Haupt S and Levy J (2007) Innate Cellular Immune Responses in HIV Infection The Biology of Dendritic Cells and HIV Infection, 10.1007/978-0-387-33785-2_8, (297-332), .

Saumet A and Lecellier C (2006) Anti-viral RNA silencing: do we look like plants ?, Retrovirology, 10.1186/1742-4690-3-3, 3:1, Online publication date: 1-Dec-2006.

García M, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C and Esteban M (2006) Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action, Microbiology and Molecular Biology Reviews, 10.1128/MMBR.00027-06, 70:4, (1032-1060), Online publication date: 1-Dec-2006.

De Clercq E (2006) Antiviral agents active against influenza A viruses, Nature Reviews Drug Discovery, 10.1038/nrd2175, 5:12, (1015-1025), Online publication date: 1-Dec-2006.

Hong Y, Lillehoj H, Lee S, Dalloul R and Lillehoj E (2006) Analysis of chicken cytokine and chemokine gene expression following Eimeria acervulina and Eimeria tenella infections, Veterinary Immunology and Immunopathology, 10.1016/j.vetimm.2006.07.007, 114:3-4, (209-223), Online publication date: 1-Dec-2006.

Koga R, Hamano S, Kuwata H, Atarashi K, Ogawa M, Hisaeda H, Yamamoto M, Akira S, Himeno K, Matsumoto M and Takeda K (2006) TLR-Dependent Induction of IFN-β Mediates Host Defense against Trypanosoma cruzi , The Journal of Immunology, 10.4049/jimmunol.177.10.7059, 177:10, (7059-7066), Online publication date: 15-Nov-2006.

Miyake K, Tsuchida K, Sugino H, Imura S, Morine Y, Fujii M and Shimada M (2006) Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha, Cancer Chemotherapy and Pharmacology, 10.1007/s00280-006-0250-5, 59:1, (113-126), Online publication date: 2-Nov-2006.

Makedonas G and Betts M (2006) Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection, Springer Seminars in Immunopathology, 10.1007/s00281-006-0025-4, 28:3, (209-219), Online publication date: 1-Nov-2006.

Passalacqua R, Buti S, Tomasello G, Longarini R, Brighenti M and Dalla Chiesa M (2014) Immunotherapy options in metastatic renal cell cancer: where we are and where we are going, Expert Review of Anticancer Therapy, 10.1586/14737140.6.10.1459, 6:10, (1459-1472), Online publication date: 1-Oct-2006.

Verri W, Cunha T, Parada C, Poole S, Cunha F and Ferreira S (2006) Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2006.04.001, 112:1, (116-138), Online publication date: 1-Oct-2006.

Billiau A (2006) Interferon: The pathways of discovery, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2006.07.001, 17:5, (381-409), Online publication date: 1-Oct-2006.

Cristina Carrillo M, de Luján Álvarez M and Darío Quiroga A (2006) Interferon alfa-2b triggers transforming growth factor-β1-induced apoptosis on preneoplastic liver, Annals of Hepatology, 10.1016/S1665-2681(19)31982-9, 5:4, (244-250), Online publication date: 1-Oct-2006.

Vilcek J (2006) Fifty Years of Interferon Research: Aiming at a Moving Target, Immunity, 10.1016/j.immuni.2006.08.008, 25:3, (343-348), Online publication date: 1-Sep-2006.

Stetson D and Medzhitov R (2006) Type I Interferons in Host Defense, Immunity, 10.1016/j.immuni.2006.08.007, 25:3, (373-381), Online publication date: 1-Sep-2006.

Hosmalin A and Lebon P (2006) Type I interferon production in HIV-infected patients, Journal of Leukocyte Biology, 10.1189/jlb.0306154, 80:5, (984-993), Online publication date: 17-Aug-2006.

Stetson D and Medzhitov R (2006) Antiviral defense: interferons and beyond, Journal of Experimental Medicine, 10.1084/jem.20061377, 203:8, (1837-1841), Online publication date: 7-Aug-2006.

Mujtaba M, Patel C, Patel R, Flowers L, Burkhart M, Waiboci L, Martin J, Haider M, Ahmed C and Johnson H (2006) The Gamma Interferon (IFN-γ) Mimetic Peptide IFN-γ(95-133) Prevents Encephalomyocarditis Virus Infection both in Tissue Culture and in Mice, Clinical and Vaccine Immunology, 10.1128/CVI.00021-06, 13:8, (944-952), Online publication date: 1-Aug-2006.

Shao X and Liu C (2006) Influence of IFN- α and IFN- γ on Lymphangiogenesis , Journal of Interferon & Cytokine Research, 10.1089/jir.2006.26.568, 26:8, (568-574), Online publication date: 1-Aug-2006.

Rezaee S, Cunningham C, Davison A and Blackbourn D (2006) Kaposi's sarcoma-associated herpesvirus immune modulation: an overview, Journal of General Virology, 10.1099/vir.0.81919-0, 87:7, (1781-1804), Online publication date: 1-Jul-2006.

Jack A, Boyes C, Aydin N, Alam K and Wallack M (2006) The treatment of melanoma with an emphasis on immunotherapeutic strategies, Surgical Oncology, 10.1016/j.suronc.2006.05.003, 15:1, (13-24), Online publication date: 1-Jul-2006.

Bazarah S, Ritenour R, Patel S, Hirsch G, Peltekian K and Cruess A (2006) Choroidal neovascularization with interferon associated retinopathy: Case report and review of literature, Annals of Hepatology, 10.1016/S1665-2681(19)32004-6, 5:3, (172-176), Online publication date: 1-Jul-2006.

Egwuagu C, Li W, Yu C, Che Mei Lin M, Chan C, Nakamura T and Chepelinsky A (2006) Interferon-γ induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors, Oncogene, 10.1038/sj.onc.1209402, 25:26, (3670-3679), Online publication date: 22-Jun-2006.

Agnello D and Gadina M (2006) The Biology of Cytokines Cytokine Gene Polymorphisms in Multifactorial Conditions, 10.1201/9781420005325.ch1, (2-33), Online publication date: 21-Jun-2006.

Sommereyns C and Michiels T (2006) N-Glycosylation of Murine IFN- β in a Putative Receptor-Binding Region , Journal of Interferon & Cytokine Research, 10.1089/jir.2006.26.406, 26:6, (406-413), Online publication date: 1-Jun-2006.

Ank N, West H and Paludan S (2006) IFN-λ: Novel Antiviral Cytokines, Journal of Interferon & Cytokine Research, 10.1089/jir.2006.26.373, 26:6, (373-379), Online publication date: 1-Jun-2006.

Lortat-Jacob H (2006) Interferon and heparan sulphate, Biochemical Society Transactions, 10.1042/BST0340461, 34:3, (461-464), Online publication date: 1-Jun-2006.

Meylan E and Tschopp J (2006) Toll-Like Receptors and RNA Helicases: Two Parallel Ways to Trigger Antiviral Responses, Molecular Cell, 10.1016/j.molcel.2006.05.012, 22:5, (561-569), Online publication date: 1-Jun-2006.

Kogut M, Swaggerty C, He H, Pevzner I and Kaiser P (2006) Toll-like receptor agonists stimulate differential functional activation and cytokine and chemokine gene expression in heterophils isolated from chickens with differential innate responses, Microbes and Infection, 10.1016/j.micinf.2006.02.026, 8:7, (1866-1874), Online publication date: 1-Jun-2006.

Chelbi-Alix M, Vidy A, Bougrini J and Blondel D (2006) Rabies Viral Mechanisms to Escape the IFN System: The Viral Protein P Interferes with IRF-3, Stat1, and PML Nuclear Bodies, Journal of Interferon & Cytokine Research, 10.1089/jir.2006.26.271, 26:5, (271-280), Online publication date: 1-May-2006.

Graham R, Kozyrev S, Baechler E, Reddy M, Plenge R, Bauer J, Ortmann W, Koeuth T, Escribano M, Collaborative Groups t, Pons-Estel B, Petri M, Daly M, Gregersen P, Martín J, Altshuler D, Behrens T and Alarcón-Riquelme M (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus, Nature Genetics, 10.1038/ng1782, 38:5, (550-555), Online publication date: 1-May-2006.

Lee G, Yi H and Lee C (2006) Stimulation of interferon-β gene expression by human cytomegalovirus via nuclear factor kappa B and phosphatidylinositol 3-kinase pathway, Virus Research, 10.1016/j.virusres.2005.08.018, 117:2, (209-214), Online publication date: 1-May-2006.

Li H, Ma B, Mi J, Jin H, Xu L and Wang J (2006) Cloning, in vitro expression and bioactivity of goose interferon-α, Cytokine, 10.1016/j.cyto.2006.04.013, 34:3-4, (177-183), Online publication date: 1-May-2006.

Wang L, Wang L, Zhang H, Zhang J, Chen W, Ruan X and Xia C (2006) In Vitro Effects of Recombinant Zebrafish IFN on Spring Viremia of Carp Virus and Infectious Hematopoietic Necrosis Virus , Journal of Interferon & Cytokine Research, 10.1089/jir.2006.26.256, 26:4, (256-259), Online publication date: 1-Apr-2006.

Javed A and Reder A (2006) Therapeutic role of beta-interferons in multiple sclerosis, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2005.08.011, 110:1, (35-56), Online publication date: 1-Apr-2006.

Tsukahara T, Kim S and Taylor M (2006) REFINEMENT: A search framework for the identification of interferon-responsive elements in DNA sequences – a case study with ISRE and GAS, Computational Biology and Chemistry, 10.1016/j.compbiolchem.2006.01.002, 30:2, (134-147), Online publication date: 1-Apr-2006.

Brod S, Nguyen M, Hood Z and Shipley G (2006) Ingested (Oral) IFN- α Represses TNF- α mRNA in Relapsing-Remitting Multiple Sclerosis , Journal of Interferon & Cytokine Research, 10.1089/jir.2006.26.150, 26:3, (150-155), Online publication date: 1-Mar-2006.

Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, Goodbourn S and Barclay W (2006) Variation in the ability of human influenza A viruses to induce and inhibit the IFN-β pathway, Virology, 10.1016/j.virol.2005.11.024, 347:1, (52-64), Online publication date: 1-Mar-2006.

Ruiz L, Reyes N, Aroche K, Báez R, Aldana R and Hardy E (2006) Some factors affecting the stability of interferon alpha 2b in solution, Biologicals, 10.1016/j.biologicals.2005.07.002, 34:1, (15-19), Online publication date: 1-Mar-2006.

Lusso P (2006) HIV and the chemokine system: 10 years later, The EMBO Journal, 10.1038/sj.emboj.7600947, 25:3, (447-456), Online publication date: 8-Feb-2006.

Alazemi S and Campos M (2005) Interferon-induced sarcoidosis, International Journal of Clinical Practice, 10.1111/j.1742-1241.2005.00651.x, 60:2, (201-211)

Cindrić M, Galić N, Vuletić M, Klarić M and Drevenkar V (2006) Evaluation of recombinant human interferon α-2b structure and stability by in-gel tryptic digestion, H/D exchange and mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis, 10.1016/j.jpba.2005.10.024, 40:3, (781-787), Online publication date: 1-Feb-2006.

Robertsen B (2006) The interferon system of teleost fish, Fish & Shellfish Immunology, 10.1016/j.fsi.2005.01.010, 20:2, (172-191), Online publication date: 1-Feb-2006.

Fuchsluger T, Hintschich C, Steuhl K and Meller D (2006) Adjuvante topische Interferon-α-2b-Therapie bei epithelialen Tumoren der Augenoberfläche Adjuvant topical interferon-α-2b treatment in epithelial tumors of the ocular surface, Der Ophthalmologe, 10.1007/s00347-005-1249-8, 103:2, (124-128), Online publication date: 1-Feb-2006.

Zhang H, Zheng C, Li J, Gu C, Wang C and Liu Y (2006) Microcalorimetric Study of Energy Metabolism of HSV-2 and FMDV Infection Processes, Chinese Journal of Chemistry, 10.1002/cjoc.200690035, 24:2, (182-186), Online publication date: 1-Feb-2006.

García-Sastre A (2006) Antiviral Response in Pandemic Influenza Viruses, Emerging Infectious Diseases, 10.3201/eid1201.051186, 12:1, (44-47)

Lens M (2006) Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease, Dermatologic Therapy, 10.1111/j.1529-8019.2005.00051.x, 19:1, (9-18), Online publication date: 1-Jan-2006.

Buontempo P, Jubin R, Buontempo C, Wagner N, Reyes G and Baroudy B (2006) Antiviral Activity of Transiently Expressed IFN-κ Is Cell-Associated, Journal of Interferon & Cytokine Research, 10.1089/jir.2006.26.40, 26:1, (40-52), Online publication date: 1-Jan-2006.

Shang L and Tomasi T (2006) The Heat Shock Protein 90-CDC37 Chaperone Complex Is Required for Signaling by Types I and II Interferons, Journal of Biological Chemistry, 10.1074/jbc.M509901200, 281:4, (1876-1884), Online publication date: 1-Jan-2006.

Fenner J, Starr R, Cornish A, Zhang J, Metcalf D, Schreiber R, Sheehan K, Hilton D, Alexander W and Hertzog P (2005) Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity, Nature Immunology, 10.1038/ni1287, 7:1, (33-39), Online publication date: 1-Jan-2006.

Haller O, Kochs G and Weber F (2006) The interferon response circuit: Induction and suppression by pathogenic viruses, Virology, 10.1016/j.virol.2005.09.024, 344:1, (119-130), Online publication date: 1-Jan-2006.

Toth A, Zhang P, Das S, George C and Samuel C (2006) Interferon Action and the Double‐Stranded RNA‐Dependent Enzymes ADAR1 Adenosine Deaminase and PKR Protein Kinase , 10.1016/S0079-6603(06)81010-X, (369-434), .

Paun A and Pitha P (2006) The Innate Antiviral Response: New Insights Into A Continuing Story , 10.1016/S0065-3527(06)69001-5, (1-66), .

Ellermann-Eriksen S (2005) Macrophages and cytokines in the early defence against herpes simplex virus, Virology Journal, 10.1186/1743-422X-2-59, 2:1, Online publication date: 1-Dec-2005.

Pokrovskaja K, Panaretakis T and Grandér D (2005) Alternative Signaling Pathways Regulating Type I Interferon-Induced Apoptosis, Journal of Interferon & Cytokine Research, 10.1089/jir.2005.25.799, 25:12, (799-810), Online publication date: 1-Dec-2005.

Ajariyakhajorn C, Mammen M, Endy T, Gettayacamin M, Nisalak A, Nimmannitya S and Libraty D (2005) Randomized, Placebo-Controlled Trial of Nonpegylated and Pegylated Forms of Recombinant Human Alpha Interferon 2a for Suppression of Dengue Virus Viremia in Rhesus Monkeys, Antimicrobial Agents and Chemotherapy, 10.1128/AAC.49.11.4508-4514.2005, 49:11, (4508-4514), Online publication date: 1-Nov-2005.

Vilcek J (2005) Cytokines Cytokines and the CNS, 10.1201/9781420039849.ch2, (23-38), Online publication date: 31-Oct-2005.

Alsharifi M, Lobigs M, Regner M, Lee E, Koskinen A and Müllbacher A (2005) Type I Interferons Trigger Systemic, Partial Lymphocyte Activation in Response to Viral Infection, The Journal of Immunology, 10.4049/jimmunol.175.7.4635, 175:7, (4635-4640), Online publication date: 1-Oct-2005.

Marcus P and Sekellick M (2005) Interferon Induction by Viruses. XXV., Acta Microbiologica et Immunologica Hungarica, 10.1556/AMicr.52.2005.3-4.3, 52:3-4, (291-308), Online publication date: 1-Oct-2005.

De Clercq E (2005) Interferon: Ten Stories in One, Acta Microbiologica et Immunologica Hungarica, 10.1556/AMicr.52.2005.3-4.2, 52:3-4, (273-289), Online publication date: 1-Oct-2005.

Höhle C, Karger A, König P, Giesow K and Keil G (2005) High-level expression of biologically active bovine alpha interferon by Bovine herpesvirus 1 interferes only marginally with recombinant virus replication in vitro, Journal of General Virology, 10.1099/vir.0.81094-0, 86:10, (2685-2695), Online publication date: 1-Oct-2005.

Roisman L, Jaitin D, Baker D and Schreiber G (2005) Mutational Analysis of the IFNAR1 Binding Site on IFNα2 Reveals the Architecture of a Weak Ligand–Receptor Binding-site, Journal of Molecular Biology, 10.1016/j.jmb.2005.08.042, 353:2, (271-281), Online publication date: 1-Oct-2005.

Gaertner F, Babiuk L, Van Moorlehem E, Beskorwayne T, Lee S, Shutter R, Armstrong J and Griebel P (2005) Amended recombinant cells (ARCs™): An economical and surprisingly effective production and delivery vehicle for recombinant bovine IFN-γ, Journal of Controlled Release, 10.1016/j.jconrel.2005.06.008, 107:2, (189-202), Online publication date: 1-Oct-2005.

Dafny N and Yang P (2005) Interferon and the central nervous system, European Journal of Pharmacology, 10.1016/j.ejphar.2005.08.029, 523:1-3, (1-15), Online publication date: 1-Oct-2005.

Berghofer B, Frommer T, Konig I, Ziegler A, Chakraborty T, Bein G and Hackstein H (2005) Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, 10.1111/j.1365-2222.2005.02325.x, 35:9, (1147-1154), Online publication date: 1-Sep-2005.

Borden E (2005) Review: Milstein Award Lecture: Interferons and Cancer: Where from Here? , Journal of Interferon & Cytokine Research, 10.1089/jir.2005.25.511, 25:9, (511-527), Online publication date: 1-Sep-2005.

Decker T, Müller M and Stockinger S (2005) The Yin and Yang of type I interferon activity in bacterial infection, Nature Reviews Immunology, 10.1038/nri1684, 5:9, (675-687), Online publication date: 1-Sep-2005.

Samuelsson C, Lienenklaus S, Müller P, Zawatzky R, Hauser H and Weiss S (2005) Transformation of mouse fibroblasts alters the induction pattern of type I IFNs after virus infection, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2005.07.124, 335:2, (584-589), Online publication date: 1-Sep-2005.

Hidmark A, McInerney G, Nordström E, Douagi I, Werner K, Liljeström P and Hedestam G (2005) Early Alpha/Beta Interferon Production by Myeloid Dendritic Cells in Response to UV-Inactivated Virus Requires Viral Entry and Interferon Regulatory Factor 3 but Not MyD88, Journal of Virology, 10.1128/JVI.79.16.10376-10385.2005, 79:16, (10376-10385), Online publication date: 15-Aug-2005.

Jiang J, Gross D, Nogusa S, Elbaum P and Murasko D (2005) Depletion of T Cells by Type I Interferon: Differences between Young and Aged Mice, The Journal of Immunology, 10.4049/jimmunol.175.3.1820, 175:3, (1820-1826), Online publication date: 1-Aug-2005.

Miller C (2005) Pleiotropic mechanisms of virus survival and persistence, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 10.1016/j.tripleo.2005.03.017, 100:2, (S27-S36), Online publication date: 1-Aug-2005.

Hengel H, Koszinowski U and Conzelmann K (2005) Viruses know it all: new insights into IFN networks, Trends in Immunology, 10.1016/j.it.2005.05.004, 26:7, (396-401), Online publication date: 1-Jul-2005.

PERRY A, CHEN G, ZHENG D, TANG H and CHENG G (2005) The host type I interferon response to viral and bacterial infections, Cell Research, 10.1038/sj.cr.7290309, 15:6, (407-422), Online publication date: 1-Jun-2005.

Roy F, Salehzada T, Bisbal C, Dougherty J and Peltz S (2005) A newly discovered function for RNase L in regulating translation termination, Nature Structural & Molecular Biology, 10.1038/nsmb944, 12:6, (505-512), Online publication date: 1-Jun-2005.

Haeryfar S (2005) The importance of being a pDC in antiviral immunity: the IFN mission versus Ag presentation?, Trends in Immunology, 10.1016/j.it.2005.04.002, 26:6, (311-317), Online publication date: 1-Jun-2005.

Reuben A (2005) Prepared minds and the introduction of imaginon for hepatitic contagions, Hepatology, 10.1002/hep.20751, 41:6, (1437-1442), Online publication date: 1-Jun-2005.

Platanias L (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling, Nature Reviews Immunology, 10.1038/nri1604, 5:5, (375-386), Online publication date: 1-May-2005.

Smith P, Lombardi G and Foster G (2005) Type I interferons and the innate immune response—more than just antiviral cytokines, Molecular Immunology, 10.1016/j.molimm.2004.11.008, 42:8, (869-877), Online publication date: 1-May-2005.

(2005) VOLUME 2, NUMBER 4, Journal of Agromedicine, 10.1300/J096v09n02_09, 9:2, (147-157), Online publication date: 11-Apr-2005.

Klebl B, Kurtenbach A, Salassidis K, Daub H and Herget T (2016) Host Cell Targets in HCV Therapy: Novel Strategy or Proven Practice?, Antiviral Chemistry and Chemotherapy, 10.1177/095632020501600201, 16:2, (69-90), Online publication date: 1-Apr-2005.

Prell R, Li B, Lin J, VanRoey M and Jooss K (2005) Administration of IFN-α Enhances the Efficacy of a Granulocyte Macrophage Colony Stimulating Factor–Secreting Tumor Cell Vaccine, Cancer Research, 10.1158/0008-5472.CAN-04-1975, 65:6, (2449-2456), Online publication date: 15-Mar-2005.

Marcus P, Rojek J and Sekellick M (2005) Interferon Induction and/or Production and Its Suppression by Influenza A Viruses, Journal of Virology, 10.1128/JVI.79.5.2880-2890.2005, 79:5, (2880-2890), Online publication date: 1-Mar-2005.

Kappos L (2005) Interferons in multiple sclerosis, Neurologic Clinics, 10.1016/j.ncl.2004.10.004, 23:1, (189-214), Online publication date: 1-Feb-2005.

Alfano M and Poli G (2005) Role of cytokines and chemokines in the regulation of innate immunity and HIV infection, Molecular Immunology, 10.1016/j.molimm.2004.06.016, 42:2, (161-182), Online publication date: 1-Feb-2005.

Hahm B, Trifilo M, Zuniga E and Oldstone M (2005) Viruses Evade the Immune System through Type I Interferon-Mediated STAT2-Dependent, but STAT1-Independent, Signaling, Immunity, 10.1016/j.immuni.2005.01.005, 22:2, (247-257), Online publication date: 1-Feb-2005.

Cummins J, Krakowka G and Thompson C Systemic effects of interferons after oral administration in animals and humans, American Journal of Veterinary Research, 10.2460/ajvr.2005.66.164, 66:1, (164-176)

OGISO S, SHIRAI J, TUCHIYA Y and HONDA E (2005) Use of Getah virus for antiviral assay of human interferon, Uirusu, 10.2222/jsv.55.317, 55:2, (317-326), .

RUTTANAPUMMA R, NAKAMURA M and TAKEHARA K (2005) High Level Expression Recombinant Chicken Interferon-.ALPHA. Using Baculovirus, Journal of Veterinary Medical Science, 10.1292/jvms.67.25, 67:1, (25-28), .

Gosain A and Gamelli R (2005) A Primer in Cytokines, Journal of Burn Care & Rehabilitation, 10.1097/01.BCR.0000150214.72984.44, 26:1, (7-12), Online publication date: 1-Jan-2005.

McDermott D (2005) Cytokine Receptor Heterogeneity Measuring Immunity, 10.1016/B978-012455900-4/50265-8, (23-34), .

Heng Z, Congyi Z, Cunxin W, Jibin W, Chaojiang G, Jie L and Yuwen L (2005) Microcalorimetric study of virus infection; The effects of hyperthermia and 1b recombinant homo interferon on the infection process of BHK-21 cells by foot and mouth disease virus, Journal of Thermal Analysis and Calorimetry, 10.1007/s10973-004-0560-y, 79:1, (45-50), Online publication date: 1-Jan-2005.

Gollnick H Systemische Therapie Dermatologie und Venerologie, 10.1007/3-540-26624-0_105, (1462-1480)

García-Sastre A Interferon Antagonists of Influenza Viruses Modulation of Host Gene Expression and Innate Immunity by Viruses, 10.1007/1-4020-3242-0_5, (95-114)

Shaw M and Palese P Viruses and the Innate Immune System Modulation of Host Gene Expression and Innate Immunity by Viruses, 10.1007/1-4020-3242-0_1, (1-18)

Moschos S, Varanasi S and Kirkwood J Interferons in the Treatment of Solid Tumors Cytokines and Cancer, 10.1007/0-387-24361-5_9, (207-241)

Parmar S and Platanias L Interferons Cytokines and Cancer, 10.1007/0-387-24361-5_3, (45-68)

D'Souza R and Foster G (2011) Pegylated interferons, Journal of Drug Evaluation, 10.3109/14791130400023643, 2:4, (113-127), Online publication date: 1-Dec-2004.

Parker N and Porter A (2004) Identification of a novel gene family that includes the interferon-inducible human genes 6–16 and ISG12, BMC Genomics, 10.1186/1471-2164-5-8, 5:1, Online publication date: 1-Dec-2004.

Horvath C (2004) Weapons of STAT destruction. Interferon evasion by paramyxovirus V proteins, European Journal of Biochemistry, 10.1111/j.1432-1033.2004.04425.x, 271:23-24, (4621-4628), Online publication date: 1-Dec-2004.

Bogdan C, Mattner J and Schleicher U (2004) The role of type I interferons in non-viral infections, Immunological Reviews, 10.1111/j.0105-2896.2004.00207.x, 202:1, (33-48), Online publication date: 1-Dec-2004.

Pestka S, Krause C and Walter M (2004) Interferons, interferon-like cytokines, and their receptors, Immunological Reviews, 10.1111/j.0105-2896.2004.00204.x, 202:1, (8-32), Online publication date: 1-Dec-2004.

Weber F, Kochs G and Haller O (2004) Inverse Interference: How Viruses Fight the Interferon System, Viral Immunology, 10.1089/vim.2004.17.498, 17:4, (498-515), Online publication date: 1-Dec-2004.

Webby R, Hoffmann E and Webster R (2004) Molecular constraints to interspecies transmission of viral pathogens, Nature Medicine, 10.1038/nm1151, 10:S12, (S77-S81), Online publication date: 1-Dec-2004.

Watanabe Y (2004) Fifty years of interference, Nature Immunology, 10.1038/ni1204-1193, 5:12, (1193-1193), Online publication date: 1-Dec-2004.

Markowitz C (2005) Development of interferon-β as a therapy for multiple sclerosis, Expert Opinion on Emerging Drugs, 10.1517/14728214.9.2.363, 9:2, (363-374), Online publication date: 1-Nov-2004.

Takemoto Y, Yano H, Momosaki S, Ogasawara S, Nishida N, Kojiro S, Kamura T and Kojiro M (2004) Antiproliferative Effects of Interferon-αCon1 on Ovarian Clear Cell Adenocarcinoma In vitro and In vivo , Clinical Cancer Research, 10.1158/1078-0432.CCR-04-0279, 10:21, (7418-7426), Online publication date: 1-Nov-2004.

Saravolatz L, Asmuth D, Nguyen H, Melcher G, Cohen S and Pollard R (2004) Treatments for Hepatitis B, Clinical Infectious Diseases, 10.1086/425010, 39:9, (1353-1362), Online publication date: 1-Nov-2004.

Luik A, Knapp S, Thursz M, Thomas H and Schlaak J (2004) Autoregulatory Role of Interleukin-10 in Hepatitis C Patients Treated with IFN-α, Journal of Interferon & Cytokine Research, 10.1089/jir.2004.24.585, 24:10, (585-593), Online publication date: 1-Oct-2004.

Dong B, Zhou Q, Zhao J, Zhou A, Harty R, Bose S, Banerjee A, Slee R, Guenther J, Williams B, Wiedmer T, Sims P and Silverman R (2004) Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon, Journal of Virology, 10.1128/JVI.78.17.8983-8993.2004, 78:17, (8983-8993), Online publication date: 1-Sep-2004.

O'Connell R, Saha S, Vaidya S, Bruhn K, Miranda G, Zarnegar B, Perry A, Nguyen B, Lane T, Taniguchi T, Miller J and Cheng G (2004) Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection, Journal of Experimental Medicine, 10.1084/jem.20040712, 200:4, (437-445), Online publication date: 16-Aug-2004.

Guo J, Sohn J, Zhu Q and Seeger C (2004) Mechanism of the interferon alpha response against hepatitis C virus replicons, Virology, 10.1016/j.virol.2004.04.031, 325:1, (71-81), Online publication date: 1-Jul-2004.

Mayr A (2004) Taking Advantage of the Positive Side-Effects of Smallpox Vaccination, Journal of Veterinary Medicine Series B, 10.1111/j.1439-0450.2004.00763.x, 51:5, (199-201), Online publication date: 1-Jun-2004.

Degen W, van Daal N, van Zuilekom H, Burnside J and Schijns V (2004) Identification and Molecular Cloning of Functional Chicken IL-12, The Journal of Immunology, 10.4049/jimmunol.172.7.4371, 172:7, (4371-4380), Online publication date: 1-Apr-2004.

Bonin-Debs A, Boche I, Gille H and Brinkmann U (2005) Development of secreted proteins as biotherapeutic agents, Expert Opinion on Biological Therapy, 10.1517/14712598.4.4.551, 4:4, (551-558), Online publication date: 1-Apr-2004.

Tilg H and Kaser A (2005) Type I interferons and their therapeutic role in Th2-regulated inflammatory disorders, Expert Opinion on Biological Therapy, 10.1517/14712598.4.4.469, 4:4, (469-481), Online publication date: 1-Apr-2004.

Hoebe K and Beutler B (2016) LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins, Journal of Endotoxin Research, 10.1177/09680519040100021001, 10:2, (130-136), Online publication date: 1-Apr-2004.

Pestka S, Krause C, Sarkar D, Walter M, Shi Y and Fisher P (2004) I nterleukin -10 and R elated C ytokines and R eceptors , Annual Review of Immunology, 10.1146/annurev.immunol.22.012703.104622, 22:1, (929-979), Online publication date: 1-Apr-2004.

Lecellier C and Voinnet O (2004) RNA silencing: no mercy for viruses?, Immunological Reviews, 10.1111/j.0105-2896.2004.00128.x, 198:1, (285-303), Online publication date: 1-Apr-2004.

Wideman R, Chapman M, Wang W and Erf G (2004) Immune modulation of the pulmonary hypertensive response to bacterial lipopolysaccharide (endotoxin) in broilers, Poultry Science, 10.1093/ps/83.4.624, 83:4, (624-637), Online publication date: 1-Apr-2004.

Vilček J and Feldmann M (2004) Historical review: Cytokines as therapeutics and targets of therapeutics, Trends in Pharmacological Sciences, 10.1016/j.tips.2004.02.011, 25:4, (201-209), Online publication date: 1-Apr-2004.

Kötter I, Günaydin I, Zierhut M and Stübiger N (2004) The use of interferon α in behçet disease: review of the literature, Seminars in Arthritis and Rheumatism, 10.1016/j.semarthrit.2003.09.010, 33:5, (320-335), Online publication date: 1-Apr-2004.

Kalvakolanu D (2004) The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression, Cytokine & Growth Factor Reviews, 10.1016/j.cytogfr.2004.01.002, 15:2-3, (169-194), Online publication date: 1-Apr-2004.

Fern??ndez-Arc??s N, Blanco A, Gait??n M, Nyqvist M, Alonso A and Reyes-Engel A (2004) Differential transcriptional expresi??n of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment, Pharmacogenetics, 10.1097/00008571-200403000-00007, 14:3, (189-193), Online publication date: 1-Mar-2004.

TOUGH D (2009) Type I Interferon as a Link Between Innate and Adaptive Immunity through Dendritic Cell Stimulation, Leukemia & Lymphoma, 10.1080/1042819031000149368, 45:2, (257-264), Online publication date: 1-Feb-2004.

Andersen J, Strandbygard D, Hartmann R and Justesen J (2004) Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1, European Journal of Biochemistry, 10.1046/j.1432-1033.2003.03966.x, 271:3, (628-636), Online publication date: 1-Feb-2004.

Shimizu K and Kuroda K (2004) 'Virus and Interferon' Expression of Host Genes in Influenza Virus Infected cells, Uirusu, 10.2222/jsv.54.189, 54:2, (189-196), .

Fern??ndez O (2004) Interferons in Relapsing-Remitting Multiple Sclerosis, CNS Drugs, 10.2165/00023210-200418150-00002, 18:15, (1057-1070), .

NAGAI A, TAIRA O, ISHIKAWA M, HIRAMATSU K, HOHDATSU T, KOYAMA H, ARAI S, SATO H, NAKANO K and MAEHARA N (2004) Cloning of cDNAs Encoding Multiple Subtypes of Feline Interferon-.ALPHA. from the Feline Epitherial Cell Line, Journal of Veterinary Medical Science, 10.1292/jvms.66.725, 66:6, (725-728), .

Kim K, Yavel R, Gross V and Brody N (2004) Intralesional Interferon alpha-2b in the Treatment of Basal Cell Carcinoma and Squamous Cell Carcinoma: Revisited, Dermatologic Surgery, 10.1111/j.1524-4725.2004.30020.x, 30:1, (116-120), Online publication date: 1-Jan-2004.

KIM K, YAVEL R, GROSS V and BRODY N (2004) Intralesional Interferon α-2b in the Treatment of Basal Cell Carcinoma and Squamous Cell Carcinoma, Dermatologic Surgery, 10.1097/00042728-200401000-00032, 30:1, (116-120), Online publication date: 1-Jan-2004.

(2009) Historical Brevium—Viral Interference and Interferon, Immunological Investigations, 10.1081/IMM-200038659, 33:4, (481-482), Online publication date: 1-Jan-2004.

Dupuy J, Bonami J and Roch P (2004) A synthetic antibacterial peptide from Mytilus galloprovincialis reduces mortality due to white spot syndrome virus in palaemonid shrimp, Journal of Fish Diseases, 10.1046/j.1365-2761.2003.00516.x, 27:1, (57-64), Online publication date: 1-Jan-2004.

Casanova J and Abel L (2004) The human model: a genetic dissection of immunity to infection in natural conditions, Nature Reviews Immunology, 10.1038/nri1264, 4:1, (55-66), Online publication date: 1-Jan-2004.

Barnes E, Semmo N and Klenerman P (2004) Immunology of hepatitis C virus Hepatitis Prevention and Treatment, 10.1007/978-3-0348-7903-3_6, (107-123), .

Lens M (2005) The role of biological response modifiers in malignant melanoma, Expert Opinion on Biological Therapy, 10.1517/14712598.3.8.1225, 3:8, (1225-1231), Online publication date: 1-Dec-2003.

Olsen E (2003) Interferon in the treatment of cutaneous T-cell lymphoma, Dermatologic Therapy, 10.1111/j.1396-0296.2003.01643.x, 16:4, (311-321), Online publication date: 1-Dec-2003.

Hertzog P, O'Neill L and Hamilton J (2003) The interferon in TLR signaling: more than just antiviral, Trends in Immunology, 10.1016/j.it.2003.08.006, 24:10, (534-539), Online publication date: 1-Oct-2003.

Kalvakolanu D (2003) Alternate interferon signaling pathways, Pharmacology & Therapeutics, 10.1016/S0163-7258(03)00070-6, 100:1, (1-29), Online publication date: 1-Oct-2003.

Cindrić M and Vuletić M (2003) Characterisation of interferon α-2b by liquid chromatography and mass spectrometry techniques, Journal of Separation Science, 10.1002/jssc.200301419, 26:14, (1263-1268), Online publication date: 26-Sep-2003.

Robinson J, Hernandez C, Anderson E and Nickoloff B (2003) Topical and light-based treatments for basal cell carcinoma, Seminars in Cutaneous Medicine and Surgery, 10.1016/S1085-5629(03)00047-6, 22:3, (171-176), Online publication date: 1-Sep-2003.

Renauld J (2003) Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators, Nature Reviews Immunology, 10.1038/nri1153, 3:8, (667-676), Online publication date: 1-Aug-2003.

Saydam G, Hakan Aydin H, Sahin F, Selvi N, Oktem G, Terzioglu E, Buyukkececi F and Omay S (2003) Involvement of protein phosphatase 2A in interferon-α-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells, Leukemia Research, 10.1016/S0145-2126(02)00347-8, 27:8, (709-717), Online publication date: 1-Aug-2003.

Šindelářová M and Šindelář L (2003) Influence of Antiviral Factor on Tobacco Mosaic Virus RNA Biosynthesis in Tobacco, Biologia plantarum, 10.1023/A:1022370319213, 46:1, (95-100), Online publication date: 1-Jul-2003.

Saladino R, Ciambecchini U, Nencioni L and Palamara A (2003) Recent advances in the chemistry of parainfluenza-1 (Sendai) virus inhibitors, Medicinal Research Reviews, 10.1002/med.10036, 23:4, (427-455), Online publication date: 1-Jul-2003.

Vassileva G, Chen S, Zeng M, Abbondanzo S, Jensen K, Gorman D, Baroudy B, Jiang Y, Murgolo N and Lira S (2003) Expression of a Novel Murine Type I IFN in the Pancreatic Islets Induces Diabetes in Mice, The Journal of Immunology, 10.4049/jimmunol.170.11.5748, 170:11, (5748-5755), Online publication date: 1-Jun-2003.

Eguchi J, Hiroishi K, Ishii S and Mitamura K (2003) Interferon-α and interleukin-12 gene therapy of cancer: interferon-α induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing, Cancer Immunology, Immunotherapy, 10.1007/s00262-002-0367-2, 52:6, (378-386), Online publication date: 1-Jun-2003.

Larkin J, Jin L, Farmen M, Venable D, Huang Y, Tan S and Glass J (2003) Synergistic Antiviral Activity of Human Interferon Combinations in the Hepatitis C Virus Replicon System, Journal of Interferon & Cytokine Research, 10.1089/107999003321829962, 23:5, (247-257), Online publication date: 1-May-2003.

Krug R, Yuan W, Noah D and Latham A (2003) Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein, Virology, 10.1016/S0042-6822(03)00119-3, 309:2, (181-189), Online publication date: 1-May-2003.

Hitzig W (2003) The discovery of agammaglobulinaemia in 1952, European Journal of Pediatrics, 10.1007/s00431-003-1153-7, 162:5, (289-304), Online publication date: 1-May-2003.

Wigley P and Kaiser P (2003) Avian cytokines in health and disease, Revista Brasileira de Ciência Avícola, 10.1590/S1516-635X2003000100001, 5:1, (1-14), Online publication date: 1-Apr-2003.

Cull V, Tilbrook P, Bartlett E, Brekalo N and James C (2003) Type I interferon differential therapy for erythroleukemia: specificity of STAT activation, Blood, 10.1182/blood-2002-05-1521, 101:7, (2727-2735), Online publication date: 1-Apr-2003.

Stewart T (2003) Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases, Cytokine & Growth Factor Reviews, 10.1016/S1359-6101(02)00088-6, 14:2, (139-154), Online publication date: 1-Apr-2003.

Brown C and Kirkwood J (2003) Medical management of melanoma, Surgical Clinics of North America, 10.1016/S0039-6109(02)00187-1, 83:2, (283-322), Online publication date: 1-Apr-2003.

Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen I, Al-Jumaah S, Yang K, Chapgier A, Eidenschenk C, Eid P, Ghonaium A, Tufenkeji H, Frayha H, Al-Gazlan S, Al-Rayes H, Schreiber R, Gresser I and Casanova J (2003) Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency, Nature Genetics, 10.1038/ng1097, 33:3, (388-391), Online publication date: 1-Mar-2003.

Noah D, Twu K and Krug R (2003) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS, Virology, 10.1016/S0042-6822(02)00127-7, 307:2, (386-395), Online publication date: 1-Mar-2003.

Tseng C and Laughlin C (2003) Antiviral Agents, RNA Viruses (Other than HIV), and Orthopoxviruses Burger's Medicinal Chemistry and Drug Discovery, 10.1002/0471266949.bmc083, (359-455), Online publication date: 21-Feb-2003.

Hagmaier K, Jennings S, Buse J, Weber F and Kochs G (2003) Novel Gene Product of Thogoto Virus Segment 6 Codes for an Interferon Antagonist , Journal of Virology, 10.1128/JVI.77.4.2747-2752.2003, 77:4, (2747-2752), Online publication date: 15-Feb-2003.

Levy D, Marié I and Prakash A (2003) Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity, Current Opinion in Immunology, 10.1016/S0952-7915(02)00011-0, 15:1, (52-58), Online publication date: 1-Feb-2003.

Clayton T (2003) Cell Products-Immunoregulators Encyclopedia of Cell Technology, 10.1002/0471250570.spi042

Lillehoj H and Okamura M (2003) Host Immunity and Vaccine Development to Coccidia and <I>Salmonella</I> Infections in Chickens, The Journal of Poultry Science, 10.2141/jpsa.40.151, 40:3, (151-193), .

Miller J and Anders E (2003) Virus–cell interactions in the induction of type 1 interferon by influenza virus in mouse spleen cells, Journal of General Virology, 10.1099/vir.0.18590-0, 84:1, (193-202), Online publication date: 1-Jan-2003.

Bushman F (2003) Rna interference: applications in vertebrates, Molecular Therapy, 10.1016/S1525-0016(02)00046-1, 7:1, (9-10), Online publication date: 1-Jan-2003.

Wang X, Basler C, Williams B, Silverman R, Palese P and García-Sastre A (2002) Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains, Journal of Virology, 10.1128/JVI.76.24.12951-12962.2002, 76:24, (12951-12962), Online publication date: 15-Dec-2002.

Brod S (2016) Ingested Type I Interferon: State of the Art as Treatment for Autoimmunity, Experimental Biology and Medicine, 10.1177/153537020222701105, 227:11, (981-988), Online publication date: 1-Dec-2002.

Curreli S, Romerio F, Secchiero P and Zella D (2002) IFN- α 2b Increases Interleukin-10 Expression in Primary Activated Human CD8 + T Cells , Journal of Interferon & Cytokine Research, 10.1089/10799900260475678, 22:12, (1167-1173), Online publication date: 1-Dec-2002.

Brod S (2002) Ingested Type I Interferon: A Potential Treatment for Autoimmunity, Journal of Interferon & Cytokine Research, 10.1089/10799900260475669, 22:12, (1153-1166), Online publication date: 1-Dec-2002.

Rönnblom L and Alm G (2002) The natural interferon-α producing cells in systemic lupus erythematosus, Human Immunology, 10.1016/S0198-8859(02)00757-7, 63:12, (1181-1193), Online publication date: 1-Dec-2002.

Kadowaki N and Liu Y (2002) Natural type I interferon-producing cells as a link between innate and adaptive immunity, Human Immunology, 10.1016/S0198-8859(02)00751-6, 63:12, (1126-1132), Online publication date: 1-Dec-2002.

Yuan W, Aramini J, Montelione G and Krug R (2002) Structural Basis for Ubiquitin-like ISG 15 Protein Binding to the NS1 Protein of Influenza B Virus: A Protein–Protein Interaction Function That Is Not Shared by the Corresponding N-terminal Domain of the NS1 Protein of Influenza A Virus, Virology, 10.1006/viro.2002.1663, 304:2, (291-301), Online publication date: 1-Dec-2002.

Kaynor C, Xin M, Wakefield J, Barsoum J and Qin X (2002) Direct Evidence That IFN- β Functions as a Tumor-Suppressor Protein , Journal of Interferon & Cytokine Research, 10.1089/10799900260442511, 22:11, (1089-1098), Online publication date: 1-Nov-2002.

He B, Paterson R, Stock N, Durbin J, Durbin R, Goodbourn S, Randall R and Lamb R (2002) Recovery of Paramyxovirus Simian Virus 5 with a V Protein Lacking the Conserved Cysteine-rich Domain: The Multifunctional V Protein Blocks both Interferon-β Induction and Interferon Signaling, Virology, 10.1006/viro.2002.1738, 303:1, (15-32), Online publication date: 1-Nov-2002.

Berraondo P, García-Navarro R, González-Aseguinolaza G, Vales Á, Blanco-Urgoiti B, Larrea E, Riezu-Boj J, Prieto J and Ruiz J (2002) The woodchuck interferon-α system: Cloning, family description, and biologic activity, Journal of Medical Virology, 10.1002/jmv.10221, 68:3, (424-432), Online publication date: 1-Nov-2002.

Romerio F and Zella D (2002) MEK and ERK inhibitors enhance the antiproliferative effect of interferon‐α2b, The FASEB Journal, 10.1096/fj.02-0120fje, 16:12, (1680-1682), Online publication date: 1-Oct-2002.

Bartlett E, Cull V, Brekalo N, Lenzo J and James C (2002) Synergy of type I interferon‐A6 and interferon‐B naked DNA immunotherapy for cytomegalovirus infection, Immunology & Cell Biology, 10.1046/j.1440-1711.2002.01103.x, 80:5, (425-435), Online publication date: 1-Oct-2002.

Molife R and Hancock B (2002) Adjuvant therapy of malignant melanoma, Critical Reviews in Oncology/Hematology, 10.1016/S1040-8428(02)00014-8, 44:1, (81-102), Online publication date: 1-Oct-2002.

Katze M, He Y and Gale M (2002) Viruses and interferon: a fight for supremacy, Nature Reviews Immunology, 10.1038/nri888, 2:9, (675-687), Online publication date: 1-Sep-2002.

Orion E, Matz H and Wolf R (2002) Interferons: unapproved uses, dosages, or indications, Clinics in Dermatology, 10.1016/S0738-081X(02)00274-2, 20:5, (493-504), Online publication date: 1-Sep-2002.

Müller F, Tieke A, Waschk D, Mühle C, Müller F, Seigelchifer M, Pesce A, Jenzelewski V and Gellissen G (2002) Production of IFNα-2a in Hansenula polymorpha, Process Biochemistry, 10.1016/S0032-9592(02)00037-7, 38:1, (15-25), Online publication date: 1-Sep-2002.

Degelmann A, MÃ¼ller F, Sieber H, Jenzelewski V, Suckow M, Strasser A and Gellissen G (2002) Strain and process development for the production of human cytokines in Hansenula polymorpha , FEMS Yeast Research, 10.1111/j.1567-1364.2002.tb00104.x, 2:3, (349-361), Online publication date: 1-Aug-2002.

Kim M, Latham A and Krug R (2002) Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: Outcome with influenza A virus is unique, Proceedings of the National Academy of Sciences, 10.1073/pnas.152327499, 99:15, (10096-10101), Online publication date: 23-Jul-2002.

Cull V, Bartlett E and James C (2002) Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis, Immunology, 10.1046/j.1365-2567.2002.01423.x, 106:3, (428-437), Online publication date: 1-Jul-2002.

Wang Y, Youngster S, Grace M, Bausch J, Bordens R and Wyss D (2002) Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications, Advanced Drug Delivery Reviews, 10.1016/S0169-409X(02)00027-3, 54:4, (547-570), Online publication date: 1-Jun-2002.

Parisien J, Lau J, Rodriguez J, Ulane C and Horvath C (2002) Selective STAT Protein Degradation Induced by Paramyxoviruses Requires both STAT1 and STAT2 but Is Independent of Alpha/Beta Interferon Signal Transduction, Journal of Virology, 10.1128/JVI.76.9.4190-4198.2002, 76:9, (4190-4198), Online publication date: 1-May-2002.

Ikeda H, Old L and Schreiber R (2002) The roles of IFNγ in protection against tumor development and cancer immunoediting, Cytokine & Growth Factor Reviews, 10.1016/S1359-6101(01)00038-7, 13:2, (95-109), Online publication date: 1-Apr-2002.

van Herpen C and De Mulder P (2002) Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma, Critical Reviews in Oncology/Hematology, 10.1016/S1040-8428(01)00173-1, 41:3, (327-334), Online publication date: 1-Mar-2002.

Jenner R and Boshoff C (2002) The molecular pathology of Kaposi’s sarcoma-associated herpesvirus, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 10.1016/S0304-419X(01)00040-3, 1602:1, (1-22), Online publication date: 1-Mar-2002.

Martinand-Mari C, Demettre E, Lebleu B and Bastide L (2002) Interferon and the 2-5A/Pathway Chronic Fatigue Syndrome, 10.1201/9781420041002.ch1, (1-15), Online publication date: 27-Feb-2002.

Chang T and Stevens S (2002) Atopic Dermatitis, American Journal of Clinical Dermatology, 10.2165/00128071-200203030-00004, 3:3, (175-183), .

Decatris M, Santhanam S and O??Byrne K (2002) Potential of Interferon-?? in Solid Tumours, BioDrugs, 10.2165/00063030-200216040-00003, 16:4, (261-281), .

Khan O, Zabad R, Caon C, Zvartau-Hind M, Tselis A and Lisak R (2002) Comparative Assessment of Immunomodulating Therapies for Relapsing-Remitting Multiple Sclerosis, CNS Drugs, 10.2165/00023210-200216080-00005, 16:8, (563-578), .

Mohanty N, Malhotra V, Nayak R and Arora R (2013) Combined Low-Dose Intravesical Immunotherapy (BCG + Interferon a-2b) in the Management of Superficial Transitional Cell Carcinoma of the Urinary Bladder: A Five-Year Follow-Up, Journal of Chemotherapy, 10.1179/joc.2002.14.2.194, 14:2, (194-197), Online publication date: 1-Jan-2002.

Gray R, Pockaj B and Kirkwood J (2017) An Update on Adjuvant Interferon for Melanoma, Cancer Control, 10.1177/107327480200900103, 9:1, (16-21), Online publication date: 1-Jan-2002.

Schechter B, Schrier A, Nagler R, Smith E and Velasquez G (2002) Regression of Presumed Primary Conjunctival and Corneal Intraepithelial Neoplasia With Topical Interferon Alpha-2b, Cornea, 10.1097/00003226-200201000-00003, 21:1, (6-11), Online publication date: 1-Jan-2002.

BASLER C and GARCÍA-SASTRE A (2009) VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION, International Reviews of Immunology, 10.1080/08830180213277, 21:4-5, (305-337), Online publication date: 1-Jan-2002.

Erickson S, Matikainen S, Thyrell L, Sangfelt O, Julkunen I, Einhorn S and Grandér D (2003) Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes, European Journal of Biochemistry, 10.1046/j.0014-2956.2002.02626.x, 269:1, (29-37), Online publication date: 1-Jan-2002.

Steinbach F, Mauel S and Beier I (2002) Recombinant equine interferons: expression cloning and biological activity, Veterinary Immunology and Immunopathology, 10.1016/S0165-2427(01)00396-8, 84:1-2, (83-95), Online publication date: 1-Jan-2002.

Hirsch K and Wright T (2002) Viral Hepatitis Practical Guidelines in Antiviral Therapy, 10.1016/B978-044450884-3/50009-X, (193-221), .

Leib D (2002) Counteraction of Interferon-Induced Antiviral Responses by Herpes Simplex Viruses Viral Proteins Counteracting Host Defenses, 10.1007/978-3-642-59421-2_11, (171-185), .

Miller D, Cebulla C and Sedmak D (2002) Human Cytomegalovirus Inhibition of Major Histocompatibility Complex Transcription and Interferon Signal Transduction Viral Proteins Counteracting Host Defenses, 10.1007/978-3-642-59421-2_10, (153-170), .

Younes H and Amsden B (2002) Interferon‐γ Therapy: Evaluation of Routes of Administration and Delivery Systems, Journal of Pharmaceutical Sciences, 10.1002/jps.10007, 91:1, (2-17), Online publication date: 1-Jan-2002.

Grace M, Youngster S, Gitlin G, Sydor W, Xie L, Westreich L, Jacobs S, Brassard D, Bausch J and Bordens R (2001) Structural and Biologic Characterization of Pegylated Recombinant IFN- α 2b , Journal of Interferon & Cytokine Research, 10.1089/107999001317205240, 21:12, (1103-1115), Online publication date: 1-Dec-2001.

Staeheli P, Puehler F, Schneider K, Göbel T and Kaspers B (2001) Cytokines of Birds: Conserved Functions—A Largely Different Look, Journal of Interferon & Cytokine Research, 10.1089/107999001317205123, 21:12, (993-1010), Online publication date: 1-Dec-2001.

Le Roy F, Bisbal C, Silhol M, Martinand C, Lebleu B and Salehzada T (2001) The 2–5A/RNase L/RNase L Inhibitor (RNI) Pathway Regulates Mitochondrial mRNAs Stability in Interferon α-treated H9 Cells, Journal of Biological Chemistry, 10.1074/jbc.M107482200, 276:51, (48473-48482), Online publication date: 1-Dec-2001.

Härle P, Lauret E, Pitha P, De Maeyer E and Carr D (2001) Expression of Human and Macaque Type I IFN Transgenes Interferes with HSV-1 Replication at the Transcriptional and Translational Levels: IFN-β Is More Potent Than IFN-α2, Virology, 10.1006/viro.2001.1178, 290:2, (237-248), Online publication date: 1-Nov-2001.

Samuel C (2001) Antiviral Actions of Interferons, Clinical Microbiology Reviews, 10.1128/CMR.14.4.778-809.2001, 14:4, (778-809), Online publication date: 1-Oct-2001.

De Clercq E (2001) Hamao Umezawa Memorial Award Lecture11Delivered by the author at the Twenty-second International Congress of Chemotherapy, Amsterdam, The Netherlands (30 June–3 July 2001)., International Journal of Antimicrobial Agents, 10.1016/S0924-8579(01)00411-3, 18:4, (309-328), Online publication date: 1-Oct-2001.

Salvatore M and Garcı́a-Sastre A (2001) Virus versus host: modulation of the host α/β interferon pathways by the influenza A virus NS1 protein, International Congress Series, 10.1016/S0531-5131(01)00634-3, 1219, (513-520), Online publication date: 1-Oct-2001.

Takahashi I, Kosaka H, Oritani K, Heath W, Ishikawa J, Okajima Y, Ogawa M, Kawamoto S, Yamada M, Azukizawa H, Itami S, Yoshikawa K, Tomiyama Y and Matsuzawa Y (2001) A New IFN-Like Cytokine, Limitin Modulates the Immune Response Without Influencing Thymocyte Development, The Journal of Immunology, 10.4049/jimmunol.167.6.3156, 167:6, (3156-3163), Online publication date: 15-Sep-2001.

Zein N (2005) Experimental and emerging therapies for chronic hepatitis C virus infection, Expert Opinion on Investigational Drugs, 10.1517/13543784.10.8.1457, 10:8, (1457-1469), Online publication date: 1-Aug-2001.

Oppenheim J (2001) Cytokines: Past, Present, and Future, International Journal of Hematology, 10.1007/BF02982543, 74:1, (3-8), Online publication date: 1-Jul-2001.

Schmidt J, Stürzebecher S, Toyka K and Gold R (2001) Interferon-β treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration, Journal of Neuroscience Research, 10.1002/jnr.1128, 65:1, (59-67), Online publication date: 1-Jul-2001.

Aurisicchio L, Ceccacci A, La Monica N, Palombo F and Traboni C (2001) Tamarin alpha-interferon is active in mouse liver upon intramuscular gene delivery, The Journal of Gene Medicine, 10.1002/jgm.196, 3:4, (394-402), Online publication date: 1-Jul-2001.

Curreli S, Romerio F, Mirandola P, Barion P, Bemis K and Zella D (2001) Human Primary CD4 + T Cells Activated in the Presence of IFN- α 2b Express Functional Indoleamine 2,3-Dioxygenase , Journal of Interferon & Cytokine Research, 10.1089/107999001750277916, 21:6, (431-437), Online publication date: 1-Jun-2001.

Shtrichman R and Samuel C (2001) The role of gamma interferon in antimicrobial immunity, Current Opinion in Microbiology, 10.1016/S1369-5274(00)00199-5, 4:3, (251-259), Online publication date: 1-Jun-2001.

Parisien J, Lau J, Rodriguez J, Sullivan B, Moscona A, Parks G, Lamb R and Horvath C (2001) The V Protein of Human Parainfluenza Virus 2 Antagonizes Type I Interferon Responses by Destabilizing Signal Transducer and Activator of Transcription 2, Virology, 10.1006/viro.2001.0856, 283:2, (230-239), Online publication date: 1-May-2001.

GONZALEZ-SANCHEZ J, MARTINEZ-CHEQUER J, HERNANDEZ-CELAYA M, BARAHONA-BUSTILLOS E and ANDRADE-MANZANO A (2001) Randomized Placebo-Controlled Evaluation of Intramuscular Interferon Beta Treatment of Recurrent Human Papillomavirus, Obstetrics & Gynecology, 10.1097/00006250-200104000-00026, 97:4, (621-624), Online publication date: 1-Apr-2001.

Jatczak B, Gejdel E, Pajk J, Podwińska J and Błach-Olszewska Z (2001) Study on Risk Factors for Transplacental Viral Infections; Effect of Bacterial Factors and Double Viral Infections on Virus Replication in Placenta and Amniotic Membranes, Placenta, 10.1053/plac.2000.0623, 22:4, (360-371), Online publication date: 1-Apr-2001.

Sammut S, Goodall G and Muscat R (2001) Acute interferon-α administration modulates sucrose consumption in the rat, Psychoneuroendocrinology, 10.1016/S0306-4530(00)00051-2, 26:3, (261-272), Online publication date: 1-Apr-2001.

Wessely R, Klingel K, Knowlton K and Kandolf R (2001) Cardioselective Infection With Coxsackievirus B3 Requires Intact Type I Interferon Signaling, Circulation, 10.1161/01.CIR.103.5.756, 103:5, (756-761), Online publication date: 6-Feb-2001.

Barber G (2001) Host defense, viruses and apoptosis, Cell Death & Differentiation, 10.1038/sj.cdd.4400823, 8:2, (113-126), Online publication date: 1-Feb-2001.

Ozawa S, Shinohara H, Kanayama H, Bruns C, Bucana C, Ellis L, Davis D and Fidler I (2001) Suppression of Angiogenesis and Therapy of Human Colon Cancer Liver Metastasis by Systemic Administration of Interferon-α, Neoplasia, 10.1038/sj.neo.7900128, 3:2, (154-164), .

Vera M, Puig S, Martí R and Castel T (2001) El uso de interferón alfa-2b en el melanoma, Piel, 10.1016/S0213-9251(01)72492-6, 16:8, (357-362), Online publication date: 1-Jan-2001.

Weissmann C (2001) Recombinant interferon - the 20th anniversary Recombinant Protein Drugs, 10.1007/978-3-0348-8346-7_1, (3-41), .

Coulam C and Rukavina D (2001) Immunomodulatory Analogies Between Trophoblastic and Cancer Cells and Their Hosts Cancer and Pregnancy, 10.1007/978-1-4471-0707-1_16, (190-208), .

García-Sastre A (2001) Inhibition of Interferon-Mediated Antiviral Responses by Influenza A Viruses and Other Negative-Strand RNA Viruses, Virology, 10.1006/viro.2000.0756, 279:2, (375-384), Online publication date: 1-Jan-2001.

Alcamı́ A, Symons J and Smith G (2000) The Vaccinia Virus Soluble Alpha/Beta Interferon (IFN) Receptor Binds to the Cell Surface and Protects Cells from the Antiviral Effects of IFN, Journal of Virology, 10.1128/JVI.74.23.11230-11239.2000, 74:23, (11230-11239), Online publication date: 1-Dec-2000.

Corssmit E, de Metz J, Sauerwein H and Romijn J (2000) Biologic Responses to IFN-α Administration in Humans, Journal of Interferon & Cytokine Research, 10.1089/107999000750053690, 20:12, (1039-1047), Online publication date: 1-Dec-2000.

Novick D, Nabioullin R, Ragsdale W, McKenna S, Weiser W, Garone L, Burkins C, Kim S, Rubinstein M, Tepper M and Arulanandam A (2000) The Neutralization of Type I IFN Biologic Actions by Anti-IFNAR-2 Monoclonal Antibodies Is Not Entirely Due to Inhibition of Jak-Stat Tyrosine Phosphorylation, Journal of Interferon & Cytokine Research, 10.1089/10799900050198417, 20:11, (971-982), Online publication date: 1-Nov-2000.

Trotta P, Antonelli G, Bausch J, Williams B, Spiegel R and von Wussow P (2000) Approval Standards for Alfa Interferon Subtypes, Drug Information Journal, 10.1177/009286150003400431, 34:4, (1231-1246), Online publication date: 1-Oct-2000.

Esteban M and Patiño C (2000) Identification by Electron Microscopy of the Maturation Steps in Vaccinia Virus Morphogenesis Inhibited by the Interferon-Induced Enzymes, Protein Kinase (PKR), 2-5A Synthetase, and Nitric Oxide Synthase (iNOS), Journal of Interferon & Cytokine Research, 10.1089/10799900050163235, 20:10, (867-877), Online publication date: 1-Oct-2000.

Bennett A, Elvin S, Wright A, Jones S and Phillpotts R (2000) An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine, Vaccine, 10.1016/S0264-410X(00)00123-7, 19:2-3, (337-347), Online publication date: 1-Sep-2000.

Naniche D, Yeh A, Eto D, Manchester M, Friedman R and Oldstone M (2000) Evasion of Host Defenses by Measles Virus: Wild-Type Measles Virus Infection Interferes with Induction of Alpha/Beta Interferon Production, Journal of Virology, 10.1128/JVI.74.16.7478-7484.2000, 74:16, (7478-7484), Online publication date: 15-Aug-2000.

Nagabhushan T and Trotta P (2000) Interferons Ullmann's Encyclopedia of Industrial Chemistry, 10.1002/14356007.a14_365

Nagabhushan T and Narula S (2000) Genetic Engineering Ullmann's Encyclopedia of Industrial Chemistry, 10.1002/14356007.a12_319

Aurisicchio L, Delmastro P, Salucci V, Paz O, Rovere P, Ciliberto G, La Monica N and Palombo F (2000) Liver-Specific Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis, Journal of Virology, 10.1128/jvi.74.10.4816-4823.2000, 74:10, (4816-4823), Online publication date: 15-May-2000.

Ben-Noun L (2016) Interferon Therapy in Liver Cirrhosis Type C, Journal of Pharmacy Technology, 10.1177/875512250001600303, 16:3, (81-88), Online publication date: 1-May-2000.

Schijns V, Weining K, Nuijten P, Rijke E and Staeheli P (2000) Immunoadjuvant activities of E. coli- and plasmid-expressed recombinant chicken IFN-α/β, IFN-γ and IL-1β in 1-day- and 3-week-old chickens, Vaccine, 10.1016/S0264-410X(99)00537-X, 18:20, (2147-2154), Online publication date: 1-Apr-2000.

Barber G (2000) The interferons and cell death: guardians of the cell or accomplices of apoptosis?, Seminars in Cancer Biology, 10.1006/scbi.2000.0313, 10:2, (103-111), Online publication date: 1-Apr-2000.

Prejean C and Colamonici O (2000) Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling, Seminars in Cancer Biology, 10.1006/scbi.2000.0311, 10:2, (83-92), Online publication date: 1-Apr-2000.

Zella D, Romerio F, Curreli S, Secchiero P, Cicala C, Zagury D and Gallo R (2000) IFN-α2b Reduces IL-2 Production and IL-2 Receptor Function in Primary CD4+ T Cells, The Journal of Immunology, 10.4049/jimmunol.164.5.2296, 164:5, (2296-2302), Online publication date: 1-Mar-2000.

Sarbah S and Younossi Z (2000) Hepatitis C, Journal of Clinical Gastroenterology, 10.1097/00004836-200003000-00005, 30:2, (125-143), Online publication date: 1-Mar-2000.

Suarez D (2000) Immunology of avian influenza virus: a review, Developmental & Comparative Immunology, 10.1016/S0145-305X(99)00078-6, 24:2-3, (269-283), Online publication date: 1-Mar-2000.

Mossman K, Saffran H and Smiley J (2000) Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon, Journal of Virology, 10.1128/JVI.74.4.2052-2056.2000, 74:4, (2052-2056), Online publication date: 15-Feb-2000.

Hiroishi K, Tüting T and Lotze M (2000) IFN-α-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLs, The Journal of Immunology, 10.4049/jimmunol.164.2.567, 164:2, (567-572), Online publication date: 15-Jan-2000.

Banks R (2008) Measurement of Cytokines in Clinical Samples Using Immunoassays: Problems and Pitfalls, Critical Reviews in Clinical Laboratory Sciences, 10.1080/10408360091174187, 37:2, (131-182), Online publication date: 1-Jan-2000.

Siatskas C and Boyd R (2000) Regulation of chicken haemopoiesis by cytokines, Developmental & Comparative Immunology, 10.1016/S0145-305X(99)00051-8, 24:1, (37-59), Online publication date: 1-Jan-2000.

García-Escaño M, Andrade R and González-Santos P (2000) Interferón y lípidos plasmáticos, Medicina Clínica, 10.1016/S0025-7753(00)71192-4, 114:2, (74-76), Online publication date: 1-Jan-2000.

GLICK B (2000) Immunophysiology Sturkie's Avian Physiology, 10.1016/B978-012747605-6/50027-4, (657-670), .

Piehler J and Schreiber G (1999) Mutational and structural analysis of the binding interface between type I interferons and their receptor ifnar2 1 1Edited by J. A. Wells, Journal of Molecular Biology, 10.1006/jmbi.1999.3230, 294:1, (223-237), Online publication date: 1-Nov-1999.

Sasseville D, Ghamdi W and Khenaizan S (2016) Interferon-Induced Cutaneous Necrosis, Journal of Cutaneous Medicine and Surgery, 10.1177/120347549900300610, 3:6, (320-323), Online publication date: 1-Oct-1999.

Verastegui-Aviles E, Mohar A, Mota A, Guadarrama A and De La Garza-Salazar J (1999) Combination of radiation therapy and interferon alpha-2b in patients with advanced cervical carcinoma: a pilot study, International Journal of Gynecological Cancer, 10.1046/j.1525-1438.1999.99053.x, 9:5, (401-405), Online publication date: 7-Sep-1999.

Piraino F and Brandt C (1999) Isolation and partial characterization of an antiviral, RC-183, from the edible mushroom Rozites caperata, Antiviral Research, 10.1016/S0166-3542(99)00035-2, 43:2, (67-78), Online publication date: 1-Sep-1999.

Garcin D, Latorre P and Kolakofsky D (1999) Sendai Virus C Proteins Counteract the Interferon-Mediated Induction of an Antiviral State, Journal of Virology, 10.1128/JVI.73.8.6559-6565.1999, 73:8, (6559-6565), Online publication date: 1-Aug-1999.

Hilleman M (1999) Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology, Immunological Reviews, 10.1111/j.1600-065X.1999.tb01325.x, 170:1, (7-27), Online publication date: 1-Aug-1999.

Brod S, Nelson L, Jin R and Wolinsky J (1999) INGESTED INTERFERON ALPHA INDUCES Mx mRNA, Cytokine, 10.1006/cyto.1998.0450, 11:7, (492-499), Online publication date: 1-Jul-1999.

Bielenberg D, McCarty M, Bucana C, Yuspa S, Morgan D, Arbeit J, Ellis L, Cleary K and Fidler I (1999) Expression of Interferon-β is Associated with Growth Arrest of Murine and Human Epidermal Cells, Journal of Investigative Dermatology, 10.1046/j.1523-1747.1999.00566.x, 112:5, (802-809), Online publication date: 1-May-1999.

Hanaoka M, Kubo K, Hayano T, Koizumi T and Kobayashi T (1999) Interferon-α elevates pulmonary blood pressure in sheep—the role of thromboxane cascade, European Journal of Pharmacology, 10.1016/S0014-2999(99)00107-7, 370:2, (145-151), Online publication date: 1-Apr-1999.

Reboul J, Gardiner K, Monneron D, Uzé G and Lutfalla G (1999) Comparative Genomic Analysis of the Interferon/Interleukin-10 Receptor Gene Cluster, Genome Research, 10.1101/gr.9.3.242, 9:3, (242-250), Online publication date: 1-Mar-1999.

Luo Y, Chen X, Downs T, DeWolf W and O’Donnell M (1999) IFN-α 2B Enhances Th1 Cytokine Responses in Bladder Cancer Patients Receiving Mycobacterium bovis Bacillus Calmette-Guérin Immunotherapy , The Journal of Immunology, 10.4049/jimmunol.162.4.2399, 162:4, (2399-2405), Online publication date: 15-Feb-1999.

Finter N (1999) Is There Life Without Interferon? Interferon: The Dawn of Recombinant Protein Drugs, 10.1007/978-3-662-03787-4_1, (1-14), .

Naitoh J, Franklin J, O’Donnell M and Belldegrun A (1999) Interferon Alpha for the Treatment of Superficial Bladder Cancer Advances in Bladder Research, 10.1007/978-1-4615-4737-2_29, (371-386), .

Xu L, Xie K and Fidler I (1998) Therapy of Human Ovarian Cancer by Transfection with the Murine Interferon β Gene: Role of Macrophage-Inducible Nitric Oxide Synthase , Human Gene Therapy, 10.1089/hum.1998.9.18-2699, 9:18, (2699-2708), Online publication date: 10-Dec-1998.

Hurd DO D and Conte DO E (2002) Practical uses of the interferons in dermatology , International Journal of Dermatology, 10.1046/j.1365-4362.1998.00466.x, 37:12, (881-896), Online publication date: 1-Dec-1998.

Aguzzi A (1998) Grafting mouse brains: from neurocarcinogenesis to neurodegeneration, The EMBO Journal, 10.1093/emboj/17.21.6107, 17:21, (6107-6114), Online publication date: 2-Nov-1998.

García-Sastre A, Durbin R, Zheng H, Palese P, Gertner R, Levy D and Durbin J (1998) The Role of Interferon in Influenza Virus Tissue Tropism, Journal of Virology, 10.1128/JVI.72.11.8550-8558.1998, 72:11, (8550-8558), Online publication date: 1-Nov-1998.

Bielenberg D, Bucana C, Sanchez R, Donawho C, Kripke M and Fidler I (1998) Molecular Regulation of UVB-Induced Cutaneous Angiogenesis, Journal of Investigative Dermatology, 10.1046/j.1523-1747.1998.00378.x, 111:5, (864-872), Online publication date: 1-Nov-1998.

ROBERTS R, LIU L, GUO Q, LEAMAN D and BIXBY J (1998) The Evolution of the Type I Interferons1, Journal of Interferon & Cytokine Research, 10.1089/jir.1998.18.805, 18:10, (805-816), Online publication date: 1-Oct-1998.

Agarwala S and Kirkwood J (1998) ADJUVANT INTERFERON TREATMENT FOR MELANOMA, Hematology/Oncology Clinics of North America, 10.1016/S0889-8588(05)70025-3, 12:4, (823-833), Online publication date: 1-Aug-1998.

Conant K, Ahmed U, Schwartz J and Major E (1998) IFN-γ inhibits AP-1 binding activity in human brain-derived cells through a nitric oxide dependent mechanism, Journal of Neuroimmunology, 10.1016/S0165-5728(98)00069-1, 88:1-2, (39-44), Online publication date: 1-Aug-1998.

Navarro L, Mowen K, Rodems S, Weaver B, Reich N, Spector D and David M (1998) Cytomegalovirus Activates Interferon Immediate-Early Response Gene Expression and an Interferon Regulatory Factor 3-Containing Interferon-Stimulated Response Element-Binding Complex, Molecular and Cellular Biology, 10.1128/MCB.18.7.3796, 18:7, (3796-3802), Online publication date: 1-Jul-1998.

Samuel C (1998) Protein–Nucleic Acid Interactions and Cellular Responses to Interferon, Methods, 10.1006/meth.1998.0620, 15:3, (161-165), Online publication date: 1-Jul-1998.

Wong L, Hatzinisiriou I, Devenish R and Ralph S (1998) IFN-γ Priming Up-Regulates IFN-Stimulated Gene Factor 3 (ISGF3) Components, Augmenting Responsiveness of IFN-Resistant Melanoma Cells to Type I IFNs, The Journal of Immunology, 10.4049/jimmunol.160.11.5475, 160:11, (5475-5484), Online publication date: 1-Jun-1998.

Stark G, Kerr I, Williams B, Silverman R and Schreiber R (1998) HOW CELLS RESPOND TO INTERFERONS, Annual Review of Biochemistry, 10.1146/annurev.biochem.67.1.227, 67:1, (227-264), Online publication date: 1-Jun-1998.

Agarwala S and Kirkwood J (1998) Adjuvant therapy of melanoma, Seminars in Surgical Oncology, 10.1002/(SICI)1098-2388(199806)14:4<302::AID-SSU6>3.0.CO;2-6, 14:4, (302-310), Online publication date: 1-Jun-1998.

HOOKER A and JAMES D (1998) Review : The Glycosylation Heterogeneity of Recombinant Human IFN-γ , Journal of Interferon & Cytokine Research, 10.1089/jir.1998.18.287, 18:5, (287-295), Online publication date: 1-May-1998.

Foster G and Finter N (2002) Are all Type I human interferons equivalent?, Journal of Viral Hepatitis, 10.1046/j.1365-2893.1998.00103.x, 5:3, (143-152), Online publication date: 1-May-1998.

Bußfeld D, Kaufmann A, Meyer R, Gemsa D and Sprenger H (1998) Differential Mononuclear Leukocyte Attracting Chemokine Production after Stimulation with Active and Inactivated Influenza A Virus, Cellular Immunology, 10.1006/cimm.1998.1295, 186:1, (1-7), Online publication date: 1-May-1998.

Li X, Blackford J and Hassel B (1998) RNase L Mediates the Antiviral Effect of Interferon through a Selective Reduction in Viral RNA during Encephalomyocarditis Virus Infection, Journal of Virology, 10.1128/JVI.72.4.2752-2759.1998, 72:4, (2752-2759), Online publication date: 1-Apr-1998.

Maillard I, Launois P, Xenarios I, Louis J, Acha-Orbea H and Diggelmann H (1998) Immune Response to Mouse Mammary Tumor Virus in Mice Lacking the Alpha/Beta Interferon or the Gamma Interferon Receptor, Journal of Virology, 10.1128/JVI.72.4.2638-2646.1998, 72:4, (2638-2646), Online publication date: 1-Apr-1998.

Stadler R (1998) INTERFERONS IN DERMATOLOGY, Dermatologic Clinics, 10.1016/S0733-8635(05)70020-6, 16:2, (377-398), Online publication date: 1-Apr-1998.

Smith G, Symons J and Alcamı́ A (1998) Poxviruses: Interfering with Interferon, Seminars in Virology, 10.1006/smvy.1997.0145, 8:5, (409-418), Online publication date: 1-Apr-1998.

Yeow W, Lawson C and Beilharz M (1998) Antiviral Activities of Individual Murine IFN-α Subtypes In Vivo: Intramuscular Injection of IFN Expression Constructs Reduces Cytomegalovirus Replication, The Journal of Immunology, 10.4049/jimmunol.160.6.2932, 160:6, (2932-2939), Online publication date: 15-Mar-1998.

Dafny N (1998) Is interferon-α a neuromodulator?, Brain Research Reviews, 10.1016/S0165-0173(97)00029-5, 26:1, (1-15), Online publication date: 1-Mar-1998.

Ruuls S and Sedgwick J (1998) Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis, Immunology and Cell Biology, 10.1046/j.1440-1711.1998.00715.x, 76:1, (65-73), Online publication date: 1-Feb-1998.

Hanley J and Haydon G (2009) The Biology of Interferon-α and the Clinical Significance of Anti-Interferon Antibodies, Leukemia & Lymphoma, 10.3109/10428199809068563, 29:3-4, (257-268), Online publication date: 1-Jan-1998.

Wall E, Cao J and Upton C (2009) Subversion of Cytokine Networks by Viruses, International Reviews of Immunology, 10.3109/08830189809084490, 17:1-4, (121-155), Online publication date: 1-Jan-1998.

De Maeyer E and De Maeyer-Guignard J (2009) Type I Interferons, International Reviews of Immunology, 10.3109/08830189809084487, 17:1-4, (53-73), Online publication date: 1-Jan-1998.

ISHIWATA K, MINAGAWA T and KAJIMOTO T (1998) Clinical Effects of the Recombinant Feline Interferon-.OMEGA. on Experimental Parvovirus Infection in Beagle Dogs., Journal of Veterinary Medical Science, 10.1292/jvms.60.911, 60:8, (911-917), .

Baron S (1998) Chapter 26 The interferons Microbiology, 10.1016/S1569-2582(97)80010-4, (439-451), .

Yamamoto A, Iwata A, Koh Y, Kawai S, Murayama S, Hamada K, Maekawa S, Ueda S and Sokawa Y (1998) Two types of chicken 2′,5′-oligoadenylate synthetase mRNA derived from alleles at a single locus, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 10.1016/S0167-4781(97)00148-6, 1395:2, (181-191), Online publication date: 1-Jan-1998.

Schlesinger R, Husak P, Bradshaw G and Panayotov P (1998) Mechanisms Involved in Natural and Experimental Neuropathogenicity of Influenza Viruses: Evidence and Speculation , 10.1016/S0065-3527(08)60811-8, (289-379), .

Nicola N and Hilton D (1998) General Classes and Functions of Four-Helix Bundle Cytokines Cytokines, 10.1016/S0065-3233(08)60432-5, (1-65), .

Lewko W, Smalley R and Oldham R (1998) Lymphokines and Cytokines Principles of Cancer Biotherapy, 10.1007/978-94-009-0029-5_10, (211-265), .

Samuel C (1998) Reoviruses and the Interferon System Reoviruses II, 10.1007/978-3-642-72095-6_7, (125-145), .

Klaus W, Gsell B, Labhardt A, Wipf B and Senn H (1997) The three-dimensional high resolution structure of human interferon α-2a determined by heteronuclear NMR spectroscopy in solution, Journal of Molecular Biology, 10.1006/jmbi.1997.1396, 274:4, (661-675), Online publication date: 1-Dec-1997.

Drescher K, Pease L and Rodriguez M (1997) Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis, Immunological Reviews, 10.1111/j.1600-065X.1997.tb01015.x, 159:1, (177-193), Online publication date: 1-Oct-1997.

Smith G, Symons J, Khanna A, Vanderplasschen A and Alcami A (1997) Vaccinia virus immune evasion, Immunological Reviews, 10.1111/j.1600-065X.1997.tb01012.x, 159:1, (137-154), Online publication date: 1-Oct-1997.

Corsini E, Gelati M, Dufour A, Massa G, Nespolo A, Ciusani E, Milanese C, La Mantia L and Salmaggi A (1997) Effects of β-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study, Journal of Neuroimmunology, 10.1016/S0165-5728(97)00114-8, 79:1, (76-83), Online publication date: 1-Oct-1997.

Stephan D, San H, Yang Z, Gordon D, Goelz S, Nabel G and Nabel E (1997) Inhcer of β-Interferon, Molecular Medicine, 10.1007/BF03401816, 3:9, (593-599), Online publication date: 1-Sep-1997.

See W and Berman C (1997) Future therapies for the treatment of bladder neoplasms, Seminars in Surgical Oncology, 10.1002/(SICI)1098-2388(199709/10)13:5<376::AID-SSU12>3.0.CO;2-L, 13:5, (376-388), Online publication date: 1-Sep-1997.

Drescher K and Whittum-Hudson J (1997) Evidence for Induction of Interferon-α and Interferon-β in Retinal Glial Cells of Müller, Virology, 10.1006/viro.1997.8661, 234:2, (309-316), Online publication date: 1-Aug-1997.

HISSONG B and CARLIN J (1997) Potentiation of Interferon-Induced Indoleamine 2,3-Dioxygenase mRNA in Human Mononuclear Phagocytes by Lipopolysaccharide and Interleukin-1, Journal of Interferon & Cytokine Research, 10.1089/jir.1997.17.387, 17:7, (387-393), Online publication date: 1-Jul-1997.

Hirose M (1997) Letter to the editor: Improvement of Langerhans' cell histiocytosis and pancreatitis by alpha-interferon, Medical and Pediatric Oncology, 10.1002/(SICI)1096-911X(199706)28:6<462::AID-MPO13>3.0.CO;2-B, 28:6, (462-463), Online publication date: 1-Jun-1997.

LAWSON C, YEOW W, LEE C and BEILHARZ M (1997) In Vivo Expression of an Interferon-α Gene by Intramuscular Injection of Naked DNA , Journal of Interferon & Cytokine Research, 10.1089/jir.1997.17.255, 17:5, (255-261), Online publication date: 1-May-1997.

ZAWADA W, CLARKE J and RUWE W (1997) NALOXONE DIFFERENTIALLY ALTERS FEVERS INDUCED BY CYTOKINES, Neurochemistry International, 10.1016/S0197-0186(96)00080-0, 30:4-5, (441-448), Online publication date: 1-Apr-1997.

DECKER T, KOVARIK P and MEINKE A (1997) GAS Elements: A Few Nucleotides with a Major Impact on Cytokine-Induced Gene Expression, Journal of Interferon & Cytokine Research, 10.1089/jir.1997.17.121, 17:3, (121-134), Online publication date: 1-Mar-1997.

Yeow W, Lai C and Beilharz M (1997) The in vivo expression patterns of individual type I interferon genes in murine cytomegalovirus infections., Antiviral Research, 10.1016/S0166-3542(96)01018-2, 34:1, (17-26), Online publication date: 1-Mar-1997.

Brod S, Kerman R, Nelson L, Marshall G, Henninger E, Khan M, Jin R and Wolinsky J (2016) Ingested IFN-α has biological effects in humans with relapsing-remitting multiple sclerosis, Multiple Sclerosis Journal, 10.1177/135245859700300101, 3:1, (1-7), Online publication date: 1-Feb-1997.

MADIYALAKAN R, YANG R, SCHULTES B, BAUM R and NOUJAIM A (1997) OVAREX™ MAb-B43.13:IFN-γ Could Improve the Ovarian Tumor Cell Sensitivity to CA125-Specific Allogenic Cytotoxic T Cells, Hybridoma, 10.1089/hyb.1997.16.41, 16:1, (41-45), Online publication date: 1-Feb-1997.

Wolf Y, Md R, Jossipov J and Werbin N (2008) Alpha-Interferon Induced Severe Pneumonitis, Journal of Toxicology: Clinical Toxicology, 10.3109/15563659709001177, 35:1, (113-114), Online publication date: 1-Jan-1997.

ZAV'YALOV V and ZAV'YALOVA G (1997) Interferons α/β and their receptors: place in the hierarchy of cytokines, APMIS, 10.1111/j.1699-0463.1997.tb00556.x, 105:1-6, (161-186), Online publication date: 1-Jan-1997.

Marumo K, Oya M and Murai M (1997) Application of the Interferon Minipellet to Human Renal Cell Carcinoma in Nude Mice, International Journal of Urology, 10.1111/j.1442-2042.1997.tb00141.x, 4:1, (55-61), Online publication date: 1-Jan-1997.

Maruo N, Uno K, Kishi A, Ueda T, Takahashi T, Ito T and Kishida T (2016) Susceptibility to Infection Due to Diminished Interferon-α-Producing Capacity in Patients with Refractory Anemia with Excess of Blasts or Refractory Anemia with Excess of Blasts in Transformation, Hematology, 10.1080/10245332.1997.11746328, 2:2, (131-138), Online publication date: 1-Jan-1997.

Michael Roberts R, Liu L and Alexenko A (1997) New and Atypical Families of Type I Interferons in Mammals: Comparative Functions, Structures, and Evolutionary Relationships1 , 10.1016/S0079-6603(08)61008-9, (287-325), .

Lengyel G, Fehér J, Dalmi L, Dávid K, Gervain J, Gógl Á, Lonovics J, Ozsvár Z, Pár A, Schneider F and Tulassay Z (1997) Long-Term Interferon-α2b Therapy in Chronic Hepatitis B. A Prospective Multicentre Study in Hungary Cell Injury and Protection in the Gastrointestinal Tract, 10.1007/978-94-011-5392-8_30, (305-311), .

Zepter K and Háffner A (1997) Topical Immunotherapy of Malignant Melanoma Strategies for Immunointerventions in Dermatology, 10.1007/978-3-642-60752-3_35, (387-398), .

Burg G, Aschoff R and Dummer R (1997) Zytokine in der Dermatotherapie Fortschritte der praktischen Dermatologie und Venerologie, 10.1007/978-3-642-60534-5_56, (371-376), .

Bisbal C (1997) RNase L: Effector Nuclease of an Activatable RNA Degradation System in Mammals Cytoplasmic fate of messenger RNA, 10.1007/978-3-642-60471-3_2, (19-34), .

Hendrzak J and Brunda M (1997) Interferons and Other Cytokines Cancer Therapeutics, 10.1007/978-1-59259-717-8_13, (263-282), .

Marcovistz R, Leal E, Matos D, Araújo H and Tsiang H (1996) Imunogenicidade da cepa avirulenta RV194-2 do vírus rábico em camundongos, Revista da Sociedade Brasileira de Medicina Tropical, 10.1590/S0037-86821996000600009, 29:6, (579-583), Online publication date: 1-Dec-1996.

Goey S, Verweij J and Stoter G (1996) Immunotherapy of metastatic renal cell cancer, Annals of Oncology, 10.1093/oxfordjournals.annonc.a010790, 7:9, (887-900), Online publication date: 1-Nov-1996.

Jonas M (1996) Interferon-α for Viral Hepatitis, Journal of Pediatric Gastroenterology &amp Nutrition, 10.1097/00005176-199608000-00001, 23:2, (93-106), Online publication date: 1-Aug-1996.

MIRE-SLUIS A, DAS R, ZOON K, PADILLA A, THORPE R and MEAGER A (1996) The Biological Properties, Assay, and Standardization of Interferon-Alpha: A Need for a WHO Collaborative Study, Journal of Interferon & Cytokine Research, 10.1089/jir.1996.16.637, 16:8, (637-643), Online publication date: 1-Aug-1996.

Kägi D and Hengartner H (1996) Different roles for rcytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses, Current Opinion in Immunology, 10.1016/S0952-7915(96)80033-1, 8:4, (472-477), Online publication date: 1-Aug-1996.

Nieforth K, Nadeau R, Patel I and Mould D (1996) Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects, Clinical Pharmacology & Therapeutics, 10.1016/S0009-9236(96)90003-X, 59:6, (636-646), Online publication date: 1-Jun-1996.

Mihm S, Hartmann H, Fayyazi A and Ramadori G (1996) Preferential virological response to interferon-α 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a lowγ-GT/ALT ratio, Digestive Diseases and Sciences, 10.1007/BF02088246, 41:6, (1256-1264), Online publication date: 1-Jun-1996.

Thanos D (1996) Mechanisms of Transcriptional Synergism of Eukaryotic Genes, Hypertension, 10.1161/01.HYP.27.4.1025, 27:4, (1025-1029), Online publication date: 1-Apr-1996.

KARACA K, SHARMA J, TOMAI M and MILLER R (1996) In Vivo and In Vitro Interferon Induction in Chickens by S-28828, an Imidazoquinolinamine Immunoenhancer , Journal of Interferon & Cytokine Research, 10.1089/jir.1996.16.327, 16:4, (327-332), Online publication date: 1-Apr-1996.

Ridge J, Terle D, Dragunsky E and Levenbook I (1996) Effects of γ-IFN and NGF on subpopulations in a human neuroblastoma cell line: Flow cytometric and morphological analysis, In Vitro Cellular & Developmental Biology - Animal, 10.1007/BF02722952, 32:4, (238-248), Online publication date: 1-Apr-1996.

Wagner R (1996) Reminiscences of a virologist wandering in Serendip, Archives of Virology, 10.1007/BF01718336, 141:3-4, (779-788), Online publication date: 1-Mar-1996.

SWINDELLS S, BALDWIN T, KELLY C, BACA-REGEN L, LOOMIS L, POST D, BRICHACEK B, STEVENSON M, DOMINGUEZ E, REDDY R, KLEIN R, LIAO M, TESTA D, MCDONALD T, BELLANTI J, SKURKOVICH S and GENDELMAN H (1996) Regulation and Characterization of the Interferon-α Present in Patients with Advanced Human Immunodeficiency Virus Type 1 Disease, Journal of Interferon & Cytokine Research, 10.1089/jir.1996.16.127, 16:2, (127-137), Online publication date: 1-Feb-1996.

Tilg H and Peschel C (2009) Interferon-Alpha and its Effects on the Cytokine Cascade: A Pro- and Anti-Inflammatory Cytokine, Leukemia & Lymphoma, 10.3109/10428199609054802, 23:1-2, (55-60), Online publication date: 1-Jan-1996.

Vriesendorp F, Fly R, Khan M, Pappolla M and Brod S (2009) Oral Administration of Type I Interferon Modulates the Course of Experimental Allergic Neuritis, Autoimmunity, 10.3109/08916939608995361, 24:3, (157-165), Online publication date: 1-Jan-1996.

Kalvakolanu D and Borden E (2009) An Overview of the Interferon System: Signal Transduction and Mechanisms of Action, Cancer Investigation, 10.3109/07357909609018435, 14:1, (25-53), Online publication date: 1-Jan-1996.

Horvath C and Darnell J (1996) The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein, Journal of Virology, 10.1128/jvi.70.1.647-650.1996, 70:1, (647-650), Online publication date: 1-Jan-1996.

Rich S, Bose M, Tempst P and Rudofsky U (1996) Purification, Microsequencing, and Immunolocalization of p36, a New Interferon-α-induced Protein That Is Associated with Human Lupus Inclusions, Journal of Biological Chemistry, 10.1074/jbc.271.2.1118, 271:2, (1118-1126), Online publication date: 1-Jan-1996.

Jonas M (1996) Hepatitis C virus infection: clinical aspects and treatment with interferon alfa, Clinical Therapeutics, 10.1016/S0149-2918(96)80203-7, 18, (110-125), Online publication date: 1-Jan-1996.

Siatskas C, W. Lowenthal J, D. Obranovich T and L. Boyd R (1996) Avian cytokines Immunology Methods Manual, 10.1016/B978-012442710-5.50255-0, (2255-XIII), .

Scott G (1996) The Use of Interferons in Respiratory Viral Infections Viral and Other Infections of the Human Respiratory Tract, 10.1007/978-94-011-7930-0_20, (383-396), .

Gerken G, Knolle P and zum Büschenfelde K (1996) Interferon Therapy of Viral Hepatitis Symposium in Immunology V, 10.1007/978-3-642-79896-2_7, (77-89), .

Dyrberg T, Mackay P, Michelsen B, Petersen J, Karlsen A and Bonnevie V (1996) Viruses and Diabetes Mellitus Microorganisms and Autoimmune Diseases, 10.1007/978-1-4613-0347-3_5, (105-127), .

Rudick R, Sibley W and Durelli L (1996) Treatment of Multiple Sclerosis with Type I Interferons Multiple Sclerosis, 10.1007/978-1-4471-1271-6_11, (223-250), .

Suresh M, Karaca K, Foster D and Sharma J (1995) Molecular and functional characterization of turkey interferon, Journal of Virology, 10.1128/jvi.69.12.8159-8163.1995, 69:12, (8159-8163), Online publication date: 1-Dec-1995.

BROEK M, MULLER U, HUANG S, ZINKERNAGEL R and AGUET M (1995) Immune Defence in Mice Lacking Type I and/or Type II Interferon Receptors, Immunological Reviews, 10.1111/j.1600-065X.1995.tb00090.x, 148:1, (5-18), Online publication date: 1-Dec-1995.

WADLER S, BURK R, NEUBERG D, RAMEAU R, RUNOWICZ C, GOLDBERG G, McGILL F, TACHEZY R, COMIS R, EDMONSON J and WIERNIK P (1995) Lack of Efficacy of Interferon-α Therapy in Recurrent, Advanced Cervical Cancer, Journal of Interferon & Cytokine Research, 10.1089/jir.1995.15.1011, 15:12, (1011-1016), Online publication date: 1-Dec-1995.

Takase K, Nakano T, Hamada M, Shiraki K, Oohashi Y, Kihira T and Tameda Y (1995) Hemolytic anemia provoked by recombinant alpha-interferon, Journal of Gastroenterology, 10.1007/BF02349651, 30:6, (795-797), Online publication date: 1-Dec-1995.

LOWENTHAL J, DIGBY M and YORK J (1995) Production of Interferon-γ by Chicken T Cells, Journal of Interferon & Cytokine Research, 10.1089/jir.1995.15.933, 15:11, (933-938), Online publication date: 1-Nov-1995.

Fine H (1995) Novel Biologic Therapies for Malignant Gliomas, Neurologic Clinics, 10.1016/S0733-8619(18)30020-3, 13:4, (827-846), Online publication date: 1-Nov-1995.

Yoshikawa M, Fukui H and Tsujii T (2012) Immunological Adverse Effects of Interferon Treatment, Clinical Immunotherapeutics, 10.1007/BF03259299, 4:5, (361-375), Online publication date: 1-Nov-1995.

Horisberger M (1995) Interferons, Mx Genes, and Resistance to Influenza Virus , American Journal of Respiratory and Critical Care Medicine, 10.1164/ajrccm/152.4_Pt_2.S67, 152:4_pt_2, (S67-S71), Online publication date: 1-Oct-1995.

Olsen E and Bunn P (1995) Interferon in the Treatment of Cutaneous T-cell Lymphoma, Hematology/Oncology Clinics of North America, 10.1016/S0889-8588(18)30060-1, 9:5, (1089-1107), Online publication date: 1-Oct-1995.

MEMAR O and TYRING S (1995) ANTIVIRAL AGENTS IN DERMATOLOGY: CURRENT STATUS AND FUTURE PROSPECTS, International Journal of Dermatology, 10.1111/j.1365-4362.1995.tb01082.x, 34:9, (597-606), Online publication date: 1-Sep-1995.

Lindenmann J (1995) The National Institute for Medical Research, Mill Hill Personal recollections from 1956/57, Archives of Virology, 10.1007/BF01322542, 140:9, (1687-1691), Online publication date: 1-Sep-1995.

Taniguchi T, Harada H and Lamphier M (1995) Regulation of the interferon system and cell growth by the IRF transcription factors, Journal of Cancer Research and Clinical Oncology, 10.1007/BF01197763, 121:9-10, (516-520), Online publication date: 1-Sep-1995.

Clark J and Weiner L (1995) Biologic treatment of human cancer, Current Problems in Cancer, 10.1016/S0147-0272(06)80005-X, 19:4, (190-261), Online publication date: 1-Jul-1995.

Malaguarnera M, Giugno I, Trovato B, Panebianco M, Siciliano R and Ruello P (1995) Lipoprotein(a) concentration in patients with chronic active hepatitis C before and after interferon treatment, Clinical Therapeutics, 10.1016/0149-2918(95)80048-4, 17:4, (721-728), Online publication date: 1-Jul-1995.

Agarwala S and Kirkwood J (1995) Potential uses of interferon α2 as adjuvant therapy in cancer, Annals of Surgical Oncology, 10.1007/BF02307071, 2:4, (365-371), Online publication date: 1-Jul-1995.

Horikoshi T, Ezoe K, Nakagawa H, Eguchi H, Hanada N and Hamaoka S (2000) Up-regulation of ICAM-1 expression on human dermal fibroblasts by IFN β in the presence of TNF-α, FEBS Letters, 10.1016/0014-5793(95)00299-O, 363:1-2, (141-144), Online publication date: 17-Apr-1995.

Schultz U, Rinderle C, Sekellick M, Marcus P and Staeheli P (1995) Recombinant Chicken Interferon from Escherichia coli and Transfected COS Cells is Biologically Active, European Journal of Biochemistry, 10.1111/j.1432-1033.1995.tb20439.x, 229:1, (73-76), Online publication date: 1-Apr-1995.

Schultz U, Rinderle C, Sekellick M, Marcus P and Staeheli P (1995) Recombinant Chicken Interferon from Escherichia coli and Transfected COS Cells is Biologically Active, European Journal of Biochemistry, 10.1111/j.1432-1033.1995.0073l.x, 229:1, (73-76), Online publication date: 1-Apr-1995.

KIRSNER R, ANHALT G and KERDEL F (1995) Treatment with alpha interferon associated with the development of paraneoplastic pemphigus, British Journal of Dermatology, 10.1111/j.1365-2133.1995.tb08688.x, 132:3, (474-478), Online publication date: 1-Mar-1995.

Hamasaki V and Vokes E (1995) Interferons and other cytokines in head and neck cancer, Medical Oncology, 10.1007/BF01571405, 12:1, (23-33), Online publication date: 1-Mar-1995.

Schultz U, Kaspers B, Rinderle C, Sekellick M, Marcus P and Staeheli P (1995) Recombinant chicken interferon: a potent antiviral agent that lacks intrinsic macrophage activating factor activity, European Journal of Immunology, 10.1002/eji.1830250332, 25:3, (847-851), Online publication date: 1-Mar-1995.

Cantell K (2009) Development of Antiviral Therapy with Alpha Interferons: Promises, False Hopes and Accomplishments, Annals of Medicine, 10.3109/07853899509031932, 27:1, (23-28), Online publication date: 1-Jan-1995.

McKee D, Goodman M and Piro L (2008) Section Reviews Biologicals & Lmmunologicals: The interferons in haematologic malignancies, Expert Opinion on Investigational Drugs, 10.1517/13543784.4.1.9, 4:1, (9-21), Online publication date: 1-Jan-1995.

SOOS J and JOHNSON H (1995) Type I Interferon Inhibition of Superantigen Stimulation: Implications for Treatment of Superantigen-Associated Disease, Journal of Interferon & Cytokine Research, 10.1089/jir.1995.15.39, 15:1, (39-45), Online publication date: 1-Jan-1995.

Waksman B and Oppenheim J (1995) The Contribution of the Cytokine Concept to Immunology Immunology, 10.1016/B978-012274020-6/50013-1, (133-143), .

Cirelli R and Tyring S (2012) Major Therapeutic Uses of Interferons, Clinical Immunotherapeutics, 10.1007/BF03259051, 3:1, (27-87), Online publication date: 1-Jan-1995.

McMillan C and Burrows D (1995) In Vitro Testing in Contact Hypersensitivity Textbook of Contact Dermatitis, 10.1007/978-3-662-03104-9_18, (306-322), .

Weinstock-Guttman B, Ransohoff R, Kinkel R and Rudick R (1995) The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis, Annals of Neurology, 10.1002/ana.410370105, 37:1, (7-15), Online publication date: 1-Jan-1995.

(1994) References, Acta Neurologica Scandinavica, 10.1111/j.1600-0404.1994.tb08119.x, 90, (52-58), Online publication date: 1-Dec-1994.

Toyofuku K, Imayama S, Yasumoto S, Kiryu H and Hori Y (2015) Clinical and Immunohistochemical Studies of Skin Eruptions: Relationship to Administration of Interferon-α, The Journal of Dermatology, 10.1111/j.1346-8138.1994.tb03278.x, 21:10, (732-737), Online publication date: 1-Oct-1994.

Alpsoy E, Yilmaz E and Başaran E (1994) Interferon therapy for Behçet's disease, Journal of the American Academy of Dermatology, 10.1016/S0190-9622(94)70226-8, 31:4, (617-619), Online publication date: 1-Oct-1994.

J. Hertzog P, Y. Hwang S and Kola I (1994) Role of interferons in the regulation of cell proliferation, differentiation, and development, Molecular Reproduction and Development, 10.1002/mrd.1080390216, 39:2, (226-232), Online publication date: 1-Oct-1994.

Sparreboom A, Rongen H and van Bennekom W (1994) Assays for interferons and interleukins in biological matrices, Analytica Chimica Acta, 10.1016/0003-2670(94)80330-7, 295:1-2, (1-26), Online publication date: 1-Sep-1994.

Ito Y (1994) Induction of interferon by virus glycoprotein(s) in lymphoid cells through interaction with the cellular receptors via lectin-like action: An alternative interferon induction mechanism, Archives of Virology, 10.1007/BF01379125, 138:3-4, (187-198), Online publication date: 1-Sep-1994.

Naz R, Chaturvedi M and Aggarwal B (2013) Role of Cytokines and Proto-oncogenes in Sperm Cell Function: Relevance to Immunologic Infertility, American Journal of Reproductive Immunology, 10.1111/j.1600-0897.1994.tb00875.x, 32:1, (26-37), Online publication date: 1-Aug-1994.

SEKELLICK M, FERRANDINO A, HOPKINS D and MARCUS P (1994) Chicken Interferon Gene: Cloning, Expression, and Analysis, Journal of Interferon Research, 10.1089/jir.1994.14.71, 14:2, (71-79), Online publication date: 1-Apr-1994.

Guidotti L, Guilhot S and Chisari F (1994) Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways, Journal of Virology, 10.1128/jvi.68.3.1265-1270.1994, 68:3, (1265-1270), Online publication date: 1-Mar-1994.

Kinkel R and Goodkin D (2012) Immunotherapy for Multiple Sclerosis, Clinical Immunotherapeutics, 10.1007/BF03258498, 1:2, (117-134), Online publication date: 1-Feb-1994.

Warren R and Sidwell R (2012) The Potential Role of Cytokines in the Treatment of Viral Infections, Clinical Immunotherapeutics, 10.1007/BF03258488, 1:1, (15-30), Online publication date: 1-Jan-1994.

Finter N (1994) Cytokines in the treatment of virus infections Cytokines in the Treatment of Infectious Diseases, 10.1007/978-94-011-0233-9_2, (151-159), .

Samuel C (1994) Cytokines in the Treatment of Human Disease: The Interferon System—from the Laboratory to the Clinic Viral Hepatitis and Liver Disease, 10.1007/978-4-431-68255-4_153, (585-590), .

Kawade Y (1994) Cytokines in the Treatment of Human Diseases: Introduction and Summary of a Plenary Session Viral Hepatitis and Liver Disease, 10.1007/978-4-431-68255-4_152, (583-584), .

Holdener E, Massimini G, Lippman S, Bollag W and Man A (1994) Das Zervixkarzinom. Gegenwärtiger Stand und neue Aspekte der systemischen Therapie Immuntherapie in der gynäkologischen Onkologie, 10.1007/978-3-642-78845-1_7, (75-92), .

Hayes M and Zoon K (1994) Production and action of interferons: New insights into molecular mechanisms of gene regulation and expression Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, 10.1007/978-3-0348-7156-3_6, (239-270), .

Steinmann G, Adolf G and Leitz G (1994) Interferons in Cancer Therapy: From Clinical Trials to New Potentials in Anticancer Drug Discovery and Development Anticancer Drug Discovery and Development: Natural Products and New Molecular Models, 10.1007/978-1-4615-2610-0_10, (183-208), .

Johnson K and Panitch H (1994) Interferon and Copolymer I Treatment in Multiple Sclerosis: Clinical and Pathobiological Implications A Multidisciplinary Approach to Myelin Diseases II, 10.1007/978-1-4615-2435-9_24, (231-238), .

Martal J, Assal N, Assal A, Zouari K, Huynh L, Chêne N, Reinaud P, Charpigny G, Charlier M and Chaouat G (1994) Immunoendocrine Functions of Trophoblast Interferons (IFN-τ or TP-1 or Trophoblastins) in the Maternal Recognition of Pregnancy Endocrinology of Embryo-Endometrium Interactions, 10.1007/978-1-4615-1881-5_16, (195-216), .

Pittman K and Selby P (1994) Immunotherapy in the Management of Metastatic Renal Cell Carcinoma Tumours in Urology, 10.1007/978-1-4471-2086-5_14, (243-262), .

Piascik P (1993) Biotechnology update, American Pharmacy, 10.1016/S0160-3450(15)30575-4, 33:12, (25-26), Online publication date: 1-Dec-1993.

Peschke T, Bender A, Nain M and Gemsa D (1993) Role of Macrophage Cytokines in Influenza A Virus lnfections, Immunobiology, 10.1016/S0171-2985(11)80365-7, 189:3-4, (340-355), Online publication date: 1-Nov-1993.

Campos M, Godson D, Hughes H, Babiuk L and Sordillo L (1993) The Role of Biological Response Modifiers in Disease Control, Journal of Dairy Science, 10.3168/jds.S0022-0302(93)77577-3, 76:8, (2407-2417), Online publication date: 1-Aug-1993.

Ross C, Tingsgaard P, Jørgensen H and Vejlsgaard G (2009) Interferon treatment of cutaneous T-cell lymphoma, European Journal of Haematology, 10.1111/j.1600-0609.1993.tb01595.x, 51:2, (63-72)

Hug H and Sarre T (1993) Antivirale Effekte von Interferon, Biologie in unserer Zeit, 10.1002/biuz.19930230423, 23:4, (243-247), Online publication date: 1-Aug-1993.

GEORGIEV V (1993) Immunomodulating Drugs: Major Advances in Research and Development, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1993.tb35844.x, 685:1 Immunomodulat, (1-10), Online publication date: 1-Jun-1993.

Pikuza O and Blinnikov I (1993) Clinical aspects of the use of recombinant interferon preparations, Kazan medical journal, 10.17816/kazmj64587, 74:1, (1-4)

Kaba A, Eladari M, Mohammad-Ali K, Rhodes-Feuillette A and Galibert F (2009) The molecular cloning and sequence of the common marmoset interferon-gamma (MaiFN-γ) gene, DNA Sequence, 10.3109/10425179309020841, 3:6, (387-392), Online publication date: 1-Jan-1993.

Geerligs I, Beijnen J, Bekers O and Underberg W (2008) Quality Control of Protein and Peptide Drugs: Monoclonal Antibodies and some Biological Response Modifiers Derived by Recombinant DNA Technology, Drug Development and Industrial Pharmacy, 10.3109/03639049309038761, 19:1-2, (33-84), Online publication date: 1-Jan-1993.

Sen G and Ransohoff R (1993) Interferon-Induced Antiviral Actions and Their Regulation , 10.1016/S0065-3527(08)60083-4, (57-102), .

Cominelli F (1993) Cytokines Immunopharmacology of the Gastrointestinal System, 10.1016/B978-0-12-732860-7.50014-9, (123-136), .

Steinmann G, Rosenkaimer F and Leitz G (1993) Clinical Experiences with lnterferon-α and Interferon-γ Cytokine-Induced Pathology - Part B: Inflammatory Cytokines, Receptors, and Disease, 10.1016/B978-0-12-364935-5.50019-5, (193-207), .

Klegerman M and Plotnikoff N (1993) Lymphokines and Monokines Biotechnology and Pharmacy, 10.1007/978-94-015-8135-6_3, (53-70), .

Engle J, Kraus D, Parent L and Dean-Holland M (1993) The Pharmacist Practitioner’s Role in Biotechnology: Clinical Application of Biotechnology Products Biotechnology and Pharmacy, 10.1007/978-94-015-8135-6_16, (402-434), .

Ferenčík M (1993) Endogeneous immunomodulators (immunohormones) Handbook of Immunochemistry, 10.1007/978-94-011-1552-0_9, (225-252), .

Goepel M and Otto T (1993) Adjuvante Therapie des Nierenzellkarzinoms Immuntherapie in der Uroonkologie, 10.1007/978-3-642-77830-8_32, (326-336), .

von Bruchhausen F, Ebel S, Hackenthal E, Dannhardt G, Frahm A, Holzgrabe U, Keller K, Nürnberg E, Rimpler H, Schneider G, Surmann P, Wolf H and Wurm G (1993) Ibrotamid Hagers Handbuch der Pharmazeutischen Praxis, 10.1007/978-3-642-57994-3_5, (517-638), .

Barber H (1993) Immunotherapy and Immunopotentiation Ovarian Carcinoma, 10.1007/978-1-4613-9232-3_28, (296-312), .

Karaçorlu M, Peyman G, Cruz S and Soike K (1992) Lack of Toxicity of Intravitreally Administered Interferon Alpha-2a, Ophthalmic Surgery, Lasers and Imaging Retina, 10.3928/1542-8877-19921201-14, 23:12, (833-835), Online publication date: 1-Dec-1992.

VINCENT M, SIERRA I, BERBERAN-SANTOS M, DIAZ A, DIAZ M, PADRON G and GALLAY J (1992) Time-resolved fluorescence study of human recombinant interferon alpha2. Association state of the protein, spatial proximity of the two tryptophan residues, European Journal of Biochemistry, 10.1111/j.1432-1033.1992.tb17500.x, 210:3, (953-961), Online publication date: 1-Dec-1992.

Stuart‐Harris R, Lauchlan R and Day R (1992) The clinical application of the interferons: a review, Medical Journal of Australia, 10.5694/j.1326-5377.1992.tb137004.x, 156:12, (869-872), Online publication date: 1-Jun-1992.

Zhang Z, Tong K, Belew M, Pettersson T and Janson J (1992) Production, purification and characterization of recombinant human interferon γ, Journal of Chromatography A, 10.1016/0021-9673(92)85539-6, 604:1, (143-155), Online publication date: 1-Jun-1992.

Lucivero G (2016) The Interferons in Clinical Practice, International Journal of Immunopathology and Pharmacology, 10.1177/039463209200500203, 5:2, (83-92), Online publication date: 1-May-1992.

Bean B (1992) Antiviral therapy: current concepts and practices, Clinical Microbiology Reviews, 10.1128/CMR.5.2.146, 5:2, (146-182), Online publication date: 1-Apr-1992.

KRUSE A, RINK L, RUTENFRANZ I, KOLANCZYK B and KIRCHNER H (1992) Interferon and Lymphokine Production by Human Placental and Cord Blood Cells, Journal of Interferon Research, 10.1089/jir.1992.12.113, 12:2, (113-117), Online publication date: 1-Apr-1992.

Awisati G and Mandelli F (1992) The Role of Interferon-α in the Management of Myelomatosis, Hematology/Oncology Clinics of North America, 10.1016/S0889-8588(18)30352-6, 6:2, (395-405), Online publication date: 1-Apr-1992.

Sen G and Lengyel P (1992) The interferon system. A bird's eye view of its biochemistry., Journal of Biological Chemistry, 10.1016/S0021-9258(18)42719-6, 267:8, (5017-5020), Online publication date: 1-Mar-1992.

Talmadge J (1992) Development of immunotherapeutic strategies for the treatment of malignant neoplasms, Biotherapy, 10.1007/BF02174208, 4:3, (215-236), Online publication date: 1-Mar-1992.

FRANCIS M, MELTZER M and GENDELMAN H (1992) Interferons in the Persistence, Pathogenesis, and Treatment of HIV Infection, AIDS Research and Human Retroviruses, 10.1089/aid.1992.8.199, 8:2, (199-207), Online publication date: 1-Feb-1992.

Gendelman H, Skillman D and Meltzer M (2009) Interferon alpha (IFN)-Macrophage Interactions in Human Immunodeficiency Virus (HIV) Infection: Role of IFN in the Tempo and Progression of HIV Disease, International Reviews of Immunology, 10.3109/08830189209056640, 8:1, (43-54), Online publication date: 1-Jan-1992.

(1992) , Nishi Nihon Hifuka, 10.2336/nishinihonhifu.54.520, 54:3, (520-531), .

Chard T and Iles R (1992) Interferon as a fetoplacental signal in pregnancy, Placenta, 10.1016/S0143-4004(05)80308-X, 13, (55-72), Online publication date: 1-Jan-1992.

Tanaka N and Taniguchi T (1992) Cytokine Gene Regulation: Regulatory cis-Elements and DNA Binding Factors Involved in the Interferon System Advances in Immunology Volume 52, 10.1016/S0065-2776(08)60877-9, (263-281), .

BURLESON F, CHAMBERS T and WIEDBRAUK D (1992) ASSAYS OF ANTIVIRAL AGENTS AND INTERFERONS Virology, 10.1016/B978-0-12-144730-4.50034-5, (144-147), .

Narayan P (1992) Immunologie der Tumoren des Urogenitaltrakts Smiths Urologie, 10.1007/978-3-642-76107-2_18, (383-397), .

Schultz R (1992) The potential role of cytokines in cancer therapy Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, 10.1007/978-3-0348-7144-0_7, (219-250), .

Tedeschi B (1992) Interferon — A Candidate Mediator of Cell Growth Pancreatic Islet Cell Regeneration and Growth, 10.1007/978-1-4615-3448-8_7, (53-58), .

Jacobs L and Munschauer F (1992) Treatment of Multiple Sclerosis with Interferons Treatment of Multiple Sclerosis, 10.1007/978-1-4471-3184-7_11, (233-250), .

Shikani A and Richtsmeier W (2016) Effect of Viruses and Interferon on Chick Embryo Otocyst Cultures, Annals of Otology, Rhinology & Laryngology, 10.1177/000348949110001211, 100:12, (1020-1023), Online publication date: 1-Dec-1991.

Robinson J (1991) Advances in the Treatment of Nonmelanoma Skin Cancer, Dermatologic Clinics, 10.1016/S0733-8635(18)30380-2, 9:4, (757-764), Online publication date: 1-Oct-1991.

Hatch K (1991) Vulvovaginal human papillomavirus infections: Clinical implications and management, American Journal of Obstetrics and Gynecology, 10.1016/S0002-9378(12)90724-3, 165:4, (1183-1188), Online publication date: 1-Oct-1991.

Healsmith M, Berth-Jones J, Fletcher A and Graham-Brown R (2018) Treatment of Basal Cell Carcinoma with Intralesional Interferon Alpha-2b, Journal of the Royal Society of Medicine, 10.1177/014107689108400907, 84:9, (524-526), Online publication date: 1-Sep-1991.

Baier J, Neumann H and Ricken O (1991) No inhibition of interferon γ release in human lymphocytes by Ciamexone, Cancer Immunology Immunotherapy, 10.1007/BF01789049, 32:5, (311-314), Online publication date: 1-Sep-1991.

Gasparini G, Dal Fior S, Pozza F, Panizzoni G, Favretto S and Von Hoff D (1991) Phase I study of escalating dose mitoxantrone in combination with α-2-interferon in patients with advanced solid tumors, Investigational New Drugs, 10.1007/BF00176977, 9:3, (245-252), Online publication date: 1-Aug-1991.

Allen R and Albertson T (1991) Steroids and Biologic Agents in the Intensive Care Unit, Critical Care Clinics, 10.1016/S0749-0704(18)30301-4, 7:3, (695-711), Online publication date: 1-Jul-1991.

Lindley C and Gordon T (2016) Application of Biotechnology Products in Oncology, Journal of Pharmacy Practice, 10.1177/089719009100400207, 4:2, (117-130), Online publication date: 1-Apr-1991.

Seymour L (2016) Review : Synthetic Polymers with Intrinsic Anticancer Activity, Journal of Bioactive and Compatible Polymers, 10.1177/088391159100600205, 6:2, (178-216), Online publication date: 1-Apr-1991.

TROTTA P (2013) Cytokines: An Overview, American Journal of Reproductive Immunology, 10.1111/j.1600-0897.1991.tb01082.x, 25:3, (137-141), Online publication date: 1-Apr-1991.

TROTTA P (2013) The Clinical Potential of Recombinant Human Interleukin 4 and Alfa-2b Interferon, American Journal of Reproductive Immunology, 10.1111/j.1600-0897.1991.tb01079.x, 25:3, (124-128), Online publication date: 1-Apr-1991.

Jernberg-Wiklund H, Pettersson M and Nilsson K (2009) Recombinant interferon- γ inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro, European Journal of Haematology, 10.1111/j.1600-0609.1991.tb00546.x, 46:4, (231-239)

Trofatter K (1991) Interferon Treatment of Anogenstal Human Papillomavirus—Related Diseases, Dermatologic Clinics, 10.1016/S0733-8635(18)30421-2, 9:2, (343-352), Online publication date: 1-Apr-1991.

Boneschi V, Brambilla L, Chiappino G, Mozzanica N and Finzi A (1991) Intralesional Alpha 2b Recombinant Interferon for Basal Cell Carcinomas, International Journal of Dermatology, 10.1111/j.1365-4362.1991.tb03859.x, 30:3, (220-224), Online publication date: 1-Mar-1991.

L'HARIDON R, BOURGET P, LEFEVRE F and LA BONNARDIERE C (1991) Production of an Hybridoma Library to Recombinant Porcine Alpha I Interferon: A Very Sensitive Assay (ISBBA) Allows the Detection of a Large Number of Clones, Hybridoma, 10.1089/hyb.1991.10.35, 10:1, (35-47), Online publication date: 1-Feb-1991.

Kuo J, Nishio Y, Kanamaru H, Okada Y, Kita M, Imanishi J, Kishida T and Yoshida O (1991) Impaired interferon-? production in whole-blood cultures from bladder cancer patients, Urological Research, 10.1007/BF00294022, 19:1, (51-56), Online publication date: 1-Feb-1991.

SCHAART F, BRATZKE B, RUSZCZAK Z, STADLER R, EHLERS G and ORFANOS C (1991) Long-term therapy of HIV-associated Kaposi's sarcoma with recombinant interferon α-2a, British Journal of Dermatology, 10.1111/j.1365-2133.1991.tb03283.x, 124:1, (62-68), Online publication date: 1-Jan-1991.

SEN G (1991) Transcriptional regulation of interferon-inducible genes The Hormonal Control of Gene Transcription, 10.1016/B978-0-444-81382-4.50023-2, (349-374), .

Pape G (1991) Wirkungsmechanismus der Interferone; unter besonderer Berücksichtigung der chronischen Hepatitis B Chronische Virushepatitis und ihre Behandlung mit Interferon alfa, 10.1007/978-3-642-76901-6_3, (18-27), .

Mann P, Eshima D, Bitner D, Griffey R, Wenk R, Born J and Matwiyoff N (1991) Biomodulation: An integrated approach to access and manipulate biological information Lectins and Cancer, 10.1007/978-3-642-76739-5_13, (179-206), .

Roberts R, Cross J, Farin C, Farin P, Kramer K, Francis H, Librach C and Fisher S (1991) Trophoblast Interferons Growth Factors in Reproduction, 10.1007/978-1-4612-3162-2_18, (235-245), .

Maheshwari R, Srikantan V, Bhartiya D, Kleinman H and Grant D (1991) Differential effects of interferon gamma and alpha on in vitro model of angiogenesis, Journal of Cellular Physiology, 10.1002/jcp.1041460121, 146:1, (164-169), Online publication date: 1-Jan-1991.

Ho M (1990) Interferon as an Agent Against Herpes Simplex Virus, Journal of Investigative Dermatology, 10.1111/1523-1747.ep12875164, 95:6, (S158-S160), Online publication date: 1-Dec-1990.

Young A, Maritim A, Kariuki D, Stagg D, Wafula J, Mutugi J, Cummins J, Richards A and Burns C (2009) Low-dose oral administration of human interferon alpha can control the development of Theileria parva infection in cattle , Parasitology, 10.1017/S0031182000063241, 101:2, (201-209), Online publication date: 1-Oct-1990.

Yaar M, Peacocke M, Cohen M and Gilchrest B (1990) Dissociation of proto-oncogene induction from growth response in normal human fibroblasts, Journal of Cellular Physiology, 10.1002/jcp.1041450107, 145:1, (39-45), Online publication date: 1-Oct-1990.

Luk S, Jay E and Jay F (1990) Structure-function analysis of the human interferon gamma. The COOH terminus is not essential for functional activity., Journal of Biological Chemistry, 10.1016/S0021-9258(19)38300-0, 265:22, (13314-13319), Online publication date: 1-Aug-1990.

Reano A, Hesse S and Viac J (1990) Effect of gamma-interferon on lectin-binding glycoproteins in cultured human keratinocytes, Archives of Dermatological Research, 10.1007/BF00371644, 282:4, (246-252), Online publication date: 1-Jun-1990.

Delforge A, Vandenplas B, Lagneaux L, Loos M, Bron D, Debusscher L and Stryckmans P (2009) Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors, European Journal of Haematology, 10.1111/j.1600-0609.1990.tb00400.x, 44:5, (307-311)

Oka T, Ohtsuki Y, Sonobe H, Furihata M and Miyoshi I (1990) Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I), Archives of Virology, 10.1007/BF01310623, 115:1-2, (63-73), Online publication date: 1-Mar-1990.

Baron E and Narula S (2008) From Cloning to a Commercial Realization: Human Alpha Interferon, Critical Reviews in Biotechnology, 10.3109/07388559009038206, 10:3, (179-190), Online publication date: 1-Jan-1990.

Staeheli P (1990) Interferon-Induced Proteins and the Antiviral State Advances in Virus Research Volume 38, 10.1016/S0065-3527(08)60862-3, (147-200), .

BIELEFELDT-OHMANN H and MARTINOD S (1990) Interferon Immunomodulation in Domestic Food Animals Immunomodulation in Domestic Food Animals, 10.1016/B978-0-12-039235-3.50014-9, (215-230), .

Edwards L, Whiting D, Rogers D, Luck K and Smiles K (1990) The effect of intralesional interferon gamma on basal cell carcinomas, Journal of the American Academy of Dermatology, 10.1016/0190-9622(90)70070-X, 22:3, (496-500), Online publication date: 1-Jan-1990.

Herrmann F (1990) Die Stellung der Interferone in der Zytokinkaskade Interferone, 10.1007/978-3-642-93383-7_3, (53-64), .

Johnston M, Black R and Myers M (1990) Interferon Nomenclature The Terminology of Biotechnology: A Multidisciplinary Problem, 10.1007/978-3-642-76011-2_7, (61-69), .

Gross G (1990) Interferons in Genital HPV Disease Genital Papillomavirus Infections, 10.1007/978-3-642-75723-5_29, (393-412), .

Hauser H (1990) Interferons Growth Factors, Differentiation Factors, and Cytokines, 10.1007/978-3-642-74856-1_18, (243-253), .

Vilček J (1990) Interferons Peptide Growth Factors and Their Receptors II, 10.1007/978-3-642-74781-6_1, (3-38), .

Horoszewicz J and Murphy G (1989) An Assessment of the Current Use of Human Interferons in Therapy of Urological Cancers, Journal of Urology, 10.1016/S0022-5347(17)39022-5, 142:5, (1173-1180), Online publication date: 1-Nov-1989.

Ijzermans J and Marquet R (1989) Interferon-gamma: A Review, Immunobiology, 10.1016/S0171-2985(89)80049-X, 179:4-5, (456-473), Online publication date: 1-Oct-1989.

Slade S and Langhorne J (1989) Production of Interferon-Gamma during Infection of Mice with Plasmodium chabaudi chabaudi, Immunobiology, 10.1016/S0171-2985(89)80041-5, 179:4-5, (353-365), Online publication date: 1-Oct-1989.

BARBER H (2013) Present Status of Tumor Immunology in Clinical Gynecology, American Journal of Reproductive Immunology, 10.1111/j.1600-0897.1989.tb00986.x, 20:4, (140-146), Online publication date: 1-Aug-1989.

Raj N, Israeli R, Kellum M and Pitha P (1989) Upstream Regulatory Elements of Murine α4-Interferon Gene Confer Inducibility and Cell Type-restricted Expression, Journal of Biological Chemistry, 10.1016/S0021-9258(18)60442-9, 264:19, (11149-11157), Online publication date: 1-Jul-1989.

Notani J, Kaizu T, Mutoh S, Otsuka K, Kusunoki C, Yamada H, Nagayoshi A, Suzuki S, Niwa M, Ueda I and Antibody M (1989) Application of Namalva Interferon-α Monoclonal Antibodies for Purification and Enzyme Immnoassay of Interferon-α, Journal of Immunoassay, 10.1080/01971528908053240, 10:2-3, (257-276), Online publication date: 1-Jun-1989.

Schellekens H (1989) Animal models in interferon research: Some current trends, Experientia, 10.1007/BF01990506, 45:6, (558-562), Online publication date: 1-Jun-1989.

Carlin J, Ozaki Y, Byrne G, Brown R and Borden E (1989) Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects, Experientia, 10.1007/BF01990503, 45:6, (535-541), Online publication date: 1-Jun-1989.

Thomas H and Sikora K (2016) Biological Approaches to Cancer Therapy, Journal of International Medical Research, 10.1177/030006058901700301, 17:3, (191-204), Online publication date: 1-May-1989.

Stadler R, Mayer-da-Silva A, Bratzke B, Garbe C and Orfanos C (1989) Interferons in dermatology, Journal of the American Academy of Dermatology, 10.1016/S0190-9622(89)70078-5, 20:4, (650-656), Online publication date: 1-Apr-1989.

MANN E, MARKOVIC S and MURASKO D (1989) Inhibition of Lymphocyte Recirculation by Murine Interferon: Effects of Various Interferon Preparations and Timing of Administration, Journal of Interferon Research, 10.1089/jir.1989.9.35, 9:1, (35-51), Online publication date: 1-Feb-1989.

Brosjö O (2009) Osteosarcoma and interferon, Acta Orthopaedica Scandinavica, 10.3109/17453678909154176, 60:sup229, (1-36), Online publication date: 1-Jan-1989.

Braathen L and McFadden N (2009) Successful treatment of mycosis fungoides with the combination of etretinate and human recombinant interferon alfa-2a, Journal of Dermatological Treatment, 10.3109/09546638909086685, 1:1, (29-32), Online publication date: 1-Jan-1989.

Kurzrock R, Gutterman J, Kantarjian H and Talpaz M (2009) Therapy of Chronic Myelogenous Leukemia with Interferon, Cancer Investigation, 10.3109/07357908909038270, 7:1, (83-91), Online publication date: 1-Jan-1989.

Triffitt J, Bauer H, Brosjo O, Joyner C and Forster S (2009) Interferon Effects on Osteoinduction, Connective Tissue Research, 10.3109/03008208909002414, 23:2-3, (145-151), Online publication date: 1-Jan-1989.

Hanssen L, Schrumpf E, Kolbenstvedt A, Tausjos J and Dolva L (2009) Recombinant α-2 Interferon with or Without Hepatic Artery Embolization in the Treatment of Midgut Carcinoid Tumours a Preliminary Report, Acta Oncologica, 10.3109/02841868909111219, 28:3, (439-443), Online publication date: 1-Jan-1989.

SHIMADA T (1989) A case of ATL for which IFN-.GAMMA. was effective., Nishi Nihon Hifuka, 10.2336/nishinihonhifu.51.776, 51:4, (776-779), .

HELSETH E, TORP S, DALEN A and UNSGAARD G (1989) Effects of interferon-gamma and tumor necrosis factor-alpha on clonogenic growth of cell lines and primary cultures from human gliomas and brain metastases, APMIS, 10.1111/j.1699-0463.1989.tb00832.x, 97:1-6, (569-574), Online publication date: 1-Jan-1989.

LAWMAN M, CAMPOS M, OHMANN H, GRIEBEL P and BABIUK L (1989) Recombinant Cytokines and their Therapeutic Value in Veterinary Medicine Animal Biotechnology, 10.1016/B978-0-08-034730-1.50010-7, (63-106), .

Malmgren R (1989) Immunotherapy Cancer Management in Man, 10.1007/978-94-009-2536-6_22, (270-280), .

Niederle N (1989) Biological Response Modifiers: Clinical Aspects Cancer Therapy, 10.1007/978-3-642-74683-3_16, (151-162), .

Wiedmann K (1989) Die Therapie der chronischen Virushepatitis — Ein noch ungelöstes Problem mit neuen Perspektiven Therapeutische Probleme bei chronischen Lebererkrankungen, 10.1007/978-3-642-74671-0_2, (4-43), .

Obrecht J and Weber-Stadelmann W (1989) Klinische Cancerologie Innere Medizin, 10.1007/978-3-642-73788-6_7, (393-487), .

Niederle N and Kummer G (1989) The Role of Interferon in the Management of Patients with Hairy Cell Leukemia and Multiple Myeloma Cancer Therapy, 10.1007/978-3-642-73721-3_14, (112-123), .

Dianzani F and Antonelli G (1989) Physiological Mechanisms of Production and Action of Interferons in Response to Viral Infections The Immune Response to Viral Infections, 10.1007/978-1-4684-5712-4_7, (47-60), .

Fergusson R and Smyth J (1989) Interferons and Lung Cancer: Preclinical and Clinical Investigations Basic and Clinical Concepts of Lung Cancer, 10.1007/978-1-4613-1593-3_11, (173-182), .

Lopez C and Fitzgerald-Bocarsly P (1989) Natural Host Defense Systems Active against Herpes Simplex Virus Infections Functions of the Natural Immune System, 10.1007/978-1-4613-0715-0_4, (85-110), .

YAAR M, PALLERONI A and GILCHREST B (1988) Normal Human Keratinocytes Contain an Interferon-like Protein That May Modulate Their Growth and Differentiation, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1988.tb18818.x, 548:1 Endocrine, Me, (299-311), Online publication date: 1-Dec-1988.

Fleischmann J (1988) Biologic Response Modifiers and Urologic Malignancies, Surgical Clinics of North America, 10.1016/S0039-6109(16)44640-2, 68:5, (1125-1145), Online publication date: 1-Oct-1988.

Lieberman B, Fiocchi C, Youngman K, Sapatnekar W and Proffitt M (1988) Interferon ? production by human intestinal mucosal mononuclear cells, Digestive Diseases and Sciences, 10.1007/BF01536683, 33:10, (1297-1304), Online publication date: 1-Oct-1988.

Thomson D (1988) Interferon‐α as cancer therapy in Australia, Medical Journal of Australia, 10.5694/j.1326-5377.1988.tb120625.x, 149:6, (290-292), Online publication date: 1-Sep-1988.

Higashihara J, Saito T, Berens M and Welander C (1988) Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay, Cancer Chemotherapy and Pharmacology, 10.1007/BF00273414, 22:3, (215-222), Online publication date: 1-Sep-1988.

Forsberg K, Paulsson Y and Westermark B (1988) Effect on platelet-derived growth factor-induced mitogenesis of double-stranded RNA: Evidence for an autocrine growth inhibition mediated by interferon-?, Journal of Cellular Physiology, 10.1002/jcp.1041360208, 136:2, (266-272), Online publication date: 1-Aug-1988.

Gastl G and Huber C (1988) The biology of interferon actions, Blut, 10.1007/BF00320105, 56:5, (193-199), Online publication date: 1-May-1988.

Nickoloff B (2015) Recent Observations Regarding Interferon, Keratinocytes and Lymphocytes In vitro and In vivo , The Journal of Dermatology, 10.1111/j.1346-8138.1988.tb03658.x, 15:2, (93-98), Online publication date: 1-Apr-1988.

Branca A (1988) Interferon receptors, In Vitro Cellular & Developmental Biology, 10.1007/BF02623541, 24:3, (155-165), Online publication date: 1-Mar-1988.

MAHESHWARI R, TANDON R, FEUILLETTE A, MAHOUY G, BADILLET G and FRIEDMAN R (1988) Interferon Inhibits Aspergillus fumigatus Growth in Mice: An Activity Against an Extracellular Infection , Journal of Interferon Research, 10.1089/jir.1988.8.35, 8:1, (35-44), Online publication date: 1-Feb-1988.

Mughal T, Robinson W, Thomas M and Spiegel R (1988) Role of recombinant interferon alpha2 and cimetidine in patients with advanced malignant melanoma, Journal of Cancer Research and Clinical Oncology, 10.1007/BF00390495, 114:1, (108-109), Online publication date: 1-Feb-1988.

Abi-hanna D and Wakefield D (2009) Increased serum neopterin levels in patients with acute anterior uveitis, Current Eye Research, 10.3109/02713688809031803, 7:5, (497-502), Online publication date: 1-Jan-1988.

Jacobsen K and Rockwood G (1988) Interferons: I. Their Origin and Actions, Journal of Veterinary Internal Medicine, 10.1111/j.1939-1676.1988.tb01977.x, 2:1, (47-53), Online publication date: 1-Jan-1988.

HATCH K, BART B, HANSEN R, MILLIKAN L, REICHMAN R and BERMAN B (1988) Evaluation of Interferon Alpha2 (SCH 30500) in the Treatment of Condyloma Acuminatum, Journal of Gynecologic Surgery, 10.1089/gyn.1988.4.187, 4:3, (187-196), Online publication date: 1-Jan-1988.

Samuel C (1988) Mechanisms of the Antiviral Action of Interferons , 10.1016/S0079-6603(08)60609-1, (27-72), .

Babiuk L, Lawman M and Ohmann H (1988) Viral-Bacterial Synergistic Interaction in Respiratory Disease , 10.1016/S0065-3527(08)60713-7, (219-249), .

Levin S (1988) Interferon Deficiency Syndrome Immunodeficiency and Disease, 10.1007/978-94-009-1275-5_7, (133-147), .

Hall M and Jeffries D (1988) Immunobiology of Sexually Transmitted Disease: Herpes Simplex Virus Immunology of Sexually Transmitted Diseases, 10.1007/978-94-009-1255-7_8, (179-207), .

Timmermann K (1988) Aktueller Stand der Therapie mit Interferonen Krebs im Alter, 10.1007/978-3-642-85368-5_18, (149-174), .

Lillford P (1988) Characterization and Functional Attributes of Protein Isolates Characterization of Proteins, 10.1007/978-1-59259-437-5_18, (467-490), .

Mogensen S (1988) Macrophages and Natural Resistance to Virus Infections Infection, 10.1007/978-1-4899-3748-3_9, (207-223), .

Sonnenfeld G (1988) The Promise of Interferon Therapy for Parasitic Diseases Clinical Aspects of Interferons, 10.1007/978-1-4613-1737-1_7, (95-105), .

Foon K and Gale R (1988) Interferon Therapy of Chronic Lymphocytic Leukemia and Viral Infections in Leukemia Patients Clinical Aspects of Interferons, 10.1007/978-1-4613-1737-1_11, (141-148), .

Roth M, Bunn P and Foon K (1988) Interferon therapy for lymphoproliferative disorders Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias, 10.1007/978-1-4613-1713-5_7, (231-252), .

Aebersold P (1988) Antiproliferative Effects of Interferon Leukolysins and Cancer, 10.1007/978-1-4612-4586-5_6, (101-117), .

Dick R and Hubbell H (1987) Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations, Journal of Neuro-Oncology, 10.1007/BF00148390, 5:4, (331-338), Online publication date: 1-Dec-1987.

Jennings L and Dick E (1987) Transmission and control of rhinovirus colds, European Journal of Epidemiology, 10.1007/BF00145641, 3:4, (327-335), Online publication date: 1-Dec-1987.

Krown S (1987) Interferon in 1987: the half full glass, Journal of Cancer Research and Clinical Oncology, 10.1007/BF00390860, 113:6, (503-506), Online publication date: 1-Nov-1987.

Shearer M and Taylor-Papadimitriou J (1987) Regulation of cell growth by interferon, Cancer and Metastasis Review, 10.1007/BF00144264, 6:3, (199-221), Online publication date: 1-Nov-1987.

NOTEBORN M, ARNHEITER H, RICHTER-MANN L, BROWNING H and WEISSMANN C (1987) Transport of the Murine Mx Protein into the Nucleus Is Dependent on a Basic Carboxy-Terminal Sequence, Journal of Interferon Research, 10.1089/jir.1987.7.657, 7:5, (657-669), Online publication date: 1-Oct-1987.

HUGHES T and BARON S (1987) Do the Interferons Act Singly or in Combination?, Journal of Interferon Research, 10.1089/jir.1987.7.603, 7:5, (603-614), Online publication date: 1-Oct-1987.

CANTELL K (1987) Is Natural Human Leukocyte Interferon Still Needed?, Journal of Interferon Research, 10.1089/jir.1987.7.597, 7:5, (597-601), Online publication date: 1-Oct-1987.

BORDEN E, ROSENZWEIG I and BYRNE G (1987) Interferons: From Virus Inhibitor to Modulator of Amino Acid and Lipid Metabolism, Journal of Interferon Research, 10.1089/jir.1987.7.591, 7:5, (591-596), Online publication date: 1-Oct-1987.

CHANY C (1987) Interferons and Sarcolectins in Coordinated Cell Growth: Reconversion of Malignant Cells to a Nononcogenic Status, Journal of Interferon Research, 10.1089/jir.1987.7.569, 7:5, (569-574), Online publication date: 1-Oct-1987.

RUBINSTEIN M (1987) Multiple Interferon Subtypes: The Phenomenon and Its Relevance, Journal of Interferon Research, 10.1089/jir.1987.7.545, 7:5, (545-551), Online publication date: 1-Oct-1987.

VILČEK J (1987) Inverse Interference by Growth Factors, Journal of Interferon Research, 10.1089/jir.1987.7.537, 7:5, (537-543), Online publication date: 1-Oct-1987.

SEHGAL P and MAY L (1987) Human Interferon-β2, Journal of Interferon Research, 10.1089/jir.1987.7.521, 7:5, (521-527), Online publication date: 1-Oct-1987.

LENGYEL P (1987) Double-Stranded RNA and Interferon Action, Journal of Interferon Research, 10.1089/jir.1987.7.511, 7:5, (511-519), Online publication date: 1-Oct-1987.

EPSTEIN L (1987) The Odyssey of an Interferonologist: From Interferon-γ to Down Syndrome, Tumor Necrosis Factor, and Interleukin-1, and Back Again, Journal of Interferon Research, 10.1089/jir.1987.7.487, 7:5, (487-495), Online publication date: 1-Oct-1987.

TANIGUCHI T (1987) B.C., D.C., and A.C. of an Interferon Gene, Journal of Interferon Research, 10.1089/jir.1987.7.481, 7:5, (481-485), Online publication date: 1-Oct-1987.

MARCUS P (1987) Personal Travels and Travails with the Interferon System, Journal of Interferon Research, 10.1089/jir.1987.7.471, 7:5, (471-479), Online publication date: 1-Oct-1987.

DE MAEYER E and DE MAEYER-GUIGNARD J (1987) You Cannot Get Away from Interferon, Journal of Interferon Research, 10.1089/jir.1987.7.467, 7:5, (467-470), Online publication date: 1-Oct-1987.

HO M (1987) An Early Interferon: "Viral Inhibitory Factor", Journal of Interferon Research, 10.1089/jir.1987.7.455, 7:5, (455-458), Online publication date: 1-Oct-1987.

FRIEDMAN R (1987) The Discovery of Interferons as an Example of the Big Scientific Heist, Journal of Interferon Research, 10.1089/jir.1987.7.451, 7:5, (451-453), Online publication date: 1-Oct-1987.

WEISSMANN C (1987) In Praise of a Prepared Mind — A Retrospective on Jean Lindenmann, Journal of Interferon Research, 10.1089/jir.1987.7.439, 7:5, (439-440), Online publication date: 1-Oct-1987.

Crockett D, Lusk R, McCabe B and Mixon J (2016) Side Effects and Toxicity of Interferon in the Treatment of Recurrent Respiratory Papillomatosis, Annals of Otology, Rhinology & Laryngology, 10.1177/000348948709600524, 96:5, (601-607), Online publication date: 1-Sep-1987.

Steiner A, Wolf C and Pehamberger H (1987) Comparison of the effects of three different treatment regimens of recombinant interferons (r-IFN ?, r-IFN ?, and r-IFN ? +cimetidine) in disseminated malignant melanoma, Journal of Cancer Research and Clinical Oncology, 10.1007/BF00390040, 113:5, (459-465), Online publication date: 1-Aug-1987.

Matsumori A, Crumpacker C and Abelmann W (1987) Prevention of viral myocarditis with recombinant human leukocyte interferon α A/D in a murine model, Journal of the American College of Cardiology, 10.1016/S0735-1097(87)80472-2, 9:6, (1320-1325), Online publication date: 1-Jun-1987.

FREEMAN D, McKEOUGH M and SPRUANCE S (1987) Recombinant Human Interferon-αA Treatment of an Experimental Cutaneous Herpes Simplex Virus Type 1 Infection of Guinea Pigs, Journal of Interferon Research, 10.1089/jir.1987.7.213, 7:2, (213-222), Online publication date: 1-Apr-1987.

Karai M and Namba M (1987) Interferon-β can induce the production of plasminogen activator by cultured human cancer cells, Experientia, 10.1007/BF01940443, 43:4, (435-437), Online publication date: 1-Apr-1987.

Hokland M and Hokland P (2009) Interferons for malignant blood diseases?, European Journal of Haematology, 10.1111/j.1600-0609.1987.tb01165.x, 38:3, (209-212)

SCHOENFELD A, OVADIA J, STEIN L, LEVAVI H, NITKE S, DOERNER T and REVEL M (2013) Treatment of Flat Facial Warts with Interferon-Beta Cream, The Journal of Dermatologic Surgery and Oncology, 10.1111/j.1524-4725.1987.tb03953.x, 13:3, (299-301), Online publication date: 1-Mar-1987.

Takao T, Kobayashi M, Nishimura O and Shimonishi Y (1987) Chemical characterization of recombinant human leukocyte interferon A using fast atom bombardment mass spectrometry., Journal of Biological Chemistry, 10.1016/S0021-9258(18)61385-7, 262:8, (3541-3547), Online publication date: 1-Mar-1987.

Taira H, Kanda T, Omata T, Shibuta H, Kawakita M and Iwasaki K (1987) Interferon induction by transfection of Sendai virus C gene cDNA, Journal of Virology, 10.1128/jvi.61.2.625-628.1987, 61:2, (625-628), Online publication date: 1-Feb-1987.

Dafny N and Reyes-Vazquez C (2009) Single Injection of Three Different Preparations of α-Interferon Modifies Morphine Abstinence Signs for a Prolonged Period, International Journal of Neuroscience, 10.3109/00207458709043352, 32:3-4, (953-961), Online publication date: 1-Jan-1987.

NOBA E (1987) Double blind comparative test of recombinat human leukocytic interferon A .GAMMA.IFN-.ALPHA.A;Ro22-8181) against herpes zoster., Nishi Nihon Hifuka, 10.2336/nishinihonhifu.49.902, 49:5, (902-911), .

Kovalenko A (1987) Antivirale eigenschaften mikrobieller polysaccharide — ein überblick, Zentralblatt für Mikrobiologie, 10.1016/S0232-4393(87)80051-3, 142:4, (301-310), .

TRINCHIERI G, KOBAYASHI M, MURPHY M and PERUSSIA B (1987) Immune Interferon and Cytotoxins: Regulatory Effects on Myeloid Cells Lymphokines, 10.1016/B978-0-12-432014-7.50015-2, (267-305), .

Baron S (1987) Mechanisms of Natural Resistance Frontiers in Microbiology, 10.1007/978-94-009-3353-8_10, (109-124), .

Niederle N and Kloke O (1987) Interferon in the Treatment of Hairy Cell Leukemia and Chronic Myelogenous Leukemia Interferons in Oncology, 10.1007/978-3-642-72805-1_2, (11-24), .

Chachoua A and Green M (1987) New antiviral compounds and impact in management of neoplastic disease and AIDS Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy, 10.1007/978-1-4613-2061-6_9, (205-232), .

Trotta P and Spiegel R (1987) Interferon: Current concepts of mechanisms of action Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy, 10.1007/978-1-4613-2061-6_6, (141-159), .

Creagan E (1987) Interferon Trials in the Management of Malignant Melanoma and Other Neoplasms: An Overview Basic and Clinical Aspects of Malignant Melanoma, 10.1007/978-1-4613-2043-2_9, (167-194), .

Suzuki T, Ikeda S, Kanoh T and Mizoguchi I (1986) Decreased phagocytosis and superoxide anion production in alveolar macrophages of rats exposed to nitrogen dioxide, Archives of Environmental Contamination and Toxicology, 10.1007/BF01054920, 15:6, (733-739), Online publication date: 1-Nov-1986.

Moritz T and Kirchner H (1986) The effect of interferons on cellular differentiation, Blut, 10.1007/BF00321098, 53:5, (361-370), Online publication date: 1-Nov-1986.

Greenway H, Cornell R, Tanner D, Peets E, Bordin G and Nagi C (1986) Treatment of basal cell carcinoma with intralesional interferon, Journal of the American Academy of Dermatology, 10.1016/S0190-9622(86)70192-8, 15:3, (437-443), Online publication date: 1-Sep-1986.

Pasechnik V (1986) Chromatographic methods for purification of leukocyte interferon, Journal of Chromatography A, 10.1016/S0021-9673(00)96226-5, 364, (359-368), Online publication date: 1-Sep-1986.

Sriskandan K, Garner P, Watkinson J, Pettingale K, Brinkley D, Calman F and Tee D (1986) A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer, Cancer Chemotherapy and Pharmacology, 10.1007/BF00253067, 18:1, (63-68), Online publication date: 1-Sep-1986.

Levy H (2016) Review : Polynucleotides as Interferon Inducers and Immune Modulators, Journal of Bioactive and Compatible Polymers, 10.1177/088391158600100306, 1:3, (348-385), Online publication date: 1-Jul-1986.

Manzin A, Bagnarelli P, Brugia M, Pauri P and Clementi M (1986) Comparative effects of α, β and γ human interferons on a HBsAg-producing human hepatoma cell line, La Ricerca in Clinica e in Laboratorio, 10.1007/BF02886741, 16:3, (457-462), Online publication date: 1-Jul-1986.

HUNNINGHAKE G (1986) Role of Alveolar Macrophage- and Lung T Cell-derived Mediators in Pulmonary Sarcoidosis, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1986.tb18483.x, 465:1 Tenth Interna, (82-90), Online publication date: 1-Jun-1986.

Finter N (1986) An Overview of Wellferon (Interferon Alfa-n1): The Product, Medical Clinics of North America, 10.1016/S0025-7125(16)36782-7, 70, (13-18), Online publication date: 1-May-1986.

Finter N and Strander H (1986) Introduction, Medical Clinics of North America, 10.1016/S0025-7125(16)36780-3, 70, (1-6), Online publication date: 1-May-1986.

Trown P, Wills R and Kamm J (1986) The preclinical development of roferon®-A, Cancer, 10.1002/1097-0142(19860415)57:8+<1648::AID-CNCR2820571303>3.0.CO;2-O, 57:S8, (1648-1656), Online publication date: 15-Apr-1986.

Vegh S, Peyman G, Vernot J and Fiscella R (1986) Toxicity of Intravitreal Interferon, Ophthalmic Surgery, Lasers and Imaging Retina, 10.3928/1542-8877-19860201-10, 17:2, (103-105), Online publication date: 1-Feb-1986.

Foon K (1986) Biological therapy of cancer, Breast Cancer Research and Treatment, 10.1007/BF01886730, 7:1, (5-14), Online publication date: 1-Feb-1986.

Rubinstein M, Orchansky P and Zoon K (2008) The Interferon Receptor, Critical Reviews in Biochemistry, 10.3109/10409238609113613, 21:3, (249-275), Online publication date: 1-Jan-1986.

Greiner J (2009) Modulation of Antigen Expression in Human Tumor Cell Populations, Cancer Investigation, 10.3109/07357908609018454, 4:3, (239-256), Online publication date: 1-Jan-1986.

Weissmann C and Weber H (1986) The Interferon Genes , 10.1016/S0079-6603(08)60026-4, (251-300), .

(1986) Bibliography Interferon Treatment of Human Neoplasia, 10.1016/S0065-230X(08)60047-0, (204-256), .

BETTS R (1986) An Update on Interferon in Infectious Diseases Advances in Immunopharmacology, 10.1016/B978-0-08-032008-3.50009-6, (69-73), .

Weck P, Brandsma J and Whisnant J (1986) Interferons in the treatment of human papillomavirus diseases, CANCER AND METASTASIS REVIEW, 10.1007/BF00046428, 5:2, (139-165), .

Stewart W (1986) Interferons and Their Roles in Virus Infections Viruses, Immunity, and Immunodeficiency, 10.1007/978-1-4613-2185-9_28, (301-306), .

Lopez C (1986) Natural Resistance Mechanisms in Herpesvirus Infections Viruses, Immunity, and Immunodeficiency, 10.1007/978-1-4613-2185-9_1, (3-11), .

Ransohoff R, Maroney P, Nayak D, Chambers T and Nilsen T (1985) Effect of human alpha A interferon on influenza virus replication in MDBK cells, Journal of Virology, 10.1128/jvi.56.3.1049-1052.1985, 56:3, (1049-1052), Online publication date: 1-Dec-1985.

Rice G, Woelfel E, Talbot P, Braheny S, Sipe J, Knobler R, Merigan T and Oldstone M (1985) Immunological complications in multiple sclerosis patients receiving interferon, Annals of Neurology, 10.1002/ana.410180405, 18:4, (439-442), Online publication date: 1-Oct-1985.

Yaar M, Karassik R, Schnipper L and Gilchrest B (1985) Effects of Alpha and Beta Interferons on Cultured Human Keratinocytes, Journal of Investigative Dermatology, 10.1111/1523-1747.ep12275353, 85:1, (70-74), Online publication date: 1-Jul-1985.

Yilma T and Breeze R (1985) New Technology for Prevention and Control of Infectious Bovine Respiratory Diseases, Veterinary Clinics of North America: Food Animal Practice, 10.1016/S0749-0720(15)31335-9, 1:2, (419-439), Online publication date: 1-Jul-1985.

Nickoloff B, Basham T, Merigan T and Morhenn V (1985) Immunomodulatory and Antiproliferative Effect of Recombinant Alpha, Beta, and Gamma Interferons on Cultured Human Malignant Squamous Cell Lines, SCL-1 and SW-1271, Journal of Investigative Dermatology, 10.1111/1523-1747.ep12273446, 84:6, (487-490), Online publication date: 1-Jun-1985.

Mizutani T (2006) Adsorption Chromatography of Biopolymers on Porous Glass, Journal of Liquid Chromatography, 10.1080/01483918508067122, 8:5, (925-983), Online publication date: 1-Apr-1985.

Kempf R and Mitchell M (2009) Effects of Chemotherapeutic Agents on the Immune Response. II, Cancer Investigation, 10.3109/07357908509040605, 3:1, (23-33), Online publication date: 1-Jan-1985.

Flodgren P, Hugander A and Sjögren H (2009) Recombinant Leukocyte a Interferon as Single Agent Therapy or in Combination with Cimetidine in Patients with Advanced Colo-Rectal Carcinoma: A phase II investigation, Acta Radiologica: Oncology, 10.3109/02841868509134361, 24:1, (25-34), Online publication date: 1-Jan-1985.

KREMPIEN U, REDMANN I and JUNGWIRTH C (1985) Purification of Chick Interferon by Zinc Chelate Affinity Chromatography and Sodium Dodecylsulfate-Polyacrylamide Gel Electrophoresis, Journal of Interferon Research, 10.1089/jir.1985.5.209, 5:1, (209-214), Online publication date: 1-Jan-1985.

MEDENICA R and SLACK N (1985) Clinical Results of Leukocyte Interferon-Induced Tumor Regression in Resistant Human Metastatic Cancer Resistant to Chemotherapy and/or Radiotherapy-Pulse Therapy Schedule, Cancer Drug Delivery, 10.1089/cdd.1985.2.53, 2:1, (53-76), Online publication date: 1-Jan-1985.

(1985) Chapter 3 Antiviral drugs: general considerations Conquest of Viral Diseases - A Topical Review of Drugs and Vaccines, 10.1016/S0168-7069(08)70011-9, (93-126), .

Siegel B (1985) Immunology and Oncology , 10.1016/S0074-7696(08)60595-1, (89-120), .

HOOKS J and DETRICK B (1985) Immunoregulatory Functions of Interferon Biological Response Modifiers, 10.1016/B978-0-12-695770-9.50008-8, (57-75), .

Hodnett E (1985) Synthetic Polymeric Inducers of Interferon Polymeric Materials in Medication, 10.1007/978-1-4899-2245-8_19, (211-226), .

Levy H and Quinn T (1985) Interferon Induction by Polymers Bioactive Polymeric Systems, 10.1007/978-1-4757-0405-1_15, (387-415), .

Williams J and Szentivanyi A (1985) Pharmacokinetic and Pharmacodynamic Parameters Affected by RE Cell Activators Pharmacology, 10.1007/978-1-4615-9406-2_1, (1-25), .

Lopez C (1985) Natural Resistance Mechanisms in Herpes Simplex Virus Infections The Herpesviruses, 10.1007/978-1-4615-8021-8_2, (37-68), .

Lebel F and Hirsch M (1985) The Role of Interferon in Immunity and Prophylaxis The Herpesviruses, 10.1007/978-1-4615-8021-8_18, (371-393), .

Schellekens H, v.d. Meide P and Dijkema R (1985) Interferons: past, present and future Supportive therapy in haematology, 10.1007/978-1-4613-2577-2_32, (325-337), .

Talal N (1985) Interferon and Natural Killer Cells in Rheumatic Diseases Immunology of Rheumatic Diseases, 10.1007/978-1-4613-2493-5_5, (141-163), .

Virelizier J (1985) Interferons: immunoregulatory agents Approaches to Antiviral Agents, 10.1007/978-1-349-06930-9_9, (261-278), .

Hovanessian A (1985) Interferons: direct effects upon viral replication Approaches to Antiviral Agents, 10.1007/978-1-349-06930-9_8, (217-260), .

Leigh Anderson N (1985) Induction of a mitochondrial matrix protein in human fibroblasts by interferon or poly I:C, Electrophoresis, 10.1002/elps.1150060606, 6:6, (277-282), .

Lotz M, Tsoukas C, Fong S, Carson D and Vaughan J (1985) Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-γ, European Journal of Immunology, 10.1002/eji.1830150518, 15:5, (520-525), .

Rose G, Pinero G, O'Neill P, Nikai H and Mahan C (2016) Human Gingival Fibroblast Production of Interferon, Journal of Dental Research, 10.1177/00220345840630120601, 63:12, (1369-1375), Online publication date: 1-Dec-1984.

Schellekens H, Reus A and Meide P (1984) The Chimpanzee as a Model to Test the Side Effects of Human Interferons, Journal of Medical Primatology, 10.1111/j.1600-0684.1984.tb00144.x, 13:5, (235-245), Online publication date: 1-Oct-1984.

Langer J and Pestka S (1984) Purification, Bacterial Expression, and Biological Activities of the Human Interferons., Journal of Investigative Dermatology, 10.1111/1523-1747.ep12282005, 83:s1, (128s-136s), Online publication date: 1-Jul-1984.

Meyer T and Horisberger M (1984) Combined action of mouse alpha and beta interferons in influenza virus-infected macrophages carrying the resistance gene Mx, Journal of Virology, 10.1128/jvi.49.3.709-716.1984, 49:3, (709-716), Online publication date: 1-Mar-1984.

Richtsmeier W and Kirkwd J (2009) Interferon—Present and Future Prospects, CRC Critical Reviews in Clinical Laboratory Sciences, 10.3109/10408368409165770, 20:1, (57-93), Online publication date: 1-Jan-1984.

Reyes-vazquez C, Prieto-gomez B, Georgiades J and Dafny N (2009) Alpha and Gamma Interferons' Effects on Cortical and Hippocampal Neurons: Microiontophoretic Application and Single Cell Recording, International Journal of Neuroscience, 10.3109/00207458408985593, 25:1-2, (113-121), Online publication date: 1-Jan-1984.

SUN C, WYDE P, WILSON S and KNIGHT V (1984) Efficacy of Aerosolized Recombinant Interferons Against Vesicular Stomatitis Virus-Induced Lung Infection in Cotton Rats, Journal of Interferon Research, 10.1089/jir.1984.4.449, 4:4, (449-459), Online publication date: 1-Jan-1984.

BHAYANI H and HUDSON L (1984) Inhibition of Cell Division and Antibody Secretion by Murine Alpha/Beta Interferon: Effects on Plasmacytoma and Hybridoma Lymphoid Cells, Journal of Interferon Research, 10.1089/jir.1984.4.41, 4:1, (41-50), Online publication date: 1-Jan-1984.

BOCCI V (1984) Evaluation of Routes of Administration of Interferon in Cancer: A Review and a Proposal, Cancer Drug Delivery, 10.1089/cdd.1984.1.337, 1:4, (337-351), Online publication date: 1-Jan-1984.

Dafny N (1984) Interferon: A candidate as the endogenous substance preventing tolerance and dependence to brain opioids, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/S0278-5846(84)80021-4, 8:3, (351-357), Online publication date: 1-Jan-1984.

Illis L and Longson M (1984) Encephalitis Contemporary Neurology, 10.1016/B978-0-407-00308-8.50046-X, (350-364), .

ZOON K (1984) Interferon: Past, Present, and Future The Impact of Protein Chemistry on the Biomedical Sciences, 10.1016/B978-0-12-622780-2.50033-X, (363-373), .

Mann R (1984) The Present Century. The Beginnings of Preventive Medicine Modern Drug use, 10.1007/978-94-009-5586-8_7, (507-596), .

Holdener E, Schnell P, Spieler P and Senn H (1984) In Vitro Effect of Interferon-α on Human Granulocyte/Macrophage Progenitor Cells and Human Clonogenic Tumor Cells Predictive Drug Testing on Human Tumor Cells, 10.1007/978-3-642-82295-7_22, (205-219), .

Kirchner H (1984) Interferon Gamma Essential and Non-Essential Metals Metabolites with Antibiotic Activity Pharmacology of Benzodiazepines Interferon Gamma Research, 10.1007/978-3-642-69872-9_4, (169-203), .

Strander H, Aparisi T, Broström L, Einhorn S, Ingimarsson S, Nilsonne U and Söderberg G (1984) Adjuvant Interferon Therapy in Primary Osteosarcoma Current Concepts of Diagnosis and Treatment of Bone and Soft Tissue Tumors, 10.1007/978-3-642-69210-9_12, (119-130), .

Levy H and Riley F (1984) Utilization of Stabilized Forms of Polynucleotides Interferons and Their Applications, 10.1007/978-3-642-69178-2_25, (515-533), .

Greenberg S and Harmon M (1984) Clinical Use of Interferons: Localized Application in Viral Diseases Interferons and Their Applications, 10.1007/978-3-642-69178-2_21, (433-453), .

Grossberg S, Jameson P and Sedmak J (1984) Assay of Interferons Interferons and Their Applications, 10.1007/978-3-642-69178-2_2, (23-43), .

Georgiades J, Baron S, Fleischmann W, Langford M, Weigent D and Stanton G (1984) Immune Interferon Interferons and Their Applications, 10.1007/978-3-642-69178-2_15, (305-337), .

Hill N (1984) Production and Characterization of Human Leukocyte Interferon Interferons and Their Applications, 10.1007/978-3-642-69178-2_12, (259-269), .

Marcus P (1984) Interferon Induction by Viruses Interferons and Their Applications, 10.1007/978-3-642-69178-2_10, (205-232), .

Krim M (1984) Interferons and Their Applications: Past, Present, and Future Interferons and Their Applications, 10.1007/978-3-642-69178-2_1, (1-22), .

Stewart W (1984) Heterogeneities of Human Interferons Biological Responses in Cancer, 10.1007/978-1-4684-4682-1_2, (19-44), .

Bocci V (1984) The Interferon System in Physiology and Medicine Immunomodulation, 10.1007/978-1-4615-9358-4_10, (131-154), .

Wolf G (1984) Tumor immunology, immune surveillance and immunotherapy of head and neck squamous carcinoma Head and Neck Oncology, 10.1007/978-1-4613-3816-1_16, (375-410), .

Becker Y (1984) Introduction: Current Trends in the Research on Antiviral Drugs Antiviral Drugs and Interferon: The Molecular Basis of Their Activity, 10.1007/978-1-4613-3804-8_1, (1-9), .

Rheinbaben F, Koenig U and Schneweis K (1983) Serum interferon levels in patients having radiotherapy for cervical carcinoma, Archives of Gynecology, 10.1007/BF02114722, 234:1, (33-38), Online publication date: 1-Nov-1983.

Epstein J (1983) Photocarcinogenesis, skin cancer, and aging, Journal of the American Academy of Dermatology, 10.1016/S0190-9622(83)70160-X, 9:4, (487-502), Online publication date: 1-Oct-1983.

Ghubril V (1983) Blockage of antiviral induction of interferon by homologous cell biochemical activity: effect of chicken embryo fibroblast mitotic cell cycle phases on Sindbis virus growth, Journal of Virology, 10.1128/jvi.47.3.637-641.1983, 47:3, (637-641), Online publication date: 1-Sep-1983.

Braude I (2006) A Simple and Efficient Method for the Purification of Human Gamma Interferon, Preparative Biochemistry, 10.1080/00327488308064247, 13:3, (177-190), Online publication date: 1-Sep-1983.

Richtsmeier W (1983) Human interferon production in tonsil and adenoid tissue cultures, American Journal of Otolaryngology, 10.1016/S0196-0709(83)80019-2, 4:5, (325-333), Online publication date: 1-Sep-1983.

Cesario T (1983) The Clinical Implications of Human Interferon, Medical Clinics of North America, 10.1016/S0025-7125(16)31171-3, 67:5, (1147-1162), Online publication date: 1-Sep-1983.

FINTER N (1983) 5 Interferon: better than Antiviral Chemotherapy?, Clinics in Immunology and Allergy, 10.1016/S0260-4639(22)00231-6, 3:2, (265-273), Online publication date: 1-Jun-1983.

Cheng Y, Colonno R and Yin F (1983) Interferon induction of fibroblast proteins with guanylate binding activity., Journal of Biological Chemistry, 10.1016/S0021-9258(18)32242-7, 258:12, (7746-7750), Online publication date: 1-Jun-1983.

Woodrow D (2018) Interferon Therapy and Immunity, Journal of the Royal Society of Medicine, 10.1177/014107688307600319, 76:3, (230-233), Online publication date: 1-Mar-1983.

Aviel A, Hahn T, Levin S, Ostfeld E, Bregman V and Marshak G (2009) Interferon Anti-Viral System in Bell's Palsy, Acta Oto-Laryngologica, 10.3109/00016488309130917, 95:1-4, (69-73), Online publication date: 1-Jan-1983.

McCabe B and Clark K (2016) Interferon and Laryngeal Papillomatosis, Annals of Otology, Rhinology & Laryngology, 10.1177/000348948309200102, 92:1, (2-7), Online publication date: 1-Jan-1983.

BOWLIN T and PROFFITT M (1983) In Vitro Inhibition of Allogeneic CTL Generation and Interferon Gamma Production by the Cells of a Chemically Induced Fibrosarcoma, Journal of Interferon Research, 10.1089/jir.1983.3.19, 3:1, (19-31), Online publication date: 1-Jan-1983.

DE MAEYER E (1983) The 1982 Kurt Paucker Memorial Lecture: The Need to Understand, Journal of Interferon Research, 10.1089/jir.1983.3.1, 3:1, (1-10), Online publication date: 1-Jan-1983.

Brigden D and Freestone D (1983) Interferon in Acute and Chronic Viral Infections Immunology of Nervous System Infections, 10.1016/S0079-6123(08)63855-8, (97-103), .

Ades E, Insel R, Gigliotti F and Schmidtke J (1983) Chapter 16. Immunotherapy of Infectious Diseases , 10.1016/S0065-7743(08)60771-X, (149-159), .

Friedman R and Vogel S (1983) Interferons with Special Emphasis on the Immune System Advances in Immunology Volume 34, 10.1016/S0065-2776(08)60378-8, (97-140), .

Gahrton G (1983) Treatment of Acute Leukemia–Advances in Chemotherapy, Immunotherapy, and Bone Marrow Transplantation , 10.1016/S0065-230X(08)60682-X, (255-329), .

Kirchner H (1983) Immunobiology of Infection with Human Cytomegalovirus , 10.1016/S0065-230X(08)60679-X, (31-105), .

Pestka S and Maeda S (1983) THE HUMAN INTERFERONS: THEIR PURIFICATION AND SEQUENCE, CLONING AND EXPRESSION IN BACTERIA, AND BIOLOGICAL PROPERTIES Humoral Factors in Host Defense, 10.1016/B978-0-12-768220-4.50019-X, (191-243), .

Taniguchi T, Ohno S, Nishi T, Itoh S and Takaoka C (1983) EXPRESSION OF THE HUMAN INTERFERON-β1 GENE IN HETEROLOGOUS HOST CELLS Humoral Factors in Host Defense, 10.1016/B978-0-12-768220-4.50015-2, (131-139), .

Torrence P, Lesiak K, Imai J, Johnston M and Sawai H (1983) 2′,5′-Oligoadenylates: Their Role in Interferon Action and Their Potential as Chemotherapeutic Agents Nucleosides, Nusleotides and their Biological Applications, 10.1016/B978-0-12-587980-4.50009-1, (67-115), .

Taniguchi T, Ohno S and Takaoka C (1983) Structure and Expression of the Cloned Genes for Human Interferon-β Nucleic Acid Research, 10.1016/B978-0-12-501650-6.50020-1, (259-278), .

Chessin M (1983) Is there a plant interferon?, The Botanical Review, 10.1007/BF02861007, 49:1, (1-28), Online publication date: 1-Jan-1983.

Wilmes E and Deinhardt F (1983) Virale Krankheiten im HNO-Bereich Teil I: Referate, 10.1007/978-3-642-82057-1_1, (1-112), .

Johnson H (1983) Interferon and Host Defense Systems Host Defenses to Intracellular Pathogens, 10.1007/978-1-4684-4481-0_11, (105-119), .

Berry L and Gaska J (1983) The Role of Humoral Factors in Endotoxin-Induced Reactions Beneficial Effects of Endotoxins, 10.1007/978-1-4684-4364-6_18, (355-380), .

Levy H and Riley F (1983) Utilization of Stabilized Forms of Polynucleotides Polymers in Medicine, 10.1007/978-1-4615-7643-3_3, (33-55), .

Becker Y and Hadar J (1983) Antiviral Drugs and Chemotherapy of Viral Diseases of Man Molecular Virology, 10.1007/978-1-4613-3906-9_26, (277-305), .

Dziewanowska Z and Pestka S (1982) The human interferons, Medicinal Research Reviews, 10.1002/med.2610020403, 2:4, (325-353), Online publication date: 1-Oct-1982.

Burke D, Tyrrell D and Burke D (1997) The mechanism of interferon production, Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 299:1094, (51-57), Online publication date: 24-Sep-1982.

Fiers W, Remaut E, Devos R, Cheroutre H, Contreras R, Gheysen D, Degrave W, Stanssens P, Tavernier J, Taya Y, Content J, Tyrrell D and Burke D (1997) The human fibroblast and human immune interferon genes and their expression in homologous and heterologous cells, Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 299:1094, (29-38), Online publication date: 24-Sep-1982.

Lindenmann J, Tyrrell D and Burke D (1997) From interference to interferon: a brief historical introduction, Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 299:1094, (3-6), Online publication date: 24-Sep-1982.

Schouten T, Weimar W, Bos C, Bos J, Cremers C and Schellekens H (2009) Treatment of Juvenile Laryngeal Papillomatosis with Two Types of Interferon, The Laryngoscope, 10.1002/lary.1982.92.6.686, 92:6, (686-688), Online publication date: 1-Jun-1982.

Ytterberg S and Schnitzer T (1982) Serum interferon levels in patients with systemic lupus erythematosus, Arthritis & Rheumatism, 10.1002/art.1780250407, 25:4, (401-406), Online publication date: 1-Apr-1982.

Levin S and Hahn T (1982) INTERFERON SYSTEM IN ACUTE VIRAL HEPATITIS, The Lancet, 10.1016/S0140-6736(82)91751-2, 319:8272, (592-594), Online publication date: 1-Mar-1982.

Grabner G, Smolin G, Okumoto M and Stebbing N (2009) Antiviral effects of highly purified bacteria-derived human leukocyte interferons (subtypes A and D) and a human fibroblast interferon against herpes virus infection of the rabbit eye, Current Eye Research, 10.3109/02713688209020012, 2:11, (785-790), Online publication date: 1-Jan-1982.

Gallati H (2009) Interferon: Wesentlich vereinfachte, enzym-immunologische Bestimmung mit zwei monoklonalen Antikörpern, cclm, 10.1515/cclm.1982.20.12.907, 20:12, (907-914), .

LYONS S, SCHOUB B, CHIU M and CRESPI M (1982) Induction of Interferon by Sendai Virus Versus Blue Tongue Virus, Journal of Interferon Research, 10.1089/jir.1982.2.543, 2:4, (543-547), Online publication date: 1-Jan-1982.

SONNENFELD G, MOREY E, WILLIAMS J and MANDEL A (1982) Effect of a Simulated Weightlessness Model on the Production of Rat Interferon, Journal of Interferon Research, 10.1089/jir.1982.2.467, 2:4, (467-470), Online publication date: 1-Jan-1982.

PAZIN G, HO M, HAVERKOS H, ARMSTRONG J, BREINIG M, WECHSLER H, ARVIN A, MERIGAN T and CANTELL K (1982) Effects of Interferon-Alpha on Human Warts, Journal of Interferon Research, 10.1089/jir.1982.2.235, 2:2, (235-243), Online publication date: 1-Jan-1982.

Butler G (2007) Synthesis and Antitumor Activity of “Pyran Copolymer”, Journal of Macromolecular Science, Part C, 10.1080/07366578208081059, 22:1, (89-130), Online publication date: 1-Jan-1982.

Sen G (1982) Mechanism of Interferon Action: Progress toward Its Understanding , 10.1016/S0079-6603(08)60599-1, (105-156), .

Wierenga W (1982) Chapter 16 Interferon Inducers , 10.1016/S0065-7743(08)60498-4, (151-161), .

Liu C (1982) Antiviral Drugs, Medical Clinics of North America, 10.1016/S0025-7125(16)31456-0, 66:1, (235-244), Online publication date: 1-Jan-1982.

Sherwin S, Fein S, Whisnant J and Oldham R (1982) PHASE I TRIALS OF RECOMBINANT AND NONRECOMBINANT ALPHA INTERFERONS IN CANCER PATIENTS Interferons, 10.1016/B978-0-12-491220-5.50043-4, (433-447), .

Ennis F, Phelan M, Mayner R and Meager A (1982) INDUCTION OF IMMUNE INTERFERON FROM HUMAN LYMPHOCYTES BY INFLUENZA-INFECTED STIMULATOR CELLS Interferons, 10.1016/B978-0-12-491220-5.50028-8, (279-285), .

Burke D, Barlow D, Morser J and Shuttleworth J (1982) CONTROL PROCESSES IN INTERFERON PRODUCTION11This work was supported by grants from the Medical Research Council, the Science Research Council and the Wellcome Trust. Interferons, 10.1016/B978-0-12-491220-5.50014-8, (97-102), .

Taniguchi T, Ohno S and Takaoka C (1982) EXPRESSION OF THE CLONED GENES FOR HUMAN INTERFERON β1 IN E. COLI AND IN CULTURED MOUSE CELLS Interferons, 10.1016/B978-0-12-491220-5.50008-2, (15-25), .

Gutterman J, Quesada J and Fein S (1982) CLINICAL INVESTIGATION OF PARTIALLY PURE AND RECOMBINANT DNA-DERIVED LEUKOCYTE INTERFERON IN HUMAN CANCER From Gene to Protein: Translation Into Biotechnology, 10.1016/B978-0-12-045560-7.50025-1, (367-390), .

Rohatiner A, Balkwill F, Griffin D, Malpas J and Lister T (1982) A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion, Cancer Chemotherapy and Pharmacology, 10.1007/BF00265387, 9:2, (97-102), .

Röthig H (1982) Interferon and Antitumour Effects Tumours of the Central Nervous System in Infancy and Childhood, 10.1007/978-3-642-95413-9_5, (42-43), .

Ackermann R (1982) Immuntherapie beim Harnblasen-Karzinom Intravesikale Chemotherapie und transurethrale Verfahren zur Behandlung und Rezidivprophylaxe des Blasenkarzinoms, 10.1007/978-3-642-72357-5_14, (62-67), .

Sehgal P, Pfeffer L and Tamm I (1982) Interferon and Its Inducers Chemotherapy of Viral Infections, 10.1007/978-3-642-68487-6_6, (205-311), .

Content J and Verhaegen-Lewalle M (1982) Molecular Basis of Interferon Action Cell Regulation by Intracellular Signals, 10.1007/978-1-4684-7718-4_23, (275-297), .

Kirchner H, Engler H, Zawatzky R and Schindler L (1982) Role of Natural Killer Cells and of Interferon in Natural Resistance against Virus Infections Macrophages and Natural Killer Cells, 10.1007/978-1-4684-4394-3_86, (785-797), .

Lengyel P (1982) Interferon Action: Control of RNA Processing, Translation and Degradation Protein Biosynthesis in Eukaryotes, 10.1007/978-1-4684-4124-6_18, (459-483), .

Sigel M, Ghaffar A, Mc Cumber L and Huggins E (1982) Immunosuppressive Agents Clinical Cellular Immunology, 10.1007/978-1-4612-5802-5_3, (67-144), .

Shibata H and Taylor-Papadimitriou J (1981) Effects of human lymphoblastoid interferon on cultured breast cancer cells, International Journal of Cancer, 10.1002/ijc.2910280409, 28:4, (447-453), Online publication date: 15-Oct-1981.

Tannock G (1981) Interferon — new wonder drug or old laboratory curiosity?, Medical Journal of Australia, 10.5694/j.1326-5377.1981.tb100998.x, 2:7, (352-356), Online publication date: 1-Oct-1981.

SETO F (1981) Early Development of the Avian Immune System, Poultry Science, 10.3382/ps.0601981, 60:9, (1981-1995), Online publication date: 1-Sep-1981.

Inoue M and Tan Y (1981) Radioimmunoassay for human beta interferon, Infection and Immunity, 10.1128/iai.33.3.763-768.1981, 33:3, (763-768), Online publication date: 1-Sep-1981.

ULLBERG M, MERRILL J and JONDAL M (1981) Interferon-Induced NK Augmentation in Humans., Scandinavian Journal of Immunology, 10.1111/j.1365-3083.1981.tb00566.x, 14:3, (285-292), Online publication date: 1-Sep-1981.

Yang K, Samanta H, Dougherty J, Jayaram B, Broeze R and Lengyel P (1981) Interferons, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human (2'-5')(a)n synthetase., Journal of Biological Chemistry, 10.1016/S0021-9258(19)52550-9, 256:17, (9324-9328), Online publication date: 1-Sep-1981.

Brysk M, Tschen E, Hudson R, Smith E, Fleischmann W and Black H (1981) The activity of interferon on ultraviolet light-induced squamous cell carcinomas in mice, Journal of the American Academy of Dermatology, 10.1016/S0190-9622(81)70078-1, 5:1, (61-63), Online publication date: 1-Jul-1981.

Gordon J and Minks M (1981) The interferon renaissance: molecular aspects of induction and action, Microbiological Reviews, 10.1128/mr.45.2.244-266.1981, 45:2, (244-266), Online publication date: 1-Jun-1981.

Hilfenhaus J (2004) Interferon - biologische Aktivitäten und Gewinnung, Chemie in unserer Zeit, 10.1002/ciuz.19810150303, 15:3, (71-77), Online publication date: 1-Jun-1981.

Tyrrell D (2018) Research on Interferon: A Review, Journal of the Royal Society of Medicine, 10.1177/014107688107400211, 74:2, (145-146), Online publication date: 1-Feb-1981.

BOCCI V (1981) PRODUCTION AND ROLE OF INTERFERON IN PHYSIOLOGICAL CONDITIONS, Biological Reviews, 10.1111/j.1469-185X.1981.tb00343.x, 56:1, (49-85), Online publication date: 1-Feb-1981.

HSU L, FINKE J, SCOTT J and PROFFITT M (1981) CTL Helper Factor(s) Produced by Peritoneal Cells of Mice Immunized to Listeria monocytogenes : Relationship to Interferon* , Journal of Interferon Research, 10.1089/jir.1981.1.271, 1:2, (271-285), Online publication date: 1-Feb-1981.

BRAUDE I, LIN L and STEWART W (1981) Isolation of a Biologically Active Fragment of Human Alpha Interferon, Journal of Interferon Research, 10.1089/jir.1981.1.245, 1:2, (245-251), Online publication date: 1-Feb-1981.

Anfinsen C (2013) Human Interferon, Interdisciplinary Science Reviews, 10.1179/isr.1981.6.2.110, 6:2, (110-118), Online publication date: 1-Jan-1981.

BLANK K and MURASKO D (1981) Effect of Anti-Interferon Serum on Friend Virus Infection and Fv-1 -Mediated Resistance , Journal of Interferon Research, 10.1089/jir.1981.1.437, 1:3, (437-442), Online publication date: 1-Jan-1981.

Pestka S, Maeda S and Staehelin T (1981) Chapter 21. The Human Interferons Annual Reports in Medicinal Chemistry Volume 16, 10.1016/S0065-7743(08)61288-9, (229-241), .

Pestka S, Maeda S, Hobbs D, Levy W, McCandliss R, Stein S, Moschera J and Staehelin T (1981) THE HUMAN INTERFERONS Cellular Responses to Molecular Modulators, 10.1016/B978-0-12-509380-4.50031-4, (455-493), .

Kaplan N and Slimmer S (1981) ANTICELLULAR ACTIVITY OF HUMAN INTERFERONS Cellular Responses to Molecular Modulators, 10.1016/B978-0-12-509380-4.50030-2, (443-453), .

Bocci V (1981) Which will be the most useful interferon?, La Ricerca in Clinica e in Laboratorio, 10.1007/BF02886684, 11:1, (27-32), Online publication date: 1-Jan-1981.

Fleischmann W and Baron S (1981) Interferon and Cancer Pediatric Oncology 1, 10.1007/978-94-009-8219-2_3, (79-98), .

Jones B (1981) Human Interferon in Topical Therapy of Herpetic Keratitis Herpetische Augenerkrankungen, 10.1007/978-3-642-80499-1_66, (395-400), .

Welsh R (1981) Natural Cell-Mediated Immunity During Viral Infections Natural Resistance to Tumors and Viruses, 10.1007/978-3-642-68069-4_6, (83-106), .

Wiranowska-Stewart M and Stewart W (1981) Interferons The Lymphokines, 10.1007/978-1-4757-1732-7_7, (133-148), .

Yancey K and Graham Smith J (1980) Interferon: Status in treatment of skin disease, Journal of the American Academy of Dermatology, 10.1016/S0190-9622(80)80071-5, 3:6, (585-595), Online publication date: 1-Dec-1980.

Bogger-Goren S and Ogra P (1980) Antiviral agents: An update—Part 2, The Indian Journal of Pediatrics, 10.1007/BF02822541, 47:6, (515-522), Online publication date: 1-Nov-1980.

SENIK A, KOLB J, ORN A and GIDLUND M (1980) Study of the Mechanism for in Vitro Activation of Mouse NK Cells by Interferon, Scandinavian Journal of Immunology, 10.1111/j.1365-3083.1980.tb00040.x, 12:1, (51-60), Online publication date: 1-Jul-1980.

Priestman T (1980) INITIAL EVALUATION OF HUMAN LYMPHOBLASTOID INTERFERON IN PATIENTS WITH ADVANCED MALIGNANT DISEASE, The Lancet, 10.1016/S0140-6736(80)90004-5, 316:8186, (113-118), Online publication date: 1-Jul-1980.

Peter H, Dallügge H, Zawatzky R, Euler S, Leibold W and Kirchner H (1980) Human peripheral null lymphocytes II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus andCorynebacterium parvum, European Journal of Immunology, 10.1002/eji.1830100712, 10:7, (547-555), Online publication date: 1-Jul-1980.

Koch-Weser J, Hirsch M and Swartz M (1980) Antiviral Agents, New England Journal of Medicine, 10.1056/NEJM198004243021705, 302:17, (949-953), Online publication date: 24-Apr-1980.

Hussain S, Rweyemamu M, Kaminjolo J, Akhtar A and Mugera G (2010) Studies on Viral Interference Induced by Rinderpest Virus: Interference and Interferon Induction by Tissue Culture Rinderpest Vaccine (TCRV) Virus in vitro, Zentralblatt für Veterinärmedizin Reihe B, 10.1111/j.1439-0450.1980.tb01905.x, 27:3, (181-189)

Berger S, Hitchcock M, Zoon K, Birkenmeier C, Friedman R and Chang E (1980) Characterization of interferon messenger RNA synthesis in Namalva cells., Journal of Biological Chemistry, 10.1016/S0021-9258(19)85834-9, 255:7, (2955-2961), Online publication date: 1-Apr-1980.

Corbel M (1980) The Effect of Synthetic Polynucleotides on the Intracellular Growth of Brucella Abortus in vitro and in vivo, British Veterinary Journal, 10.1016/S0007-1935(17)32341-2, 136:2, (175-181), Online publication date: 1-Mar-1980.

IZADKHAH Z, MANDEL A and SONNENFELD G (1980) Effect of Treatment of Mice with Sera Containing Gamma Interferon on the Course of Infection with Salmonella typhimurium Strain LT-2 , Journal of Interferon Research, 10.1089/jir.1980.1.137, 1:1, (137-145), Online publication date: 1-Jan-1980.

STRINGFELLOW D, VANDERBERG H and WEED S (1980) Interferon Induction by 5-Halo-6-Phenyl Pyrimidinones, Journal of Interferon Research, 10.1089/jir.1980.1.1, 1:1, (1-14), Online publication date: 1-Jan-1980.

Rocklin R, Bendtzen K and Greineder D (1980) Mediators of Immunity: Lymphokines and Monokines Advances in Immunology Volume 29, 10.1016/S0065-2776(08)60043-7, (55-136), .

Keller R (1980) REGULATORY CAPACITIES OF MONONUCLEAR PHAGOCYTES WITH PARTICULAR REFERENCE TO NATURAL IMMUNITY AGAINST TUMORS11This work was supported by the Swiss National Science Foundation (grant 3.173.77) and the Canton of Zurich. Abbreviations: ADCC: antibody-dependent cellular cytotoxicity. AM: activated macrophages. CSA: colony stimulating activity. DMBA: dimethylbenz(a)anthracene. LPS: bacterial lipopolysaccharide. MAF: macrophage activating factor. PMA: phorbol myristate acetate. PMN: polymorphonuclear leukocyte. Natural Cell-mediated Immunity Against Tumors, 10.1016/B978-0-12-341350-5.50099-2, (1219-1269), .

Kirchner H (1980) INTERFERON PRODUCTION IN MURINE SPLEEN CELL CULTURES Natural Cell-mediated Immunity Against Tumors, 10.1016/B978-0-12-341350-5.50095-5, (1185-1191), .

White R, Klein F, Chan J and Stroshane R (1980) Large-Scale Production of Human Interferons , 10.1016/B978-0-12-040304-2.50015-1, (209-234), .

HOVANESSIAN A (1979) Intracellular Events in Interferon-Treated Cells, Differentiation, 10.1111/j.1432-0436.1979.tb01044.x, 15:1-3, (139-151), Online publication date: 1-Dec-1979.

Geme J (1979) Therapeutic control of viral infections: Chemotherapy, interferon and gamma globulin, Current Problems in Pediatrics, 10.1016/S0045-9380(79)80019-5, 10:1, (1-46), Online publication date: 1-Nov-1979.

Butler G (1979) Synthesis and Properties of Novel Polyanions of Potential Antitumor Activity, Journal of Macromolecular Science: Part A - Chemistry, 10.1080/00222337908068107, 13:3, (351-368), Online publication date: 1-Apr-1979.

Mogensen S (1979) Role of macrophages in natural resistance to virus infections, Microbiological Reviews, 10.1128/mr.43.1.1-26.1979, 43:1, (1-26), Online publication date: 1-Mar-1979.

Torrence P and Friedman R (1979) Are double-stranded RNA-directed inhibition of protein synthesis in interferon-treated cells and interferon induction related phenomena?, Journal of Biological Chemistry, 10.1016/S0021-9258(17)34196-0, 254:4, (1259-1267), Online publication date: 1-Feb-1979.

Leopold I and Murray D (1979) Noncorticosteroidal Anti-Inflammatory Agents in Ophthalmology, Ophthalmology, 10.1016/S0161-6420(79)35546-4, 86:1, (142-155), Online publication date: 1-Jan-1979.

Zinkernagel R and Doherty P (1979) MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness Advances in Immunology Volume 27, 10.1016/S0065-2776(08)60262-X, (51-177), .

Neumann C and Sorg C (1979) DIFFERENT CELLULAR SOURCES FOR THE PRODUCTION OF IMMUNE INTERFERON AND MACROPHAGE MIGRATION INHIBITORY FACTOR Cell Biology and Immunology of Leukocyte Function, 10.1016/B978-0-12-569650-0.50069-3, (521-534), .

EPSTEIN L (1979) The Comparative Biology of Immune and Classical Interferons Biology of the Lymphokines, 10.1016/B978-0-12-178250-4.50022-2, (443-514), .

De Maeyer E and De Maeyer-Guignard J (1979) Interferons Comprehensive Virology, 10.1007/978-1-4613-3009-7_5, (205-284), .

HERON I and BERG K (1978) The actions of interferon are potentiated at elevated temperature, Nature, 10.1038/274508a0, 274:5670, (508-510), Online publication date: 1-Aug-1978.

Idso S and Brazel A (1978) Response : Atmospheric Dust: Climatological Consequences , Science, 10.1126/science.201.4353.378.b, 201:4353, (378-379), Online publication date: 28-Jul-1978.

Idso S and Brazel A (1978) Response : Atmospheric Dust: Climatological Consequences , Science, 10.1126/science.201.4353.378-b, 201:4353, (378-379), Online publication date: 28-Jul-1978.

Romano A, Kaplinsky C, Frand M, Rotem Y, Stein R and Blumenthal M (1978) Systemic and Topical Use of Poly I.C. in Treatment of Generalized Neonatal Herpes Simplex Infection with Severe Ocular Involvement, Journal of Pediatric Ophthalmology & Strabismus, 10.3928/0191-3913-19780701-13, 15:4, (239-245), Online publication date: 1-Jul-1978.

Hirsch M (1978) Interferon — Its Hour Come at Last?, New England Journal of Medicine, 10.1056/NEJM197805042981811, 298:18, (1022-1023), Online publication date: 4-May-1978.

Bollin E, Vastola K and Oleszek D (2006) The Interaction of Mammalian Interferons with Immobilized Cibacron Blue F3Ga: Modulation of Binding Strength, Preparative Biochemistry, 10.1080/00327487808065525, 8:4, (259-274), Online publication date: 1-Jan-1978.

Tamm I and Sehgal P (1978) Halobenzimidazole Ribosides and RNA Synthesis of Cells and Viruses Advances in Virus Research Volume 22, 10.1016/S0065-3527(08)60775-7, (187-258), .

Pestka S (1978) HUMAN INTERFERON: THE PROTEINS, THE mRNA, THE GENES, THE FUTURE Dimensions in Health Research: Search for the Medicines of Tomorrow, 10.1016/B978-0-12-744260-0.50011-7, (29-56), .

Pollard R and Merigan T (1978) Experience with clinical applications of interferon and interferon inducers, Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors, 10.1016/0362-5478(78)90015-3, 2:4, (783-811), Online publication date: 1-Jan-1978.

Saksena K and Lemke P (1978) Viruses in Fungi Newly Characterized Protist and Invertebrate Viruses, 10.1007/978-1-4684-2724-0_2, (103-143), .

Strander H (1977) Interferons: Anti-neoplastic drugs?, Blut, 10.1007/BF00996140, 35:4, (277-288), Online publication date: 1-Oct-1977.

Neumann C and Sorg C (1977) Immune interferon I. Production by lymphokine-activated murine macrophages, European Journal of Immunology, 10.1002/eji.1830071014, 7:10, (719-725), Online publication date: 1-Oct-1977.

YARON M, YARON I, GURARI-ROTMAN D, REVEL M, LINDNER H and ZOR U (1977) Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I) · poly(C) and human interferon, Nature, 10.1038/267457a0, 267:5610, (457-459), Online publication date: 1-Jun-1977.

Geber W, Lefkowitz S and Hung C (2009) Duration of interferon inhibition following single and multiple injections of morphine, Journal of Toxicology and Environmental Health, 10.1080/15287397709529458, 2:3, (577-582), Online publication date: 1-Jan-1977.

GALASSO G and PAYNE F (1977) Chemotherapy of Viral Diseases: Present Status and Future Prospects Human and Related Viruses, 10.1016/B978-0-12-429702-9.50012-0, (249-296), .

Smith K (1977) Physiology of Plant Virus Diseases Plant Viruses, 10.1007/978-94-010-9653-9_3, (16-42), .

Gresser I (1977) Antitumor Effects of Interferon Chemotherapy, 10.1007/978-1-4615-6628-1_18, (521-571), .

(1976) Interferon Therapy in Chronic Hepatitis B, The Lancet, 10.1016/S0140-6736(76)91094-1, 308:7995, (1122-1124), Online publication date: 1-Nov-1976.

GRESSER I, MAURY C, TOVEY M, MOREL-MAROGER L and PONTILLON F (1976) Progressive glomerulonephritis in mice treated with interferon preparations at birth, Nature, 10.1038/263420a0, 263:5576, (420-422), Online publication date: 1-Sep-1976.

TAN Y (1976) Chromosome 21 and the cell growth inhibitory effect of human interferon preparations, Nature, 10.1038/260141a0, 260:5547, (141-143), Online publication date: 1-Mar-1976.

Epstein L (1976) The Ability of Macrophages to Augment in Vitro Mitogen- and Antigen-Stimulated Production of Interferon and Other Mediators of Cellular Immunity by Lymphocytes Immunobiology of the Macrophage, 10.1016/B978-0-12-514550-3.50014-1, (201-234), .

Tran Ba Loc P (1976) Effects of Anti-DNA and Anti-RNA Antibodies Bound to Melphalan and Methotrexate on C3H Mammary Adenocarcinoma and L 1210 Leukaemia Chemotherapy, 10.1007/978-1-4613-4352-3_5, (17-20), .

Florman A and Holzman R (1975) Nonspecific enhancers of resistance in man, The Journal of Pediatrics, 10.1016/S0022-3476(75)80121-1, 87:6, (1094-1102), Online publication date: 1-Dec-1975.

DAHL H and DEGRE M (1975) Separation of antiviral activity of human interferon from cell growth inhibitory effect, Nature, 10.1038/257799a0, 257:5529, (799-801), Online publication date: 1-Oct-1975.

Dianzani F (1975) Viral interference and interferon, La Ricerca in Clinica e in Laboratorio, 10.1007/BF02908284, 5:3, (196-213), Online publication date: 1-Jul-1975.

Chirigos M and Papas T (1975) Immunological and Chemotherapeutic Prevention and Control of Oncogenic Viruses , 10.1016/S1054-3589(08)60220-3, (89-124), .

Sulkin S and Allen R (1975) Interferon and Rabies Virus Infection The Natural History of Rabies, 10.1016/B978-0-12-072401-7.50024-1, (355-369), .

Sundmacher R, Neumann-Haefelin D and Shrestha B (1975) Die Wirkung von Human-Leukocyten-Interferon (HIF) auf experimentelle Viruskeratitiden bei Affen The effect of human leukocyte interferon (HIF) on experimental viral keratitis in monkeys, Albrecht von Graefes Archiv f�r Klinische und Experimentelle Ophthalmologie, 10.1007/BF00414939, 195:4, (263-270), .

Butler G (1975) Mechanistic Considerations of Cyclocopolymerization and Some Properties of ‘Pyran’ Copolymer Polyelectrolytes and their Applications, 10.1007/978-94-010-1783-1_6, (97-117), .

BESANCON F and ANKEL H (1974) Inhibition of interferon action by plant lectins, Nature, 10.1038/250784a0, 250:5469, (784-786), Online publication date: 1-Aug-1974.

(1974) Bibliography The Biology of Animal Viruses, 10.1016/B978-0-12-253040-1.50023-3, (642-775), .

Smith K (1974) Physiology of Plant Virus Diseases Plant Viruses, 10.1007/978-1-4899-3041-5_3, (16-39), .

Levy H (1973) Chapter 16. Antiviral and Antitumor Chemotherapy with the Interferon System , 10.1016/S0065-7743(08)61244-0, (150-159), .

Gresser I (1973) Antitumor Effects Of Interferon , 10.1016/S0065-230X(08)60339-5, (97-140), .

LESHEM Y (1973) Interferon The Molecular and Hormonal Basis of Plant-Growth Regulation, 10.1016/B978-0-08-017649-9.50016-9, (86-90), .

Butler G and Wu C (1973) Some Gel Permeation Chromatographic Studies on Cyclocopolymers of Maleic Anhydride Water-Soluble Polymers, 10.1007/978-1-4613-4583-1_23, (369-386), .

Bozarth R (1972) Mycoviruses: a new dimension in microbiology., Environmental Health Perspectives, 10.1289/ehp.720223, 2, (23-39), Online publication date: 1-Oct-1972.

Grossberg S (1972) The Interferons and Their Inducers: Molecular and Therapeutic Considerations, New England Journal of Medicine, 10.1056/NEJM197207062870104, 287:1, (13-19), Online publication date: 6-Jul-1972.

Jennings R (2009) Interferon induction by influenza type C, Journal of Hygiene, 10.1017/S002217240002204X, 70:1, (13-21), Online publication date: 1-Mar-1972.

Herman R (2012) THE EFFECTS OF INTERFERON AND ITS INDUCERS ON EXPERIMENTAL PROTOZOAN PARASITIC INFECTIONS*, Transactions of the New York Academy of Sciences, 10.1111/j.2164-0947.1972.tb02672.x, 34:2 Series II, (176-180), Online publication date: 1-Feb-1972.

Tytell A, Kirk Field A and Ho M (2008) Interferons and Host Resistance: With Particular Emphasis on Induction by Complexed Polynucleotide, CRC Critical Reviews in Biochemistry, 10.3109/10409237209102542, 1:1, (1-32), Online publication date: 1-Jan-1972.

Rodgers R and Merigan T (2008) Interferon and Its Inducers: Antiviral and Other Effects, CRC Critical Reviews in Clinical Laboratory Sciences, 10.3109/10408367209151324, 3:2, (131-162), Online publication date: 1-Jan-1972.

Ng M and Vilček J (1972) Interferons: Physicochemical Properties and Control of Cellular Synthesis , 10.1016/S0065-3233(08)60141-2, (173-241), .

Harvey P, Levings C and Wernsman E (1972) The Role of Extrachromosomal Inheritance in Plant Breeding , 10.1016/S0065-2113(08)60632-X, (1-27), .

Bodo G (1971) Interferone, Die Naturwissenschaften, 10.1007/BF00624615, 58:9, (425-429), Online publication date: 1-Sep-1971.

Suzuki S, Suzuki M and Imaya M (2013) Interferon-Inducing Activity of Acidic Polysaccharides, Japanese Journal of Microbiology, 10.1111/j.1348-0421.1971.tb00609.x, 15:6, (485-492), Online publication date: 1-Jun-1971.

Young C (1971) Interferon Induction in Cancer: With Some Observations on the Clinical Effects of Poly l:C, Medical Clinics of North America, 10.1016/S0025-7125(16)32513-5, 55:3, (721-728), Online publication date: 1-May-1971.

Colby C (1971) The Induction of Interferon by Natural and Synthetic Polynucleotides , 10.1016/S0079-6603(08)60324-4, (1-32), .

Bloom B (1971) In Vitro Approaches to the Mechanism of Cell-Mediated Immune Reactions Advances in Immunology Volume 13, 10.1016/S0065-2776(08)60184-4, (101-208), .

Niblack J (1971) INTERFERON INDUCERS IN ANTIVIRAL RESEARCH XXIIIrd International Congress of Pure and Applied Chemistry, 10.1016/B978-0-408-70317-8.50010-7, (111-131), .

Hilleman M, Lampson G, Tytell A, Field A, Nemes M, Krakoff I and Young C (1971) Double-Stranded RNA’s in Relation to Interferon Induction and Adjuvant Activity Biological Effects of Polynucleotides, 10.1007/978-3-642-85772-0_3, (27-44), .

Wacker A (1971) Neuere Aspekte einer antiviralen Therapie Verhandlungen der Deutschen Gesellschaft für Innere Medizin, 10.1007/978-3-642-85466-8_27, (850-856), .

Ho M (1970) Interferon and Herpes Zoster, New England Journal of Medicine, 10.1056/NEJM197011262832212, 283:22, (1222-1223), Online publication date: 26-Nov-1970.

MERIGAN T (1970) Interferon stimulated by Double Stranded RNA, Nature, 10.1038/228219a0, 228:5268, (219-222), Online publication date: 1-Oct-1970.

Overall J and Glasgow L (1970) Virus infections of the fetus and newborn infant, The Journal of Pediatrics, 10.1016/S0022-3476(70)80346-8, 77:2, (315-333), Online publication date: 1-Aug-1970.

Murthy Y and Anders H (1970) Interferons, Angewandte Chemie International Edition in English, 10.1002/anie.197004801, 9:7, (480-488), Online publication date: 1-Jul-1970.

Graff S, Kassel R and Kastner O (2012) INTERFERON*,†, Transactions of the New York Academy of Sciences, 10.1111/j.2164-0947.1970.tb02730.x, 32:5 Series II, (545-556), Online publication date: 1-May-1970.

Valand S, Acton J and Myrvik Q (1970) Nitrogen Dioxide Inhibition of Viral-Induced Resistance in Alveolar Monocytes, Archives of Environmental Health: An International Journal, 10.1080/00039896.1970.10665597, 20:3, (303-309), Online publication date: 1-Mar-1970.

Van Dijck P, Claesen M and De Somer P (2016) Effect of polyacrylic acid on experimental malaria and trypanosomiasis in mice, Annals of Tropical Medicine & Parasitology, 10.1080/00034983.1970.11686658, 64:1, (5-9), Online publication date: 1-Mar-1970.

(2008) Interferon-Producing enterovirus vaccines, CRC Critical Reviews in Clinical Laboratory Sciences, 10.3109/10408367009014726, 1:1, (117-118), Online publication date: 1-Jan-1970.

ANDREWS R (1970) Introduction Viral Interference and Interferon, 10.1016/B978-0-433-00651-0.50004-2, (1-8), .

Fanta (1970) Zehnte wissenschaftliche Sitzung Auge und Immunologie, 10.1007/978-3-642-47086-8_11, (425-452), .

Wang W, Chong W, Li C, Chen Y, Chen Z, Zhou H, Wan Y, Chen W, Gery I, Caspi R, Liu Y and Chen J Non-Redundant Requirement for CXCR3 Signaling for Effective Treatment of CNS Autoimmunity with Type I IFNs, SSRN Electronic Journal, 10.2139/ssrn.3259134

HUPPERT J, HILLOVA J and GRESLAND L (1969) Viral RNA Synthesis in Chicken Cells infected with Ultraviolet Irradiated Newcastle Disease Virus, Nature, 10.1038/2231015a0, 223:5210, (1015-1017), Online publication date: 1-Sep-1969.

BOPARDIKAR M (1969) MICROBIOLOGY OF A WASTE STABILIZATION POND Advances in Water Pollution Research, 10.1016/B978-0-08-012999-0.50070-8, (595-601), .

Henneberg G (1969) Literatur Masernschutzimpfung, 10.1007/978-3-642-87419-2_7, (77-91), .

Ho M (1969) Das Interferonsystem und seine Bedeutung für die Virustherapie FÜnfundsiebzigster Kongress, 10.1007/978-3-642-47085-1_155, (612-618), .

De Maeyer E, Jullien P and de Maeyer-Guignard J (2009) Interferon Synthesis in X-irradiated Animals, International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 10.1080/09553006814550451, 13:5, (417-431), Online publication date: 1-Jan-1968.

Hoyle L (1968) The Influenza Viruses The Influenza Viruses, 10.1007/978-3-7091-2046-0_1, (1-375), .

(1967) Interferon Induction, New England Journal of Medicine, 10.1056/NEJM196712142772411, 277:24, (1316-1317), Online publication date: 14-Dec-1967.

Merigan T and Regelson W (1967) Interferon Induction in Man by a Synthetic Polyanion of Defined Composition, New England Journal of Medicine, 10.1056/NEJM196712142772403, 277:24, (1283-1287), Online publication date: 14-Dec-1967.

Blackmore R (1967) Research in virology, The Journal of the American Dental Association, 10.14219/jada.archive.1967.0415, 74:7, (1526-1531), Online publication date: 1-Jun-1967.

Feingold D, Parris E and Merigan T (1967) Interferons of Mice and Men, New England Journal of Medicine, 10.1056/NEJM196704202761608, 276:16, (913-920), Online publication date: 20-Apr-1967.

BARRY R and CRUICKSHANK J (1967) The Multiplication of Viruses Viral and Rickettsial Infections of Animals, 10.1016/B978-1-4832-3319-2.50010-X, (119-165), .

ANDREWES C (1967) General Nature of Viruses Viral and Rickettsial Infections of Animals, 10.1016/B978-1-4832-3319-2.50007-X, (1-26), .

Schmidt E and Janssen M (1967) Der protektive Effekt von Frauenmilch- und Kuhmilchmucoiden bei der experimentellen Grippevirusinfektion der Maus, Zeitschrift f�r Kinderheilkunde, 10.1007/BF00523642, 98:4, (307-314), .

Fanconi G (1967) Poliomyelitis Krankheiten durch Viren, 10.1007/978-3-662-39826-5_2, (13-65), .

Fanconi G (1967) Poliomyelitis Krankheiten durch Viren, 10.1007/978-3-642-87072-9_2, (13-65), .

Bock M (1967) Chemotherapie der Viruserkrankungen Current Topics in Microbiology and Immunology, 10.1007/978-3-642-46062-3_5, (100-143), .

(1966) Bacterial Interference, New England Journal of Medicine, 10.1056/NEJM196611242752113, 275:21, (1197-1198), Online publication date: 24-Nov-1966.

Blattner R (1966) Interferon, an antiviral substance, The Journal of Pediatrics, 10.1016/S0022-3476(66)80257-3, 68:3, (488-491), Online publication date: 1-Mar-1966.

Oswald N (1965) Presidential address the immunological approach to respiratory disease, Tubercle, 10.1016/S0041-3879(65)80015-0, 46:4, (426-435), Online publication date: 1-Dec-1965.

REINICKE V (2017) THE INFLUENCE OF STEROID HORMONES AND GROWTH HORMONES ON HETEROLOGOUS VIRAL INTERFERENCE IN TISSUE CULTURE, Acta Pathologica Microbiologica Scandinavica, 10.1111/apm.1965.64.4.543, 64:4, (543-552), Online publication date: 1-Sep-1965.

St. Geme J, Prince J, Burke B, Good R and Krivit W (1965) Impaired Cellular Resistance to Herpes-Simplex Virus in Wiskott-Aldrich Syndrome, New England Journal of Medicine, 10.1056/NEJM196507292730501, 273:5, (229-234), Online publication date: 29-Jul-1965.

(1965) Interferon and the Control of Acute Viral Diseases, New England Journal of Medicine, 10.1056/NEJM196507222730411, 273:4, (221-222), Online publication date: 22-Jul-1965.

HAHNEMANN F and REINICKE V (2017) IN OVO PRODUCTION OF INTERFERON INDUCED BY INFLUENZA VIRUS OF VARYING DEGREES OF INCOMPLETENESS, Acta Pathologica Microbiologica Scandinavica, 10.1111/apm.1965.63.2.241, 63:2, (241-248), Online publication date: 1-Jul-1965.

Glasgow L (1965) Interferon: A review, The Journal of Pediatrics, 10.1016/S0022-3476(65)80311-0, 67:1, (104-121), Online publication date: 1-Jul-1965.

Aurelian L and Roizman B (1965) Abortive infection of canine cells by herpes simplex virus, Journal of Molecular Biology, 10.1016/S0022-2836(65)80009-2, 11:3, (539-548), Online publication date: 1-Mar-1965.

CHANG S and RASMUSSEN A (1965) Stress-induced Suppression of Interferon Production in Virus-infected Mice, Nature, 10.1038/205623a0, 205:4971, (623-624), Online publication date: 1-Feb-1965.

BELL T (1965) VIRAL INTERFERENCE AND ANTI-VIRAL SUBSTANCES An Introduction to General Virology, 10.1016/B978-1-4832-0037-8.50011-8, (46-51), .

BELL T (1965) THE HISTORY AND NATURE OF VIRUSES An Introduction to General Virology, 10.1016/B978-1-4832-0037-8.50005-2, (1-4), .

Mayr A (1965) Über Resistenz und Immunität Handbuch der Schutzimpfungen, 10.1007/978-3-642-92897-0_1, (1-19), .

Poetschke G and Klamerth O (1965) Virus und Virusinfektionen, eine Einführung in die Grundlagen Belebte Umweltfaktoren, 10.1007/978-3-642-85739-3_5, (315-505), .

CROMPTON D (1964) CORTICOSTEROIDS EXACERBATE OCULAR HERPES SIMPLEX, Medical Journal of Australia, 10.5694/j.1326-5377.1964.tb109899.x, 2:24, (950-954), Online publication date: 1-Dec-1964.

Moritsch H and Krausler J (1964) Einflu� der unspezifischen und spezifischen Abwehr des Organismus auf den Virusbefall des Zentralnervensystems bei einer biphasischen Meningencephalitis, Acta Neurovegetativa, 10.1007/BF01252147, 26:4, (518-525), Online publication date: 1-Dec-1964.

Paucker K (2016) Basic Science Review : Interferon, Clinical Pediatrics, 10.1177/000992286400301112, 3:11, (671-678), Online publication date: 1-Nov-1964.

Uhlmann W (2010) Versuche mit einem in Dauerpassagen in Mäusen zunehmenden Alters modifizierten Maul- und Klauenseuche-Virusstamm des Typs „SAT 2”, Zentralblatt für Veterinärmedizin Reihe B, 10.1111/j.1439-0450.1964.tb01090.x, 11:8, (657-673)

Bellanti J and Artenstein M (1964) Mechanisms of Immunity and Resistance to Virus Infections, Pediatric Clinics of North America, 10.1016/S0031-3955(16)31582-6, 11:3, (549-561), Online publication date: 1-Aug-1964.

FRIEDMAN R and SONNABEND J (1964) Inhibition of Interferon Action by p-Fluorophenylalanine, Nature, 10.1038/203366a0, 203:4943, (366-367), Online publication date: 25-Jul-1964.

Wagner R (2016) The Interferons: Biologic Basis for Their Role in Viral Infections, Postgraduate Medicine, 10.1080/00325481.1964.11695119, 35:5, (512-517), Online publication date: 1-May-1964.

Baron S (1964) Mechanism of Recovery from Viral Infection Advances in Virus Research Volume 10, 10.1016/S0065-3527(08)60696-X, (39-64), .

Isaacs A (1964) Interferon Advances in Virus Research Volume 10, 10.1016/S0065-3527(08)60695-8, (1-38), .

THOMPSON R (1964) Chemoprophylaxis and Chemotherapy of Viral Diseases Advances in Chemotheraphy, 10.1016/B978-1-4831-9929-0.50009-7, (85-131), .

Tietze K and Friederiszick F (1964) Riesenzellpneumonie nach Masern im Kindesalter beim mit Endoxan behandelten Reticulumzellsarkom, Zeitschrift f�r Kinderheilkunde, 10.1007/BF00438839, 90:3, (241-250), .

Haagen E (1964) Myxoviren Viruskrankheiten des Menschen, 10.1007/978-3-642-85280-0_2, (59-462), .

Katz S and Carver D (2016) Current Status of Antiviral Substances, Postgraduate Medicine, 10.1080/00325481.1963.11694836, 34:3, (222-227), Online publication date: 1-Sep-1963.

Horstmann D and Hstung G (2016) Myxovirus Infections and Respiratory Illnesses in Children, Clinical Pediatrics, 10.1177/000992286300200707, 2:7, (378-386), Online publication date: 1-Jul-1963.

Denys P (1963) PROTECTIVE EFFECT OF INTERFERON IN RATS INFECTED WITH SINDBIS VIRUS, The Lancet, 10.1016/S0140-6736(63)92806-X, 282:7300, (174), Online publication date: 1-Jul-1963.

Lockart R (1963) PRODUCTION OF AN INTERFERON BY L CELLS INFECTED WITH WESTERN EQUINE ENCEPHALOMYELITIS VIRUS, Journal of Bacteriology, 10.1128/jb.85.3.556-566.1963, 85:3, (556-566), Online publication date: 1-Mar-1963.

ROTEM Z, COX R and ISAACS A (1963) Inhibition of Virus Multiplication by Foreign Nucleic Acid, Nature, 10.1038/197564a0, 197:4867, (564-566), Online publication date: 9-Feb-1963.

LINK F, BLAŠKOVIČ D and RAUS J (1963) Effect of an Exogenous Interferon on Experimental Influenza Virus Infection and Interferon Production in White Mice, Nature, 10.1038/197821a0, 197:4869, (821-822), Online publication date: 1-Feb-1963.

Negroni G (1963) Progress with Some Tumor Viruses of Chickens and Mammals: The Problem of Passenger Viruses , 10.1016/S0065-230X(08)60988-4, (515-561), .

Sellers R and Fitzpatrick M (1963) Multiplication, Interferon Production and Interferon Sensitivity of Viruses in Dog Kidney Tissue Cultures, Research in Veterinary Science, 10.1016/S0034-5288(18)34893-8, 4:1, (151-159), Online publication date: 1-Jan-1963.

HAWKING F (1963) History of Chemotherapy Experimental Chemotherapy, 10.1016/B978-1-4832-3178-5.50006-X, (1-24), .

Ellem K and Colter J (1963) Nucleic Acids and Nucleoproteins Metabolic Inhibitors, 10.1016/B978-0-12-395622-4.50013-6, (287-313), .

Modest E, Foley G and Farber S (1963) Polypeptides and Proteins as Inhibitors Metabolic Inhibitors, 10.1016/B978-0-12-395622-4.50007-0, (75-129), .

Vivell O, Zischinsky H, Plückthun H, Brugsch H, Ehrengut W, Grundler E, Goetz O, Sauthoff R, Gädeke R, Schreier K, Thomas K, Waltenberger H, Plückthun H, Windorfer A, Legeźyński S, Oehme J, Fischer L, Nöller H, Grüninger U, Hertl M, Schmid F, Troost E, Lederbogen K, Winterboff D and Grüger H (1963) Virusinfektionen Infektionskrankheiten, 10.1007/978-3-642-94871-8_3, (38-300), .

WAGNER R and SNYDER R (1962) Viral Interference induced in Mice by Acute or Persistent Infection with the Virus of Lymphocytic Choriomeningitis, Nature, 10.1038/196393a0, 196:4852, (393-394), Online publication date: 1-Oct-1962.

Isaacs A (2016) Symposium on Interferon, Proceedings of the Royal Society of Medicine, 10.1177/003591576205500901, 55:9, (725-732), Online publication date: 1-Sep-1962.

Ho M (1962) Interferons, New England Journal of Medicine, 10.1056/NEJM196206142662406, 266:24, (1258-1264), Online publication date: 14-Jun-1962.

Jackson G, Dowling H and Muldoon R (1962) VII. Present Concepts of the Common Cold, American Journal of Public Health and the Nations Health, 10.2105/AJPH.52.6.940, 52:6, (940-945), Online publication date: 1-Jun-1962.

Cooper P (1962) The Plaque Assay of Animal Viruses Advances in Virus Research Volume 8, 10.1016/S0065-3527(08)60689-2, (319-378), .

Pereira H (1962) The Cytopathic Effect of Animal Viruses Advances in Virus Research Volume 8, 10.1016/S0065-3527(08)60687-9, (245-285), .

Bang F and Luttrell C (1962) Factors in the Pathogenesis of Virus Diseases Advances in Virus Research Volume 8, 10.1016/S0065-3527(08)60686-7, (199-244), .

Cantell K (1962) Mumps Virus Advances in Virus Research Volume 8, 10.1016/S0065-3527(08)60684-3, (123-164), .

PUMPER R, YAMASHIROYA H and ALFRED L (1961) Cytopathic Protective Factor: its Production by Normal Uninfected Serum-free Cell Cultures, Nature, 10.1038/1921101a0, 192:4807, (1101-1102), Online publication date: 16-Dec-1961.

LINK F and RAUS J (1961) Multiplication of Mouse-adapted Influenza Virus in Mouse Lungs after Infection with Very Low Doses, Nature, 10.1038/192478a0, 192:4801, (478-479), Online publication date: 1-Nov-1961.

Wasielewski E, Thiele G and Stauter H (1961) Experimentelle Studien zum Wesen des Cortisoneingriffs bei Virusinfektionen unter besonderer Berücksichtigung von Interferenzmechanismen, Zeitschrift für Hygiene und Infektionskrankheiten, 10.1007/BF02162285, 147:6, (504-520), Online publication date: 1-Sep-1961.

KILBOURNE E, SMART K and POKORNY B (1961) Inhibition by Cortisone of the Synthesis and Action of Interferon, Nature, 10.1038/190650a0, 190:4776, (650-651), Online publication date: 1-May-1961.

Smorodintsev A (1961) Basic Mechanisms of Nonspecific Resistance to Viruses in Animals and Man Advances in Virus Research Volume 7, 10.1016/S0065-3527(08)60013-5, (327-376), .

Hale J (1961) Duration of Immunity in Virus Diseases , 10.1016/S0065-2776(08)60766-X, (263-282), .

Thomssen R (1961) Pathogenese der Poliomyelitis Klinische Probleme der Poliomyelitis und verwandter Viruskrankheiten, 10.1007/978-3-642-94813-8_3, (21-34), .

Cantell K and Tommila V (1960) EFFECT OF INTERFERON ON EXPERIMENTAL VACCINIA AND HERPES-SIMPLEX VIRUS INFECTIONS IN RABBITS' EYES, The Lancet, 10.1016/S0140-6736(60)91751-7, 276:7152, (682-684), Online publication date: 1-Sep-1960.

VILČEK J (1960) An Interferon-like Substance released from Tick-borne Encephalitis Virus-infected Chick Embryo Fibroblast Cells, Nature, 10.1038/187073a0, 187:4731, (73-74), Online publication date: 1-Jul-1960.

Isaacs A and Hitchcock G (1960) ROLE OF INTERFERON IN RECOVERY FROM VIRUS INFECTIONS, The Lancet, 10.1016/S0140-6736(60)91215-0, 276:7141, (69-71), Online publication date: 1-Jul-1960.

Lindenmann J (1960) Interferon und inverse Interferenz, Zeitschrift für Hygiene und Infektionskrankheiten, 10.1007/BF02152258, 146:4, (287-309), Online publication date: 1-Apr-1960.

Pollard E (2006) PANEL DISCUSSION, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1960.tb40944.x, 83:4, (752-760)

(1960) Notes and News, The Lancet, 10.1016/S0140-6736(60)90103-3, 275:7116, (179-180), Online publication date: 1-Jan-1960.

Lindenmann J (1960) Neuere Aspekte der Virus-Interferenz Ergebnisse der Mikrobiologie Immunitätsforschung und Experimentellen Therapie, 10.1007/978-3-662-42621-0_8, (369-397), .

ISAACS A and WESTWOOD M (1959) Duration of Protective Action of Interferon Against Infection with West Nile Virus, Nature, 10.1038/1841232a0, 184:4694, (1232-1233), Online publication date: 1-Oct-1959.

Porterfield J (1959) A SIMPLE PLAQUE INHIBITION TEST FOR ANTIVIRAL AGENTS : APPLICATION TO ASSAY OF INTERFERON, The Lancet, 10.1016/S0140-6736(59)91362-5, 274:7098, (326-327), Online publication date: 1-Sep-1959.

Isaacs A and Westwood M (1959) INHIBITION BY INTERFERON OF THE GROWTH OF VACCINIA VIRUS IN THE RABBIT SKIN, The Lancet, 10.1016/S0140-6736(59)91361-3, 274:7098, (324-325), Online publication date: 1-Sep-1959.

TYRRELL D (1959) Interferon produced by Cultures of Calf Kidney Cells, Nature, 10.1038/184452a0, 184:4684, (452-453), Online publication date: 1-Aug-1959.

CLARK R, ISAACS A and WALKER J (2012) DERIVATIVES OF 3: 4-XYLIDINE AND RELATED COMPOUNDS AS INHIBITORS OF INFLUENZA VIRUS: RELATIONSHIPS BETWEEN CHEMICAL STRUCTURE AND BIOLOGICAL ACTIVITY, British Journal of Pharmacology and Chemotherapy, 10.1111/j.1476-5381.1958.tb00233.x, 13:4, (424-435), Online publication date: 1-Dec-1958.

ISAACS A and BURKE D (1958) Mode of Action of Interferon, Nature, 10.1038/1821073a0, 182:4642, (1073-1074), Online publication date: 1-Oct-1958.

(1957) A LEAD TOWARDS VIRUS CHEMOTHERAPY?, The Lancet, 10.1016/S0140-6736(57)92390-5, 270:7002, (931-932), Online publication date: 1-Nov-1957.

(1957) Hindquarter Amputation, The Lancet, 10.1016/S0140-6736(57)92389-9, 270:7002, (930-931), Online publication date: 1-Nov-1957.

Abstract

Footnotes

This Issue

Your password must have 8 characters or more and contain 3 of the following:

Virus interference. I. The interferon

Abstract

Footnotes

This Issue